Audit Information |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Audit Information [Abstract] | |
| Auditor Name | PricewaterhouseCoopers LLP |
| Auditor Location | New York, New York |
| Auditor Firm ID | 238 |
Consolidated Statements of Financial Position (Parenthetical) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|---|---|
| Fixed Maturities, Available-for-sale, allowance for credit losses | $ 40,414 | $ 2,008 | $ 4,769 | |
| Fixed maturities, available-for-sale, amortized cost | 36,980,933 | 27,538,066 | ||
| Fixed maturities, trading, amortized cost | 4,415,277 | 3,476,746 | ||
| Equity securities, at cost | 2,650,542 | 824,270 | ||
| Commercial mortgage and other loans, allowance for credit losses | 37,715 | 37,689 | $ 20,263 | $ 5,951 |
| Other invested assets, at fair value | 68,623 | 85,025 | ||
| Reinsurance recoverable and deposit receivables, embedded derivatives at fair value | $ 645,193 | $ 192,642 | ||
| Common stock, par value (in dollars per share) | $ 10 | $ 10 | ||
| Common stock, shares authorized | 1,000,000 | 1,000,000 | ||
| Common stock, shares issued | 250,000 | 250,000 | ||
| Common stock, shares outstanding | 250,000 | 250,000 | ||
| ASU 2016-13 | ||||
| Short-term investments, allowance for credit losses | $ 49 | $ 0 |
Consolidated Statement of Operations and Comprehensive Income - USD ($) $ in Thousands |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||||
| REVENUES | |||||||||
| Premiums (includes $(2,690), $6,978 and $(1,250) of gains (losses) from change in estimates on deferred profit liability amortization for the year ended December 31, 2024, 2023 and 2022, respectively) | $ 393,127 | $ 328,897 | $ 265,208 | ||||||
| Policy charges and fee income | 7,382,797 | 1,536,606 | 1,230,601 | ||||||
| Net investment income | 2,422,017 | 1,675,522 | 884,001 | ||||||
| Asset administration fees | 223,563 | 232,950 | 284,182 | ||||||
| Other Income (loss) | 759,756 | 751,363 | [1] | (636,273) | [1] | ||||
| Realized investment gains (losses), net | 451,417 | (1,147,099) | [1] | 289,929 | [1] | ||||
| Change in value of market risk benefits, net of related hedging gain (losses) | (433,955) | (106,773) | [2] | (700,581) | |||||
| TOTAL REVENUES | 11,198,722 | 3,271,466 | 1,617,067 | ||||||
| BENEFITS AND EXPENSES | |||||||||
| Policyholders’ benefits | 8,352,333 | 503,789 | 458,373 | ||||||
| Changes in estimates of liability for future policy benefits | (20,643) | 3,952 | 55,099 | ||||||
| Interest credited to policyholders’ account balances | 1,037,731 | 621,645 | [1] | 445,215 | |||||
| Amortization of deferred policy acquisition costs | (372,201) | 539,510 | [1] | 521,269 | [1] | ||||
| General, administrative and other expense | 1,228,443 | 1,124,923 | [1] | 1,129,700 | [1] | ||||
| TOTAL BENEFITS AND EXPENSES | 10,225,663 | 2,793,819 | 2,609,656 | ||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF SUBSIDIARIES AND OPERATING JOINT VENTURE | 973,059 | 477,647 | (992,589) | ||||||
| Income tax expense (benefit) | 135,149 | 26,468 | [1] | (296,687) | [1] | ||||
| INCOME (LOSS) FROM OPERATIONS BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | 837,910 | 451,179 | (695,902) | ||||||
| Equity in earnings of operating joint venture, net of taxes | (425) | (433) | (75,137) | ||||||
| Net income (loss) | 837,485 | 450,746 | [2] | (771,039) | [2] | ||||
| Less: Income (loss) attributable to noncontrolling interests | 13,495 | 488 | 0 | ||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | 823,990 | 450,258 | (771,039) | ||||||
| Other comprehensive income (loss), before tax: | |||||||||
| Foreign currency translation adjustments | (4,595) | 2,419 | (9,337) | ||||||
| Net unrealized investment gains (losses) | (335,093) | 691,952 | (2,254,037) | ||||||
| Interest rate remeasurement of future policy benefits | 58,676 | (60,978) | 310,353 | ||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (441,138) | (659,927) | [1] | 1,440,305 | |||||
| Total | (722,150) | (26,534) | (512,716) | ||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (151,234) | (5,638) | [1] | (106,197) | |||||
| Other comprehensive income (loss), net of tax | (570,916) | (20,896) | (406,519) | ||||||
| Comprehensive income (loss) | 266,569 | 429,850 | (1,177,558) | ||||||
| Less: Comprehensive income (loss) attributable to noncontrolling interests | 13,495 | 488 | 0 | ||||||
| Comprehensive income (loss) attributable to Pruco Life Insurance Company | $ 253,074 | $ 429,362 | $ (1,177,558) | ||||||
| |||||||||
Consolidated Statements of Stockholder's Equity - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Retained Earnings / (Accumulated Deficit) |
Accumulated Other Comprehensive Income (Loss) |
Total Pruco Life Insurance Company Equity |
Noncontrolling Interests |
Total Equity |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning Balance at Dec. 31, 2021 | [1] | $ 2,500 | $ 6,042,491 | $ (230,690) | $ 396,454 | $ 6,210,755 | $ 0 | $ 6,210,755 | ||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||
| Return of Capital | 0 | |||||||||||||||||||
| Contributed capital | 17,861 | 17,861 | 17,861 | |||||||||||||||||
| Contributed (distributed) capital-parent/child asset transfers | (22,438) | (22,438) | (22,438) | |||||||||||||||||
| Comprehensive income (loss): | ||||||||||||||||||||
| Net income (loss) | $ (771,039) | [2] | (771,039) | [1] | (771,039) | [1] | (771,039) | [1] | ||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (406,519) | (406,519) | (406,519) | 0 | (406,519) | |||||||||||||||
| Comprehensive income (loss) | (1,177,558) | (771,039) | [1] | (406,519) | [1] | (1,177,558) | [1] | 0 | [1] | (1,177,558) | [1] | |||||||||
| Ending Balance at Dec. 31, 2022 | [1] | 2,500 | 6,037,914 | (1,001,729) | (10,065) | 5,028,620 | 0 | 5,028,620 | ||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||
| Return of Capital | (1,400,000) | (1,400,000) | (1,400,000) | |||||||||||||||||
| Contributed capital | 412,382 | 412,382 | 412,382 | |||||||||||||||||
| Contributions from noncontrolling interests | 29,706 | 29,706 | ||||||||||||||||||
| Contributed (distributed) capital-parent/child asset transfers | 2,306 | 2,306 | 2,306 | |||||||||||||||||
| Comprehensive income (loss): | ||||||||||||||||||||
| Net income (loss) | 450,746 | [2] | 450,258 | [1] | 450,258 | [1] | 488 | [1] | 450,746 | [1] | ||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (20,896) | (20,896) | [1] | (20,896) | [1] | 0 | [1] | (20,896) | [1] | |||||||||||
| Comprehensive income (loss) | 429,850 | 450,258 | (20,896) | 429,362 | 488 | 429,850 | ||||||||||||||
| Ending Balance at Dec. 31, 2023 | 4,502,864 | 2,500 | [1] | 5,052,602 | [1] | (551,471) | [1] | (30,961) | [1] | 4,472,670 | [1] | 30,194 | [1] | 4,502,864 | [1] | |||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||||
| Return of Capital | 550,000 | (550,000) | (550,000) | (550,000) | ||||||||||||||||
| Contributed capital | 415,696 | 415,696 | 415,696 | |||||||||||||||||
| Contributions from noncontrolling interests | 250,422 | 250,422 | ||||||||||||||||||
| Distributions to noncontrolling interests | (188,572) | (188,572) | ||||||||||||||||||
| Contributed (distributed) capital-parent/child asset transfers | 5,001 | 5,001 | 5,001 | |||||||||||||||||
| Comprehensive income (loss): | ||||||||||||||||||||
| Net income (loss) | 837,485 | 823,990 | 823,990 | 13,495 | 837,485 | |||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (570,916) | (570,916) | 0 | (570,916) | |||||||||||||||
| Comprehensive income (loss) | 266,569 | 823,990 | (570,916) | 253,074 | 13,495 | 266,569 | ||||||||||||||
| Ending Balance at Dec. 31, 2024 | $ 4,701,980 | $ 2,500 | $ 4,923,299 | $ 272,519 | $ (601,877) | $ 4,596,441 | $ 105,539 | $ 4,701,980 | ||||||||||||
| ||||||||||||||||||||
Consolidated Statements of Cash Flows - USD ($) $ in Thousands |
12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net income (loss) | $ 837,485 | $ 450,746 | [1] | $ (771,039) | [1] | ||||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||||||||
| Policy charges and fee income | 53,496 | 69,986 | 131,936 | ||||||||
| Interest credited to policyholders’ account balances | 1,037,731 | 621,645 | [1] | 445,215 | |||||||
| Realized investment gains (losses), net | (451,417) | 1,147,099 | [2] | (289,929) | [2] | ||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | 433,955 | 106,773 | [1] | 700,581 | |||||||
| Change in: | |||||||||||
| Future policy benefits and other insurance liabilities | 2,689,669 | 2,241,530 | 3,743,780 | ||||||||
| Reinsurance related-balances | [3] | (1,124,001) | (678,725) | [1] | (1,786,851) | [1] | |||||
| Accrued investment income | (116,571) | (110,760) | (58,762) | ||||||||
| Net payables to (receivables from) parent and affiliates | (36,204) | (120,565) | 80,370 | ||||||||
| Deferred policy acquisition costs | (950,022) | (581,925) | [1] | (468,074) | [1] | ||||||
| Income taxes | (228,166) | (40,796) | [1] | (335,921) | [1] | ||||||
| Derivatives, net | 1,461,192 | (282,729) | (651,654) | ||||||||
| Other, net | [3] | (126,696) | (362,384) | 1,085,312 | |||||||
| Cash flows from (used in) operating activities | 3,480,451 | 2,459,895 | 1,824,964 | ||||||||
| Proceeds from the sale/maturity/prepayment of: | |||||||||||
| Fixed maturities, available-for-sale | 4,240,000 | 1,736,809 | 1,688,079 | ||||||||
| Fixed maturities, trading | 802,378 | 97,693 | 907,941 | ||||||||
| Equity securities | 961,421 | 189,237 | 242,292 | ||||||||
| Policy loans | 188,153 | 182,973 | 169,723 | ||||||||
| Ceded policy loans | (113,148) | (119,787) | (112,164) | ||||||||
| Short-term investments | 1,303,977 | 456,983 | 632,069 | ||||||||
| Commercial mortgage and other loans | 731,440 | 167,888 | 196,672 | ||||||||
| Other invested assets | 99,852 | 19,693 | 60,349 | ||||||||
| Notes receivable from parent and affiliates | [3] | 722 | 4,500 | 833 | |||||||
| Payments for the purchase/origination of: | |||||||||||
| Fixed maturities, available-for-sale | (13,766,055) | (7,544,596) | (7,009,578) | ||||||||
| Fixed maturities, trading | (1,819,224) | (857,717) | (425,267) | ||||||||
| Equity securities | (2,373,486) | (678,847) | (281,684) | ||||||||
| Policy loans | (255,811) | (1,162,959) | (144,764) | ||||||||
| Ceded policy loans | 125,795 | 151,019 | 71,402 | ||||||||
| Short-term investments | (1,441,031) | (690,173) | (558,161) | ||||||||
| Commercial mortgage and other loans | (2,392,198) | (1,341,450) | (1,076,351) | ||||||||
| Other invested assets | (460,721) | (190,826) | (166,345) | ||||||||
| Notes receivable from parent and affiliates | [3] | (367,700) | (44) | (62) | |||||||
| Derivatives, net | 171,230 | (55,091) | (366,805) | ||||||||
| Other, net | (3,264) | (4,808) | 57,687 | ||||||||
| Cash flows from (used in) investing activities | (14,367,670) | (9,639,503) | (6,114,134) | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
| Policyholders’ account deposits | 17,265,165 | 12,101,043 | 9,996,128 | ||||||||
| Ceded policyholders’ account deposits | (1,169,002) | (1,189,331) | (1,216,195) | ||||||||
| Policyholders’ account withdrawals | (3,980,496) | (3,695,248) | (3,727,579) | ||||||||
| Ceded policyholders’ account withdrawals | 764,421 | 625,238 | 638,392 | ||||||||
| Net change in securities sold under agreement to repurchase and cash collateral for loaned securities | (96,928) | 131,577 | 83,762 | ||||||||
| Contributed capital | 0 | 405,000 | 0 | ||||||||
| Return of capital | (550,000) | (1,400,000) | 0 | ||||||||
| Contributed (distributed) capital - parent/child asset transfers | 6,332 | 2,919 | (11,478) | ||||||||
| Net change in all other financing arrangements (maturities 90 days or less) | 0 | (584) | 584 | ||||||||
| Repayments of debt (maturities longer than 90 days) | (180,411) | (121,772) | 0 | ||||||||
| Drafts outstanding | (84,531) | (885) | 63,579 | ||||||||
| Contributions from Noncontrolling Interests | [3] | 250,422 | 29,706 | 0 | |||||||
| Distributions to Noncontrolling Interests | (188,572) | 0 | 0 | ||||||||
| Other, net | [3] | 36,725 | 34,110 | (59,327) | |||||||
| Cash flows from (used in) financing activities | 12,073,125 | 6,921,773 | 5,767,866 | ||||||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 1,185,906 | (257,835) | 1,478,696 | ||||||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 2,139,792 | 2,397,627 | 918,931 | ||||||||
| CASH AND CASH EQUIVALENTS, END OF YEAR | 3,325,698 | 2,139,792 | 2,397,627 | ||||||||
| SUPPLEMENTAL CASH FLOW INFORMATION | |||||||||||
| Income taxes paid (refunded), net | 363,208 | 67,203 | 39,201 | ||||||||
| Interest paid | $ 2,644 | $ 4,533 | $ 7,863 | ||||||||
| |||||||||||
Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Capital contributions | Prudential Insurance | |||
| Non-cash activity | $ 416 | ||
| Assets | Prudential Insurance | |||
| Non-cash activity | $ 18 | ||
| FLIAC | Reinsurance agreement | |||
| Non-cash activity | $ 475 | 4,656 | |
| Lotus Re | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | $ 531 | ||
| PARCC | Affiliated Entity | |||
| Non-cash activity | (78) | ||
| PARCC | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | (102) | ||
| PURE and Prudential Insurance | Affiliated Entity | |||
| Non-cash activity | 936 | ||
| PURE and Prudential Insurance | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | 1,129 | ||
| PAR U | Affiliated Entity | |||
| Non-cash activity | 7,190 | ||
| Non-cash activity | (6,722) | ||
| PAR U | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | 7,218 | ||
| Non-cash activity | (6,722) | ||
| Wilton Re | Reinsurance agreement | |||
| Non-cash activity | 6,722 | ||
| Non-cash activity | $ (7,469) | ||
Unaudited Interim Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Income Statement [Abstract] | |||
| Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Amortization Expense, Realized Gain (Loss) | $ (2,690) | $ 6,978 | $ (1,250) |
Business and Basis of Presentation |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Business and Basis of Presentation | BUSINESS AND BASIS OF PRESENTATION Pruco Life Insurance Company, (“Pruco Life”) is a wholly-owned subsidiary of The Prudential Insurance Company of America ("Prudential Insurance"), which in turn is a direct wholly-owned subsidiary of Prudential Financial, Inc. (“Prudential Financial”). Pruco Life is a stock life insurance company organized in 1971 under the laws of the State of Arizona. It is licensed to sell life insurance and annuities in the District of Columbia, Guam and in all states except New York, and sells such products primarily through affiliated and unaffiliated distributors. Pruco Life has one wholly-owned insurance subsidiary, Pruco Life Insurance Company of New Jersey, (“PLNJ”). PLNJ is a stock life insurance company organized in 1982 under the laws of the State of New Jersey. It is licensed to sell life insurance and annuities in New Jersey and New York only. Pruco Life and its subsidiaries are together referred to as the "Company", "we" or "our" and all financial information is shown on a consolidated basis. Prudential Financial Sale of PALAC Effective April 1, 2022, Prudential Financial completed the sale of Prudential Annuities Life Assurance Corporation (“PALAC”) to Fortitude Group Holdings, LLC (“Fortitude”). As such, PALAC is no longer an affiliate of Prudential Financial or the Company. Fortitude subsequently renamed the company Fortitude Life Insurance & Annuity Company (“FLIAC”). Basis of Presentation The Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the accounts of Pruco Life and entities over which the Company exercises control, including majority-owned subsidiaries. Intercompany balances and transactions have been eliminated. Segment Information Although there are separate products within Pruco Life, the Company is organized as a single reportable segment and manages the business activities on a consolidated basis. The accounting policies are the same as those described in Note 2. The Company analyzes operating performance using “Income (loss) from operations before income taxes and equity in earnings of operating joint venture”, as determined in accordance with U.S. GAAP. This is the measure of profit or loss used by the Company’s chief operating decision maker to evaluate performance and allocate resources. The measure of segment assets is reported as “Total Assets” on the Consolidated Statements of Financial Position. Segment revenue is reported as “Total Revenues” on the Consolidated Statements of Operations and Comprehensive Income (Loss). As the Company has one reportable segment, there are no intersegment revenues. The Company discloses all significant expense categories separately on the Consolidated Statements of Operations and Comprehensive Income (Loss). The Company’s chief operating decision maker is a group of Prudential Financial executives that include the chief financial officer, controller, treasurer, and business leaders, which include the Company’s chief executive officer and chief financial officer. Overall business decisions for the Company are made by this group of executives. Such business decisions include the allocation of capital, distribution/sale of products, and allocation/deployment of overall Prudential Financial resources. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining future policy benefits; policyholders' account balances and reinsurance related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; market risk benefits; the valuation of investments including derivatives, the measurement of allowance for credit losses, and the recognition of other-than-temporary impairments; reinsurance recoverables; any provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters. Reclassifications Certain amounts in prior periods have been reclassified to conform to the current period presentation. Revision to Prior Period Financial Statements In the fourth quarter of 2024, the Company identified misstatements in the previously issued Consolidated Financial Statements for the years ended December 31, 2023 and 2022. Prior period amounts have been revised in the Consolidated Financial Statements and related disclosures to correct this error. Management evaluated these adjustments and concluded they were not material to any previously reported quarterly or annual Consolidated Financial Statements. See Note 17 for a more detailed description of the revisions and for comparisons of amounts previously reported to the revised amounts.
|
Significant Accounting Policies and Pronouncements |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Significant Accounting Policies and Pronouncements | SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS ASSETS Fixed maturities, available-for-sale, at fair value ("AFS debt securities") includes bonds, notes and redeemable preferred stock that are carried at fair value. See Note 5 for additional information regarding the determination of fair value. The purchased cost of fixed maturities is adjusted for amortization of premiums and accretion of discounts to maturity or, if applicable, call date. AFS debt securities, where fair value is below amortized cost, are reviewed quarterly to determine whether the amortized cost basis of the security is recoverable. For mortgage-backed and asset-backed AFS debt securities, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. A credit impairment recorded cannot exceed the difference between the amortized cost and fair value of the respective security. The net present value used to measure a credit impairment is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the AFS debt security at the date of acquisition. Once the Company has deemed all or a portion of the amortized cost uncollectible, the allowance is removed from the balance sheet by writing down the amortized cost basis of the AFS debt security. Any amount of an AFS debt security’s change in fair value not recorded as an allowance for credit losses will be recorded in Other Comprehensive Income (loss) (“OCI”). For all other AFS debt securities, qualitative factors are first considered including, but not limited to, the extent of the decline and the reasons for the decline in value (e.g., credit events, currency or interest-rate related, including general credit spread widening), and the financial condition of the issuer. If analysis of these qualitative factors results in the security needing to be impaired, a credit impairment will be recognized and measured using the same process for mortgage-backed and asset-backed AFS debt securities. When an AFS debt security's fair value is below amortized cost and the Company has the intent to sell the AFS debt security, or it is more likely than not the Company will be required to sell the AFS debt security before its anticipated recovery, the amortized cost basis of the AFS debt security is written down to fair value and any previously recognized allowance is reversed. The write-down is reported in "Realized investment gains (losses), net". Interest income, including amortization of premium and accretion of discount, are included in “Net investment income” under the effective yield method. Prepayment premiums are also included in “Net investment income”. For high credit quality mortgage-backed and asset-backed AFS debt securities (those rated AA or above), the amortized cost and effective yield of the securities are adjusted as necessary to reflect historical prepayment experience and changes in estimated future prepayments. The adjustments to amortized cost are recorded as a charge or credit to “Net investment income” in accordance with the retrospective method. For mortgage-backed and asset-backed AFS debt securities rated below AA, the effective yield is adjusted prospectively for any changes in the estimated timing and amount of cash flows unless the investment is purchased with credit deterioration or an allowance is currently recorded for the respective security. If an investment is impaired, any changes in the estimated timing and amount of cash flows will be recorded as the credit impairment, as opposed to a yield adjustment. If the asset is purchased with credit deterioration (or previously impaired), the effective yield will be adjusted if there are favorable changes in cash flows subsequent to the allowance being reduced to zero. For mortgage-backed and asset-backed AFS debt securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. These assumptions can significantly impact income recognition, unrealized gains and loss recorded in OCI, and the amount of impairment recognized in earnings. The payment priority of the respective security is also considered. For all other AFS debt securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. The Company has developed these estimates using information based on its historical experience as well as using market observable data, such as industry analyst reports and forecasts, sector credit ratings and other data relevant to the collectability of a security, such as the general payment terms of the security and the security’s position within the capital structure of the issuer. Fixed maturities, trading, at fair value ("Trading debt securities") includes debt securities that are carried at fair value. See Note 5 for additional information regarding the determination of fair value. Realized and unrealized gains and losses for these investments are reported in “Other income (loss),” and interest income from these investments is reported in “Net investment income”. Equity securities, at fair value consists of common stock and mutual fund shares carried at fair value. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and dividend income is reported in “Net investment income” on the ex-dividend date. Policy loans represents funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in “Net investment income” at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Short-term investments primarily consists of highly liquid debt instruments with a maturity of twelve months or less and greater than three months when purchased. These investments are generally carried at fair value or amortized cost that approximates fair value and include certain money market investments, funds managed similar to regulated money market funds, short-term debt securities issued by government sponsored entities and other highly liquid debt instruments. Commercial mortgage and other loans consist of commercial mortgage loans, agricultural property loans, as well as certain other collateralized loans. Commercial mortgage and other loans held for investment are generally carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses and net of any current expected credit loss ("CECL") allowance. Certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans, and certain unfunded mortgage loan commitments where the Company cannot unconditionally cancel the commitment) are also subject to a CECL allowance. See Note 16 for additional information. Commercial mortgage and other loans acquired, including those related to the acquisition of a business, are recorded at fair value when purchased, reflecting any premiums or discounts to unpaid principal balances. Interest income, and the amortization of the related premiums or discounts, are included in “Net investment income” under the effective yield method. Prepayment fees are also included in “Net investment income.” The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets or off-balance sheet credit exposures. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. The allowance is calculated separately for commercial mortgage loans, agricultural mortgage loans and other collateralized loans. For commercial mortgage and agricultural mortgage loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. Similar risk characteristics used to create the pools include, but are not limited to, vintage, maturity, credit rating, and collateral type. Key inputs to the CECL model include unpaid principal balances, internal credit ratings, annual expected loss factors, average lives of the loans adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Information about certain key inputs is detailed below. Key factors in determining the internal credit ratings for commercial mortgage and agricultural mortgage loans include loan-to-value and debt-service-coverage ratios. Other factors include amortization, loan term, and estimated market value growth rate and volatility for the property type and region. The loan-to-value ratio compares the carrying amount of the loan to the fair value of the underlying property or properties collateralizing the loan, and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the carrying amount of the loan exceeds the collateral value. A loan-to-value ratio less than 100% indicates an excess of collateral value over the carrying amount of the loan. The debt service coverage ratio is a property’s net operating income as a percentage of its debt service payments. Debt service coverage ratios less than 1.0 indicates that property operations do not generate enough income to cover the loan’s current debt payments. A debt service coverage ratio greater than 1.0 indicates an excess of net operating income over the debt service payments. The values utilized in calculating these ratios are developed as part of the Company’s periodic review of the commercial mortgage loan and agricultural property loan portfolios, which includes an internal appraisal of the underlying collateral value. The Company’s periodic review also includes a quality re-rating process, whereby the internal quality rating originally assigned at underwriting is updated based on current loan, property and market information using a proprietary quality rating system. See Note 3 for additional information related to the loan-to-value ratios and debt service coverage ratios related to the Company’s commercial mortgage and agricultural loan portfolios. Annual expected loss rates are based on historical default and loss experience factors. Using average lives, the annual expected loss rates are converted into life-of-loan loss expectations. When individual loans no longer have the credit risk characteristics of the commercial or agricultural mortgage loan pools, they are removed from the pools and are evaluated individually for an allowance. The allowance is determined based on the outstanding loan balance less the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent. The CECL allowance on commercial mortgage and other loans can increase or decrease from period to period based on the factors noted above. The change in allowance is reported in “Realized investment gains (losses), net”. As it relates to unfunded commitments that are in scope of this guidance, the CECL allowance is reported in “Other liabilities”, and the change in the allowance is reported in “Realized investment gains (losses), net”. The CECL allowance for other collateralized loans carried at amortized cost is determined based on probability of default and loss given default assumptions by sector, credit quality and average lives of the loans. Additions to or releases of the allowance are reported in “Realized investment gains (losses), net.” Once the Company has deemed a portion of the amortized cost to be uncollectible, the uncollectible portion of allowance is removed from the balance sheet by writing down the amortized cost basis of the loan. The carrying amount of the loan is not adjusted for subsequent recoveries in value. Interest received on loans that are past due is either applied against the principal or reported as net investment income based on the Company’s assessment as to the collectability of the principal. The Company defines “past due” as principal or interest not collected at least 30 days past the scheduled contractual due date. See Note 3 for additional information about the Company’s past due loans. The Company discontinues accruing interest on loans after the loans become 90 days delinquent as to principal or interest payments, or earlier when the Company has doubts about collectability. When the Company discontinues accruing interest on a loan, any accrued but uncollectible interest on the loan and other loans backed by the same collateral, if any, is charged against interest income in the same period. Generally, a loan is restored to accrual status only after all delinquent interest and principal are brought current and, in the case of loans where the payment of interest has been interrupted for a substantial period, or the loan has been modified, a regular payment performance has been established. Commercial mortgage and other loans are occasionally restructured. These restructurings generally include one or more of the following: full or partial payoffs outside of the original contract terms; changes to interest rates; extensions of maturity; or additions or modifications to covenants. Additionally, the Company may accept assets in full or partial satisfaction of the debt. Effective January 1, 2023, the Company adopted Accounting Standard Update ("ASU") 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosure, on a prospective basis. This ASU eliminates the accounting guidance for Troubled Debt Restructurings (“TDR”) for creditors and requires all loan restructurings to follow the modification guidance in ASC 310-20. Prior to the adoption of ASU 2022-02, when restructurings occurred, they were evaluated individually to determine whether the restructuring or modification constituted a TDR as defined by authoritative accounting guidance. If the borrower was experiencing financial difficulty and the Company granted a concession, the restructuring, including those that involved a partial payoff or the receipt of assets in full satisfaction of the debt was deemed to be a TDR. If a loan modification was a TDR, the CECL allowance of the loan was remeasured using the modified terms and the loan's original effective yield. Post adoption of ASU 2022-02, all restructurings are evaluated under the modification guidance in ASC 310-20. When a loan is modified, the Company evaluates whether the restructuring results in a continuation of the existing loan or a new loan. For modifications that result in a continuation of the existing loan, the CECL allowance of the loan is remeasured using the modified terms, including the loan’s post-modification effective yield, and the allowance is adjusted accordingly. For modifications that result in a new loan, any CECL allowance is reversed and a direct write-down of the loan is recorded for the amount of the allowance, and any additional loss, net of recoveries, or any gain is recorded for the difference between the fair value of the new loan and the recorded investment in the loan. The new loan is evaluated prospectively for credit impairment based on the CECL allowance process noted above. Other invested assets consist of the Company’s non-coupon investments in limited partnerships and limited liability companies ("LPs/LLCs"), other than operating joint ventures, as well as derivative assets. LPs/LLCs interests are accounted for using either the equity method of accounting, or at fair value. The Company’s income from investments in LPs/LLCs accounted for using the equity method, other than the Company’s investments in operating joint ventures, is included in “Net investment income”. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. In applying the equity method (including assessment for OTTI), the Company uses financial information provided by the investee, generally on a to three-month lag. For the investments reported at fair value with changes in fair value reported in current earnings, the associated realized and unrealized gains and losses are reported in “Other income (loss)”. Realized investment gains (losses) are computed using the specific identification method. Realized investment gains and losses are generated from numerous sources, including the sales of fixed maturity securities, investments in joint ventures and limited partnerships and other types of investments, as well as changes to the allowance for credit losses recognized in earnings. Realized investment gains and losses also reflect fair value changes on commercial mortgage loans carried at fair value, and fair value changes on embedded derivatives and free-standing derivatives that do not qualify for hedge accounting treatment. See “Derivative Financial Instruments” below for additional information regarding the accounting for derivatives. Cash and cash equivalents includes cash on hand, amounts due from banks, certain money market investments, funds managed similar to regulated money market funds, other debt instruments with maturities of three months or less when purchased, other than cash equivalents that are included in "Fixed maturities, available-for-sale, at fair value,” and receivables related to securities purchased under agreements to resell (see also "Securities sold under agreements to repurchase" below.) The Company also engages in overnight borrowing and lending of funds with Prudential Financial and affiliates which are considered cash and cash equivalents. These assets are generally carried at fair value or amortized cost which approximates fair value. Deferred policy acquisition costs ("DAC") represents costs directly related to the successful acquisition of new and renewal insurance and annuity business. Such DAC primarily includes commissions, costs of policy issuance and underwriting, and certain other expenses that are directly related to successfully acquired contracts. In each reporting period, previously capitalized DAC is amortized and included in “Amortization of deferred policy acquisition costs”. Upon the adoption of ASU 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, the carrying amount of DAC for long-duration contracts is no longer subject to recoverability testing. DAC for most long-duration contracts is amortized on a constant-level basis at a grouped contract level over the expected life of the underlying insurance contracts. Contracts are grouped consistent with the groupings used to estimate the liability for future policy benefits (or other related balances) for the corresponding contracts. Since contracts within a grouping may be of different sizes, contracts within a group are weighted to achieve appropriate amortization and to ensure that DAC is derecognized when a policy is no longer in force. The constant-level basis used to weight contracts within a grouping and amortize DAC is generally defined as follows: •Life insurance contracts – DAC associated with life insurance contracts is generally amortized in proportion to the initial face amount of life insurance in force. This is applicable to traditional and universal life insurance products. •Payout annuity contracts – DAC associated with payout annuity contracts is amortized in proportion to annual benefit payments. •Deferred annuity contracts – DAC associated with fixed and variable deferred annuity contracts is amortized in proportion to deposits. For single premium immediate annuities without life contingencies, acquisition expenses are deferred and amortized over the expected life of the contracts using the interest method. Current period DAC amortization reflects the impact of changes in actual insurance in force during the period and changes in future assumptions effected as of the end of the quarter, where applicable. The Company typically updates actuarial assumptions annually in the second quarter, (see "Annual Assumptions Review" below), unless a material change is observed in an interim period that is indicative of a long-term trend. Generally, the Company does not expect trends to change significantly in the short-term and, to the extent these trends may change, the Company expects such changes to be gradual over the long-term. Assumptions used for DAC are consistent with those used in estimating the liability for future policy benefits (or any other related balance) for the corresponding contract. Determining the level of aggregation and actuarial assumptions used in projecting in force terminations requires judgment. Internal criteria are developed to determine the level of aggregation by considering both qualitative and quantitative materiality thresholds. The assumptions used in projecting in force terminations are mortality, mortality improvement, and lapse assumptions. These assumptions are generally based on the Company’s experience, industry experience and/or other factors, as applicable. For variable deferred annuity contracts, lapse rates are adjusted at the contract level based on the in-the-moneyness of the living benefits and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For some products, policyholders can elect to modify product benefits, features, rights or coverages by exchanging a contract for a new contract or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. These transactions are known as internal replacements. If policyholders surrender traditional life insurance policies in exchange for life insurance policies that do not have fixed and guaranteed terms, the Company immediately charges to expense the remaining unamortized DAC on the surrendered policies. For other internal replacement transactions, except those that involve the addition of a non-integrated contract feature that does not change the existing base contract, the unamortized DAC is immediately charged to expense if the terms of the new policies are not substantially similar to those of the former policies. If the new terms are substantially similar to those of the earlier policies, the DAC is retained with respect to the new policies and amortized over the expected life of the new policies. See Note 6 for additional information regarding DAC. Accrued investment income primarily includes accruals of interest and dividend income from investments that have been earned but not yet received. Reinsurance recoverables and deposit receivables includes amounts recoverable under reinsurance agreements and receivables that follow the deposit method of accounting (see “Reinsurance” below). Market risk benefit assets represents market risk benefits ("MRBs") in an asset position and are presented separately from MRBs in a liability position. See “Market risk benefit liabilities” below. MRB assets also reflect ceded MRBs resulting from reinsurance of the Company's Prudential Defined Income ("PDI") traditional variable annuity contracts. See Note 11 for additional information regarding the reinsurance of PDI. Deferred Sales Inducements ("DSI") are amounts that are credited to a policyholders’ account balance primarily as an inducement to purchase fixed and/or variable deferred annuity contracts. The Company defers sales inducements and amortizes them over the expected life of the policy using the same methodology, factors and assumptions used to amortize DAC. The Company records amortization of DSI in “Interest credited to policyholders’ account balances.” Unlike DAC, DSI are considered contractual cash flows and, as a result, are subject to periodic recoverability testing. See Note 6 for additional information regarding DSI. Income tax assets primarily represents the net deferred tax asset and the Company’s estimated taxes receivable for the current year and open audit years. The Company is a member of the federal income tax return of Prudential Financial and primarily files separate company state and local tax returns. Pursuant to the tax allocation arrangement with Prudential Financial, total federal income tax expense is determined on a separate company basis. Members record tax benefits to the extent tax losses or tax credits are recognized in the consolidated federal tax provision. Items required by tax regulations to be included in the tax return may differ from the items reflected in the financial statements. As a result, the effective tax rate reflected in the financial statements may be different than the actual rate applied on the tax return. Some of these differences are permanent such as expenses that are not deductible in the Company’s tax return, and some differences are temporary, reversing over time, such as valuation of insurance reserves. Temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a tax deduction or credit in future years for which the Company has already recorded the tax benefit in the Company’s Consolidated Statements of Operations. Deferred tax liabilities generally represent tax expense recognized in the Company’s financial statements for which payment has been deferred, or expenditures for which the Company has already taken a deduction in the Company’s tax return but have not yet been recognized in the Company’s financial statements. Deferred income taxes are recognized, based on enacted rates, when assets and liabilities have different values for financial statement and tax reporting purposes. The application of U.S. GAAP requires the Company to evaluate the recoverability of the Company’s deferred tax assets and establish a valuation allowance if necessary to reduce the Company’s deferred tax assets to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. See Note 12 for a discussion of factors considered when evaluating the need for a valuation allowance. U.S. GAAP prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on tax returns. The application of this guidance is a two-step process. First, the Company determines whether it is more likely than not, based on the technical merits, that the tax position will be sustained upon examination. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. The Company measures the tax position as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate resolution with a taxing authority that has full knowledge of all relevant information. This measurement considers the amounts and probabilities of the outcomes that could be realized upon ultimate settlement using the facts, circumstances, and information available at the reporting date. The Company accrues a liability for unrecognized tax benefits, interest and penalties which relate to tax years still subject to review by the Internal Revenue Service ("IRS") or other taxing jurisdictions. Audit periods remain open for review until the statute of limitations has passed. Generally, for tax years which produce net operating losses, capital losses or tax credit carryforwards (“tax attributes”), the statute of limitations does not close, to the extent of these tax attributes, until the expiration of the statute of limitations for the tax year in which they are fully utilized. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company classifies all interest and penalties related to tax uncertainties as income tax expense. See Note 12 for additional information regarding income taxes. Other assets consists primarily of deferred reinsurance losses ("DRL") (see "Reinsurance" below) which are amortized over the expected life of the reinsured contracts on a constant-level basis, receivables resulting from sales of securities that had not yet settled at the balance sheet date, premiums due, prepaid tax expenses, and the Company’s investments in operating joint ventures. Investments in operating joint ventures are generally accounted for under the equity method. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. Separate account assets represents segregated funds that are invested for certain policyholders, and other customers. The assets consist primarily of equity securities, fixed maturities, real estate-related investments, real estate mortgage loans, short-term investments and derivative instruments and are reported at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. The investment income and realized investment gains or losses from separate account assets generally accrue to the policyholders and are not included in the Company’s results of operations. Mortality, policy administration and surrender charges assessed against the accounts are included in “Policy charges and fee income”. Asset administration fees charged to the accounts are included in “Asset administration fees”. Seed money that the Company invests in separate accounts is reported in the appropriate general account asset line. Investment income and realized investment gains or losses from seed money invested in separate accounts accrue to the Company and are included in the Company’s results of operations. See Note 7 for additional information regarding separate account arrangements with contractual guarantees. See also “Separate account liabilities” below. LIABILITIES Future policy benefits primarily consists of the present value of expected future payments to or on behalf of policyholders, where the timing and amount of such payments depend on policyholder mortality or morbidity, less the present value of expected future net premiums (where net premiums are gross premiums multiplied by the Net-To-Gross ("NTG") ratio discussed below). The liability for future policy benefits is accrued over time as premium revenue is recognized. See Note 8 for additional information regarding future policy benefits. The reserving methodology used for non-participating traditional and limited-payment contracts include the following: •Cash Flow Assumptions. In measuring the liability for future policy benefits, the net premium valuation methodology is utilized. Under this methodology, a liability for future policy benefits is established using current best estimate insurance assumptions and interest rate assumptions locked-in at contract issuance date. The NTG ratio is calculated as the ratio of the present value of expected policy benefits and non-level claim settlement expenses divided by the present value of expected gross premiums. The NTG ratio is applied to gross premiums, as premium revenue is recognized, to determine net premiums. The liability is then determined as the present value of expected future policy benefits and non-level claim settlement expenses less the present value of expected future net premiums. For purposes of liability measurement, contracts are grouped into cohorts based primarily on issue year and major product line. The NTG ratio is generally updated quarterly for actual experience and annually in the second quarter of each year for future cash flow assumption updates during the Company’s annual assumptions review process unless a material change is observed in an interim period that is indicative of a long-term trend (see “Annual Assumptions Review” below), with the exception of claim settlement expense assumptions which the Company has made an entity-wide election to lock-in as of contract issuance. The NTG ratio is subject to a retrospective unlocking method whereby the Company updates its best estimate of cash flows expected over the life of the cohort using actual historical experience and updated future cash flow assumptions. These updated cash flows are used to calculate the revised NTG ratio, which is used to derive an updated liability for future policy benefits as of the beginning of the current reporting period, discounted at the original contract issuance discount rate. The updated liability for future policy benefit amount as of the beginning of the quarter is then compared to the carrying amount of the liability as of that same date, before the updates for actual experience or future cash flow assumptions, to determine the current period change in liability estimate. This current period change in the liability is the liability remeasurement gain or loss that is recorded through current period earnings in “Change in estimates of liability for future policy benefits”. In subsequent periods, the revised NTG ratio is used to measure the liability for future policy benefits, subject to future revisions. If a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for expected future policy benefits and non-level claim settlement expenses, the NTG ratio is capped at 100%. In these instances, all changes in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately. While the liability for future policy benefits cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”), the NTG ratio may be negative. This would be the case whereby conditions have improved such that the present value of future net premiums plus the existing liability for future policy benefits as of the valuation date exceed the present value of expected future policy benefits and non-level claim settlement expenses. In this case, the negative NTG ratio would be applied going forward to gross premiums received, effectively amortizing the gain into income and reducing the liability over time. In addition, for limited-payment contracts, the liability for future policy benefits also includes a Deferred Profit Liability ("DPL") representing gross premiums received in excess of net premiums and is generally recognized in revenue in a constant relationship with insurance in force for life contracts or with the amount of expected future benefit payments for annuity contracts. The DPL is subject to a retrospective unlocking adjustment consistent with the liability for future policy benefits discussed above. The DPL cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”). For contracts issued prior to January 1, 2021, the modified retrospective transition method was used to transition to ASU 2018-12. Under this method, the transition date of January 1, 2021 serves as the new issue date of the contracts in force for purposes of retrospectively unlocking the NTG ratio and DPL as described above. •Discount Rate Assumption. The locked-in discount rate is generally based on expected investment returns at contract inception for contracts issued prior to January 1, 2021 and the upper medium grade fixed income corporate instrument yield (i.e., global single A) at contract inception for contracts issued on or after January 1, 2021. The discount rate in effect at contract inception is locked-in for the calculation of the NTG ratio and accretion of interest cost on the liability through net income. However, for balance sheet remeasurement purposes, the discount rate is updated using the current single A rate at each reporting period, with the effect on the liability resulting from such update recorded in “Interest rate remeasurement of future policy benefits" in OCI. The methodology used in constructing the single A discount rate curve for discounting cash flows used to calculate the liability for future policy benefits is intended to be reflective of the characteristics of the applicable insurance liabilities. The single A discount rate curve is developed by reference to upper medium grade (low credit risk) fixed income instrument yields that reflect the duration characteristics of the applicable insurance liabilities. The single A discount curve for the United States is developed using government bond rates plus public corporate A spreads in the observable periods. The definition of upper medium grade is based on Moody’s definition which includes the spectrum of A (i.e., A- to A+). Liquidity is considered in defining the observable period and linear extrapolation is performed to the Company's ultimate long-term economic assumptions. See “Annual Assumptions Review” below for further discussion regarding the Company’s long-term economic assumption setting process. The Company’s liability for future policy benefits also includes net liabilities for guaranteed benefits related to certain long-duration life contracts, such as no-lapse guarantee contract features (Additional Insurance Reserves or "AIR" liability), for which a liability is established when associated assessments are recognized (which include investment margin on policyholders' account balances deposited to fixed and indexed funds and all policy charges including charges for administration, mortality, expense, surrender, and other charges). This liability is established using current best estimate assumptions and is based on the ratio of the present value of total expected excess payments (i.e., payments in excess of account value) over the life of the contract divided by the present value of total expected assessments (i.e., benefit ratio). Any adjustments to this liability related to net unrealized gains (losses) on securities classified as available-for-sale are included in AOCI. For universal life type contracts and participating contracts, the Company performs premium deficiency tests using best estimate assumptions as of the testing date. If the liabilities determined based on these best estimate assumptions are greater than the net reserves (i.e., GAAP reserves including unearned revenue reserves ("URR"), net of reinsurance and any DSI asset), the existing net reserves are adjusted by first reducing assets, such as DSI or deferred reinsurance loss, by the amount of the deficiency or to zero through a charge to current period earnings. If the deficiency is more than these asset balances for insurance contracts, the net reserves are increased by the excess through a charge to current period earnings included in "Policyholders' benefits". Since investment yields are used as the discount rate, the premium deficiency test is also performed using a discount rate based on the market yield (i.e., assuming what would be the impact if any unrealized gains (losses) were realized as of the testing date). In the event that by using the market yield a deficiency occurs, an adjustment is established for the deficiency and is included in AOCI. The Company’s liability for future policy benefits also includes a liability for unpaid claims and claim adjustment expenses. The Company does not establish claim liabilities until a loss has been incurred. However, unpaid claims and claim adjustment expenses include estimates of claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. Policyholders’ account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability is primarily associated with the accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance, as applicable. These policyholders’ account balances also include provision for benefits under non-life contingent payout annuities and certain unearned revenues. The unearned revenue liability represents policy charges for services to be provided in future periods. The charges are deferred as incurred and are generally amortized over the expected life of the contract using the same methodology, factors, and assumption used to amortize DAC. See Note 9 for additional information regarding policyholders’ account balances. Policyholders' account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products. For additional information regarding the valuation of these embedded derivatives, see Note 5. Market risk benefit liabilities represents contracts or contract features that provide protection to the contractholder and exposes the Company to other than nominal capital market risk, primarily related to deferred annuities with guaranteed minimum benefits associated with annuities products including guaranteed minimum death benefits (“GMDB”), guaranteed minimum income benefits (“GMIB”), guaranteed minimum accumulation benefits (“GMAB”), guaranteed minimum withdrawal benefits (“GMWB”) and guaranteed minimum income and withdrawal benefits (“GMIWB”). The benefits are accounted for using a fair value measurement framework. If a contract contains multiple market risk benefits, the benefits are bundled together and accounted for as a single compound market risk benefit. Market risk benefits in an asset position are presented separately from those in a liability position as there is no legal right of offset between contracts. The fair value of market risk benefits is calculated as the present value of expected future benefit payments to contractholders less the present value of expected future rider fees attributable to the market risk benefits. The fair value of market risk benefits is based on assumptions a market participant would use in valuing market risk benefits. For additional information regarding the valuation of market risk benefits, see Note 5. On a quarterly basis, changes in the fair value of market risk benefits are recorded in net income, net of related hedges, in "Change in value of market risk benefits, net of related hedging gains (losses)", except for the portion of the change attributable to changes in the Company’s non-performance risk ("NPR") which is recorded in OCI. See Note 10 for additional information regarding market risk benefits. See "Reinsurance" below for information regarding the reinsurance of MRBs. Cash collateral for loaned securities represents liabilities to return cash proceeds from security lending transactions. Securities lending transactions are used primarily to earn spread income. As part of securities lending transactions, the Company transfers U.S. and foreign debt and equity securities, as well as U.S. government and government agency securities, and receives cash as collateral. Cash proceeds from securities lending transactions are primarily used to earn spread income, and are typically invested in cash equivalents, short-term investments or fixed maturities. Securities lending transactions are treated as financing arrangements and are recorded at the amount of cash received. The Company obtains collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of the Company’s securities lending transactions are with large brokerage firms and large banks. Income and expenses associated with securities lending transactions used to earn spread income are reported as "Net investment income". Securities sold under agreements to repurchase represents liabilities associated with securities repurchase agreements that are used primarily to earn spread income. As part of securities repurchase agreements, the Company transfers U.S. government and government agency securities to a third-party, and receives cash as collateral. For securities repurchase agreements, the cash received is typically invested in cash equivalents, short-term investments or fixed maturities. Receivables associated with securities purchased under agreements to resell are generally reflected as cash equivalents. As part of securities resale agreements, the Company invests cash and receives as collateral U.S. government securities or other debt securities. Securities repurchase and resale agreements that satisfy certain criteria are treated as secured borrowing or secured lending arrangements. These agreements are carried at the amounts at which the securities will be subsequently resold or reacquired, as specified in the respective transactions. For securities purchased under agreements to resell, the Company’s policy is to take possession or control of the securities either directly or through a third-party custodian. These securities are valued daily, and additional securities or cash collateral is received, or returned, when appropriate to protect against credit exposure. Securities to be resold are the same, or substantially the same, as the securities received. The majority of these transactions are with large brokerage firms and large banks. For securities sold under agreements to repurchase, the market value of the securities to be repurchased is monitored, and additional collateral is obtained where appropriate, to protect against credit exposure. The Company obtains collateral in an amount at least equal to 95% of the fair value of the securities sold. Securities to be repurchased are the same, or substantially the same, as those sold. The majority of these transactions are with highly rated money market funds. Income and expenses related to these transactions executed within the insurance companies used to earn spread income are reported as “Net investment income.” Reinsurance and funds withheld payables represents amounts payable under reinsurance agreements (see “Reinsurance” below). Reinsurance and funds withheld payables may also include derivative instruments for which fair values are determined as described below under "Derivative Financial Instruments". Other liabilities consists primarily of deferred reinsurance gains ("DRG") (see "Reinsurance" below), accrued expenses, technical overdrafts, payables resulting from purchases of securities that had not yet settled at the balance sheet date. The amortization method for DRG is amortized over the expected life of the reinsured contracts on a constant-level basis. Separate account liabilities primarily represents the contractholders’ account balances in separate account assets and to a lesser extent borrowings of the separate account, and will be equal and offsetting to total separate account assets. See also “Separate account assets” above. Short-term and long-term debt liabilities are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issuance costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within “General, administrative and other expenses” in the Company’s Consolidated Statements of Operations. Short-term debt is debt coming due in the next twelve months, including that portion of debt otherwise classified as long-term. The short-term debt caption may exclude short-term debt items for which the Company has the intent and ability to refinance on a long-term basis in the near term. See Note 15 for additional information regarding short-term and long-term debt. Commitments and contingent liabilities are accrued if it is probable that a liability has been incurred and an amount is reasonably estimable. Management evaluates whether there are incremental legal or other costs directly associated with the ultimate resolution of the matter that are reasonably estimable and, if so, they are included in the accrual. These accruals are generally reported in “Other liabilities”. REVENUES, BENEFITS AND EXPENSES Insurance Revenue and Expense Recognition Premiums from individual life products, other than universal and variable life contracts, are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for all expected future policy benefits and non-level claim settlement expenses) is generally deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in "Future policy benefits" above. Premiums from single premium immediate annuities with life contingencies are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue based on expected future benefit payments. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in "Future policy benefits" above. Certain individual annuity contracts provide the contractholder a guarantee that the benefit received upon death or annuitization will be no less than a minimum prescribed amount. These benefits are generally accounted for as market risk benefits (see “Market risk benefits” above). Amounts received from policyholders as payment for universal or variable individual life contracts, deferred fixed or variable annuities and other contracts without life contingencies are reported as deposits to “Policyholders’ account balances” and/or “Separate account liabilities.” Revenues from these contracts are reflected in “Policy charges and fee income” consisting primarily of fees assessed during the period against the policyholders’ account balances for mortality and other benefit charges, policy administration charges and surrender charges. In addition to fees, the Company earns investment income from the investment of deposits in the Company’s general account portfolio. Fees assessed that represent compensation to the Company for services to be provided in future periods and certain other fees are generally deferred and amortized into revenue over the life of the related contracts using the same methodology, factors, and assumption used to amortize DAC as described above. Benefits and expenses for these products include claims in excess of related account balances, expenses of contract administration, interest credited to policyholders’ account balances and amortization of DAC and DSI. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products where changes in the value of the embedded derivatives are recorded through "Realized investment gains (losses), net". For additional information regarding the valuation of these embedded derivatives, see Note 5. Asset administration fees primarily include asset administration fee income received on contractholders’ account balances invested in The Prudential Series Funds, which are a portfolio of mutual fund investments related to the Company’s separate account products. Also, the Company receives fee income calculated on contractholder separate account balances invested in the Advanced Series Trust ("AST") (see Note 15). In addition, the Company receives fees from contractholders’ account balances invested in funds managed by companies other than affiliates of Prudential Insurance. Asset administration fees are recognized as income when earned. Other income (loss) includes realized and unrealized gains or losses from investments reported as “Fixed maturities, trading, at fair value”, “Equity securities, at fair value”, and “Other invested assets” that are measured at fair value as well as interest income related to affiliated cash collateral. See Note 15 for more information related to affiliated cash collateral. Realized investment gains (losses), net includes realized gains or losses from sales and maturities of investments, changes to the allowance for credit losses, other impairments, fair value changes on mortgage loans where the fair value option has been elected, and derivative gains or losses. The derivative gains or losses include the impact of maturities, terminations and changes in fair value of the derivative instruments, including embedded derivatives, and other hedging instruments. Realized investment gains (losses) from the sales of securities are generally calculated using the specific identification method. OTHER ACCOUNTING POLICIES Derivative Financial Instruments Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and NPR used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties, while others are bilateral contracts between two counterparties. Derivative positions are carried at fair value, generally by obtaining quoted market prices or through the use of valuation models. Derivatives are used to manage the interest rate and currency characteristics of assets or liabilities. Additionally, derivatives may be used to reduce exposure to risks such as interest rate, credit, foreign currency and equity associated with assets held or expected to be purchased or sold, and liabilities incurred or expected to be incurred. As discussed in detail below and in Note 4, all realized and unrealized changes in fair value of derivatives are recorded in current earnings, with the exception of cash flow hedges. Cash flows from derivatives are reported in the operating, investing or financing activities sections in the Consolidated Statements of Cash Flows based on the nature and purpose of the derivative. Derivatives are recorded either as assets, within “Other invested assets”, or as liabilities, within “Payables to parent and affiliates”, except for embedded derivatives which are recorded with the associated host contract. The Company nets the fair value of all derivative financial instruments with counterparties for which a master netting arrangement has been executed. The Company designates derivatives as either (1) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow” hedge); or (2) a derivative that does not qualify for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. The Company formally documents at inception all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives designated as cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded in AOCI until earnings are affected by the variability of cash flows being hedged (e.g., when periodic settlements on a variable-rate asset or liability are recorded in earnings). At that time, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in the Consolidated Statements of Operations line item associated with the hedged item. If it is determined that a derivative no longer qualifies as an effective cash flow hedge or management removes the hedge designation, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net”. The component of AOCI related to discontinued cash flow hedges is reclassified to the Consolidated Statements of Operations line associated with the hedged cash flows consistent with the earnings impact of the original hedged cash flows. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, or because it is probable that the forecasted transaction will not occur by the end of the specified time period, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net”. Any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized currently in “Realized investment gains (losses), net”. Gains and losses that were in AOCI pursuant to the hedge of a forecasted transaction are recognized immediately in “Realized investment gains (losses), net”. If a derivative does not qualify for hedge accounting, all changes in its fair value, including net receipts and payments, are included in “Realized investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments that contain derivative instruments that are “embedded” in the financial instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are clearly and closely related to the economic characteristics of the remaining component of the financial instrument (i.e., the host contract) and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When it is determined that (1) the embedded instrument possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded instrument qualifies as an embedded derivative that is separated from the host contract, carried at fair value, and changes in its fair value are included in “Realized investment gains (losses), net”. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company may elect to carry the entire instrument at fair value and report it within "Other invested assets" and "Reinsurance recoverable and deposit receivables", or as liabilities, within “Payables to parent and affiliates” or "Reinsurance and funds withheld payables". The Company sells variable annuity contracts that include optional living benefit features that may be treated from an accounting perspective as embedded derivatives. The embedded derivatives related to the living benefit features and the related reinsurance agreements are carried at fair value and included in “Future policy benefits" and “Reinsurance recoverables and deposit receivables”. Additionally, changes in the fair value are determined using valuation models as described in Note 5 and are recorded in “Realized investment gains (losses), net". Reinsurance The Company participates in reinsurance arrangements in various capacities as either the ceding entity or as the reinsurer (i.e., assuming entity). See Note 11 for additional information regarding the Company’s reinsurance arrangements. Reinsurance assumed business is generally accounted for consistent with direct business. Amounts currently recoverable under reinsurance agreements are included in “Reinsurance recoverables and deposit receivables” and amounts payable are included in “Reinsurance and funds withheld payables”. “Reinsurance recoverables and deposit receivables” also includes deposit receivables where the Company has ceded fixed indexed annuities, including from coinsurance with funds withheld arrangements and receivables from modified coinsurance arrangements where the Company is the cedant, and in certain instances are net of the payables under these arrangements which generally reflect the fair value of the invested assets retained by the cedant. “Reinsurance and funds withheld payables” also includes amounts payable to the reinsurer under coinsurance with funds withheld arrangements where the Company is the cedant, and generally reflect the fair value of the invested assets retained by the Company. The receivables and payables associated with each of these coinsurance with funds withheld and modified coinsurance arrangements each contain an embedded derivative that is bifurcated and accounted for at fair value separately from the host contract, with changes in fair value recorded through “Realized investment gains (losses), net”, and are ultimately presented net within “Reinsurance recoverables and deposit receivables”. Revenues and benefits and expenses include amounts assumed under reinsurance agreements and are reflected net of reinsurance ceded. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. Reinsurance recoverables are reported on the Consolidated Statements of Financial Position net of the CECL allowance. The CECL allowance considers the credit quality of the reinsurance counterparty and is generally determined based on the probability of default and loss given default assumptions, after considering any applicable collateral arrangements. The CECL allowance does not apply to reinsurance recoverables with affiliated counterparties under common control. Additions to or releases of the allowance are reported in “Policyholders’ benefits”. Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured long-duration contracts under coinsurance arrangements are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. For reinsurance of in force blocks of non-participating traditional and limited-payment contracts, the current value of the direct liability as of inception of the reinsurance agreement is used to calculate the reinsurance recoverable and cost of reinsurance such that there is no immediate other comprehensive income or loss from recognition of the reinsurance recoverable at inception. Consistent with the direct liability, the reinsurance recoverable for non-participating traditional and limited-payment contracts is remeasured each period using current single A rates with the effect on the reinsurance recoverable resulting from such updates recorded in "Interest rate remeasurement of future policy benefits" in OCI. For reinsurance of limited-payment contracts, the Company establishes a cost of reinsurance asset relating to the direct DPL and amortizes this balance through “Premiums” using the same methodology and assumptions used to amortize the direct DPL. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference between the fair value of the net consideration exchanged and the net liabilities ceded related to the underlying reinsured contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. This initial net cost of reinsurance is deferred and amortized into income over the remaining life of the reinsured policies on a basis consistent with the methodologies and assumptions used for amortizing DAC. This initial net cost of reinsurance may result in a deferred reinsurance gain which is recorded in "Other liabilities" and amortized through "Other income (loss)", or a deferred reinsurance loss which is recorded in "Other assets" and amortized through "General, administrative and other expenses". Consistent with direct contracts, reinsurance agreements may also include features that meet the definition of an MRB and, if so, are accounted for at fair value. The fair value of direct or assumed MRBs reflects the Company's NPR, while the fair value of ceded MRBs reflects the counterparty credit risk of the reinsurer. Changes in the fair value of ceded MRBs, including the impact of changes in counterparty credit risk, are recorded in net income in "Change in value of market risk benefits, net of related hedging gains (losses)". Coinsurance arrangements contrast with the Company’s yearly renewable term ("YRT") arrangements, where only mortality risk is transferred to the reinsurer and premiums are paid to the reinsurer to reinsure that risk. The mortality risk that is reinsured under YRT arrangements represents the difference between the stated death benefits in the underlying reinsured contracts and the corresponding reserves or account value carried by the Company on those same contracts. The premiums paid to the reinsurer are based upon negotiated amounts, not on the actual premiums paid by the underlying contractholders to the Company. As YRT arrangements are usually entered into by the Company with the expectation that the contracts will be in force for the lives of the underlying policies, they are considered to be long-duration reinsurance contracts. The cost of reinsurance for universal life products is generally recognized based on the gross assessments of the underlying direct policies. The cost of reinsurance for term insurance products is generally recognized in proportion to direct premiums over the life of the underlying policies. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in “Reinsurance and funds withheld payables” and deposits made are included in “Reinsurance recoverables and deposit receivables”. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as “Other income (loss)” or “General, administrative and other expenses”, as appropriate. Annual Assumptions Review Annually, the Company performs a comprehensive review of the assumptions set for purposes of estimating future premiums, benefits, and other cash flows. Assumptions include those that are economic and those that are insurance related. Insurance related assumptions are based on the Company’s best estimates of future rates of mortality, morbidity, lapse, surrender, annuitization, expenses and other items. The Company generally looks to relevant Company experience as the primary basis for these assumptions. If relevant Company experience is not available or does not have sufficient credibility, the Company may look to experience of similar blocks of business, either in the Company or the industry. Mortality rate assumptions are generally based on Company experience, sometimes blending Company experience with an industry table where the Company experience alone is not sufficiently credible. The Company sets mortality and morbidity assumptions that vary by major type of business. Within type of business, rates vary by age and gender. The Company applies an adjustment for future mortality improvement, consistent with observed long-term trends of population mortality over time. Lapse and surrender assumptions are based on Company and industry experience, where available. The Company sets rates that vary by product type, taking into account features specific to the product. As part of this review, the Company may update these assumptions and make refinements to its models based upon emerging experience, future expectations and other data, including any observable market data it feels is indicative of a long-term trend. These assumptions are generally updated annually, unless a material change is observed in an interim period that the Company feels is also indicative of a long-term trend. Generally, the Company does not expect trends to change significantly in the short-term and, to the extent these trends may change, it expects such changes to be gradual over the long-term. The Company also performs a comprehensive review of the economic assumptions, including long-term interest rate assumptions and equity return assumptions that impact reserve calculations. The Company generally utilizes relevant economic outlook information and industry surveys as the primary basis for these assumptions, which may be used to project future rates of return on investments. RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the FASB in the form of ASUs to the FASB Accounting Standards Codification ("ASC"). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of December 31, 2024, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material. ASUs adopted as of December 31, 2024
ASUs issued but not yet adopted as of December 31, 2024
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | 3. INVESTMENTS Fixed Maturity Securities The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
(1) Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (2) Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
(1) Includes credit-tranched securities collateralized by loan obligations, auto loans, education loans and home equity loans. (2) Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. The following tables set forth the fair value and gross unrealized losses on fixed maturity, available-for-sale securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
As of December 31, 2024 and 2023, the gross unrealized losses on fixed maturity, available-for-sale securities without an allowance of $2,059 million and $1,634 million, respectively, related to “1” highest quality or “2” high quality securities based on the National Association of Insurance Commissioners (“NAIC”) or equivalent rating and $102 million and $106 million, respectively, related to other than high or highest quality securities based on NAIC or equivalent rating. As of December 31, 2024, the $1,894 million of gross unrealized losses of twelve months or more were concentrated in the Company’s corporate securities within the finance, consumer non-cyclical and utility sectors. As of December 31, 2023, the $1,700 million of gross unrealized losses of twelve months or more were concentrated in the Company's corporate securities within the finance, consumer non-cyclical and utility sectors. In accordance with its policy described in Note 2, the Company concluded that an adjustment to earnings for credit losses related to these fixed maturity securities was not warranted at December 31, 2024. This conclusion was based on a detailed analysis of the underlying credit and cash flows for each security. Gross unrealized losses are primarily attributable to increases in interest rates, general credit spread widening and foreign currency exchange rate movements. As of December 31, 2024, the Company did not intend to sell these securities, and it was not more likely than not that the Company would be required to sell these securities before the anticipated recovery of the remaining amortized cost basis. The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:
Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Asset-backed, commercial mortgage-backed and residential mortgage-backed securities are shown separately in the table above, as they do not have a single maturity date. The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
(1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $(158.4) million, $57.4 million and $(53.9) million for the years ended December 31, 2024, 2023 and 2022, respectively. (2)Amounts represent write-downs of credit adverse securities and securities actively marketed for sale. The following tables set forth the balance of and changes in the allowance for credit losses for fixed maturity securities, as of and for the periods indicated:
See Note 2 for additional information about the Company's methodology for developing its allowance and expected losses. For the year ended December 31, 2024, the net increase in the allowance for credit losses on available-for-sale securities was primarily related to net additions within the consumer cyclical, consumer non-cyclical and energy sectors within corporate securities due to adverse projected cash flows. For the year ended December 31, 2023, the net decrease in the allowance for credit losses on available-for-sale securities was primarily related to net reductions within the capital goods and utility sectors within corporate securities due to restructurings, partially offset by net additions within the finance sector within corporate securities due to adverse projected cash flows. The Company did not have any fixed maturity securities purchased with credit deterioration as of both December 31, 2024 and 2023. Fixed Maturities, Trading The net change in unrealized gains (losses) from fixed maturities, trading still held at period end, recorded within “Other income (loss)” was $(182.9) million, $65.6 million and $(728.6) million during the years ended December 31, 2024, 2023 and 2022, respectively. Equity Securities The net change in unrealized gains (losses) from equity securities still held at period end, recorded within “Other income (loss)” was $(34.2) million, $25.8 million and $(10.2) million during the years ended December 31, 2024, 2023 and 2022, respectively. Commercial Mortgage and Other Loans The following table sets forth the composition of “Commercial mortgage and other loans”, as of the dates indicated:
As of December 31, 2024, the commercial mortgage and agricultural property loans were secured by properties geographically dispersed throughout the United States with the largest concentrations in California (25%), Florida (9%) and Texas (8%) and included loans secured by properties in Europe (8%), Mexico (1%) and Australia (1%). The following table sets forth the balance of and changes in the allowance for credit losses for commercial mortgage and other loans, as of and for the periods ended:
See Note 2 for additional information about the Company's methodology for developing the allowance and expected losses. For the year ended December 31, 2024, net additions to the allowance for credit losses on commercial mortgage and other loans were primarily related to increases in loan-specific allowances in commercial mortgage loans within the retail and office sectors and in agricultural property loans. For the year ended December 31, 2023, net additions to the allowance for credit losses on commercial mortgage and other loans was primarily related to increases in the portfolio reserve to reflect declining market conditions and in loan-specific allowances, both within the office sector, as well as loan originations. For the year ended December 31, 2024, there were $9.4 million of write-downs charged against the allowance related to a loan originated in 2016. The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:
See Note 2 for additional information about the Company’s commercial mortgage and other loans credit quality monitoring process. The Company may grant loan modifications in its commercial mortgage and other loan portfolios to borrowers experiencing financial difficulties. These loan modifications may be in the form of principal forgiveness, interest rate reduction, other-than-insignificant payment delay, term extension or some combination thereof. The amount, timing and extent of modifications granted and subsequent performance are considered in determining any allowance for credit losses. The following table sets forth the amortized cost basis of loan modifications made to borrowers experiencing financial difficulties for the date indicated:
The modifications added less than one year to the weighted average life in the commercial mortgage loan portfolio. During the year ended December 31, 2023, the Company did not modify any loans to borrowers experiencing financial difficulties. The Company did not have any commitments to lend additional funds to borrowers experiencing financial difficulties on modified loans as of both December 31, 2024 and 2023. The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
(1)As of December 31, 2024, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2.
(1)As of December 31, 2023, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2. Loans on non-accrual status recognized interest income of $0.7 million and $0.0 million for the years ended December 31, 2024 and 2023, respectively. Loans on non-accrual status that did not have a related allowance for credit losses were $2.0 million and $1.3 million as of December 31, 2024 and 2023, respectively. For the years ended December 31, 2024 and 2023, there were $12.6 million and $0.0 million, respectively, of commercial mortgage loans acquired, other than those through direct origination. For both the years ended December 31, 2024 and 2023, there were no commercial mortgage and other loans sold. The Company did not have any commercial mortgage and other loans purchased with credit deterioration as of both December 31, 2024 and 2023. Other Invested Assets The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
(1)Prior period amounts have been updated to conform to current period presentation. (2)Includes tax advantaged investments and investments in separate account funds. Equity Method Investments The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in operating joint ventures. Changes between periods in the tables below reflect changes in the activities within the operating joint ventures and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
(1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party borrowed funds and other miscellaneous liabilities.
(1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses. Accrued Investment Income The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
There were no write-downs on accrued investment income for the years ended December 31, 2024 and 2023. Net Investment Income The following table sets forth “Net investment income” by investment type, for the periods indicated:
The carrying value of non-income producing assets included $55.3 million in fixed maturities, available-for-sale and $0.9 million in fixed maturities, trading as of December 31, 2024. Non-income producing assets represent investments that had not produced income for the twelve months preceding December 31, 2024. Realized Investment Gains (Losses), Net The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
(1)Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading. (2)Prior period amounts have been updated to conform to current period presentation. (3)Includes changes in the value of reinsurance payables and funds withheld payables, primarily reflecting the impact of net investment income on withheld assets that are ceded to certain reinsurance counterparties. (4)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Net Unrealized Gains (Losses) on Investments within AOCI The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
(1)For additional information regarding cash flow hedges, see Note 4. (2)Includes net unrealized gains (losses) on certain joint ventures that are strategic in nature and are included in “Other assets.” Repurchase Agreements and Securities Lending In the normal course of business, the Company sells securities under agreements to repurchase and enters into securities lending transactions. As of both December 31, 2024 and 2023, the Company had no repurchase agreements. The following table sets forth the composition of “Cash collateral for loaned securities,” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
(1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated. Securities Pledged, Restricted Assets and Special Deposits The Company pledges as collateral investment securities it owns through certain transactions, including securities lending, securities sold under agreements to repurchase, collateralized borrowings and postings of collateral with derivative counterparties. The following table sets forth the carrying value of investments pledged to third-parties and the carrying amount of the associated liabilities supported by the pledged collateral, as of the dates indicated:
(1)Prior period amounts have been updated to conform to current period presentation. In the normal course of its business activities, the Company accepts collateral that can be sold or repledged. The primary sources of this collateral are securities purchased under agreements to resell. As of December 31, 2024 and 2023, there were $0 million and $25 million, respectively, of collateral that could be sold or repledged. As of both December 31, 2024 and 2023, there was $3.6 million on deposit with governmental authorities or trustees as required by certain insurance laws.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments | DERIVATIVES AND HEDGING Types of Derivative Instruments and Derivative Strategies Interest Rate Contracts Interest rate swaps, interest rate total return swaps, options, and futures are used by the Company to reduce risks from changes in interest rates, manage interest rate exposures arising from mismatches between assets and liabilities and to hedge against changes in the values it owns or anticipates acquiring or selling. Swaps may be attributed to specific assets or liabilities or to a portfolio of assets or liabilities. Under interest rate swaps, the Company agrees with counterparties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed upon notional principal amount. Under interest rate total return swaps, the company agrees with counterparties to exchange, at specified intervals, the difference between the return on a fixed income market index and Secured Overnight Financing Rate (“SOFR”) plus an associated funding spread based on a notional amount. The Company also uses interest rate swaptions, caps and floors to manage interest rate risk. A swaption is an option to enter into a swap with a forward starting effective date. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. In an interest rate cap, the buyer receives payments at the end of each period in which the interest rate exceeds the agreed strike price. Similarly, in an interest rate floor, the buyer receives payments at the end of each period in which the interest rate is below the agreed strike price. Swaptions, caps and floors are included in interest rate options. In standardized exchange-traded interest rate futures transactions, the Company purchases or sells a specified number of contracts, the values of which are determined by the daily market values of underlying referenced investments. The Company enters into exchange-traded futures with regulated futures commission's merchants who are members of a trading exchange. Equity Contracts Equity options, equity total return swaps, and futures are used by the Company to manage its exposure to the equity markets which impacts the value of assets and liabilities it owns or anticipates acquiring or selling. Equity index options are contracts which will settle in cash based on differentials in the underlying indices at the time of exercise and the strike price. The Company uses combinations of purchases and sales of equity index options to hedge the effects of adverse changes in equity indices within a predetermined range. Equity total return swaps are contracts whereby the Company agrees with counterparties to exchange, at specified intervals, the difference between the return on an asset (or market index) and Secured Overnight Financing Rate (“SOFR”) plus an associated funding spread based on a notional amount. The Company generally uses total return swaps to hedge the effect of adverse changes in equity indices. In standardized exchange-traded equity futures transactions, the Company purchases or sells a specified number of contracts, the values of which are determined by the daily market values of underlying referenced equity indices. The Company enters into exchange-traded futures with regulated futures commission's merchants who are members of a trading exchange. Foreign Exchange Contracts Currency derivatives, including currency swaps and forwards, are used by the Company to reduce risks from changes in currency exchange rates with respect to investments denominated in foreign currencies that the Company either holds or intends to acquire or sell. Under currency forwards, the Company agrees with counterparties to deliver a specified amount of an identified currency at a specified future date. Typically, the price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. The Company executes forward sales of the hedged currency in exchange for U.S. dollars at a specified exchange rate. The maturities of these forwards correspond with the future periods in which the non-U.S. dollar-denominated earnings are expected to be generated. Under currency swaps, the Company agrees with counterparties to exchange, at specified intervals, the difference between one currency and another at an exchange rate and calculated by reference to an agreed principal amount. Generally, the principal amount of each currency is exchanged at the beginning and termination of the currency swap by each party. Credit Contracts The Company writes credit protection to gain exposure similar to investment in public fixed maturity cash instruments. With these credit derivatives the Company sells credit protection on a single name reference, or certain index reference, and in return receives a quarterly premium. This premium or credit spread generally corresponds to the difference between the yield on the referenced name (or an index’s referenced names) public fixed maturity cash instruments and swap rates, at the time the agreement is executed. If there is an event of default by the referenced name or one of the referenced names in the index, as defined by the agreement, then the Company is obligated to pay the referenced amount of the contract to the counterparty and receive in return the referenced defaulted security or similar security or (in the case of a credit default index) pay the referenced amount less the auction recovery rate. In addition to selling credit protection, the Company purchases credit protection using credit derivatives in order to hedge specific credit exposures in the Company’s investment portfolio. Embedded Derivatives The Company offers certain products (for example, indexed annuities and index-linked universal life) which may include features that are accounted for as embedded derivatives; related to certain of these derivatives, the Company has entered into reinsurance agreements with both affiliated and unaffiliated parties. See Note 11 for additional information on the reinsurance agreements. These embedded derivatives and reinsurance agreements, also accounted for as derivatives, are carried at fair value and marked to market through “Realized investment gains (losses), net” based on the change in value of the underlying contractual guarantees, which are determined using valuation models, as described in Note 5. Synthetic Guarantees The Company sells synthetic guarantees in the form of stable value wrap guarantees on third-party banked owned life insurance contracts. The synthetic guarantees are issued in respect of assets that are owned by the third-party insurer, who invest the assets according to the contract terms agreed to with the Company. The contracts establish policyholder balances and credit interest thereon. The policyholder balances are supported by the underlying assets. In connection with certain policyholder-initiated withdrawals, the contract guarantees that after all underlying assets are liquidated, any remaining policyholder balances will be paid by the Company. These guarantees are accounted for as derivatives and recorded at fair value. Primary Risks Managed by Derivatives The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables and deposit receivables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral.
(1)Excludes embedded derivatives which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $11,968 million and $7,505 million as of December 31, 2024 and 2023, respectively, primarily included in "Policyholders' account balances". (2)Recorded in “Other invested assets” and “Payables to parent and affiliates” on the Consolidated Statements of Financial Position. Offsetting Assets and Liabilities The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverable and deposit receivables), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position.
(1)Amounts exclude the excess of collateral received/pledged from/to the counterparty. For information regarding the rights of offset associated with the derivative assets and liabilities in the table above see “Credit Risk” below and Note 15. For securities purchased under agreements to resell and securities sold under agreements to repurchase, the Company monitors the value of the securities and maintains collateral, as appropriate, to protect against credit exposure. Where the Company has entered into repurchase and resale agreements with the same counterparty, in the event of default, the Company would generally be permitted to exercise rights of offset. For additional information on the Company’s accounting policy for securities repurchase and resale agreements, see Note 2 to the Consolidated Financial Statements. Cash Flow Hedges The primary derivative instruments used by the Company in its cash flow hedge accounting relationships are currency swaps and interest rate swaps. These instruments are only designated for hedge accounting in instances where the appropriate criteria are met. The Company does not use futures, options, credit, or equity derivatives in any of its cash flow hedge accounting relationships. The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, excluding the offset of the hedged item in an effective hedge relationship.
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
The changes in fair value of cash flow hedges are deferred in AOCI and are included in "Net unrealized investment gains (losses)" in the Consolidated Statements of Operations and Comprehensive Income (Loss); these amounts are then reclassified to earnings when the hedged item affects earnings. Using December 31, 2024 values, it is estimated that a pre-tax gain of $41 million is expected to be reclassified from AOCI to earnings during the subsequent twelve months ending December 31, 2025. The exposures the Company is hedging with these qualifying cash flow hedges include the variability of the payment or receipt of interest or foreign currency amounts on existing financial instruments. There were no material amounts reclassified from AOCI into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging. Credit Derivatives Credit Derivatives, where the Company has written credit protection on certain index references, have outstanding notional amounts of $912 million and $643 million as of December 31, 2024 and 2023, respectively. These credit derivatives are reported at fair value as an asset of $10 million and $8 million as of December 31, 2024 and 2023, respectively. As of December 31, 2024 the notional amount of these credit derivatives had $877 million in NAIC 3 and $35 million in NAIC 6. The Company has no exposure on purchased credit protection as of December 31, 2024 and 2023. Counterparty Credit Risk The Company is exposed to credit-related losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by entering into derivative transactions with regulated derivatives exchanges for exchange traded derivatives and its affiliate, Prudential Global Funding LLC (“PGF”), related to its over-the-counter ("OTC") derivatives. PGF, in turn, manages its credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review. Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value of Assets and Liabilities | FAIR VALUE OF ASSETS AND LIABILITIES Fair Value Measurement - Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative fair value guidance establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1 - Fair value is based on unadjusted quoted prices in active markets that are accessible to the Company for identical assets or liabilities. The Company’s Level 1 assets and liabilities primarily include certain cash equivalents and short-term investments, equity securities, and derivative contracts that trade on an active exchange market included in other invested assets and other liabilities. Level 2 - Fair value is based on significant inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability through corroboration with observable market data. Level 2 inputs include quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, and other market observable inputs. The Company’s Level 2 assets and liabilities include: fixed maturities (corporate public and private bonds, most government securities, certain asset-backed and mortgage-backed securities, etc.), certain equity securities (mutual funds, which do not trade in active markets because they are not publicly available), certain cash equivalents (primarily commercial paper), short-term investments, certain OTC derivatives, separate account assets, receivables from parent and affiliates and other liabilities. Level 3 - Fair value is based on at least one significant unobservable input for the asset or liability. The assets and liabilities in this category may require significant judgment or estimation in determining the fair value. The Company’s Level 3 assets and liabilities primarily include: certain private fixed maturities and equity securities, certain manually priced public equity securities and fixed maturities, certain highly structured OTC derivative contracts, contracts or contract features pertaining to living benefit features (market risk benefits) of the Company's variable annuity contracts, embedded derivatives associated with the index-linked features of certain universal life and annuity products, receivables from parent and affiliates, short-term investments, cash equivalents and other liabilities. Assets and Liabilities by Hierarchy Level - The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.
(1)“Netting” amounts represent cash collateral of $(8,311) million and $(9,569) million as of December 31, 2024 and 2023, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (3)Equity securities excluded from the fair value hierarchy include a fund for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. As of December 31, 2023, the fair value of this investment was $14.6 million. (4)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at NAV per share (or its equivalent) as a practical expedient. At December 31, 2024 and 2023, the fair value of such investments was $44 million and $67 million, respectively. (5)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Consolidated Statements of Financial Position. (6)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund. At December 31, 2024 and 2023, the fair value of such investments was $6,444 million and $5,259 million, respectively. (7)Prior period amounts have been updated to conform to current period presentation. (8)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. The methods and assumptions the Company uses to estimate the fair value of assets and liabilities measured at fair value on a recurring basis are summarized below. Fixed Maturity Securities - The fair values of the Company’s public fixed maturity securities are generally based on prices obtained from independent pricing services. Prices for each security are generally sourced from multiple pricing vendors, and a vendor hierarchy is maintained by asset type based on historical pricing experience and vendor expertise. The Company ultimately uses the price from the pricing service highest in the vendor hierarchy based on the respective asset type. The pricing hierarchy is updated for new financial products and recent pricing experience with various vendors. Consistent with the fair value hierarchy described above, securities with validated quotes from pricing services are generally reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. Typical inputs used by these pricing services include but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, and/or estimated cash flow, prepayment speeds, and default rates. If the pricing information received from third-party pricing services is deemed not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process with the pricing service or classify the securities as Level 3. If the pricing service updates the price to be more consistent with the presented market observations, the security remains within Level 2. Internally-developed valuations or indicative broker quotes are also used to determine fair value in circumstances where vendor pricing is not available, or where the Company ultimately concludes that pricing information received from the independent pricing services is not reflective of market activity. If the Company concludes the values from both pricing services and brokers are not reflective of market activity, it may override the information with an internally-developed valuation. As of December 31, 2024 and 2023, overrides on a net basis were not material. Pricing service overrides, internally-developed valuations and indicative broker quotes are generally included in Level 3 in the fair value hierarchy. The Company conducts several specific price monitoring activities. Daily analyses identify price changes over predetermined thresholds defined at the financial instrument level. Various pricing integrity reports are reviewed on a daily and monthly basis to determine if pricing is reflective of market activity or if it would warrant any adjustments. Other procedures performed include, but are not limited to, reviews of third-party pricing services methodologies, reviews of pricing trends and back testing. The fair values of private fixed maturities, which are originated by internal private asset managers, are primarily determined using discounted cash flow models. These models primarily use observable inputs that include Treasury or similar base rates plus estimated credit spreads to value each security. The credit spreads are obtained through a survey of private market intermediaries who are active in both primary and secondary transactions, and consider, among other factors, the credit quality and the reduced liquidity associated with private placements. Internal adjustments are made to reflect variation in observed sector spreads. Since most private placements are valued using standard market observable inputs and inputs derived from, or corroborated by, market observable data including, but not limited to observed prices and spreads for similar publicly or privately traded issues, they have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model may incorporate significant unobservable inputs, which reflect the Company’s own assumptions about the inputs that market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the price of a security, a Level 3 classification is made. Equity Securities - Equity securities consist principally of investments in common and preferred stock of publicly traded companies, privately traded securities, as well as mutual fund shares. The fair values of most publicly traded equity securities are based on quoted prices in active markets for identical assets and are classified within Level 1 in the fair value hierarchy. Estimated fair values for most privately traded equity securities are determined using discounted cash flow, earnings multiple and other valuation models that require a substantial level of judgment around inputs and therefore are classified within Level 3. The fair values of mutual fund shares that transact regularly (but do not trade in active markets because they are not publicly available) are based on transaction prices of identical fund shares and are classified within Level 2 in the fair value hierarchy. Derivative Instruments - Derivatives are recorded at fair value either as assets, within “Other invested assets”, or as liabilities within “Payables to parent and affiliates” or "Other liabilities", except for embedded derivatives which are recorded with the associated host contract. The fair values of derivative contracts can be affected by changes in interest rates, foreign exchange rates, credit spreads, market volatility, expected returns, NPR, liquidity and other factors. The Company's exchange-traded futures and options include treasury and equity futures. Exchange-traded futures and options are valued using quoted prices in active markets and are classified within Level 1 in the fair value hierarchy. The majority of the Company’s derivative positions are traded in the OTC derivative market and are classified within Level 2 in the fair value hierarchy. OTC derivatives classified within Level 2 are valued using models that utilize actively quoted or observable market inputs from external market data providers, third-party pricing vendors and/or recent trading activity. The Company’s policy is to use mid-market pricing in determining its best estimate of fair value. The fair values of most OTC derivatives, including interest rate and cross-currency swaps, currency forward contracts and credit default swaps are determined using discounted cash flow models. The fair values of European style option contracts are determined using Black-Scholes option pricing models. These models’ key inputs include the contractual terms of the respective contract, along with significant observable inputs, including interest rates, currency rates, credit spreads, equity prices, index dividend yields, NPR, volatility and other factors. The Company’s cleared interest rate swaps and credit derivatives linked to an index are valued using models that utilize actively quoted or observable market inputs, including SOFR, obtained from external market data providers, third-party pricing vendors and/or recent trading activity. These derivatives are classified as Level 2 in the fair value hierarchy. Cash Equivalents and Short-Term Investments - Cash equivalents and short-term investments include money market instruments, commercial paper and other highly liquid debt instruments. Certain money market instruments are valued using unadjusted quoted prices in active markets that are accessible for identical assets and are primarily classified as Level 1. The remaining instruments in this category are generally fair valued based on market observable inputs and these investments have primarily been classified within Level 2. Separate Account Assets - Separate account assets include fixed maturity securities, treasuries, equity securities, real estate, mutual funds and commercial mortgage loans for which values are determined consistent with similar instruments described above under “Fixed Maturity Securities” and “Equity Securities”. Reinsurance Recoverables and Deposit Receivables - Reinsurance recoverables and deposit receivables primarily include (1) an embedded derivative associated with net receivables from modified coinsurance arrangements where the Company is the cedant; and (2) an embedded derivatives on deposit receivables where the Company has ceded fixed indexed annuities. The methods and assumptions used to estimate the fair value are consistent with those described below in “Policyholders' account balances”. Receivables from Parent and Affiliates - Receivables from parent and affiliates carried at fair value include affiliated bonds within the Company’s legal entity where fair value is determined consistent with similar securities described above under “Fixed Maturity Securities” managed by affiliated asset managers. Market Risk Benefits - As a result of the adoption of ASU 2018-12 in the first quarter of 2023, the Company is required to measure all market risk benefits (e.g., living benefit and death benefit guarantees associated with variable annuities) at fair value. Market risk benefit liabilities (or assets) represent contracts or contract features that provide protection to the contractholder and expose the insurance entity to other than nominal capital market risk, primarily related to deferred annuities with guaranteed minimum benefits in the annuities products including GMDB, GMIB, GMAB, GMWB and GMIWB. The benefits are bundled together and accounted for as single compound market risk benefits using a fair value measurement framework. The fair value of these market risk benefits is calculated as the present value of expected future benefit payments to contractholders less the present value of expected future rider fees attributable to the market risk benefits. The fair value of these benefit features is based on assumptions a market participant would use in valuing market risk benefits. This methodology could result in either a liability or asset balance, given changing capital market conditions and various actuarial assumptions. Since there is no observable active market for the transfer of these obligations, the valuations are calculated using internally-developed models with option pricing techniques. The models are based on a risk neutral valuation framework and incorporate premiums for risks inherent in valuation techniques, inputs, and the general uncertainty around the timing and amount of future cash flows. The determination of these risk premiums requires the use of management’s judgment. The significant inputs to the valuation models for these market risk benefits include capital market assumptions, such as interest rate levels and volatility assumptions, the Company’s market-perceived NPR, as well as actuarially determined assumptions, including contractholder behavior, such as lapse rates, benefit utilization rates, withdrawal rates, and mortality rates. Since many of these assumptions are unobservable and are considered to be significant inputs to the valuations, the assets and liabilities included in market risk benefits have been reflected within Level 3 in the fair value hierarchy. Capital market inputs and actual policyholders’ account values are updated each quarter based on capital market conditions as of the end of the quarter, including interest rates, equity markets and volatility. In the risk neutral valuation, the initial swap curve drives the total return used to grow the policyholders’ account values. The Company’s discount rate assumption is based on the SOFR swap curve adjusted for an additional spread relative to SOFR to reflect the Company’s market-perceived NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with Company issued funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements, living benefit guarantees, and index-linked interest crediting guarantees are insurance liabilities and are therefore senior to debt. Actuarial assumptions, including contractholder behavior and mortality, are reviewed at least annually, and updated based upon Company emerging experience and industry studies, future expectations and other data, including any observable market data. These assumptions are generally updated annually unless a material change that the Company feels is indicative of a long-term trend is observed in an interim period. Policyholders' Account Balances - The liability for policyholders’ account balances is related to certain embedded derivative instruments associated with certain universal life and annuity products that provide policyholders with index-linked interest credited over contract specified term periods. The fair values of these liabilities are determined using discounted cash flow models which include capital market assumptions such as interest rates and equity index volatility assumptions, the Company’s market-perceived NPR and actuarially determined assumptions for mortality, lapses and projected hedge costs. As there is no observable active market for these liabilities, the fair value is determined as the present value of account balances paid to policyholders in excess of contractually guaranteed minimums using option pricing techniques for index term periods that contain deposits as of the valuation date, and the expected option cost for future index term periods, where the terms of index crediting rates have not yet been declared by the Company. Premiums for risks inherent in valuation techniques, inputs, and the general uncertainty around the timing and amount of future cash flows are also incorporated in the fair value of these liabilities. Since the valuation of these liabilities requires the use of management’s judgment to determine these risk premiums and the use of unobservable inputs, these liabilities are reflected within Level 3 in the fair value hierarchy. Capital market inputs, including interest rates and equity markets volatility, and actual policyholders’ account values are updated each quarter. Actuarial assumptions are reviewed at least annually and updated based upon emerging Company experience, future expectations and other data, including any observable market data. Aside from these annual updates, assumptions are generally updated only if a material change is observed in an interim period that the Company believes is indicative of a long-term trend. Reinsurance and Funds Withheld Payables - Reinsurance and funds withheld payables primarily includes an embedded derivative associated with certain funds withheld reinsurance arrangements that are described in Note 11. The fair value is determined based on the valuation of the underlying funds withheld assets identified to support the payable due to the applicable reinsurance counterparties. Other Liabilities - Other liabilities include certain derivative instruments. The fair values of derivative instruments are primarily determined consistent with those described above under "Derivative Instruments." Quantitative Information Regarding Internally-Priced Level 3 Assets and Liabilities - The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities.
(1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Directional impacts for MRB assets and liabilities are associated with the directional impacts of direct and assumed MRBs. (3)Includes assets classified as fixed maturities, available-for-sale and fixed maturities, trading. (4)Represents multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (6)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances. (7)The spread over the SOFR swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company's estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of December 31, 2024 and 2023, respectively. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar Life Insurance Company ("AuguStar"), an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits. See Note 11 for additional information regarding this transaction. As a result of this transaction, a ceded MRB asset balance was established to fair value the reinsurance reimbursements to the Company. The establishment of the fair value also required an estimate of NPR for AuguStar, which may differ from the Company's; however, the NPR spreads for AuguStar were developed using a methodology similar to that of the Company. (8)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (9)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of December 31, 2024 and 2023, the minimum withdrawal rate assumption is 78% and 81%, respectively. As of December 31, 2024 and 2023, the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (10)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age and duration. A mortality improvement assumption is also incorporated into the overall mortality table. (11)Includes deposit assets related to reinsurance agreements using deposit method of accounting and modified coinsurance agreements, which include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain annuity products. (12)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (13)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives. (14)Prior period amounts have been updated to conform to current period presentation. (15)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Interrelationships Between Unobservable Inputs - In addition to the sensitivities of fair value measurements to changes in each unobservable input in isolation, as reflected in the table above, interrelationships between these inputs may also exist, such that a change in one unobservable input may give rise to a change in another, or multiple, inputs. Examples of such interrelationships for significant internally-priced Level 3 assets and liabilities are as follows: Corporate Securities – The rate used to discount future cash flows reflects current risk-free rates plus credit and liquidity spread requirements that market participants would use to value an asset. The discount rate may be influenced by many factors, including market cycles, expectations of default, collateral, term and asset complexity. Each of these factors can influence discount rates, either in isolation, or in response to other factors. During weaker economic cycles, as the expectations of default increase, credit spreads widen, which results in a decrease in fair value. Commercial Mortgage-backed Securities – Interrelationships may exist between the prepayment rate, the default rate and/or loss severity, depending on specific market conditions. In stronger economic cycles, prepayment rates are generally driven by underlying property appreciation and subsequent cash-out refinances, while default rates and loss severity may be lower. During weaker economic cycles, prepayment rates may decline, while default rates and loss severity increase. Generally, a change in the assumption used for the probability of default would be accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumption used for prepayment rates. The impact of these factors on average life and economics varies with the deal structure and tranche subordination. Market Risk Benefits – The Company expects efficient benefit utilization and withdrawal rates to generally be correlated with lapse rates. However, behavior is generally highly dependent on the facts and circumstances surrounding the individual contractholder, such as their liquidity needs or tax situation, which could drive lapse behavior independent of other contractholder behavior assumptions. To the extent more efficient contractholder behavior results in greater in-the-moneyness at the contract level, lapse rates may decline for those contracts. Similarly, to the extent that increases in equity volatility are correlated with overall declines in the capital markets, lapse rates may decline as contracts become more in-the-money. Changes in Level 3 Assets and Liabilities - The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds. (4)Includes asset-backed and commercial mortgage-backed securities. (5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward. (6)Excludes MRB assets of $2,637 million and $2,367 million and MRB liabilities of $4,281 million and $5,157 million as of December 31, 2024 and 2023, respectively. See Note 10 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (8)Prior period amounts have been updated to conform to current period presentation. (9)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Nonrecurring Fair Value Measurements - The following tables present information for assets measured at fair value on a nonrecurring basis. The fair value measurement is nonrecurring as these assets are measured at fair value only when there is a triggering event (e.g., an evidence of impairment). Assets included in the table are those that were impaired during the respective reporting periods and that are still held as of the reporting date. The estimated fair values for these amounts were determined using significant unobservable inputs (Level 3). For the years ended December 31, 2024 and 2023, there were no triggering events.
Fair Value of Financial Instruments The tables below present the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
(1)Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. (2)Prior period amounts have been updated to conform to current period presentation. The fair values presented above have been determined by using available market information and by applying market valuation methodologies, as described in more detail below. Commercial Mortgage and Other Loans The fair value of most commercial mortgage loans is based upon the present value of the expected future cash flows discounted at the appropriate U.S. Treasury rate or foreign government bond rate (for non-U.S. dollar-denominated loans) plus an appropriate credit spread for loans of similar quality, average life and currency. The quality ratings for these loans, a primary determinant of the credit spreads and a significant component of the pricing process, are based on an internally-developed methodology. Certain commercial mortgage loans are valued incorporating other factors, including the terms of the loans, the relative strength of the underlying collateral, the principal exit strategies for the loans, prevailing interest rates and credit risk. Policy Loans The Company's valuation technique for policy loans is to discount cash flows at the current policy loan coupon rate. Policy loans are fully collateralized by the cash surrender value of underlying insurance policies. As a result, the carrying value of the policy loans approximates the fair value. Short-Term Investments, Cash and Cash Equivalents, Accrued Investment Income, Receivables from Parent and Affiliates and Other Assets The Company believes that due to the short-term nature of certain assets, the carrying value approximates fair value. These assets include: certain short-term investments, which are not securities, recorded at amortized cost, cash and cash equivalent instruments; accrued investment income; receivables from parent and affiliates; and other assets that meet the definition of financial instruments, including receivables such as unsettled trades and accounts receivable. Reinsurance Recoverables and Deposit Receivables Reinsurance recoverables and deposit receivables include receivables from modified coinsurance arrangements and other reinsurance arrangements between the Company and related parties. See Note 11 for additional information about the Company's reinsurance arrangements. Deposit receivables primarily consist of deposit assets related to the reinsurance agreements. Deposits made are included in “Reinsurance recoverables and deposit receivables”. The deposit assets are adjusted as amounts are paid, consistent with the underlying contracts. Policyholders’ Account Balances - Investment Contracts Only the portion of policyholders’ account balances related to products that are investment contracts (those without significant mortality or morbidity risk) are reflected in the table above. For fixed deferred annuities, payout annuities and other similar contracts without life contingencies, fair values are generally derived using discounted projected cash flows based on interest rates that are representative of the Company’s financial strength ratings, and hence reflect the Company’s NPR. For those balances that can be withdrawn by the customer at any time without prior notice or penalty, the fair value is the amount estimated to be payable to the customer as of the reporting date, which is generally the carrying value. Cash Collateral for Loaned Securities Cash collateral for loaned securities represents the collateral received or paid in connection with loaning or borrowing securities. Due to the short-term nature of these transactions, the carrying value approximates fair value. Debt The fair value of short-term and long-term debt is generally determined by either prices obtained from independent pricing services, which are validated by the Company, or discounted cash flow models. These fair values consider the Company’s NPR. Discounted cash flow models predominately use market observable inputs such as the borrowing rates currently available to the Company for debt and financial instruments with similar terms and remaining maturities. For debt with a maturity of less than 90 days, the carrying value approximates fair value. Reinsurance and Funds Withheld Payables Reinsurance and funds withheld payables include amounts payable to the reinsurer under coinsurance with funds withheld arrangements where the Company is the cedant. Deposits received are included in "Reinsurance and funds withheld payables." The deposit liabilities are adjusted as amounts are received, consistent with the underlying contracts. Payables to Parent and Affiliates Payables to parent and affiliates is primarily related to accrued expense payables. Due to the short-term until settlement of most of these liabilities, the Company believes that carrying value approximates fair value. Other Liabilities Other liabilities are primarily payables, such as unsettled trades, drafts, and escrow deposits. Due to the short-term until settlement of most of these liabilities, the Company believes that carrying value approximates fair value.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Charges, Insurers [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements | DEFERRED POLICY ACQUISITION COSTS, DEFERRED REINSURANCE AND DEFERRED SALES INDUCEMENTS Deferred Policy Acquisition Costs The following table shows a rollforward for the lines of business that contain DAC balances, along with a reconciliation to the Company's total DAC balance:
(1) Includes the impact of the reinsurance agreement with Lotus Re. See Note 11 for additional information. (2) Includes the impact of the reinsurance agreement with AuguStar. See Note 11 for additional information. (3) Includes the impacts of the Universal Life reinsurance transaction with PAR U and PURE. See Note 11 for additional information. (4) Includes the impacts of the Term Life reinsurance transaction with PARCC. See Note 11 for additional information. (5) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Deferred Reinsurance Losses The following table shows a rollforward for the lines of business that contain DRL balances, which is included in Other assets, along with a reconciliation to the Company's total DRL balance:
(1) Includes $979 million DRL related to the reinsurance transaction with Wilton Re. See Note 11 for additional information. (2) Includes $351 million DRL related to the reinsurance transaction with PARCC. See Note 11 for additional information. Deferred Reinsurance Gains The following table shows a rollforward for the lines of business that contain DRG balances, which is included in Other liabilities, along with a reconciliation to the Company's total DRG balance:
(1) Includes $1,352 million DRG related to the reinsurance agreement with Lotus Re, entered into January 1, 2022. See Note 11 for additional information. (2) Includes the impact of the reinsurance agreement with AuguStar. See Note 11 for additional information. (3) Includes the impact of the Universal Life reinsurance transactions with PAR U, PURE and Prudential Insurance effective January 1, 2024, including $1,207 million of DRG, partially offset by a $116 million write-off of the DRG that was recognized with the previous reinsurance agreement. See Note 11 for additional information. (4) Includes the impact of the Universal Life reinsurance transactions with PAR U and Prudential Insurance effective October 2024, including $798 million DRG, partially offset by a $94 million write-off of the DRG that was recognized with the previous reinsurance agreement. See Note 11 for additional information. Deferred Sales Inducements The following table shows a rollforward of DSI balances for variable annuity products, which is the only line of business that contains a DSI balance, along with a reconciliation to the Company's total DSI balance:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Accounts | SEPARATE ACCOUNTS The Company issues variable annuity and variable life insurance contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contractholder. Most variable annuity and variable life insurance contracts are offered with both separate and general account options. See Note 9 for additional information. The assets supporting the variable portion of variable annuity and variable life insurance contracts are carried at fair value and reported as “Separate account assets” with an equivalent amount reported as “Separate account liabilities”. The liabilities related to the net amount at risk are reflected within "Future policy benefits" or "Market risk benefit liabilities" (or "assets," if applicable). Amounts assessed against the contractholders for mortality, administration, and other services are included within revenue in “Policy charges and fee income” and changes in liabilities for minimum guarantees are generally included in “Policyholders’ benefits” or “Change in value of market risk benefits, net of related hedging gains (losses)”. Separate Account Assets The aggregate fair value of assets, by major investment asset category, supporting separate accounts is as follows:
For the periods ended December 31, 2024, 2023 and 2022, there were no transfers of assets, other than cash, from the general account to a separate account; therefore, no gains or losses were recorded. Separate Account Liabilities The balances of and changes in separate account liabilities as of and for the periods indicated are as follows:
(1) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (2) Variable life includes $900 million of funding for a policy loan to an affiliated irrevocable trust. See Note 15 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefits | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability; and •Additional Insurance Reserves In 2024, the Company recognized an impact to net income attributable to our annual reviews and update of assumptions and other refinements. Overall impact is immaterial for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort. Additionally, for direct and assumed AIR, the Company recognized an unfavorable impact primarily due to updates to policyholder behavior assumptions on universal life policies with secondary guarantees. In 2023, the Company recognized an impact to net income attributable to the annual reviews and update of assumptions and other refinements. Overall impact is immaterial for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort. Additionally, for direct and assumed AIR, the Company recognized an unfavorable impact primarily due to unfavorable model refinements, partially offset by updates to economic assumptions, including expected future rates of returns on universal life policies with secondary guarantees. In 2022, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed benefit reserves, primarily due to updates to mortality assumptions on individual term life insurance. Additionally, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update and other refinements for direct and assumed additional insurance reserves, primarily due to updates to policyholder behavior assumptions on universal life policies with secondary guarantees. Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:
For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss. In 2024, there was a $29 million gain in net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, which was offset by a $28 million charge, reflecting the impact of ceded reinsurance on the affected cohorts. In 2023, there was a $31 million gain in net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, which was offset by a $30 million charge, reflecting the impact of ceded reinsurance on the affected cohorts. In 2022, there was an $83 million charge to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, mostly offset by an $82 million gain, reflecting the impact of ceded reinsurance on the affected cohorts. The balances of and changes in DPL for the years ended December 31, are as follows:
Additional Insurance Reserves AIR represents the additional liability for annuitization, death, or other insurance benefits, including guaranteed minimum death benefits ("GMDB") and guaranteed minimum income benefits ("GMIB") contract features, that are above and beyond the contractholder's account balance for certain long-duration life contracts. The following table shows a rollforward of AIR balances for variable and universal life products, for the years ended December 31,:
(1) Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from the above rollforwards, Benefit Reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for Future Policy Benefits as reported on the Company's Consolidated Statements of Financial Position for the years ended December 31,:
(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations for the periods indicated:
(1)Represents "Gross premiums" for benefit reserves; "Revenue" for DPL and "Gross assessments" for AIR.
The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
(1) Other adjustments for December 31, 2023 primarily includes $638 million related to the reinsurance transaction with AuguStar. See Note 11 for additional information. (2) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. In both 2024 and 2023, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to policyholder behavior assumptions on certain variable annuities. In 2022, the Company recognized a favorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to mortality and policyholder behavior assumptions on certain variable annuities. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed variable annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed variable annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following table presents accompanying information to the rollforward table above.
(1) For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The table below reconciles MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholders' Liabilities | POLICYHOLDERS' ACCOUNT BALANCES The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
(1) Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2) Variable life includes $900 million of funding for a policy loan to an affiliated irrevocable trust. See Note 15 for additional information. (3) The net amount at risk calculation includes both general and separate account balances. (4) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (5) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. The Company issues variable life and universal life insurance contracts which may also include a “no-lapse guarantee” where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the “no-lapse guarantee” premium is paid. The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns. The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 10 for additional information, including the net amount at risk associated with these guarantees. The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums are as follows:
(1) Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options. Unearned Revenue Reserve The balances of and changes in URR as of and for the periods ended are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefits |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefits | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability; and •Additional Insurance Reserves In 2024, the Company recognized an impact to net income attributable to our annual reviews and update of assumptions and other refinements. Overall impact is immaterial for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort. Additionally, for direct and assumed AIR, the Company recognized an unfavorable impact primarily due to updates to policyholder behavior assumptions on universal life policies with secondary guarantees. In 2023, the Company recognized an impact to net income attributable to the annual reviews and update of assumptions and other refinements. Overall impact is immaterial for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort. Additionally, for direct and assumed AIR, the Company recognized an unfavorable impact primarily due to unfavorable model refinements, partially offset by updates to economic assumptions, including expected future rates of returns on universal life policies with secondary guarantees. In 2022, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed benefit reserves, primarily due to updates to mortality assumptions on individual term life insurance. Additionally, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update and other refinements for direct and assumed additional insurance reserves, primarily due to updates to policyholder behavior assumptions on universal life policies with secondary guarantees. Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:
For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss. In 2024, there was a $29 million gain in net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, which was offset by a $28 million charge, reflecting the impact of ceded reinsurance on the affected cohorts. In 2023, there was a $31 million gain in net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, which was offset by a $30 million charge, reflecting the impact of ceded reinsurance on the affected cohorts. In 2022, there was an $83 million charge to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, mostly offset by an $82 million gain, reflecting the impact of ceded reinsurance on the affected cohorts. The balances of and changes in DPL for the years ended December 31, are as follows:
Additional Insurance Reserves AIR represents the additional liability for annuitization, death, or other insurance benefits, including guaranteed minimum death benefits ("GMDB") and guaranteed minimum income benefits ("GMIB") contract features, that are above and beyond the contractholder's account balance for certain long-duration life contracts. The following table shows a rollforward of AIR balances for variable and universal life products, for the years ended December 31,:
(1) Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from the above rollforwards, Benefit Reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for Future Policy Benefits as reported on the Company's Consolidated Statements of Financial Position for the years ended December 31,:
(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations for the periods indicated:
(1)Represents "Gross premiums" for benefit reserves; "Revenue" for DPL and "Gross assessments" for AIR.
The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
(1) Other adjustments for December 31, 2023 primarily includes $638 million related to the reinsurance transaction with AuguStar. See Note 11 for additional information. (2) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. In both 2024 and 2023, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to policyholder behavior assumptions on certain variable annuities. In 2022, the Company recognized a favorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to mortality and policyholder behavior assumptions on certain variable annuities. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed variable annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed variable annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following table presents accompanying information to the rollforward table above.
(1) For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The table below reconciles MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance | REINSURANCE The Company participates in reinsurance with its affiliates PARCC, PAR U, PURE, Lotus Re, PALAC, a former subsidiary of Prudential Financial that was sold to Fortitude on April 1, 2022, prior to January 1, 2024 with its affiliates Prudential Universal Reinsurance Company (“PURC”) and Gibraltar Universal Life Reinsurance Company (“GUL Re”), and prior to October 1, 2024 with its affiliates Prudential Arizona Reinsurance Term Company (“PAR Term”), Prudential Term Reinsurance Company (“Term Re”) and Dryden Arizona Reinsurance Term Company (“DART”). The Company also participates in reinsurance with its parent company Prudential Insurance, as well as third-parties. The reinsurance agreements provide risk diversification and additional capacity for future growth, limit the maximum net loss potential, manage statutory capital, and facilitate the Company's capital market hedging program. Life reinsurance is accomplished through various plans of reinsurance, primarily YRT and coinsurance. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. The Company believes a material reinsurance liability resulting from such inability of reinsurers to meet their obligations is unlikely. Effective October 2024, the Company entered into an agreement with Wilton Re to coinsure a closed block of GUL policies, resulting in a DRL of $979 million. To effectuate this transaction the Company recaptured all risks associated with the subject GUL policies from PAR U and subsequently established YRT reinsurance for the subject GUL business with Prudential Insurance. As a result of these transactions, the Company recognized a $270 million pre-tax recapture gain and a $798 million DRG, respectively. The DRL and DRG will be amortized into income over the remaining life of the reinsured policies. Effective January 2024, the Company entered into an agreement with Somerset Reinsurance Ltd. (“Somerset Re”) to coinsure a closed block of guaranteed universal life (“GUL”) policies to PURE, a wholly-owned subsidiary of Prudential Insurance, with retrocession by PURE of such liabilities on a modified coinsurance basis, to Somerset Re. This transaction is effective as of January 1, 2024, whereby, the Company recaptured all risks associated with the subject GUL policies from PAR U, PURC and GUL Re and subsequently established YRT reinsurance for the subject GUL business with Prudential Insurance. As a result of these transactions, the Company recognized a $990 million pre-tax recapture loss and a $1,207 million DRG, respectively. The DRG will be amortized into income over the estimated remaining life of the reinsured policies. Reserves related to reinsured long-duration contracts are accounted for using assumptions consistent with those used to account for the underlying contracts. Amounts recoverable from reinsurers for long-duration reinsurance arrangements are estimated in a manner consistent with the claim liabilities and policy benefits associated with the reinsured policies. Reinsurance policy charges and fee income ceded for universal life and variable annuity products are accounted for as a reduction of policy charges and fee income. Reinsurance premiums ceded for term insurance products are accounted for as a reduction of premiums. Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance are recorded within “Reinsurance recoverables and deposit receivables” and the corresponding funds withheld liability for assets retained under these reinsurance agreements are recorded within “Reinsurance and funds withheld payables”. Balances associated with these agreements are included in the tables below. "Change in value of market risk benefits, net of related hedging gains (losses)" include the impact of reinsurance agreements, particularly reinsurance agreements involving living benefit guarantees. The Company has entered into reinsurance agreements to transfer the risk related to the living benefit guarantees on variable annuities within the PLNJ business to Prudential Insurance. These reinsurance agreements are market risk benefits and have been accounted for in the same manner. Reinsurance amounts included in the Company’s Consolidated Statements of Financial Position as of December 31, were as follows:
(1)Prior period amounts have been updated to conform to current period presentation. (2)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Unaffiliated reinsurance amounts included in the table above and in the Company's Consolidated Statements of Financial Position as of December 31, were as follows:
(1)Includes $699 million of deferred policy acquisition costs related to the transaction with Wilton Re. (2)Prior period amounts have been updated to conform to current period presentation. (3)Includes $979 million deferred loss related to the reinsurance transaction with Wilton Re. (4)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Reinsurance recoverables and deposit receivables by counterparty as of December 31, were as follows:
(1)Prior period amounts have been updated to conform to current period presentation. (2)Includes balances with Wilton Re, FLIAC, Somerset Re and other counterparties. See below for further information on significant third-party reinsurance arrangements. (3)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Reinsurance amounts, included in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, were as follows:
(1)Current period amounts include the impacts of the recaptures from PAR U as discussed above. (2)Amounts include reinsurance agreements using the deposit method of accounting. (3)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Unaffiliated reinsurance assumed and ceded amounts included in the table above and in the Company's Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, were as follows:
(1)Amounts include reinsurance agreements using the deposit method of accounting. (2)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. The gross and net amounts of life insurance face amount in force as of December 31, were as follows:
Significant Affiliated Reinsurance Agreements PAR U Pruco Life reinsures 70% of all the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2011. Effective July 1, 2012, PLNJ reinsures 95% of all the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates through December 31, 2019, excluding those policies that are subject to principle-based reserving. On January 2, 2013, Pruco Life began to assume GUL business from Prudential Insurance in connection with the acquisition of the Hartford Life Business. The GUL business assumed from Prudential Insurance was subsequently retroceded to PAR U. Effective January 1, 2024, Pruco Life recaptured the policies equal to 70% of all the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2011. Effective January 1, 2024, Pruco Life reinsures 25% of the risks associated with universal life policies with effective dates prior to January 1, 2015 and 100% of the risks associated with universal life policies with effective dates beginning January 1, 2015. Effective January 1, 2024, PLNJ recaptured the policies previously reinsured by PAR U with effective dates prior to January 1, 2015. Effective January 1, 2024, PLNJ reinsures 100% of the risks associated with universal life policies, with effective dates from January 1, 2015 to December 31, 2019. Effective October 1, 2024, Pruco Life recaptured the remaining portion of the policies equal to 25% of the risks associated with universal life policies with effective dates prior to January 1, 2015 and 100% of the risks associated with universal life policies with effective dates beginning January 1, 2015. As a result of the recapture, the Company recognized a $270 million pre-tax recapture gain, as discussed above, which includes the recognition of a prior $94 million DRG related to the previous reinsurance agreement. Following the result of this recapture, Pruco Life only cedes the GUL business in connection with the Hartford Life Business to PAR U as of December 31, 2024. Effective October 1, 2024, PLNJ recaptured 100% of the risks associated with the remaining universal life policies, with effective dates from January 1, 2015 to December 31, 2019. As a result of the recapture, the Company recognized a $29 million pre-tax recapture loss which is part of the $270 million pre-tax recapture gain discussed above. The loss includes the recognition of a prior $8 million DRG related to the previous reinsurance agreement. Following the result of this recapture, PLNJ no longer cedes to PAR U as of December 31, 2024. On March 28, 2024, PURC and GUL Re merged into PAR U. PURE Effective January 1, 2024, Pruco Life reinsures 75% of the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2015. Effective January 1, 2024, PLNJ reinsures 100% of the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2015. PALAC Effective April 1, 2016, the Company entered into a reinsurance agreement to reinsure its variable annuity base contracts, along with the living benefit guarantees to PALAC, excluding the PLNJ business, which was reinsured to Prudential Insurance. This reinsurance agreement excluded business reinsured externally. As of December 31, 2020, the Company discontinued the sales of traditional variable annuities with guaranteed living benefit riders. This discontinuation had no impact on the reinsurance agreement between PALAC, Prudential Insurance, and the Company. Effective July 1, 2021, the Company recaptured the risks related to its business, as discussed above, that had previously been reinsured to PALAC from April 1, 2016 through June 30, 2021. The recapture did not impact PLNJ, which continued to reinsure its business to Prudential Insurance. The product risks related to the previously reinsured business that were being managed in PALAC, were transferred to the Company. In addition, the living benefit hedging program related to the previously reinsured living benefit riders were being managed within the Company. On April 1, 2022, PALAC was sold to Fortitude as discussed in Note 1 and is no longer considered an affiliate of the Company. PURC Pruco Life reinsures 70% of all the risks associated with its Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates from January 1, 2011 through December 31, 2013, with PURC and 95% of all the risks associated with Universal Protector policies having no-lapse guarantees, as well as certain other universal life policies, with effective dates from January 1, 2014 through December 31, 2016. Effective January 1, 2024, the Company recaptured the policies previously reinsured by PURC. As a result of the recapture, the Company recorded a write-off of $116 million of DRG that was recognized with the previous reinsurance agreement. On March 28, 2024, PURC merged into PAR U. PARCC Prior to July 1, 2019, the Company reinsured 90% of the risks under its term life insurance policies, with effective dates prior to January 1, 2010 through an automatic coinsurance agreement with PARCC. Effective July 1, 2019, the Company amended the coinsurance agreement to increase the percentage from 90% to 100% of the policy risk amount reinsured. The amended agreement does not impact contracts issued by PLNJ, which remain at the original percentage. Effective October 1, 2024, the Company revised the existing coinsurance terms with PARCC, increasing the quota share of reinsured policies to 100% which includes policies which were previously reinsured to PAR Term, Term Re and DART. As a result of the revised terms, the Company recognized a $351 million DRL that will be amortized into income over the estimated remaining life of the reinsured policies. On November 20, 2024, PAR Term, Term Re and DART merged into PARCC. GUL Re Effective January 1, 2017, Pruco Life entered into an automatic coinsurance agreement with GUL Re to reinsure 95% of all the risks associated with Universal Protector policies having no-lapse guarantees, as well as certain other universal life policies, with effective dates on or after January 1, 2017 through December 31, 2019, excluding those policies that are subject to principle-based reserving. Effective July 1, 2017, Pruco Life amended this agreement to include 30% of Universal Protector policies having no-lapse guarantees as well as certain other universal life policies with effective dates prior to January 1, 2014. Effective January 1, 2024, the Company recaptured the policies previously reinsured by GUL Re. On March 28, 2024, GUL Re merged into PAR U. PAR Term Prior to July 1, 2019, the Company reinsures 95% of the risks under its term life insurance policies with effective dates January 1, 2010 through December 31, 2013, through an automatic coinsurance agreement with PAR Term. Effective July 1, 2019, the Company amended the coinsurance agreement to increase the percentage from 95% to 100% of the policy risk amount reinsured. The amended agreement does not impact contracts issued by PLNJ, which remain at the original percentage. On November 20, 2024, PAR Term merged into PARCC. Prudential of Taiwan On January 31, 2001, Pruco Life transferred all of its assets and liabilities associated with its Taiwanese branch, including its Taiwanese insurance book of business, to Prudential of Taiwan. The mechanism used to transfer this block of business in Taiwan is referred to as a “full acquisition and assumption” transaction. Under this mechanism, Pruco Life is jointly liable with Prudential of Taiwan for two years from the giving of notice to all obligees for all matured obligations and for two years after the maturity date of not-yet-matured obligations. Prudential of Taiwan is also contractually liable, under indemnification provisions of the transaction, for any liabilities that may be asserted against Pruco Life. The transfer of the insurance related assets and liabilities was accounted for as a long-duration coinsurance transaction under U.S. GAAP. Under this accounting treatment, the insurance related liabilities remain on the books of Pruco Life and an offsetting reinsurance recoverable is established. These assets and liabilities are denominated in U.S. dollars. On August 11, 2020, Prudential International Insurance Holdings, Ltd. (“PIIH”), a subsidiary of Prudential Financial, entered into a Share Purchase Agreement with Taishin Financial Holding Co., Ltd. (the “Buyer”) pursuant to which PIIH has agreed to sell to the Buyer all of the issued and outstanding capital stock of Prudential of Taiwan. The Share Purchase Agreement contains customary warranties and covenants of PIIH and the Buyer. On June 30, 2021, PIIH completed the sale of Prudential of Taiwan to the Buyer. This resulted in the removal of the insurance related liabilities and offsetting reinsurance recoverables previously on the books of Pruco Life. The Buyer provided Pruco Life a backstop indemnification and Pruco Life provided a guarantee to stand ready to perform in the event of default by both Prudential of Taiwan and the Buyer. Refer to Note 16 for details on the guarantee. Term Re The Company reinsures 95% of the risks under its term life insurance policies, with effective dates on or after January 1, 2014 through December 31, 2017, through an automatic coinsurance agreement with Term Re. On November 20, 2024, Term Re merged into PARCC. Prudential Insurance The Company has a YRT reinsurance agreement with Prudential Insurance and reinsures the majority of all mortality risks not otherwise reinsured. This agreement was terminated for new business effective January 1, 2020, with certain new business (primarily universal life policies) terminated as early as 2017. The Company now reinsures a portion of the mortality risk directly to third-party reinsurers and retains all of the non-reinsured portion of the mortality risk. Effective July 1, 2019, certain term life insurance policies were recaptured and subsequently reinsured to PARCC and PAR Term as noted above. As of January 1, 2022, most of the variable life insurance policies were recaptured resulting in a $305 million loss recorded through "Policy charges and fee income". Those policies were then reinsured to Lotus Re as mentioned below. Effective January 1, 2024, the Company recaptured all GUL policies with Prudential Insurance and subsequently entered into a YRT reinsurance agreement with Prudential Insurance to reinsure the mortality risk for the totality of GUL policies reinsured to PURE. Effective October 1, 2024, the Company recaptured the term business from Prudential Insurance, and revised the existing coinsurance terms with PARCC to reflect revised quota share. As a result of the recapture, the Company recognized a $3 million pre-tax recapture loss. Additionally, effective October 1, 2024, the Company entered into a YRT reinsurance agreement with Prudential Insurance to reinsure the mortality risk of recaptured GUL policies from PAR U. On January 2, 2013, Pruco Life began to assume GUL business from Prudential Insurance in connection with the acquisition of the Hartford Financial Services Group, Inc. ("Hartford Financial"). The GUL business assumed from Prudential Insurance was subsequently retroceded to PAR U. In May 2018, Hartford Financial sold a group of operating subsidiaries, which includes two of Prudential Insurance's counterparties to these reinsurance arrangements. There was no impact to the terms, rights or obligations of Prudential Insurance, or operation of these reinsurance arrangements, as a result of this change in control of such counterparties. Similarly, there was no impact to the Company's reinsurance arrangements with respect to such GUL business as a result of this change in control. In January 2021, there was a definitive agreement announced to subsequently sell the two counterparties mentioned above, which were then acquired by Sixth Street in July 2021. There was no impact to the terms, rights or obligations of the Company, or operation of these reinsurance arrangements, as a result of this change in control of such counterparties. The Company has reinsured a group annuity contract with Prudential Insurance, in consideration for a single premium payment by the Company, providing reinsurance equal to 100% of all payments due under the contract. Effective April 1, 2016, PLNJ entered into a reinsurance agreement to reinsure its variable annuity base contracts, along with the living benefit guarantees to Prudential Insurance. This reinsurance agreement covers new and in force business. Effective February 1, 2023, PLNJ began selling indexed variable annuities products, which is reinsured to Prudential Insurance through the existing reinsurance agreement. The reinsurance of the indexed variable annuities transfers all significant risks, including mortality risk, embedded in the reinsured contracts to Prudential Insurance. As a result of the agreement, reinsurance payables includes the ceded modified coinsurance arrangement, which reflects the value of the invested assets retained by the Company and the associated asset returns. Lotus Re Effective October 1, 2021, the Company entered into an automatic coinsurance agreement with Lotus Re to reinsure $32 million of liabilities associated with the risks associated with a portion of its variable life policies in the extended term policy status. Effective January 1, 2022 the Company recaptured the risks that were previously ceded to Lotus Re from October 1, 2021 through December 31, 2021. Immediately thereafter, the Company entered into a reinsurance agreement with Lotus Re to cede 100% of the risks associated with a closed block of variable life business on a coinsurance and modified coinsurance basis including policies in the extended term policy status. The amount of the net liabilities associated with the transaction for coinsurance and modified coinsurance were $1,387 million and $14,037 million, respectively. As part of the consideration, the Company also ceded to Lotus Re $855 million of policy loan assets associated with the reinsured policies while receiving $820 million in cash from Lotus Re. As a result, the Company recorded a $1,352 million deferred gain, which will be recognized over the remaining life of the underlying policies. In tandem with the transaction, effective January 1, 2022, Lotus Re established an automatic YRT agreement with the Company to cede back a portion of the mortality risks associated with the reinsured policies for the purposes of the Company maintaining YRT reinsurance with external counterparties. Effective December 15, 2024, the Company entered into a reinsurance agreement with Lotus Re to cede 100% of the risks associated with certain fixed index annuities and multi-year guaranteed annuity contracts issued on or after the effective date of the agreement on a coinsurance basis. The deposit receivables was $52 million as of December 31, 2024. DART Effective January 1, 2018, the Company entered into an automatic coinsurance agreement with DART to reinsure 95% of the risks associated with its term life insurance policies with effective dates on or after January 1, 2018 through December 31, 2019, excluding those policies that are subject to principle-based reserving. On November 20, 2024, DART merged into PARCC. Significant Third-Party Reinsurance Arrangements AuguStar Life Insurance Company (Formerly Known as The Ohio National Life Insurance Company) Effective April 1, 2023, the Company entered into an agreement with AuguStar, an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits. This block represents approximately 10% of the Company’s remaining legacy in force traditional variable annuity block by account value. The Company ceded 100% of separate account liabilities under modified coinsurance and 100% of general account liabilities under coinsurance of its PDI traditional variable annuity contracts. The general account liabilities associated with PDI's guaranteed living and death benefits and the corresponding reinsurance of those liabilities are accounted for as market risk benefits. As a result of the transaction, the Company recognized a $277 million DRG at inception that is amortized into income over the estimated remaining life of the reinsured policies. FLIAC Effective December 1, 2021, the Company entered into a reinsurance agreement with FLIAC under which the Company assumed all of FLIAC's indexed variable annuities under modified coinsurance. The reinsurance of the indexed variable annuities transfers all significant risks, including mortality risk, embedded in the reinsured contracts to the Company. As a result of the agreement, "Reinsurance recoverables and deposit receivables" includes the assumed modified coinsurance receivable, which reflects the value of the invested assets retained by FLIAC and the associated asset returns. The Company also assumed via coinsurance all of FLIAC’s fixed indexed annuities and fixed annuities with a guaranteed lifetime withdrawal income feature which are accounted for under the deposit method of accounting. The reinsurance agreement offers the policyholders the opportunity to novate their contracts from FLIAC to the Company and any such novated contracts shall cease to be reinsured under this agreement. As of December 31, 2024, the total account value of contracts novated from FLIAC to the Company were $5.3 billion for indexed variable annuities contracts and $2 billion for fixed annuities and fixed indexed annuities contracts, which is approximately 80% of the total reinsured block. Reinsurance recoverables was $1,395 million and $1,429 million as of December 31, 2024 and 2023, respectively. Somerset Re Effective October 1, 2021, the Company entered into a reinsurance agreement with Somerset Re to coinsure business, on a quota share funds withheld basis, related to fixed indexed annuities. Under the reinsurance agreement, the Company cedes to Somerset Re its quota share of the insurance liabilities with respect to the reinsured contracts. The deposit assets on reinsurance totaled $2,582 million and $1,526 million at December 31, 2024 and 2023, respectively. The funds withheld liabilities totaled $2,434 million and $1,412 million at December 31, 2024 and 2023, respectively. Union Hamilton Between April 1, 2015 and December 31, 2016, the Company, excluding its subsidiary, reinsured approximately 50% of the new business related to “highest daily” living benefits rider guarantees on HDI v.3.0 product, available with Prudential Premier® Retirement Variable Annuity, to Union Hamilton. This reinsurance remains in force for the duration of the underlying annuity contracts. New sales of HDI v.3.0 subsequent to December 31, 2016 are not covered by this external reinsurance agreement. As of December 31, 2024, $1.9 billion of HDI v.3.0 account values are reinsured to Union Hamilton. Wilton Re Effective October 1, 2024, the Company entered into a reinsurance agreement with Wilton Re to coinsure a closed block of GUL policies. Reinsurance recoverables was $7,478 million as of December 31, 2024.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Taxes | INCOME TAXES The following schedule discloses significant components of income tax expense (benefit) for each year presented:
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Reconciliation of Expected Tax at Statutory Rates to Reported Income Tax Expense (Benefit) The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2024, 2023 and 2022, and the reported income tax expense (benefit) are summarized as follows:
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. The effective tax rate is the ratio of “Income tax expense (benefit)” divided by “Income (loss) from operations before income taxes and equity in earnings of operating joint venture.” The Company’s effective tax rate for fiscal years 2024, 2023 and 2022 was 13.9%, 5.5% and 29.9%, respectively. The following is a description of items that had a significant impact on the difference between the Company’s statutory U.S. federal income tax rate of 21% applicable for 2024, 2023 and 2022, and the Company’s effective tax rate during the periods presented: Non-Taxable Investment Income. The U.S. Dividends Received Deduction (“DRD”) reduces the amount of dividend income subject to U.S. tax and is included in the non-taxable investment income shown in the table above. More specifically, the U.S. DRD constitutes $41 million of the total $43 million of 2024 non-taxable investment income, $40 million of the total $43 million of 2023 non-taxable investment income, and $44 million of the total $46 million of 2022 non-taxable investment income. The DRD for the current period was estimated using information from 2023, current year investment results, and current year’s equity market performance. The actual current year DRD can vary based on factors such as, but not limited to, changes in the amount of dividends received that are eligible for the DRD, changes in the amount of distributions received from fund investments, changes in the account balances of variable life and annuity contracts, and the Company’s taxable income before the DRD. Tax credits. These amounts primarily represent tax credits relating to foreign taxes withheld on the Company’s separate account investments. Other. This line item represents reconciling items that are individually less than 5% of the computed expected federal income tax expense (benefit) and have therefore been aggregated for purposes of this reconciliation in accordance with relevant disclosure guidance. Schedule of Deferred Tax Assets and Deferred Tax Liabilities
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. The application of U.S. GAAP requires the Company to evaluate the recoverability of deferred tax assets and establish a valuation allowance if necessary to reduce the deferred tax asset to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, the Company considers many factors, including: (1) the nature of the deferred tax assets and liabilities; (2) whether they are ordinary or capital; (3) in which tax jurisdictions they were generated and the timing of their reversal; (4) taxable income in prior carryback years as well as projected taxable earnings exclusive of reversing temporary differences and carryforwards; (5) the length of time that carryovers can be utilized in the various taxing jurisdictions; (6) any unique tax rules that would impact the utilization of the deferred tax assets; and (7) any tax planning strategies that the Company would employ to avoid a tax benefit from expiring unused. Although realization is not assured, management believes it is more likely than not that the deferred tax assets, net of valuation allowances, will be realized. Changes in market conditions, including the significant rise in interest rates since the beginning of 2022, resulted in the recording of deferred tax assets related to net unrealized tax capital losses in the Company. When assessing recoverability of these deferred tax assets, the Company considers its ability and intent to hold the underlying securities to recovery in value, if necessary, as well as other factors as noted above. As of December 31, 2024, based on all available evidence, including capital loss carryback capacity, the Company concluded that the deferred tax assets related to the unrealized tax capital losses on the available-for-sale securities portfolios are, more likely than not, expected to be realized. The Company had no valuation allowance as of December 31, 2024, and 2023. Adjustments to the valuation allowance will be made if there is a change in management’s assessment of the amount of deferred tax asset that is realizable. The Company’s “Income (loss) from operations before income taxes and equity in earnings of operating joint venture” includes income from domestic operations of $973 million, $478 million and $(993) million for the years ended December 31, 2024, 2023 and 2022, respectively. Tax Audit and Unrecognized Tax Benefits The Company’s liability for income taxes includes the liability for unrecognized tax benefits and interest that relate to tax years still subject to review by the IRS or other taxing authorities. The completion of review or the expiration of the Federal statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company had no unrecognized tax benefits as of December 31, 2024, 2023, and 2022. The Company does not anticipate any significant changes within the next twelve months to its total unrecognized tax benefits related to tax years for which the statute of limitations has not expired. The Company classifies all interest and penalties related to tax uncertainties as income tax expense (benefit). The Company did not recognize tax related interest and penalties. At December 31, 2024, the Company remains subject to examination in the U.S. for tax years 2014 through 2024. The Company participates in the IRS’s Compliance Assurance Program. Under this program, the IRS assigns an examination team to review completed transactions as they occur in order to reach agreement with the Company on how they should be reported in the relevant tax returns. If disagreements arise, accelerated resolutions programs are available to resolve the disagreements in a timely manner.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity | EQUITY Accumulated Other Comprehensive Income (Loss) AOCI represents the cumulative OCI items that are reported separate from net income and detailed on the Consolidated Statements of Operations and Comprehensive Income (Loss). Net unrealized investment gains (losses) are described in further detail in Note 2, Note 8 (Interest rate remeasurement of Liability for Future Policy Benefits) and Note 10 (Gains (losses) from Changes in Nonperformance Risk on Market Risk Benefits). The balance of and changes in each component of AOCI as of and for the years ended December 31, are as follows:
(1)Includes cash flow hedges of $111 million, $12 million, and $139 million as of December 31, 2024, 2023 and 2022, respectively. (2)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Reclassifications out of Accumulated Other Comprehensive Income (Loss)
(1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 4 for additional information on cash flow hedges. (4)See table below for additional information on unrealized investment gains (losses), including the impact on future policy benefits and policyholders’ account balances. Net Unrealized Investment Gains (Losses) Net unrealized investment gains (losses) on available-for-sale fixed maturity securities and certain other invested assets and other assets are included in the Company’s Consolidated Statements of Financial Position as a component of AOCI. Changes in these amounts include reclassification adjustments to exclude from OCI those items that are included as part of “Net income (loss)” for a period that had been part of OCI in earlier periods. The amounts for the periods indicated below, split between amounts related to net unrealized investment gains (losses) on available-for-sale fixed maturity securities on which an allowance for credit losses has been recognized, and all other net unrealized investment gains (losses), are as follows:
(1)Includes cash flow hedges. See Note 4 for information on cash flow hedges. (2)"Other costs" primarily includes reinsurance recoverables and DRL. Noncontrolling interests For certain subsidiaries, the Company owns a controlling interest that is less than 100% ownership of the subsidiary but must consolidate 100% of the subsidiary’s financial statements in accordance with U.S. GAAP. Noncontrolling interests represent the portion of equity ownership in a consolidated subsidiary that is not attributable to the Company.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statutory Net Income and Surplus and Dividend Restrictions |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statutory Net Income and Surplus and Dividend Restrictions | STATUTORY NET INCOME AND SURPLUS AND DIVIDEND RESTRICTIONS The Company is required to prepare statutory financial statements in accordance with accounting practices prescribed or permitted by the Arizona Department of Insurance ("AZDOI"). It's subsidiary PLNJ is required to prepare statutory financial statements in accordance with accounting practices prescribed or permitted by the New Jersey Department of Insurance and Banking. Statutory accounting practices primarily differ from U.S. GAAP by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions as well as valuing investments and certain assets and accounting for deferred taxes on a different basis. The following table summarizes certain statutory financial information for the Company, including its subsidiary PLNJ, for the periods indicated:
(1) 2022 amounts include adjustments made to the audited statutory financial statements as of December 31, 2022. The Company does not utilize prescribed or permitted practices that vary materially from the statutory accounting practices prescribed by the NAIC. The Company is subject to Arizona law, which limits the amount of dividends that insurance companies can pay to stockholders without approval of the AZDOI. The maximum dividend, which may be paid in any twelve-month period without notification or approval, is limited to the lesser of 10% of statutory surplus as of December 31 of the preceding year or the net gain from operations of the preceding calendar year. Cash dividends may only be paid out of surplus derived from realized net profits. The Company must obtain approval from AZDOI prior to paying a dividend if the dividend, together with other dividend distributions made within the preceding twelve months, would exceed the lesser of 10% of statutory surplus or net gain from operations. Based on these limitations, there is no capacity to pay a dividend in 2025 without prior approval. In 2024, there was $550 million return of capital to Prudential Insurance. The Company did not pay dividends to Prudential Insurance in 2024, 2023 and 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions | RELATED PARTY TRANSACTIONS The Company has extensive transactions and relationships with Prudential Insurance and other affiliates. Although we seek to ensure that these transactions and relationships are fair and reasonable, it is possible that the terms of these transactions are not the same as those that would result from transactions among unrelated parties. Expense Charges and Allocations The majority of the Company’s expenses are allocations or charges from Prudential Insurance or other affiliates. These expenses can be grouped into general and administrative expenses and agency distribution expenses. The Company’s general and administrative expenses are charged to the Company using allocation methodologies based on business production processes. Management believes that the methodology is reasonable and reflects costs incurred by Prudential Insurance to process transactions on behalf of the Company. The Company operates under service and lease agreements whereby services of officers and employees, supplies, use of equipment and office space are provided by Prudential Insurance. The Company reviews its allocation methodology periodically which it may adjust accordingly. General and administrative expenses include allocations of stock compensation expenses related to a stock-based awards program and a deferred compensation program issued by Prudential Financial. The expense charged to the Company for the stock-based awards program was $1 million for each of the years ended December 31, 2024, 2023 and 2022. The expense charged to the Company for the deferred compensation program was $6 million, $5 million and $5 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company is charged for its share of employee benefit expenses. These expenses include costs for funded and non-funded, non-contributory defined benefit pension plans. Some of these benefits are based on final earnings and length of service while others are based on an account balance, which takes into consideration age, service and earnings during a career. The Company’s share of net expense for the pension plans was $11 million, $13 million and $19 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company is also charged for its share of the costs associated with welfare plans issued by Prudential Insurance. These expenses include costs related to medical, dental, life insurance and disability. The Company's share of net expense for the welfare plans was $18 million, $14 million and $15 million for the years ended December 31, 2024, 2023 and 2022, respectively. Prudential Insurance sponsors voluntary savings plans for its employee 401(k) plans. The plans provide for salary reduction contributions by employees and matching contributions by the Company of up to 4% of annual salary. The Company’s expense for its share of the voluntary savings plan was $8 million, $7 million and $9 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company is charged distribution expenses from Prudential’s proprietary nationwide sales organization, “Prudential Advisors” through a transfer pricing agreement, which is intended to reflect a market-based pricing arrangement. Prudential Advisors distributes Prudential life insurance, annuities, and investment products with proprietary and non-proprietary product options. In November 2024, the Company, along with three other affiliated entities, entered into several agreements with a third-party, LPL Financial Holdings Inc. (“LPL”). Under these agreements, the Company pays distribution expenses to LPL, of which 98% are returned to Prudential Advisors. Distribution expenses paid by the Company to LPL and subsequently returned to Prudential Advisors were $56 million for the year ended December 31, 2024. The Company pays commissions and certain other fees to Prudential Annuities Distributors, Inc. (“PAD”) in consideration for PAD’s marketing and underwriting of the Company’s annuity products. Commissions and fees are paid by PAD to broker-dealers who sell the Company’s annuity products. Commissions and fees paid by the Company to PAD were $820 million, $587 million and $611 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company is charged for its share of corporate expenses incurred by Prudential Financial to benefit its businesses, such as advertising, executive oversight, external affairs and philanthropic activity. The Company’s share of corporate expenses was $131 million, $144 million and $105 million for the years ended December 31, 2024, 2023 and 2022, respectively. Corporate-Owned Life Insurance The Company has sold five Corporate Owned Life Insurance (“COLI”) policies to Prudential Insurance, and one to Prudential Financial. The cash surrender value included in separate accounts for these COLI policies was $4,657 million and $4,156 million as of December 31, 2024 and 2023, respectively. Fees related to these COLI policies were $55 million, $50 million and $52 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company reinsures the risk associated with these COLI policies to an affiliate reinsurer as part of a broader program related to variable insurance policies. In May 2023, the Company funded a policy loan from the Prudential Financial COLI policy noted above in an amount of $900 million to an affiliated irrevocable trust, commonly referred to as a “rabbi trust”, which Prudential Financial created to support certain non-qualified retirement plans. The outstanding balance of the policy loan with the rabbi trust was $897 million and $898 million as of December 31, 2024 and 2023, respectively. Interest income related to the policy loan was $42 million and $26 million for the years ended December 31, 2024 and 2023, respectively. Affiliated Investment Management Expenses In accordance with an agreement with PGIM, Inc. ("PGIM"), the Company pays investment management expenses to PGIM who acts as investment manager to certain Company general account and separate account assets. Investment management expenses paid to PGIM related to this agreement were $69 million, $53 million and $41 million for the years ended December 31, 2024, 2023 and 2022, respectively. These expenses are recorded as “Net investment income” in the Consolidated Statements of Operations and Comprehensive Income. Derivative Trades In its ordinary course of business, the Company enters into OTC derivative contracts with an affiliate, PGF. For these OTC derivative contracts, PGF has a substantially equal and offsetting position with an external counterparty. See Note 4 for additional information. The interest income to the Company from PGF related to affiliated cash collateral was $490 million, $499 million and $137 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are included in "Other income (loss)". Joint Ventures The Company has made investments in joint ventures with certain subsidiaries of Prudential Financial. "Other invested assets" includes $1,100 million and $754 million of investments in joint ventures as of December 31, 2024 and 2023, respectively. "Net investment income" related to these ventures includes gains of $68 million, $5 million and $21 million for the years ended December 31, 2024, 2023 and 2022, respectively. Affiliated Asset Administration Fee Income The Company has a revenue sharing agreement with AST Investment Services, Inc. ("ASTISI") and PGIM Investments LLC ("PGIM Investments") whereby the Company receives fee income based on policyholders' separate account balances invested in the Advanced Series Trust. Income received from ASTISI and PGIM Investments related to this agreement was $271 million, $274 million and $306 million for the years ended December 31, 2024, 2023 and 2022, respectively. These revenues are recorded as “Asset administration fees” in the Consolidated Statements of Operations and Comprehensive Income. The Company has a revenue sharing agreement with PGIM Investments, whereby the Company receives fee income based on policyholders’ separate account balances invested in The Prudential Series Fund. Income received from PGIM Investments related to this agreement was $47 million, $38 million and $36 million for the years ended December 31, 2024, 2023 and 2022, respectively. These revenues are recorded as “Asset administration fees” in the Consolidated Statements of Operations and Comprehensive Income (Loss).Affiliated Notes Receivable Affiliated notes receivable included in “Receivables from parent and affiliates” at December 31, were as follows:
(1)All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances. The affiliated notes receivable shown above are classified as available-for-sale securities and other trading assets carried at fair value. The Company monitors the internal and external credit ratings of these loans and loan performance. The Company also considers any guarantees made by Prudential Insurance for loans due from affiliates. Accrued interest receivable related to these loans was $1 million at both December 31, 2024 and 2023, and is included in “Other assets.” Revenues related to these loans were $3 million for each of the years ended December 31, 2024, 2023 and 2022, respectively, and are included in “Other income (loss).” Affiliated Commercial Mortgage Loan The affiliated commercial mortgage loan included in "Commercial mortgage and other loans" at December 31, was as follows:
On October 16, 2024, the Company repaid in full its affiliated commercial mortgage loan. As a result, no remaining obligations exist as of December 31, 2024. The commercial mortgage loan shown above is carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses, and net of an allowance for losses. The Company reviews the performance and credit quality of the commercial mortgage loan on an on-going basis. Accrued interest receivable related to the loan was $0 million and $0.5 million at December 31, 2024 and 2023, respectively, and is included in "Accrued investment income". Revenues were $5.5 million, $6.9 million and $4.6 million for the years ended December 31, 2024, 2023, and 2022, respectively, and is included in "Net investment income." Affiliated Asset Transfers The Company participates in affiliated asset trades with parent and sister companies. Book and market value differences for trades with a parent and sister are recognized within "Additional paid-in capital" ("APIC") and "Realized investment gains (losses), net," respectively. The table below shows affiliated asset trades for the years ended December 31, 2024 and 2023.
Debt Agreements The Company is authorized to borrow funds up to $7 billion from affiliates to meet its capital and other funding needs. The following table provides the breakout of the Company's short-term debt. There was no debt outstanding as of December 31, 2024.
(1)Includes $180 million of loans reclassified as current portion of long-term debt as of December 31, 2023. The total interest expense to the Company related to affiliated loans and cash collateral with PGF was $39 million, $17 million and $3 million for the years ended December 31, 2024, 2023 and 2022, respectively. All debt outstanding as of December 31, 2023 is that of Pruco Life. Contributed Capital and Dividends In December 2024, the Company received capital contributions in the amount of $416 million from Prudential Insurance in the form of invested assets. In February and December 2023, the Company received capital contributions in the amount of $405 million and $7 million, respectively, from Prudential Insurance. In March, June and September of 2022, the Company received capital contributions in the amount of $8 million, $3 million and $7 million, respectively, from Prudential Insurance. In June 2024, there was a $550 million return of capital to Prudential Insurance. In June, September, and December 2023, there was a $300 million, $650 million, and $450 million return of capital, respectively, to Prudential Insurance. There was no return of capital in 2022. In 2024, 2023 and 2022, the Company did not pay any dividends to Prudential Insurance. Reinsurance with Affiliates As discussed in Note 11, the Company participates in reinsurance transactions with certain affiliates.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingent Liabilities | COMMITMENTS AND CONTINGENT LIABILITIES Commitments The Company has made commitments to fund commercial mortgage loans. As of December 31, 2024 and 2023, the outstanding balances on these commitments were $230 million and $270 million, respectively. These amounts include unfunded commitments that are not unconditionally cancellable. For related credit exposure, there was an allowance for credit losses of $0.3 million as of both December 31, 2024 and 2023, which is a change of $0.0 million and $0.3 million for the years ended December 31, 2024 and 2023, respectively. The Company also made commitments to purchase or fund investments, mostly fund investments and private fixed maturities, some of which are contingent upon events or circumstances not under the Company’s control, including those at the discretion of the Company’s counterparties. The Company anticipates a portion of these commitments will ultimately be funded from its separate accounts. As of December 31, 2024 and 2023, $1,359 million and $1,182 million, respectively, of these commitments were outstanding. These amounts include unfunded commitments that are not unconditionally cancellable. There were no related charges for credit losses for both the years ended December 31, 2024 and 2023. Guarantees In July 2017, Pruco Life formed a joint venture with CT Corp to provide life insurance solutions in Indonesia. Pruco Life owns a 49% interest in the joint venture and has entered into a shareholders agreement with CT Corp that sets out their respective rights and obligations with respect to the joint venture. Among other things, the shareholders agreement obligates Pruco Life and CT Corp to provide capital to the joint venture, as necessary to comply with applicable law or to maintain a specified minimum amount of capital in the joint venture. This obligation is not limited to a maximum amount. Pruco Life does not expect to make any payments on this guarantee and is not carrying any liabilities associated with the guarantee. Since 2001, Pruco Life entered into an arrangement with Prudential of Taiwan as discussed in Note 11. In June 2021, PIIH completed the sale of Prudential of Taiwan. As a result of the sale, Pruco Life has a financial guarantee to stand ready to perform in an event that both Prudential of Taiwan and the Buyer default and fail to perform their obligations to make payments to the policyholders. Pruco Life has a liability of $32 million as of both December 31, 2024 and 2023, which represents the fair value of the guarantee and is amortized in revenue over a period which approximates the life of the underlying insurance in force. Since this obligation is not subject to limitations, it is not possible to determine the maximum potential amount due under this guarantee. Guarantees of Asset Values
Certain contracts underwritten by Pruco Life include guarantees related to financial assets owned by the guaranteed party. These contracts are accounted for as derivatives and carried at fair value. The collateral supporting these guarantees is not reflected on the Consolidated Statements of Financial Position. Contingent Liabilities On an ongoing basis, the Company and its regulators review its operations including, but not limited to, sales and other customer interface procedures and practices, and procedures for meeting obligations to its customers and other parties. These reviews may result in the modification or enhancement of processes or the imposition of other action plans, including concerning management oversight, sales and other customer interface procedures and practices, and the timing or computation of payments to customers and other parties. In certain cases, if appropriate, the Company may offer customers or other parties remediation and may incur charges, including the cost of such remediation, administrative costs and regulatory fines. The Company is subject to the laws and regulations of states and other jurisdictions concerning the identification, reporting and escheatment of unclaimed or abandoned funds, and is subject to audit and examination for compliance with these requirements. It is possible that the results of operations or the cash flows of the Company in a particular quarterly or annual period could be materially affected as a result of payments in connection with the matters discussed above or other matters depending, in part, upon the results of operations or cash flows for such period. Management believes, however, that ultimate payments in connection with these matters, after consideration of applicable reserves and rights to indemnification, should not have a material adverse effect on the Company’s financial position. Litigation and Regulatory Matters The Company is subject to legal and regulatory actions in the ordinary course of its business. Pending legal and regulatory actions include proceedings specific to the Company and proceedings generally applicable to business practices in the industry in which it operates. The Company is subject to class action lawsuits and other litigation involving a variety of issues and allegations involving sales practices, claims payments and procedures, premium charges, policy servicing and breach of fiduciary duty to customers. The Company is also subject to litigation arising out of its general business activities, such as its investments, contracts, leases and labor and employment relationships, including claims of discrimination and harassment, and could be exposed to claims or litigation concerning certain business or process patents. In addition, the Company, along with other participants in the businesses in which it engages, may be subject from time to time to investigations, examinations and inquiries, in some cases industry-wide, concerning issues or matters upon which such regulators have determined to focus. In some of the Company’s pending legal and regulatory actions, parties are seeking large and/or indeterminate amounts, including punitive or exemplary damages. The outcome of litigation or a regulatory matter, and the amount or range of potential loss at any particular time, is often inherently uncertain. The Company establishes accruals for litigation and regulatory matters when it is probable that a loss has been incurred and the amount of that loss can be reasonably estimated. For litigation and regulatory matters where a loss may be reasonably possible, but not probable, or is probable but not reasonably estimable, no accrual is established, but the matter, if material, is disclosed. The Company estimates that as of December 31, 2024, the aggregate range of reasonably possible losses in excess of accruals established for those litigation and regulatory matters for which such an estimate currently can be made is less than $100 million. This estimate is not an indication of expected loss, if any, or the Company's maximum possible loss exposure on such matters. The Company reviews relevant information with respect to its litigation and regulatory matters on a quarterly and annual basis and updates its accruals, disclosures and estimates of reasonably possible loss based on such reviews. Individual Annuities and Individual Life California Advocates for Nursing Home Reform v. The Prudential Insurance Company of America and Pruco Life Insurance Company, et al. In January 2024, a putative class action complaint entitled California Advocates for Nursing Home Reform v. The Prudential Insurance Company of America and Pruco Life Insurance Company, et al., was filed in California Superior Court, Alameda County, alleging that the Company has failed to comply with California laws requiring that life insurance policies issued or delivered in California: (i) provide for a contractual 60-day grace period pre-lapse during which a policy must stay in force; (ii) provide policyholders and designees with notice of payment default within 30 days and a 30-day advance written notice of pending lapse; and (iii) notify policyholders annually of their right to designate additional recipients for lapse notices. The complaint asserts claims for violation of California’s Unfair Competition law and seeks unspecified damages along with declaratory and injunctive relief. In February 2024, defendants removed the action from California state court to the United States District Court for the Northern District of California. Plaintiff filed a motion to remand the action to the California Superior Court, Alameda County, and in December 2024, the motion was granted. Regulatory Variable Products The Company has received regulatory inquiries and requests for information from state and federal regulators, including subpoenas from the U.S. Securities and Exchange Commission (the “SEC”) concerning the appropriateness of variable product sales and replacement activity. The Company is cooperating with regulators and may become subject to additional regulatory inquiries and other actions related to this matter. In September 2024, the SEC notified the Company that the SEC has concluded its investigation and is not recommending an enforcement action. Summary The Company’s litigation and regulatory matters are subject to many uncertainties, and given their complexity and scope, their outcome cannot be predicted. It is possible that the Company’s results of operations or cash flows in a particular quarterly or annual period could be materially affected by an ultimate unfavorable resolution of pending litigation and regulatory matters depending, in part, upon the results of operations or cash flows for such period. In light of the unpredictability of the Company’s litigation and regulatory matters, it is also possible that in certain cases an ultimate unfavorable resolution of one or more pending litigation or regulatory matters could have a material adverse effect on the Company’s financial statements. Management believes, however, that, based on information currently known to it, the ultimate outcome of all pending litigation and regulatory matters, after consideration of applicable reserves and rights to indemnification, is not likely to have a material adverse effect on the Company’s financial statements.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revision to Prior Period Financial Statements |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prior Period Adjustment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revision to Prior Year Information | REVISION TO PRIOR PERIOD FINANCIAL STATEMENTS Revision to Financial Statements as of and for the Years Ended December 31, 2023 and 2022 The Company identified multiple errors which impacted the previously issued Consolidated Financial Statements for the years ended December 31, 2023 and 2022. Certain reinsurance recoverable balances associated with the coinsurance with funds withheld of fixed indexed annuities, certain deferred acquisition cost balances associated with indexed variable annuities, and certain other immaterial items were not properly accounted for. Prior period amounts have been revised in the Consolidated Financial Statements to correct these errors as shown below. Management assessed the materiality of the misstatements described above on prior period Consolidated Financial Statements in accordance with SEC Staff Accounting Bulletin ("SAB") No. 99, Materiality, codified in ASC 250-10, Accounting Changes and Error Corrections ("ASC 250"), and concluded that these misstatements were not material to the current period and any prior periods. However, management determined it was appropriate to correctly present and revise the Consolidated Financial Statements as of and for the years ended December 31, 2023 and 2022. The Consolidated Financial Statements for the impacted interim periods during 2024 will be revised when they are presented within the Quarterly Report on Form 10-Q for the interim periods in 2025. The following are the impacted line items from the Consolidated Financial Statements illustrating the effects of the revisions: Consolidated Statements of Financial Position
(1) As previously reported balances have been updated to conform to the current period presentation. Consolidated Statements of Operations and Comprehensive Income (Loss)
Consolidated Statements of Equity
Consolidated Statements of Cash Flows
(1) As previously reported balances have been updated to conform to the current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | SUBSEQUENT EVENTS In February 2025, the Company received a capital contribution of $220 million from Prudential Insurance. In March 2025, the Company entered into an agreement with The Prudential Life Insurance Company, Ltd. (“Prudential of Japan”) to reinsure guaranteed minimum death benefits associated with JPY denominated variable whole life policies.
|
Schedule I - Summary of Investments Other Than investments in Related Parties |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule I - Summary of Investments Other Than investments in Related Parties |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule II - Condensed Financial Information of Registrant |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule II - Condensed Financial Information of Registrant | PRUCO LIFE INSURANCE COMPANY Schedule II Condensed Financial Information of Registrant Condensed Statements of Financial Position December 31, 2024 and 2023 (in thousands, except share amounts)
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for the amounts of the errors which were revised and for additional information on these errors. (2) Prior period amounts have been reclassified to conform to current period presentation.
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for the amounts of the errors which were revised and for additional information on these errors.
(1) Prior period amounts have been updated to conform to current period presentation. Significant Non-Cash Transactions 2024 "Cash flows from (used in) operating activities" and "Cash flows from (used in) investing activities" for the year ended December 31, 2024, excludes certain non-cash activities in the amount of $(7,469) million primarily related to reinsurance recoverables and $6,722 million related to invested asset transfers, respectively. These transactions are associated with the unaffiliated reinsurance agreement with Wilton Reassurance Company and Wilton Reinsurance Bermuda Limited (collectively, "Wilton Re"), effective October 1, 2024. Associated with the transaction with Wilton Re, "Cash flows from (used in) operating activities" and "Cash flows from (used in) investing activities" for the year ended December 31, 2024, exclude largely offsetting affiliated non-cash activities in the amount of $7,190 million, primarily related to reinsurance recoverables and payables, and $(6,722) million related to invested asset transfers, respectively. These are related to the recapture of the risks associated with the business that had previously been reinsured with Prudential Arizona Reinsurance Universal Company ("PAR U") as well as assumption of those recaptured by Pruco Life Insurance Company of New Jersey from PAR U. See Note 11 for additional information. "Cash flows from (used in) operating activities" for the year ended December 31, 2024 excludes certain non-cash activities in the amount of $(78) million related to the affiliated reinsurance transaction with Prudential Arizona Reinsurance Captive Company, effective October 1, 2024. See Note 11 for additional information. "Cash flows from (used in) operating activities" for the year ended December 31, 2024 excludes certain non-cash activities in the amount of $936 million related to the affiliated reinsurance transaction with Prudential Universal Reinsurance Entity Company and The Prudential Insurance Company of America, effective January 1, 2024. See Note 11 for additional information. "Cash flows from (used in) investing activities" and "Cash flows from (used in) financing activities" for the year ended December 31, 2024 excludes non-cash activities related to invested asset transfers in the amount of $416 million, related to capital contributions the Company received from Prudential Insurance. See Note 15 for additional information. 2023 "Cash flows from (used in) operating activities" for the year ended December 31, 2023 excludes certain non-cash activities in the amount of $475 million related to the novated indexed variable annuities under the reinsurance agreement with Fortitude Life Insurance & Annuity Company (“FLIAC”). See Note 11 for more details regarding this transaction. 2022 "Cash flows from (used in) operating activities" for the year ended December 31, 2022 excludes certain non-cash activities in the amount of $531 million related to the Company entering into an affiliated reinsurance agreement with Lotus Reinsurance Company Ltd. ("Lotus Re") on January 1, 2022 and $4,656 million related to the indexed variable annuities novated to the Company in connection with the reinsurance agreement with FLIAC. See Note 11 for more details regarding these transactions. The Company also received $18 million of non-cash assets from Prudential Insurance. See Note 15 for additional information. 1.ORGANIZATION AND PRESENTATION Pruco Life Insurance Company, (“Pruco Life”) is a wholly-owned subsidiary of The Prudential Insurance Company of America, which in turn is a direct wholly-owned subsidiary of Prudential Financial, Inc. Pruco Life is a stock life insurance company organized in 1971 under the laws of the State of Arizona. It is licensed to sell life insurance and annuities in the District of Columbia, Guam and in all states except New York, and sells such products primarily through affiliated and unaffiliated distributors. The condensed financial information of Pruco Life should be read in conjunction with the consolidated financial statements of Pruco Life and its subsidiaries and the notes thereto (the “Consolidated Financial Statements”). The condensed financial statements of Pruco Life reflect its direct wholly-owned subsidiary and majority-owned subsidiaries using the equity method of accounting.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pay vs Performance Disclosure - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Pay vs Performance Disclosure | |||
| Net Income (Loss) | $ 823,990 | $ 450,258 | $ (771,039) |
Insider Trading Arrangements |
3 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Trading Arrangements, by Individual | |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
Cybersecurity Risk Management and Strategy Disclosure |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Cybersecurity Risk Management, Strategy, and Governance [Line Items] | |
| Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] | Because of the size and scope of our business, we are subject to numerous and evolving cybersecurity risks, any of which, if it materializes, could affect our business strategy, results of operations, or financial condition. See “Item 1A. Risk Factors—Operational Risk” for a discussion of such risks. Cybersecurity risk management is integrated within our risk management framework. We conduct risk identification through several processes at the business unit, corporate, senior management, and Board levels. This framework includes escalation points to Prudential's risk committees, allowing cyber risk and control matters to be elevated to the Board of Directors or its Audit Committee for oversight. In order to respond to the threat of security breaches and cyber-attacks, Prudential Financial has developed an information security program designed to protect and preserve the confidentiality, integrity, and continued availability of information owned by, or in the care of, the Company. This information security program provides for the coordination of various corporate functions and governance groups, including global technology, risk, legal, compliance and corporate audit, and serves as a framework for the execution of responsibilities across businesses and operational roles. Among other things, the information security program establishes security standards for our technological resources and includes training for employees, contractors and third-parties. Employees with access to our Company’s systems are subject to comprehensive annual training on responsible information security, data security, and cybersecurity practices and how to protect data against cyber threats. As part of the information security program, we conduct periodic exercises with independent outside advisors to assess the effectiveness of our program and our internal response preparedness. We regularly engage with the broader cybersecurity community and monitor cyber threat information. To address risks associated with third-parties, Prudential Financial has established an enterprise-wide Third-Party Risk Management Program. This program’s features include, among other things, identifying, assessing and managing cybersecurity risks throughout the life of our third-party relationships. We also maintain an incident response plan, which specifies escalation and evaluation processes for cyber events. This plan is executed in close coordination with our corporate functions, including a dedicated cyber and privacy law function, external affairs, and risk management, and is designed to ensure, among other things, appropriate and timely reporting and disclosure. During the period covered by this Report, we did not identify any cybersecurity threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition. See “Item 1A. Risk Factors—Operational Risk” for a discussion of risks related to cybersecurity.
|
| Cybersecurity Risk Management Processes Integrated [Flag] | true |
| Cybersecurity Risk Management Processes Integrated [Text Block] | Cybersecurity risk management is integrated within our risk management framework. We conduct risk identification through several processes at the business unit, corporate, senior management, and Board levels. This framework includes escalation points to Prudential's risk committees, allowing cyber risk and control matters to be elevated to the Board of Directors or its Audit Committee for oversight.
|
| Cybersecurity Risk Management Third Party Engaged [Flag] | true |
| Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] | true |
| Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] | false |
| Cybersecurity Risk Board of Directors Oversight [Text Block] | Prudential Financial's Audit Committee of the Board of Directors which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. At least annually, Prudential Financial's Board and the Audit Committee also receive updates about the results of program reviews, including exercises and response readiness assessments led by outside advisors who provide a third-party independent assessment of our technical program and internal response preparedness. To the extent cybersecurity controls are related to internal control over financial reporting, such controls are considered in the context of Prudential Financial's annual external integrated audit. Prudential Financial's Audit Committee regularly briefs the full Board of Directors on these matters, and the full Board of Directors also receives periodic briefings on cyber threats in order to enhance our directors’ literacy on cyber issues.
|
| Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] | Prudential Financial's Audit Committee of the Board of Directors which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. |
| Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] | Prudential Financial's Audit Committee of the Board of Directors which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. At least annually, Prudential Financial's Board and the Audit Committee also receive updates about the results of program reviews, including exercises and response readiness assessments led by outside advisors who provide a third-party independent assessment of our technical program and internal response preparedness. To the extent cybersecurity controls are related to internal control over financial reporting, such controls are considered in the context of Prudential Financial's annual external integrated audit.
|
| Cybersecurity Risk Role of Management [Text Block] | Prudential Financial's information security program is overseen by the Chief Information Security Officer (“CISO”) and Information Security Office, as well as the Head of Global Technology and Operations (“HGTO”). The CISO and Information Security Office are responsible for monitoring for, and informing management of, cybersecurity incidents impacting Prudential’s systems.Prudential Financial's Audit Committee of the Board of Directors which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. |
| Cybersecurity Risk Management Positions or Committees Responsible [Flag] | true |
| Cybersecurity Risk Management Positions or Committees Responsible [Text Block] | Prudential Financial's information security program is overseen by the Chief Information Security Officer (“CISO”) and Information Security Office, as well as the Head of Global Technology and Operations (“HGTO”). |
| Cybersecurity Risk Management Expertise of Management Responsible [Text Block] | The CISO has served in various roles in information technology and information security for over 25 years, including serving as the head of information technology risk at two large public companies. The CISO holds a graduate degree in technology management and has attained the professional certifications of Certified Information Systems Security Professional and Certified Information Privacy Professional. |
| Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] | Prudential Financial's Audit Committee of the Board of Directors which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. At least annually, Prudential Financial's Board and the Audit Committee also receive updates about the results of program reviews, including exercises and response readiness assessments led by outside advisors who provide a third-party independent assessment of our technical program and internal response preparedness. Prudential Financial's Audit Committee regularly briefs the full Board of Directors on these matters, and the full Board of Directors also receives periodic briefings on cyber threats in order to enhance our directors’ literacy on cyber issues.
|
| Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] | true |
Significant Accounting Policies and Pronouncements (Policies) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basis of Presentation | Basis of Presentation The Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the accounts of Pruco Life and entities over which the Company exercises control, including majority-owned subsidiaries. Intercompany balances and transactions have been eliminated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining future policy benefits; policyholders' account balances and reinsurance related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; market risk benefits; the valuation of investments including derivatives, the measurement of allowance for credit losses, and the recognition of other-than-temporary impairments; reinsurance recoverables; any provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters. Annual Assumptions Review Annually, the Company performs a comprehensive review of the assumptions set for purposes of estimating future premiums, benefits, and other cash flows. Assumptions include those that are economic and those that are insurance related. Insurance related assumptions are based on the Company’s best estimates of future rates of mortality, morbidity, lapse, surrender, annuitization, expenses and other items. The Company generally looks to relevant Company experience as the primary basis for these assumptions. If relevant Company experience is not available or does not have sufficient credibility, the Company may look to experience of similar blocks of business, either in the Company or the industry. Mortality rate assumptions are generally based on Company experience, sometimes blending Company experience with an industry table where the Company experience alone is not sufficiently credible. The Company sets mortality and morbidity assumptions that vary by major type of business. Within type of business, rates vary by age and gender. The Company applies an adjustment for future mortality improvement, consistent with observed long-term trends of population mortality over time. Lapse and surrender assumptions are based on Company and industry experience, where available. The Company sets rates that vary by product type, taking into account features specific to the product. As part of this review, the Company may update these assumptions and make refinements to its models based upon emerging experience, future expectations and other data, including any observable market data it feels is indicative of a long-term trend. These assumptions are generally updated annually, unless a material change is observed in an interim period that the Company feels is also indicative of a long-term trend. Generally, the Company does not expect trends to change significantly in the short-term and, to the extent these trends may change, it expects such changes to be gradual over the long-term. The Company also performs a comprehensive review of the economic assumptions, including long-term interest rate assumptions and equity return assumptions that impact reserve calculations. The Company generally utilizes relevant economic outlook information and industry surveys as the primary basis for these assumptions, which may be used to project future rates of return on investments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reclassifications | Reclassifications Certain amounts in prior periods have been reclassified to conform to the current period presentation. Revision to Prior Period Financial Statements In the fourth quarter of 2024, the Company identified misstatements in the previously issued Consolidated Financial Statements for the years ended December 31, 2023 and 2022. Prior period amounts have been revised in the Consolidated Financial Statements and related disclosures to correct this error. Management evaluated these adjustments and concluded they were not material to any previously reported quarterly or annual Consolidated Financial Statements. See Note 17 for a more detailed description of the revisions and for comparisons of amounts previously reported to the revised amounts.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments and Investment-Related Liabilities | Fixed maturities, available-for-sale, at fair value ("AFS debt securities") includes bonds, notes and redeemable preferred stock that are carried at fair value. See Note 5 for additional information regarding the determination of fair value. The purchased cost of fixed maturities is adjusted for amortization of premiums and accretion of discounts to maturity or, if applicable, call date. AFS debt securities, where fair value is below amortized cost, are reviewed quarterly to determine whether the amortized cost basis of the security is recoverable. For mortgage-backed and asset-backed AFS debt securities, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. A credit impairment recorded cannot exceed the difference between the amortized cost and fair value of the respective security. The net present value used to measure a credit impairment is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the AFS debt security at the date of acquisition. Once the Company has deemed all or a portion of the amortized cost uncollectible, the allowance is removed from the balance sheet by writing down the amortized cost basis of the AFS debt security. Any amount of an AFS debt security’s change in fair value not recorded as an allowance for credit losses will be recorded in Other Comprehensive Income (loss) (“OCI”). For all other AFS debt securities, qualitative factors are first considered including, but not limited to, the extent of the decline and the reasons for the decline in value (e.g., credit events, currency or interest-rate related, including general credit spread widening), and the financial condition of the issuer. If analysis of these qualitative factors results in the security needing to be impaired, a credit impairment will be recognized and measured using the same process for mortgage-backed and asset-backed AFS debt securities. When an AFS debt security's fair value is below amortized cost and the Company has the intent to sell the AFS debt security, or it is more likely than not the Company will be required to sell the AFS debt security before its anticipated recovery, the amortized cost basis of the AFS debt security is written down to fair value and any previously recognized allowance is reversed. The write-down is reported in "Realized investment gains (losses), net". Interest income, including amortization of premium and accretion of discount, are included in “Net investment income” under the effective yield method. Prepayment premiums are also included in “Net investment income”. For high credit quality mortgage-backed and asset-backed AFS debt securities (those rated AA or above), the amortized cost and effective yield of the securities are adjusted as necessary to reflect historical prepayment experience and changes in estimated future prepayments. The adjustments to amortized cost are recorded as a charge or credit to “Net investment income” in accordance with the retrospective method. For mortgage-backed and asset-backed AFS debt securities rated below AA, the effective yield is adjusted prospectively for any changes in the estimated timing and amount of cash flows unless the investment is purchased with credit deterioration or an allowance is currently recorded for the respective security. If an investment is impaired, any changes in the estimated timing and amount of cash flows will be recorded as the credit impairment, as opposed to a yield adjustment. If the asset is purchased with credit deterioration (or previously impaired), the effective yield will be adjusted if there are favorable changes in cash flows subsequent to the allowance being reduced to zero. For mortgage-backed and asset-backed AFS debt securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. These assumptions can significantly impact income recognition, unrealized gains and loss recorded in OCI, and the amount of impairment recognized in earnings. The payment priority of the respective security is also considered. For all other AFS debt securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. The Company has developed these estimates using information based on its historical experience as well as using market observable data, such as industry analyst reports and forecasts, sector credit ratings and other data relevant to the collectability of a security, such as the general payment terms of the security and the security’s position within the capital structure of the issuer. Fixed maturities, trading, at fair value ("Trading debt securities") includes debt securities that are carried at fair value. See Note 5 for additional information regarding the determination of fair value. Realized and unrealized gains and losses for these investments are reported in “Other income (loss),” and interest income from these investments is reported in “Net investment income”. Equity securities, at fair value consists of common stock and mutual fund shares carried at fair value. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and dividend income is reported in “Net investment income” on the ex-dividend date. Policy loans represents funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in “Net investment income” at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Short-term investments primarily consists of highly liquid debt instruments with a maturity of twelve months or less and greater than three months when purchased. These investments are generally carried at fair value or amortized cost that approximates fair value and include certain money market investments, funds managed similar to regulated money market funds, short-term debt securities issued by government sponsored entities and other highly liquid debt instruments. Commercial mortgage and other loans consist of commercial mortgage loans, agricultural property loans, as well as certain other collateralized loans. Commercial mortgage and other loans held for investment are generally carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses and net of any current expected credit loss ("CECL") allowance. Certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans, and certain unfunded mortgage loan commitments where the Company cannot unconditionally cancel the commitment) are also subject to a CECL allowance. See Note 16 for additional information. Commercial mortgage and other loans acquired, including those related to the acquisition of a business, are recorded at fair value when purchased, reflecting any premiums or discounts to unpaid principal balances. Interest income, and the amortization of the related premiums or discounts, are included in “Net investment income” under the effective yield method. Prepayment fees are also included in “Net investment income.” The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets or off-balance sheet credit exposures. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. The allowance is calculated separately for commercial mortgage loans, agricultural mortgage loans and other collateralized loans. For commercial mortgage and agricultural mortgage loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. Similar risk characteristics used to create the pools include, but are not limited to, vintage, maturity, credit rating, and collateral type. Key inputs to the CECL model include unpaid principal balances, internal credit ratings, annual expected loss factors, average lives of the loans adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Information about certain key inputs is detailed below. Key factors in determining the internal credit ratings for commercial mortgage and agricultural mortgage loans include loan-to-value and debt-service-coverage ratios. Other factors include amortization, loan term, and estimated market value growth rate and volatility for the property type and region. The loan-to-value ratio compares the carrying amount of the loan to the fair value of the underlying property or properties collateralizing the loan, and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the carrying amount of the loan exceeds the collateral value. A loan-to-value ratio less than 100% indicates an excess of collateral value over the carrying amount of the loan. The debt service coverage ratio is a property’s net operating income as a percentage of its debt service payments. Debt service coverage ratios less than 1.0 indicates that property operations do not generate enough income to cover the loan’s current debt payments. A debt service coverage ratio greater than 1.0 indicates an excess of net operating income over the debt service payments. The values utilized in calculating these ratios are developed as part of the Company’s periodic review of the commercial mortgage loan and agricultural property loan portfolios, which includes an internal appraisal of the underlying collateral value. The Company’s periodic review also includes a quality re-rating process, whereby the internal quality rating originally assigned at underwriting is updated based on current loan, property and market information using a proprietary quality rating system. See Note 3 for additional information related to the loan-to-value ratios and debt service coverage ratios related to the Company’s commercial mortgage and agricultural loan portfolios. Annual expected loss rates are based on historical default and loss experience factors. Using average lives, the annual expected loss rates are converted into life-of-loan loss expectations. When individual loans no longer have the credit risk characteristics of the commercial or agricultural mortgage loan pools, they are removed from the pools and are evaluated individually for an allowance. The allowance is determined based on the outstanding loan balance less the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent. The CECL allowance on commercial mortgage and other loans can increase or decrease from period to period based on the factors noted above. The change in allowance is reported in “Realized investment gains (losses), net”. As it relates to unfunded commitments that are in scope of this guidance, the CECL allowance is reported in “Other liabilities”, and the change in the allowance is reported in “Realized investment gains (losses), net”. The CECL allowance for other collateralized loans carried at amortized cost is determined based on probability of default and loss given default assumptions by sector, credit quality and average lives of the loans. Additions to or releases of the allowance are reported in “Realized investment gains (losses), net.” Once the Company has deemed a portion of the amortized cost to be uncollectible, the uncollectible portion of allowance is removed from the balance sheet by writing down the amortized cost basis of the loan. The carrying amount of the loan is not adjusted for subsequent recoveries in value. Interest received on loans that are past due is either applied against the principal or reported as net investment income based on the Company’s assessment as to the collectability of the principal. The Company defines “past due” as principal or interest not collected at least 30 days past the scheduled contractual due date. See Note 3 for additional information about the Company’s past due loans. The Company discontinues accruing interest on loans after the loans become 90 days delinquent as to principal or interest payments, or earlier when the Company has doubts about collectability. When the Company discontinues accruing interest on a loan, any accrued but uncollectible interest on the loan and other loans backed by the same collateral, if any, is charged against interest income in the same period. Generally, a loan is restored to accrual status only after all delinquent interest and principal are brought current and, in the case of loans where the payment of interest has been interrupted for a substantial period, or the loan has been modified, a regular payment performance has been established. Commercial mortgage and other loans are occasionally restructured. These restructurings generally include one or more of the following: full or partial payoffs outside of the original contract terms; changes to interest rates; extensions of maturity; or additions or modifications to covenants. Additionally, the Company may accept assets in full or partial satisfaction of the debt. Effective January 1, 2023, the Company adopted Accounting Standard Update ("ASU") 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosure, on a prospective basis. This ASU eliminates the accounting guidance for Troubled Debt Restructurings (“TDR”) for creditors and requires all loan restructurings to follow the modification guidance in ASC 310-20. Prior to the adoption of ASU 2022-02, when restructurings occurred, they were evaluated individually to determine whether the restructuring or modification constituted a TDR as defined by authoritative accounting guidance. If the borrower was experiencing financial difficulty and the Company granted a concession, the restructuring, including those that involved a partial payoff or the receipt of assets in full satisfaction of the debt was deemed to be a TDR. If a loan modification was a TDR, the CECL allowance of the loan was remeasured using the modified terms and the loan's original effective yield. Post adoption of ASU 2022-02, all restructurings are evaluated under the modification guidance in ASC 310-20. When a loan is modified, the Company evaluates whether the restructuring results in a continuation of the existing loan or a new loan. For modifications that result in a continuation of the existing loan, the CECL allowance of the loan is remeasured using the modified terms, including the loan’s post-modification effective yield, and the allowance is adjusted accordingly. For modifications that result in a new loan, any CECL allowance is reversed and a direct write-down of the loan is recorded for the amount of the allowance, and any additional loss, net of recoveries, or any gain is recorded for the difference between the fair value of the new loan and the recorded investment in the loan. The new loan is evaluated prospectively for credit impairment based on the CECL allowance process noted above. Other invested assets consist of the Company’s non-coupon investments in limited partnerships and limited liability companies ("LPs/LLCs"), other than operating joint ventures, as well as derivative assets. LPs/LLCs interests are accounted for using either the equity method of accounting, or at fair value. The Company’s income from investments in LPs/LLCs accounted for using the equity method, other than the Company’s investments in operating joint ventures, is included in “Net investment income”. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. In applying the equity method (including assessment for OTTI), the Company uses financial information provided by the investee, generally on a to three-month lag. For the investments reported at fair value with changes in fair value reported in current earnings, the associated realized and unrealized gains and losses are reported in “Other income (loss)”. Realized investment gains (losses) are computed using the specific identification method. Realized investment gains and losses are generated from numerous sources, including the sales of fixed maturity securities, investments in joint ventures and limited partnerships and other types of investments, as well as changes to the allowance for credit losses recognized in earnings. Realized investment gains and losses also reflect fair value changes on commercial mortgage loans carried at fair value, and fair value changes on embedded derivatives and free-standing derivatives that do not qualify for hedge accounting treatment. See “Derivative Financial Instruments” below for additional information regarding the accounting for derivatives. Realized investment gains (losses), net includes realized gains or losses from sales and maturities of investments, changes to the allowance for credit losses, other impairments, fair value changes on mortgage loans where the fair value option has been elected, and derivative gains or losses. The derivative gains or losses include the impact of maturities, terminations and changes in fair value of the derivative instruments, including embedded derivatives, and other hedging instruments. Realized investment gains (losses) from the sales of securities are generally calculated using the specific identification method.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | Cash and cash equivalents includes cash on hand, amounts due from banks, certain money market investments, funds managed similar to regulated money market funds, other debt instruments with maturities of three months or less when purchased, other than cash equivalents that are included in "Fixed maturities, available-for-sale, at fair value,” and receivables related to securities purchased under agreements to resell (see also "Securities sold under agreements to repurchase" below.) The Company also engages in overnight borrowing and lending of funds with Prudential Financial and affiliates which are considered cash and cash equivalents. These assets are generally carried at fair value or amortized cost which approximates fair value.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred policy acquisition costs | Deferred policy acquisition costs ("DAC") represents costs directly related to the successful acquisition of new and renewal insurance and annuity business. Such DAC primarily includes commissions, costs of policy issuance and underwriting, and certain other expenses that are directly related to successfully acquired contracts. In each reporting period, previously capitalized DAC is amortized and included in “Amortization of deferred policy acquisition costs”. Upon the adoption of ASU 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, the carrying amount of DAC for long-duration contracts is no longer subject to recoverability testing. DAC for most long-duration contracts is amortized on a constant-level basis at a grouped contract level over the expected life of the underlying insurance contracts. Contracts are grouped consistent with the groupings used to estimate the liability for future policy benefits (or other related balances) for the corresponding contracts. Since contracts within a grouping may be of different sizes, contracts within a group are weighted to achieve appropriate amortization and to ensure that DAC is derecognized when a policy is no longer in force. The constant-level basis used to weight contracts within a grouping and amortize DAC is generally defined as follows: •Life insurance contracts – DAC associated with life insurance contracts is generally amortized in proportion to the initial face amount of life insurance in force. This is applicable to traditional and universal life insurance products. •Payout annuity contracts – DAC associated with payout annuity contracts is amortized in proportion to annual benefit payments. •Deferred annuity contracts – DAC associated with fixed and variable deferred annuity contracts is amortized in proportion to deposits. For single premium immediate annuities without life contingencies, acquisition expenses are deferred and amortized over the expected life of the contracts using the interest method. Current period DAC amortization reflects the impact of changes in actual insurance in force during the period and changes in future assumptions effected as of the end of the quarter, where applicable. The Company typically updates actuarial assumptions annually in the second quarter, (see "Annual Assumptions Review" below), unless a material change is observed in an interim period that is indicative of a long-term trend. Generally, the Company does not expect trends to change significantly in the short-term and, to the extent these trends may change, the Company expects such changes to be gradual over the long-term. Assumptions used for DAC are consistent with those used in estimating the liability for future policy benefits (or any other related balance) for the corresponding contract. Determining the level of aggregation and actuarial assumptions used in projecting in force terminations requires judgment. Internal criteria are developed to determine the level of aggregation by considering both qualitative and quantitative materiality thresholds. The assumptions used in projecting in force terminations are mortality, mortality improvement, and lapse assumptions. These assumptions are generally based on the Company’s experience, industry experience and/or other factors, as applicable. For variable deferred annuity contracts, lapse rates are adjusted at the contract level based on the in-the-moneyness of the living benefits and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For some products, policyholders can elect to modify product benefits, features, rights or coverages by exchanging a contract for a new contract or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. These transactions are known as internal replacements. If policyholders surrender traditional life insurance policies in exchange for life insurance policies that do not have fixed and guaranteed terms, the Company immediately charges to expense the remaining unamortized DAC on the surrendered policies. For other internal replacement transactions, except those that involve the addition of a non-integrated contract feature that does not change the existing base contract, the unamortized DAC is immediately charged to expense if the terms of the new policies are not substantially similar to those of the former policies. If the new terms are substantially similar to those of the earlier policies, the DAC is retained with respect to the new policies and amortized over the expected life of the new policies. See Note 6 for additional information regarding DAC.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued investment income | Accrued investment income primarily includes accruals of interest and dividend income from investments that have been earned but not yet received.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance | Reinsurance recoverables and deposit receivables includes amounts recoverable under reinsurance agreements and receivables that follow the deposit method of accounting (see “Reinsurance” below). Reinsurance and funds withheld payables represents amounts payable under reinsurance agreements (see “Reinsurance” below). Reinsurance and funds withheld payables may also include derivative instruments for which fair values are determined as described below under "Derivative Financial Instruments". Reinsurance The Company participates in reinsurance arrangements in various capacities as either the ceding entity or as the reinsurer (i.e., assuming entity). See Note 11 for additional information regarding the Company’s reinsurance arrangements. Reinsurance assumed business is generally accounted for consistent with direct business. Amounts currently recoverable under reinsurance agreements are included in “Reinsurance recoverables and deposit receivables” and amounts payable are included in “Reinsurance and funds withheld payables”. “Reinsurance recoverables and deposit receivables” also includes deposit receivables where the Company has ceded fixed indexed annuities, including from coinsurance with funds withheld arrangements and receivables from modified coinsurance arrangements where the Company is the cedant, and in certain instances are net of the payables under these arrangements which generally reflect the fair value of the invested assets retained by the cedant. “Reinsurance and funds withheld payables” also includes amounts payable to the reinsurer under coinsurance with funds withheld arrangements where the Company is the cedant, and generally reflect the fair value of the invested assets retained by the Company. The receivables and payables associated with each of these coinsurance with funds withheld and modified coinsurance arrangements each contain an embedded derivative that is bifurcated and accounted for at fair value separately from the host contract, with changes in fair value recorded through “Realized investment gains (losses), net”, and are ultimately presented net within “Reinsurance recoverables and deposit receivables”. Revenues and benefits and expenses include amounts assumed under reinsurance agreements and are reflected net of reinsurance ceded. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. Reinsurance recoverables are reported on the Consolidated Statements of Financial Position net of the CECL allowance. The CECL allowance considers the credit quality of the reinsurance counterparty and is generally determined based on the probability of default and loss given default assumptions, after considering any applicable collateral arrangements. The CECL allowance does not apply to reinsurance recoverables with affiliated counterparties under common control. Additions to or releases of the allowance are reported in “Policyholders’ benefits”. Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured long-duration contracts under coinsurance arrangements are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. For reinsurance of in force blocks of non-participating traditional and limited-payment contracts, the current value of the direct liability as of inception of the reinsurance agreement is used to calculate the reinsurance recoverable and cost of reinsurance such that there is no immediate other comprehensive income or loss from recognition of the reinsurance recoverable at inception. Consistent with the direct liability, the reinsurance recoverable for non-participating traditional and limited-payment contracts is remeasured each period using current single A rates with the effect on the reinsurance recoverable resulting from such updates recorded in "Interest rate remeasurement of future policy benefits" in OCI. For reinsurance of limited-payment contracts, the Company establishes a cost of reinsurance asset relating to the direct DPL and amortizes this balance through “Premiums” using the same methodology and assumptions used to amortize the direct DPL. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference between the fair value of the net consideration exchanged and the net liabilities ceded related to the underlying reinsured contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. This initial net cost of reinsurance is deferred and amortized into income over the remaining life of the reinsured policies on a basis consistent with the methodologies and assumptions used for amortizing DAC. This initial net cost of reinsurance may result in a deferred reinsurance gain which is recorded in "Other liabilities" and amortized through "Other income (loss)", or a deferred reinsurance loss which is recorded in "Other assets" and amortized through "General, administrative and other expenses". Consistent with direct contracts, reinsurance agreements may also include features that meet the definition of an MRB and, if so, are accounted for at fair value. The fair value of direct or assumed MRBs reflects the Company's NPR, while the fair value of ceded MRBs reflects the counterparty credit risk of the reinsurer. Changes in the fair value of ceded MRBs, including the impact of changes in counterparty credit risk, are recorded in net income in "Change in value of market risk benefits, net of related hedging gains (losses)". Coinsurance arrangements contrast with the Company’s yearly renewable term ("YRT") arrangements, where only mortality risk is transferred to the reinsurer and premiums are paid to the reinsurer to reinsure that risk. The mortality risk that is reinsured under YRT arrangements represents the difference between the stated death benefits in the underlying reinsured contracts and the corresponding reserves or account value carried by the Company on those same contracts. The premiums paid to the reinsurer are based upon negotiated amounts, not on the actual premiums paid by the underlying contractholders to the Company. As YRT arrangements are usually entered into by the Company with the expectation that the contracts will be in force for the lives of the underlying policies, they are considered to be long-duration reinsurance contracts. The cost of reinsurance for universal life products is generally recognized based on the gross assessments of the underlying direct policies. The cost of reinsurance for term insurance products is generally recognized in proportion to direct premiums over the life of the underlying policies. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in “Reinsurance and funds withheld payables” and deposits made are included in “Reinsurance recoverables and deposit receivables”. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as “Other income (loss)” or “General, administrative and other expenses”, as appropriate.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefit (assets and liabilities) | Market risk benefit assets represents market risk benefits ("MRBs") in an asset position and are presented separately from MRBs in a liability position. See “Market risk benefit liabilities” below. MRB assets also reflect ceded MRBs resulting from reinsurance of the Company's Prudential Defined Income ("PDI") traditional variable annuity contracts. See Note 11 for additional information regarding the reinsurance of PDI. Market risk benefit liabilities represents contracts or contract features that provide protection to the contractholder and exposes the Company to other than nominal capital market risk, primarily related to deferred annuities with guaranteed minimum benefits associated with annuities products including guaranteed minimum death benefits (“GMDB”), guaranteed minimum income benefits (“GMIB”), guaranteed minimum accumulation benefits (“GMAB”), guaranteed minimum withdrawal benefits (“GMWB”) and guaranteed minimum income and withdrawal benefits (“GMIWB”). The benefits are accounted for using a fair value measurement framework. If a contract contains multiple market risk benefits, the benefits are bundled together and accounted for as a single compound market risk benefit. Market risk benefits in an asset position are presented separately from those in a liability position as there is no legal right of offset between contracts. The fair value of market risk benefits is calculated as the present value of expected future benefit payments to contractholders less the present value of expected future rider fees attributable to the market risk benefits. The fair value of market risk benefits is based on assumptions a market participant would use in valuing market risk benefits. For additional information regarding the valuation of market risk benefits, see Note 5. On a quarterly basis, changes in the fair value of market risk benefits are recorded in net income, net of related hedges, in "Change in value of market risk benefits, net of related hedging gains (losses)", except for the portion of the change attributable to changes in the Company’s non-performance risk ("NPR") which is recorded in OCI. See Note 10 for additional information regarding market risk benefits. See "Reinsurance" below for information regarding the reinsurance of MRBs.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred sales inducements | Deferred Sales Inducements ("DSI") are amounts that are credited to a policyholders’ account balance primarily as an inducement to purchase fixed and/or variable deferred annuity contracts. The Company defers sales inducements and amortizes them over the expected life of the policy using the same methodology, factors and assumptions used to amortize DAC. The Company records amortization of DSI in “Interest credited to policyholders’ account balances.” Unlike DAC, DSI are considered contractual cash flows and, as a result, are subject to periodic recoverability testing. See Note 6 for additional information regarding DSI.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income taxes assets | Income tax assets primarily represents the net deferred tax asset and the Company’s estimated taxes receivable for the current year and open audit years. The Company is a member of the federal income tax return of Prudential Financial and primarily files separate company state and local tax returns. Pursuant to the tax allocation arrangement with Prudential Financial, total federal income tax expense is determined on a separate company basis. Members record tax benefits to the extent tax losses or tax credits are recognized in the consolidated federal tax provision. Items required by tax regulations to be included in the tax return may differ from the items reflected in the financial statements. As a result, the effective tax rate reflected in the financial statements may be different than the actual rate applied on the tax return. Some of these differences are permanent such as expenses that are not deductible in the Company’s tax return, and some differences are temporary, reversing over time, such as valuation of insurance reserves. Temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a tax deduction or credit in future years for which the Company has already recorded the tax benefit in the Company’s Consolidated Statements of Operations. Deferred tax liabilities generally represent tax expense recognized in the Company’s financial statements for which payment has been deferred, or expenditures for which the Company has already taken a deduction in the Company’s tax return but have not yet been recognized in the Company’s financial statements. Deferred income taxes are recognized, based on enacted rates, when assets and liabilities have different values for financial statement and tax reporting purposes. The application of U.S. GAAP requires the Company to evaluate the recoverability of the Company’s deferred tax assets and establish a valuation allowance if necessary to reduce the Company’s deferred tax assets to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. See Note 12 for a discussion of factors considered when evaluating the need for a valuation allowance. U.S. GAAP prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on tax returns. The application of this guidance is a two-step process. First, the Company determines whether it is more likely than not, based on the technical merits, that the tax position will be sustained upon examination. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. The Company measures the tax position as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate resolution with a taxing authority that has full knowledge of all relevant information. This measurement considers the amounts and probabilities of the outcomes that could be realized upon ultimate settlement using the facts, circumstances, and information available at the reporting date. The Company accrues a liability for unrecognized tax benefits, interest and penalties which relate to tax years still subject to review by the Internal Revenue Service ("IRS") or other taxing jurisdictions. Audit periods remain open for review until the statute of limitations has passed. Generally, for tax years which produce net operating losses, capital losses or tax credit carryforwards (“tax attributes”), the statute of limitations does not close, to the extent of these tax attributes, until the expiration of the statute of limitations for the tax year in which they are fully utilized. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company classifies all interest and penalties related to tax uncertainties as income tax expense. See Note 12 for additional information regarding income taxes.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other assets and Other liabilities | Other assets consists primarily of deferred reinsurance losses ("DRL") (see "Reinsurance" below) which are amortized over the expected life of the reinsured contracts on a constant-level basis, receivables resulting from sales of securities that had not yet settled at the balance sheet date, premiums due, prepaid tax expenses, and the Company’s investments in operating joint ventures. Investments in operating joint ventures are generally accounted for under the equity method. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. Other liabilities consists primarily of deferred reinsurance gains ("DRG") (see "Reinsurance" below), accrued expenses, technical overdrafts, payables resulting from purchases of securities that had not yet settled at the balance sheet date. The amortization method for DRG is amortized over the expected life of the reinsured contracts on a constant-level basis.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate account assets and Separate account liabilities | Separate account assets represents segregated funds that are invested for certain policyholders, and other customers. The assets consist primarily of equity securities, fixed maturities, real estate-related investments, real estate mortgage loans, short-term investments and derivative instruments and are reported at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. The investment income and realized investment gains or losses from separate account assets generally accrue to the policyholders and are not included in the Company’s results of operations. Mortality, policy administration and surrender charges assessed against the accounts are included in “Policy charges and fee income”. Asset administration fees charged to the accounts are included in “Asset administration fees”. Seed money that the Company invests in separate accounts is reported in the appropriate general account asset line. Investment income and realized investment gains or losses from seed money invested in separate accounts accrue to the Company and are included in the Company’s results of operations. See Note 7 for additional information regarding separate account arrangements with contractual guarantees. See also “Separate account liabilities” below. Separate account liabilities primarily represents the contractholders’ account balances in separate account assets and to a lesser extent borrowings of the separate account, and will be equal and offsetting to total separate account assets. See also “Separate account assets” above.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Future policy benefits | Future policy benefits primarily consists of the present value of expected future payments to or on behalf of policyholders, where the timing and amount of such payments depend on policyholder mortality or morbidity, less the present value of expected future net premiums (where net premiums are gross premiums multiplied by the Net-To-Gross ("NTG") ratio discussed below). The liability for future policy benefits is accrued over time as premium revenue is recognized. See Note 8 for additional information regarding future policy benefits. The reserving methodology used for non-participating traditional and limited-payment contracts include the following: •Cash Flow Assumptions. In measuring the liability for future policy benefits, the net premium valuation methodology is utilized. Under this methodology, a liability for future policy benefits is established using current best estimate insurance assumptions and interest rate assumptions locked-in at contract issuance date. The NTG ratio is calculated as the ratio of the present value of expected policy benefits and non-level claim settlement expenses divided by the present value of expected gross premiums. The NTG ratio is applied to gross premiums, as premium revenue is recognized, to determine net premiums. The liability is then determined as the present value of expected future policy benefits and non-level claim settlement expenses less the present value of expected future net premiums. For purposes of liability measurement, contracts are grouped into cohorts based primarily on issue year and major product line. The NTG ratio is generally updated quarterly for actual experience and annually in the second quarter of each year for future cash flow assumption updates during the Company’s annual assumptions review process unless a material change is observed in an interim period that is indicative of a long-term trend (see “Annual Assumptions Review” below), with the exception of claim settlement expense assumptions which the Company has made an entity-wide election to lock-in as of contract issuance. The NTG ratio is subject to a retrospective unlocking method whereby the Company updates its best estimate of cash flows expected over the life of the cohort using actual historical experience and updated future cash flow assumptions. These updated cash flows are used to calculate the revised NTG ratio, which is used to derive an updated liability for future policy benefits as of the beginning of the current reporting period, discounted at the original contract issuance discount rate. The updated liability for future policy benefit amount as of the beginning of the quarter is then compared to the carrying amount of the liability as of that same date, before the updates for actual experience or future cash flow assumptions, to determine the current period change in liability estimate. This current period change in the liability is the liability remeasurement gain or loss that is recorded through current period earnings in “Change in estimates of liability for future policy benefits”. In subsequent periods, the revised NTG ratio is used to measure the liability for future policy benefits, subject to future revisions. If a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for expected future policy benefits and non-level claim settlement expenses, the NTG ratio is capped at 100%. In these instances, all changes in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately. While the liability for future policy benefits cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”), the NTG ratio may be negative. This would be the case whereby conditions have improved such that the present value of future net premiums plus the existing liability for future policy benefits as of the valuation date exceed the present value of expected future policy benefits and non-level claim settlement expenses. In this case, the negative NTG ratio would be applied going forward to gross premiums received, effectively amortizing the gain into income and reducing the liability over time. In addition, for limited-payment contracts, the liability for future policy benefits also includes a Deferred Profit Liability ("DPL") representing gross premiums received in excess of net premiums and is generally recognized in revenue in a constant relationship with insurance in force for life contracts or with the amount of expected future benefit payments for annuity contracts. The DPL is subject to a retrospective unlocking adjustment consistent with the liability for future policy benefits discussed above. The DPL cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”). For contracts issued prior to January 1, 2021, the modified retrospective transition method was used to transition to ASU 2018-12. Under this method, the transition date of January 1, 2021 serves as the new issue date of the contracts in force for purposes of retrospectively unlocking the NTG ratio and DPL as described above. •Discount Rate Assumption. The locked-in discount rate is generally based on expected investment returns at contract inception for contracts issued prior to January 1, 2021 and the upper medium grade fixed income corporate instrument yield (i.e., global single A) at contract inception for contracts issued on or after January 1, 2021. The discount rate in effect at contract inception is locked-in for the calculation of the NTG ratio and accretion of interest cost on the liability through net income. However, for balance sheet remeasurement purposes, the discount rate is updated using the current single A rate at each reporting period, with the effect on the liability resulting from such update recorded in “Interest rate remeasurement of future policy benefits" in OCI. The methodology used in constructing the single A discount rate curve for discounting cash flows used to calculate the liability for future policy benefits is intended to be reflective of the characteristics of the applicable insurance liabilities. The single A discount rate curve is developed by reference to upper medium grade (low credit risk) fixed income instrument yields that reflect the duration characteristics of the applicable insurance liabilities. The single A discount curve for the United States is developed using government bond rates plus public corporate A spreads in the observable periods. The definition of upper medium grade is based on Moody’s definition which includes the spectrum of A (i.e., A- to A+). Liquidity is considered in defining the observable period and linear extrapolation is performed to the Company's ultimate long-term economic assumptions. See “Annual Assumptions Review” below for further discussion regarding the Company’s long-term economic assumption setting process. The Company’s liability for future policy benefits also includes net liabilities for guaranteed benefits related to certain long-duration life contracts, such as no-lapse guarantee contract features (Additional Insurance Reserves or "AIR" liability), for which a liability is established when associated assessments are recognized (which include investment margin on policyholders' account balances deposited to fixed and indexed funds and all policy charges including charges for administration, mortality, expense, surrender, and other charges). This liability is established using current best estimate assumptions and is based on the ratio of the present value of total expected excess payments (i.e., payments in excess of account value) over the life of the contract divided by the present value of total expected assessments (i.e., benefit ratio). Any adjustments to this liability related to net unrealized gains (losses) on securities classified as available-for-sale are included in AOCI. For universal life type contracts and participating contracts, the Company performs premium deficiency tests using best estimate assumptions as of the testing date. If the liabilities determined based on these best estimate assumptions are greater than the net reserves (i.e., GAAP reserves including unearned revenue reserves ("URR"), net of reinsurance and any DSI asset), the existing net reserves are adjusted by first reducing assets, such as DSI or deferred reinsurance loss, by the amount of the deficiency or to zero through a charge to current period earnings. If the deficiency is more than these asset balances for insurance contracts, the net reserves are increased by the excess through a charge to current period earnings included in "Policyholders' benefits". Since investment yields are used as the discount rate, the premium deficiency test is also performed using a discount rate based on the market yield (i.e., assuming what would be the impact if any unrealized gains (losses) were realized as of the testing date). In the event that by using the market yield a deficiency occurs, an adjustment is established for the deficiency and is included in AOCI. The Company’s liability for future policy benefits also includes a liability for unpaid claims and claim adjustment expenses. The Company does not establish claim liabilities until a loss has been incurred. However, unpaid claims and claim adjustment expenses include estimates of claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholders' account balances | Policyholders’ account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability is primarily associated with the accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance, as applicable. These policyholders’ account balances also include provision for benefits under non-life contingent payout annuities and certain unearned revenues. The unearned revenue liability represents policy charges for services to be provided in future periods. The charges are deferred as incurred and are generally amortized over the expected life of the contract using the same methodology, factors, and assumption used to amortize DAC. See Note 9 for additional information regarding policyholders’ account balances. Policyholders' account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products. For additional information regarding the valuation of these embedded derivatives, see Note 5. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash collateral for loaned securities | Cash collateral for loaned securities represents liabilities to return cash proceeds from security lending transactions. Securities lending transactions are used primarily to earn spread income. As part of securities lending transactions, the Company transfers U.S. and foreign debt and equity securities, as well as U.S. government and government agency securities, and receives cash as collateral. Cash proceeds from securities lending transactions are primarily used to earn spread income, and are typically invested in cash equivalents, short-term investments or fixed maturities. Securities lending transactions are treated as financing arrangements and are recorded at the amount of cash received. The Company obtains collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of the Company’s securities lending transactions are with large brokerage firms and large banks. Income and expenses associated with securities lending transactions used to earn spread income are reported as "Net investment income".
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Securities sold under agreements to repurchase | Securities sold under agreements to repurchase represents liabilities associated with securities repurchase agreements that are used primarily to earn spread income. As part of securities repurchase agreements, the Company transfers U.S. government and government agency securities to a third-party, and receives cash as collateral. For securities repurchase agreements, the cash received is typically invested in cash equivalents, short-term investments or fixed maturities. Receivables associated with securities purchased under agreements to resell are generally reflected as cash equivalents. As part of securities resale agreements, the Company invests cash and receives as collateral U.S. government securities or other debt securities. Securities repurchase and resale agreements that satisfy certain criteria are treated as secured borrowing or secured lending arrangements. These agreements are carried at the amounts at which the securities will be subsequently resold or reacquired, as specified in the respective transactions. For securities purchased under agreements to resell, the Company’s policy is to take possession or control of the securities either directly or through a third-party custodian. These securities are valued daily, and additional securities or cash collateral is received, or returned, when appropriate to protect against credit exposure. Securities to be resold are the same, or substantially the same, as the securities received. The majority of these transactions are with large brokerage firms and large banks. For securities sold under agreements to repurchase, the market value of the securities to be repurchased is monitored, and additional collateral is obtained where appropriate, to protect against credit exposure. The Company obtains collateral in an amount at least equal to 95% of the fair value of the securities sold. Securities to be repurchased are the same, or substantially the same, as those sold. The majority of these transactions are with highly rated money market funds. Income and expenses related to these transactions executed within the insurance companies used to earn spread income are reported as “Net investment income.”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Short-term and long-term debt | Short-term and long-term debt liabilities are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issuance costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within “General, administrative and other expenses” in the Company’s Consolidated Statements of Operations. Short-term debt is debt coming due in the next twelve months, including that portion of debt otherwise classified as long-term. The short-term debt caption may exclude short-term debt items for which the Company has the intent and ability to refinance on a long-term basis in the near term. See Note 15 for additional information regarding short-term and long-term debt.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and contingent liabilities | Commitments and contingent liabilities are accrued if it is probable that a liability has been incurred and an amount is reasonably estimable. Management evaluates whether there are incremental legal or other costs directly associated with the ultimate resolution of the matter that are reasonably estimable and, if so, they are included in the accrual. These accruals are generally reported in “Other liabilities”.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance Revenue and Expense Recognition | Insurance Revenue and Expense Recognition Premiums from individual life products, other than universal and variable life contracts, are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for all expected future policy benefits and non-level claim settlement expenses) is generally deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in "Future policy benefits" above. Premiums from single premium immediate annuities with life contingencies are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue based on expected future benefit payments. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in "Future policy benefits" above. Certain individual annuity contracts provide the contractholder a guarantee that the benefit received upon death or annuitization will be no less than a minimum prescribed amount. These benefits are generally accounted for as market risk benefits (see “Market risk benefits” above). Amounts received from policyholders as payment for universal or variable individual life contracts, deferred fixed or variable annuities and other contracts without life contingencies are reported as deposits to “Policyholders’ account balances” and/or “Separate account liabilities.” Revenues from these contracts are reflected in “Policy charges and fee income” consisting primarily of fees assessed during the period against the policyholders’ account balances for mortality and other benefit charges, policy administration charges and surrender charges. In addition to fees, the Company earns investment income from the investment of deposits in the Company’s general account portfolio. Fees assessed that represent compensation to the Company for services to be provided in future periods and certain other fees are generally deferred and amortized into revenue over the life of the related contracts using the same methodology, factors, and assumption used to amortize DAC as described above. Benefits and expenses for these products include claims in excess of related account balances, expenses of contract administration, interest credited to policyholders’ account balances and amortization of DAC and DSI. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products where changes in the value of the embedded derivatives are recorded through "Realized investment gains (losses), net". For additional information regarding the valuation of these embedded derivatives, see Note 5.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset administration fees | Asset administration fees primarily include asset administration fee income received on contractholders’ account balances invested in The Prudential Series Funds, which are a portfolio of mutual fund investments related to the Company’s separate account products. Also, the Company receives fee income calculated on contractholder separate account balances invested in the Advanced Series Trust ("AST") (see Note 15). In addition, the Company receives fees from contractholders’ account balances invested in funds managed by companies other than affiliates of Prudential Insurance. Asset administration fees are recognized as income when earned. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other income | Other income (loss) includes realized and unrealized gains or losses from investments reported as “Fixed maturities, trading, at fair value”, “Equity securities, at fair value”, and “Other invested assets” that are measured at fair value as well as interest income related to affiliated cash collateral. See Note 15 for more information related to affiliated cash collateral. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Financial Instruments | Derivative Financial Instruments Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and NPR used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties, while others are bilateral contracts between two counterparties. Derivative positions are carried at fair value, generally by obtaining quoted market prices or through the use of valuation models. Derivatives are used to manage the interest rate and currency characteristics of assets or liabilities. Additionally, derivatives may be used to reduce exposure to risks such as interest rate, credit, foreign currency and equity associated with assets held or expected to be purchased or sold, and liabilities incurred or expected to be incurred. As discussed in detail below and in Note 4, all realized and unrealized changes in fair value of derivatives are recorded in current earnings, with the exception of cash flow hedges. Cash flows from derivatives are reported in the operating, investing or financing activities sections in the Consolidated Statements of Cash Flows based on the nature and purpose of the derivative. Derivatives are recorded either as assets, within “Other invested assets”, or as liabilities, within “Payables to parent and affiliates”, except for embedded derivatives which are recorded with the associated host contract. The Company nets the fair value of all derivative financial instruments with counterparties for which a master netting arrangement has been executed. The Company designates derivatives as either (1) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow” hedge); or (2) a derivative that does not qualify for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. The Company formally documents at inception all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives designated as cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded in AOCI until earnings are affected by the variability of cash flows being hedged (e.g., when periodic settlements on a variable-rate asset or liability are recorded in earnings). At that time, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in the Consolidated Statements of Operations line item associated with the hedged item. If it is determined that a derivative no longer qualifies as an effective cash flow hedge or management removes the hedge designation, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net”. The component of AOCI related to discontinued cash flow hedges is reclassified to the Consolidated Statements of Operations line associated with the hedged cash flows consistent with the earnings impact of the original hedged cash flows. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, or because it is probable that the forecasted transaction will not occur by the end of the specified time period, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net”. Any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized currently in “Realized investment gains (losses), net”. Gains and losses that were in AOCI pursuant to the hedge of a forecasted transaction are recognized immediately in “Realized investment gains (losses), net”. If a derivative does not qualify for hedge accounting, all changes in its fair value, including net receipts and payments, are included in “Realized investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments that contain derivative instruments that are “embedded” in the financial instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are clearly and closely related to the economic characteristics of the remaining component of the financial instrument (i.e., the host contract) and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When it is determined that (1) the embedded instrument possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded instrument qualifies as an embedded derivative that is separated from the host contract, carried at fair value, and changes in its fair value are included in “Realized investment gains (losses), net”. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company may elect to carry the entire instrument at fair value and report it within "Other invested assets" and "Reinsurance recoverable and deposit receivables", or as liabilities, within “Payables to parent and affiliates” or "Reinsurance and funds withheld payables". The Company sells variable annuity contracts that include optional living benefit features that may be treated from an accounting perspective as embedded derivatives. The embedded derivatives related to the living benefit features and the related reinsurance agreements are carried at fair value and included in “Future policy benefits" and “Reinsurance recoverables and deposit receivables”. Additionally, changes in the fair value are determined using valuation models as described in Note 5 and are recorded in “Realized investment gains (losses), net".
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| New accounting pronouncements including the Adoption of ASU 2018-12 | ASUs adopted as of December 31, 2024
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Future Adoption Of New Accounting Pronouncements | ASUs issued but not yet adopted as of December 31, 2024
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities, Available-for-sale Securities | Fixed Maturity Securities The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
(1) Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (2) Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
(1) Includes credit-tranched securities collateralized by loan obligations, auto loans, education loans and home equity loans. (2) Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Duration Of Gross Unrealized Losses On Fixed Maturity Securities | The following tables set forth the fair value and gross unrealized losses on fixed maturity, available-for-sale securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities Classified by Contractual Maturity Date | The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sources of Fixed Maturity Proceeds and Related Investment Gains (Losses), and Losses on Impairments | The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
(1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $(158.4) million, $57.4 million and $(53.9) million for the years ended December 31, 2024, 2023 and 2022, respectively. (2)Amounts represent write-downs of credit adverse securities and securities actively marketed for sale.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allowance for Credit Losses for Fixed Maturity Securities | The following tables set forth the balance of and changes in the allowance for credit losses for fixed maturity securities, as of and for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commercial Mortgage and Other Loans | The following table sets forth the composition of “Commercial mortgage and other loans”, as of the dates indicated:
The affiliated commercial mortgage loan included in "Commercial mortgage and other loans" at December 31, was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allowance for Credit Losses | The following table sets forth the balance of and changes in the allowance for credit losses for commercial mortgage and other loans, as of and for the periods ended:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Receivable Credit Quality Indicators | The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amortized Cost Basis of Loan Modifications made to Borrowers Experiencing Financial Difficulties | The following table sets forth the amortized cost basis of loan modifications made to borrowers experiencing financial difficulties for the date indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aging of Past Due Commercial Mortgage and Other Loans and Nonaccrual Status | The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
(1)As of December 31, 2024, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2.
(1)As of December 31, 2023, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Invested Assets | The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
(1)Prior period amounts have been updated to conform to current period presentation. (2)Includes tax advantaged investments and investments in separate account funds.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Method Investments | The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in operating joint ventures. Changes between periods in the tables below reflect changes in the activities within the operating joint ventures and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
(1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party borrowed funds and other miscellaneous liabilities.
(1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued Investment Income | The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Investment Income | The following table sets forth “Net investment income” by investment type, for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Realized Investment Gains (Losses), Net | The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
(1)Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading. (2)Prior period amounts have been updated to conform to current period presentation. (3)Includes changes in the value of reinsurance payables and funds withheld payables, primarily reflecting the impact of net investment income on withheld assets that are ceded to certain reinsurance counterparties. (4)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Unrealized Gains and (Losses) on Investments | The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
(1)For additional information regarding cash flow hedges, see Note 4. (2)Includes net unrealized gains (losses) on certain joint ventures that are strategic in nature and are included in “Other assets.”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase Agreements and Securities Lending | The following table sets forth the composition of “Cash collateral for loaned securities,” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
(1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Securities Pledged | The following table sets forth the carrying value of investments pledged to third-parties and the carrying amount of the associated liabilities supported by the pledged collateral, as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables and deposit receivables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral.
(1)Excludes embedded derivatives which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $11,968 million and $7,505 million as of December 31, 2024 and 2023, respectively, primarily included in "Policyholders' account balances". (2)Recorded in “Other invested assets” and “Payables to parent and affiliates” on the Consolidated Statements of Financial Position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting of Financial Assets | The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverable and deposit receivables), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position.
(1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting of Financial Liabilities | The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverable and deposit receivables), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position.
(1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, excluding the offset of the hedged item in an effective hedge relationship.
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments Recognized in Accumulated Other Comprehensive Income(Loss) Before Taxes | Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Assets and Liabilities Measured on Recurring Basis | The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.
(1)“Netting” amounts represent cash collateral of $(8,311) million and $(9,569) million as of December 31, 2024 and 2023, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (3)Equity securities excluded from the fair value hierarchy include a fund for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. As of December 31, 2023, the fair value of this investment was $14.6 million. (4)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at NAV per share (or its equivalent) as a practical expedient. At December 31, 2024 and 2023, the fair value of such investments was $44 million and $67 million, respectively. (5)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Consolidated Statements of Financial Position. (6)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund. At December 31, 2024 and 2023, the fair value of such investments was $6,444 million and $5,259 million, respectively. (7)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information | The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities.
(1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Directional impacts for MRB assets and liabilities are associated with the directional impacts of direct and assumed MRBs. (3)Includes assets classified as fixed maturities, available-for-sale and fixed maturities, trading. (4)Represents multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (6)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances. (7)The spread over the SOFR swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company's estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of December 31, 2024 and 2023, respectively. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar Life Insurance Company ("AuguStar"), an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits. See Note 11 for additional information regarding this transaction. As a result of this transaction, a ceded MRB asset balance was established to fair value the reinsurance reimbursements to the Company. The establishment of the fair value also required an estimate of NPR for AuguStar, which may differ from the Company's; however, the NPR spreads for AuguStar were developed using a methodology similar to that of the Company. (8)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (9)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of December 31, 2024 and 2023, the minimum withdrawal rate assumption is 78% and 81%, respectively. As of December 31, 2024 and 2023, the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (10)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age and duration. A mortality improvement assumption is also incorporated into the overall mortality table. (11)Includes deposit assets related to reinsurance agreements using deposit method of accounting and modified coinsurance agreements, which include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain annuity products. (12)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (13)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives. (14)Prior period amounts have been updated to conform to current period presentation. (15)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds. (4)Includes asset-backed and commercial mortgage-backed securities. (5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward. (6)Excludes MRB assets of $2,637 million and $2,367 million and MRB liabilities of $4,281 million and $5,157 million as of December 31, 2024 and 2023, respectively. See Note 10 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (8)Prior period amounts have been updated to conform to current period presentation. (9)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds. (4)Includes asset-backed and commercial mortgage-backed securities. (5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward. (6)Excludes MRB assets of $2,637 million and $2,367 million and MRB liabilities of $4,281 million and $5,157 million as of December 31, 2024 and 2023, respectively. See Note 10 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (8)Prior period amounts have been updated to conform to current period presentation. (9)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Measurements, Nonrecurring | The following tables present information for assets measured at fair value on a nonrecurring basis. The fair value measurement is nonrecurring as these assets are measured at fair value only when there is a triggering event (e.g., an evidence of impairment). Assets included in the table are those that were impaired during the respective reporting periods and that are still held as of the reporting date. The estimated fair values for these amounts were determined using significant unobservable inputs (Level 3). For the years ended December 31, 2024 and 2023, there were no triggering events.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosure Financial Instruments Not Carried at Fair Value | The tables below present the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
(1)Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. (2)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Charges, Insurers [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Costs | The following table shows a rollforward for the lines of business that contain DAC balances, along with a reconciliation to the Company's total DAC balance:
(1) Includes the impact of the reinsurance agreement with Lotus Re. See Note 11 for additional information. (2) Includes the impact of the reinsurance agreement with AuguStar. See Note 11 for additional information. (3) Includes the impacts of the Universal Life reinsurance transaction with PAR U and PURE. See Note 11 for additional information. (4) Includes the impacts of the Term Life reinsurance transaction with PARCC. See Note 11 for additional information. (5) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Reinsurance Losses | The following table shows a rollforward for the lines of business that contain DRL balances, which is included in Other assets, along with a reconciliation to the Company's total DRL balance:
(1) Includes $979 million DRL related to the reinsurance transaction with Wilton Re. See Note 11 for additional information. (2) Includes $351 million DRL related to the reinsurance transaction with PARCC. See Note 11 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Reinsurance Gains | The following table shows a rollforward for the lines of business that contain DRG balances, which is included in Other liabilities, along with a reconciliation to the Company's total DRG balance:
(1) Includes $1,352 million DRG related to the reinsurance agreement with Lotus Re, entered into January 1, 2022. See Note 11 for additional information. (2) Includes the impact of the reinsurance agreement with AuguStar. See Note 11 for additional information. (3) Includes the impact of the Universal Life reinsurance transactions with PAR U, PURE and Prudential Insurance effective January 1, 2024, including $1,207 million of DRG, partially offset by a $116 million write-off of the DRG that was recognized with the previous reinsurance agreement. See Note 11 for additional information. (4) Includes the impact of the Universal Life reinsurance transactions with PAR U and Prudential Insurance effective October 2024, including $798 million DRG, partially offset by a $94 million write-off of the DRG that was recognized with the previous reinsurance agreement. See Note 11 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Sales Inducements | The following table shows a rollforward of DSI balances for variable annuity products, which is the only line of business that contains a DSI balance, along with a reconciliation to the Company's total DSI balance:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account Assets | The aggregate fair value of assets, by major investment asset category, supporting separate accounts is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account Liabilities | The balances of and changes in separate account liabilities as of and for the periods indicated are as follows:
(1) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (2) Variable life includes $900 million of funding for a policy loan to an affiliated irrevocable trust. See Note 15 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefits | The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:
The balances of and changes in DPL for the years ended December 31, are as follows:
The following table shows a rollforward of AIR balances for variable and universal life products, for the years ended December 31,:
(1) Represents the portion of gross assessments required to fund the future policy benefits.
The following table presents the reconciliation of the ending balances from the above rollforwards, Benefit Reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for Future Policy Benefits as reported on the Company's Consolidated Statements of Financial Position for the years ended December 31,:
(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations for the periods indicated:
(1)Represents "Gross premiums" for benefit reserves; "Revenue" for DPL and "Gross assessments" for AIR.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balance | The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
(1) Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2) Variable life includes $900 million of funding for a policy loan to an affiliated irrevocable trust. See Note 15 for additional information. (3) The net amount at risk calculation includes both general and separate account balances. (4) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (5) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balance, Guaranteed Minimum Crediting Rate | The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums are as follows:
(1) Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Additional Liability, Long-Duration Insurance | The balances of and changes in URR as of and for the periods ended are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefits (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefits | The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
(1) Other adjustments for December 31, 2023 primarily includes $638 million related to the reinsurance transaction with AuguStar. See Note 11 for additional information. (2) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. The following table presents accompanying information to the rollforward table above.
(1) For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The table below reconciles MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance impact on balance sheet | Reinsurance amounts included in the Company’s Consolidated Statements of Financial Position as of December 31, were as follows:
(1)Prior period amounts have been updated to conform to current period presentation. (2)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Unaffiliated reinsurance amounts included in the table above and in the Company's Consolidated Statements of Financial Position as of December 31, were as follows:
(1)Includes $699 million of deferred policy acquisition costs related to the transaction with Wilton Re. (2)Prior period amounts have been updated to conform to current period presentation. (3)Includes $979 million deferred loss related to the reinsurance transaction with Wilton Re. (4)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables by counterparty | Reinsurance recoverables and deposit receivables by counterparty as of December 31, were as follows:
(1)Prior period amounts have been updated to conform to current period presentation. (2)Includes balances with Wilton Re, FLIAC, Somerset Re and other counterparties. See below for further information on significant third-party reinsurance arrangements. (3)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance impact on income statement | Reinsurance amounts, included in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, were as follows:
(1)Current period amounts include the impacts of the recaptures from PAR U as discussed above. (2)Amounts include reinsurance agreements using the deposit method of accounting. (3)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information. Unaffiliated reinsurance assumed and ceded amounts included in the table above and in the Company's Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, were as follows:
(1)Amounts include reinsurance agreements using the deposit method of accounting. (2)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross and net life insurance in force | The gross and net amounts of life insurance face amount in force as of December 31, were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Components of Income Tax Expense (Benefit) | The following schedule discloses significant components of income tax expense (benefit) for each year presented:
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Effective Income Tax Rate Reconciliation | The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2024, 2023 and 2022, and the reported income tax expense (benefit) are summarized as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Deferred Tax Assets and Liabilities | Schedule of Deferred Tax Assets and Deferred Tax Liabilities
(1) Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Components of Accumulated Other Comprehensive Income (Loss) | The balance of and changes in each component of AOCI as of and for the years ended December 31, are as follows:
(1)Includes cash flow hedges of $111 million, $12 million, and $139 million as of December 31, 2024, 2023 and 2022, respectively. (2)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reclassification out of Accumulated Other Comprehensive Income (Loss) | Reclassifications out of Accumulated Other Comprehensive Income (Loss)
(1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 4 for additional information on cash flow hedges. (4)See table below for additional information on unrealized investment gains (losses), including the impact on future policy benefits and policyholders’ account balances.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OTTI, Allowance and All Other Net Unrealized Investment Gains (Losses) AOCI Rollforward |
(1)Includes cash flow hedges. See Note 4 for information on cash flow hedges. (2)"Other costs" primarily includes reinsurance recoverables and DRL.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statutory Net Income and Surplus and Dividend Restrictions (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statutory Net Income and Surplus and Dividend Restrictions | The following table summarizes certain statutory financial information for the Company, including its subsidiary PLNJ, for the periods indicated:
(1) 2022 amounts include adjustments made to the audited statutory financial statements as of December 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Affiliated Notes Receivable | Affiliated notes receivable included in “Receivables from parent and affiliates” at December 31, were as follows:
(1)All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Affiliated Commercial Mortgage Loans | The following table sets forth the composition of “Commercial mortgage and other loans”, as of the dates indicated:
The affiliated commercial mortgage loan included in "Commercial mortgage and other loans" at December 31, was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Affiliated Asset Transfers | The table below shows affiliated asset trades for the years ended December 31, 2024 and 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Agreements | The following table provides the breakout of the Company's short-term debt. There was no debt outstanding as of December 31, 2024.
(1)Includes $180 million of loans reclassified as current portion of long-term debt as of December 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Guarantees | Guarantees of Asset Values
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revision to Prior Year Financial Statement (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prior Period Adjustment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revision to Prior Period Financial Statements | The following are the impacted line items from the Consolidated Financial Statements illustrating the effects of the revisions: Consolidated Statements of Financial Position
(1) As previously reported balances have been updated to conform to the current period presentation. Consolidated Statements of Operations and Comprehensive Income (Loss)
Consolidated Statements of Equity
Consolidated Statements of Cash Flows
(1) As previously reported balances have been updated to conform to the current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business and Basis of Presentation (Narrative) (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2024
segment
subsidiary
| |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Number Of Subsidiaries | subsidiary | 1 |
| Number of reportable segments | segment | 1 |
Significant Accounting Policies and Pronouncements (Narrative) (Details) |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Accounting Policies [Abstract] | ||
| Commercial mortgage and other loans, Loan-to-value ratios (greater than) | 100.00% | |
| Commercial mortgage and other loans, Loan-to-value ratios (less than) | 100.00% | |
| Commercial mortgage and other loans, Debt service coverage ratios (less than) | 1.0 | |
| Commercial mortgage and agricultural mortgage loans, Debt service coverage ratios (greater than) | 1.0 | |
| Securities Loaned Transactions Collateral Fair Value of Domestic Securities | 102.00% | |
| Securities Loaned Transactions Collateral Fair Value of Foreign Securities | 105.00% | |
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
| Equity, Attributable to Parent | $ 4,596,441,000 | $ 4,472,670,000 |
| Maximum | ||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
| Equity method investment, financial information, lag period | 3 months | |
| Net To Gross Ratio | 1 | |
| Minimum | ||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
| Equity method investment, financial information, lag period | 1 month | |
| Repurchase and Resale Agreements, Collateral, Percentage | 95.00% | |
| Minimum | Liability for Future Policy Benefit | ||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
| Liability for Future Policy Benefits, cohort level and balance floored | $ 0 | |
| Minimum | Deferred Profit Liability | ||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
| Liability for Future Policy Benefits, cohort level and balance floored | $ 0 |
Investments (Fixed Maturities Securities Excluding Investments Classified as Trading) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | $ 36,980,933 | $ 27,538,066 | |
| Gross Unrealized Gains | 208,233 | 335,759 | |
| Gross Unrealized Losses | 2,162,592 | 1,740,037 | |
| Allowance for credit losses | 40,414 | 2,008 | $ 4,769 |
| Fair Value | 34,986,160 | 26,131,780 | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 1,199,628 | 1,009,937 | |
| Gross Unrealized Gains | 8,357 | 38,858 | |
| Gross Unrealized Losses | 108,744 | 73,508 | |
| Allowance for credit losses | 0 | 0 | 0 |
| Fair Value | 1,099,241 | 975,287 | |
| Obligations of U.S. states and their political subdivisions | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 570,253 | 789,856 | |
| Gross Unrealized Gains | 1,156 | 5,288 | |
| Gross Unrealized Losses | 30,343 | 18,517 | |
| Allowance for credit losses | 0 | 0 | |
| Fair Value | 541,066 | 776,627 | |
| Foreign government securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 362,154 | 330,830 | |
| Gross Unrealized Gains | 646 | 1,840 | |
| Gross Unrealized Losses | 52,466 | 50,684 | |
| Allowance for credit losses | 0 | 0 | 5 |
| Fair Value | 310,334 | 281,986 | |
| U.S. public corporate securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 14,134,828 | 10,159,089 | |
| Gross Unrealized Gains | 60,917 | 98,047 | |
| Gross Unrealized Losses | 957,316 | 760,274 | |
| Allowance for credit losses | 1 | 950 | |
| Fair Value | 13,238,428 | 9,495,912 | |
| U.S. private corporate securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 6,030,898 | 5,207,699 | |
| Gross Unrealized Gains | 35,828 | 37,435 | |
| Gross Unrealized Losses | 301,451 | 254,828 | |
| Allowance for credit losses | 11,178 | 812 | |
| Fair Value | 5,754,097 | 4,989,494 | |
| Foreign public corporate securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 3,804,503 | 1,809,347 | |
| Gross Unrealized Gains | 21,136 | 12,658 | |
| Gross Unrealized Losses | 126,767 | 115,673 | |
| Allowance for credit losses | 21 | 238 | |
| Fair Value | 3,698,851 | 1,706,094 | |
| Foreign private corporate securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 5,838,939 | 4,902,391 | |
| Gross Unrealized Gains | 43,334 | 109,806 | |
| Gross Unrealized Losses | 511,426 | 381,215 | |
| Allowance for credit losses | 29,214 | 0 | |
| Fair Value | 5,341,633 | 4,630,982 | |
| Asset-backed securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 3,728,073 | 2,016,028 | |
| Gross Unrealized Gains | 31,431 | 23,035 | |
| Gross Unrealized Losses | 8,841 | 11,512 | |
| Allowance for credit losses | 0 | 1 | 0 |
| Fair Value | 3,750,663 | 2,027,550 | |
| Commercial mortgage-backed securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 944,652 | 913,347 | |
| Gross Unrealized Gains | 4,567 | 4,776 | |
| Gross Unrealized Losses | 53,444 | 66,345 | |
| Allowance for credit losses | 0 | 0 | 0 |
| Fair Value | 895,775 | 851,778 | |
| Residential mortgage-backed securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Amortized Cost | 367,005 | 399,542 | |
| Gross Unrealized Gains | 861 | 4,016 | |
| Gross Unrealized Losses | 11,794 | 7,481 | |
| Allowance for credit losses | 0 | 7 | $ 9 |
| Fair Value | 356,072 | $ 396,070 | |
| Fixed maturities | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Fair Value | 1,099,241 | ||
| Fixed maturities | Obligations of U.S. states and their political subdivisions | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Fair Value | 541,066 | ||
| Fixed maturities | Foreign government securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Fair Value | 310,334 | ||
| Fixed maturities | Asset-backed securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Fair Value | 3,750,663 | ||
| Fixed maturities | Commercial mortgage-backed securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Fair Value | 895,775 | ||
| Fixed maturities | Residential mortgage-backed securities | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Fair Value | $ 356,072 |
Investments (Fair Value and Losses by Investment Category and Length of Time in a Loss Position) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | $ 10,716,329 | $ 2,492,369 |
| Less than Twelve Months, Gross Unrealized Losses | 267,215 | 39,568 |
| Twelve Months or More Fair Value | 11,256,350 | 13,312,102 |
| Twelve Months or More, Gross Unrealized Losses | 1,893,641 | 1,699,993 |
| Total, Fair Value | 21,972,679 | 15,804,471 |
| Total, Gross Unrealized Losses | 2,160,856 | 1,739,561 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 377,531 | 98,174 |
| Less than Twelve Months, Gross Unrealized Losses | 13,829 | 945 |
| Twelve Months or More Fair Value | 238,723 | 214,889 |
| Twelve Months or More, Gross Unrealized Losses | 94,915 | 72,563 |
| Total, Fair Value | 616,254 | 313,063 |
| Total, Gross Unrealized Losses | 108,744 | 73,508 |
| Obligations of U.S. states and their political subdivisions | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 226,731 | 83,729 |
| Less than Twelve Months, Gross Unrealized Losses | 5,019 | 293 |
| Twelve Months or More Fair Value | 212,060 | 218,375 |
| Twelve Months or More, Gross Unrealized Losses | 25,324 | 18,224 |
| Total, Fair Value | 438,791 | 302,104 |
| Total, Gross Unrealized Losses | 30,343 | 18,517 |
| Foreign government securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 118,168 | 10,226 |
| Less than Twelve Months, Gross Unrealized Losses | 2,615 | 116 |
| Twelve Months or More Fair Value | 171,166 | 233,757 |
| Twelve Months or More, Gross Unrealized Losses | 49,851 | 50,568 |
| Total, Fair Value | 289,334 | 243,983 |
| Total, Gross Unrealized Losses | 52,466 | 50,684 |
| U.S. public corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 4,320,552 | 782,904 |
| Less than Twelve Months, Gross Unrealized Losses | 105,145 | 10,009 |
| Twelve Months or More Fair Value | 4,677,336 | 5,201,353 |
| Twelve Months or More, Gross Unrealized Losses | 852,171 | 750,265 |
| Total, Fair Value | 8,997,888 | 5,984,257 |
| Total, Gross Unrealized Losses | 957,316 | 760,274 |
| U.S. private corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 1,999,008 | 707,674 |
| Less than Twelve Months, Gross Unrealized Losses | 41,931 | 16,613 |
| Twelve Months or More Fair Value | 2,379,755 | 2,794,697 |
| Twelve Months or More, Gross Unrealized Losses | 259,489 | 238,181 |
| Total, Fair Value | 4,378,763 | 3,502,371 |
| Total, Gross Unrealized Losses | 301,420 | 254,794 |
| Foreign public corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 1,088,644 | 92,955 |
| Less than Twelve Months, Gross Unrealized Losses | 20,465 | 1,063 |
| Twelve Months or More Fair Value | 716,172 | 948,963 |
| Twelve Months or More, Gross Unrealized Losses | 106,294 | 114,169 |
| Total, Fair Value | 1,804,816 | 1,041,918 |
| Total, Gross Unrealized Losses | 126,759 | 115,232 |
| Foreign private corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 1,977,169 | 429,212 |
| Less than Twelve Months, Gross Unrealized Losses | 69,399 | 8,035 |
| Twelve Months or More Fair Value | 2,107,705 | 2,461,367 |
| Twelve Months or More, Gross Unrealized Losses | 440,330 | 373,180 |
| Total, Fair Value | 4,084,874 | 2,890,579 |
| Total, Gross Unrealized Losses | 509,729 | 381,215 |
| Asset-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 363,744 | 208,970 |
| Less than Twelve Months, Gross Unrealized Losses | 5,510 | 1,761 |
| Twelve Months or More Fair Value | 140,090 | 532,814 |
| Twelve Months or More, Gross Unrealized Losses | 3,331 | 9,750 |
| Total, Fair Value | 503,834 | 741,784 |
| Total, Gross Unrealized Losses | 8,841 | 11,511 |
| Commercial mortgage-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 101,821 | 42,621 |
| Less than Twelve Months, Gross Unrealized Losses | 1,356 | 298 |
| Twelve Months or More Fair Value | 489,490 | 580,931 |
| Twelve Months or More, Gross Unrealized Losses | 52,088 | 66,047 |
| Total, Fair Value | 591,311 | 623,552 |
| Total, Gross Unrealized Losses | 53,444 | 66,345 |
| Residential mortgage-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 142,961 | 35,904 |
| Less than Twelve Months, Gross Unrealized Losses | 1,946 | 435 |
| Twelve Months or More Fair Value | 123,853 | 124,956 |
| Twelve Months or More, Gross Unrealized Losses | 9,848 | 7,046 |
| Total, Fair Value | 266,814 | 160,860 |
| Total, Gross Unrealized Losses | $ 11,794 | $ 7,481 |
Investments (Narrative) (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Schedule of Investments [Line Items] | |||
| Fixed Maturity Purchased with Credit Deterioration | $ 0 | $ 0 | |
| Accrued Investment Income Write Down | 0 | 0 | |
| Securities sold under agreements to repurchase | $ 0 | $ 0 | |
| Commercial mortgage loans, Percentage | 100.00% | 100.00% | |
| Write-downs charged against allowance | $ 9,367,000 | ||
| Loans on non-accrual status recognized in interest income | 700,000 | $ 0.0 | |
| Loans on non-accrual status, do not have allowance for credit losses | 2,000,000.0 | 1,300,000 | |
| Loans acquired | 12,600,000 | 0.0 | |
| Loans sold | 0 | 0 | |
| Commercial mortgage and other loans purchased with credit deterioration | 0 | 0 | |
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 34,986,160,000 | 26,131,780,000 | |
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,845,045,000 | 2,796,446,000 | |
| Fair value of collateral that could be sold or repledged | 0 | 25,000,000 | |
| Assets Deposited With Governmental Authorities | 3,600,000 | 3,600,000 | |
| Gross Unrealized Losses | 2,160,856,000 | 1,739,561,000 | |
| Twelve Months or More, Gross Unrealized Losses | $ 1,893,641,000 | 1,699,993,000 | |
| Commercial mortgage Loans | Extended Maturity | |||
| Schedule of Investments [Line Items] | |||
| Financing Receivable, Modified, Weighted Average Term Increase from Modification | 1 year | ||
| Carrying value of non-income producing assets | |||
| Schedule of Investments [Line Items] | |||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | $ 55,300,000 | ||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 900,000 | ||
| Fixed maturities | Trading | |||
| Schedule of Investments [Line Items] | |||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,845,045,000 | ||
| NAIC high or highest quality rating | Fixed maturities | |||
| Schedule of Investments [Line Items] | |||
| Gross Unrealized Losses | 2,059,000,000 | 1,634,000,000 | |
| NAIC other than high or highest quality rating | Fixed maturities | |||
| Schedule of Investments [Line Items] | |||
| Gross Unrealized Losses | $ 102,000,000 | 106,000,000 | |
| California | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 25.00% | ||
| Florida | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 9.00% | ||
| Texas | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 8.00% | ||
| Europe | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 8.00% | ||
| Mexico | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 1.00% | ||
| Australia | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 1.00% | ||
| Other Income | Fixed maturities | Trading | |||
| Schedule of Investments [Line Items] | |||
| Unrealized Gain (Loss) on Investments | $ (182,900,000) | 65,600,000 | $ (728,600,000) |
| Other Income | Equity securities | |||
| Schedule of Investments [Line Items] | |||
| Unrealized Gain (Loss) on Investments | (34,200,000) | 25,800,000 | $ (10,200,000) |
| Fixed maturities | |||
| Schedule of Investments [Line Items] | |||
| Twelve Months or More, Gross Unrealized Losses | $ 1,894,000,000 | $ 1,700,000,000 | |
Investments (Amortized Cost and Fair Value of Fixed Maturities by Contractual Maturities) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Amortized Cost | ||
| Due in one year or less | $ 1,139,538 | |
| Due after one year through five years | 11,753,438 | |
| Due after five years through ten years | 10,291,196 | |
| Due after ten years | 8,757,031 | |
| Amortized Cost | 36,980,933 | $ 27,538,066 |
| Fair Value | ||
| Due in one year or less | 1,118,484 | |
| Due after one year through five years | 11,477,710 | |
| Due after five years through ten years | 9,883,263 | |
| Due after ten years | 7,504,193 | |
| Fair Value | 34,986,160 | 26,131,780 |
| Asset-backed securities | ||
| Amortized Cost | ||
| Debt Securities, Available-for-sale,Maturity, without Single Maturity Date,Amortized Cost | 3,728,073 | |
| Amortized Cost | 3,728,073 | 2,016,028 |
| Fair Value | ||
| Debt Securities, Available-for-sale,Maturity, without Single Maturity Date,Fair Value | 3,750,663 | |
| Fair Value | 3,750,663 | 2,027,550 |
| Commercial mortgage-backed securities | ||
| Amortized Cost | ||
| Debt Securities, Available-for-sale,Maturity, without Single Maturity Date,Amortized Cost | 944,652 | |
| Amortized Cost | 944,652 | 913,347 |
| Fair Value | ||
| Debt Securities, Available-for-sale,Maturity, without Single Maturity Date,Fair Value | 895,775 | |
| Fair Value | 895,775 | 851,778 |
| Residential mortgage-backed securities | ||
| Amortized Cost | ||
| Debt Securities, Available-for-sale,Maturity, without Single Maturity Date,Amortized Cost | 367,005 | |
| Amortized Cost | 367,005 | 399,542 |
| Fair Value | ||
| Debt Securities, Available-for-sale,Maturity, without Single Maturity Date,Fair Value | 356,072 | |
| Fair Value | $ 356,072 | $ 396,070 |
Investments (Fixed Maturities Securities Proceeds) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Debt Securities, Available-for-sale [Line Items] | |||
| Proceeds from maturities/prepayments | $ 4,240,000 | $ 1,736,809 | $ 1,688,079 |
| Fixed maturities | Available-for-sale | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Proceeds from sales | 2,097,519 | 460,596 | 1,117,293 |
| Proceeds from maturities/prepayments | 2,300,919 | 1,218,844 | 624,640 |
| Gross investment gains from sales and maturities | 23,978 | 11,482 | 5,647 |
| Gross investment losses from sales and maturities | (143,432) | (43,078) | (58,432) |
| Write-downs recognized in earnings | (9,534) | (2,358) | (20,600) |
| (Addition to) release of allowance for credit losses | (38,406) | 2,761 | (620) |
| Noncash or part noncash divestiture, amount of consideration received | $ (158,400) | $ 57,400 | $ (53,900) |
Investments (Credit Losses Recognized In Earnings on Fixed Maturity Securities Held by the Company) (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | $ 2,008 | $ 4,769 |
| Additions to allowance for credit losses not previously recorded | 39,605 | 4,268 |
| Reductions for securities sold during the period | (2,002) | (5,120) |
| Addition (reductions) on securities with previous allowance | 324 | 431 |
| Write-downs charged against the allowance | (2,340) | |
| Assets transferred to parent and affiliates | 479 | |
| Balance, end of period | 40,414 | 2,008 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Addition (reductions) on securities with previous allowance | 0 | 0 |
| Write-downs charged against the allowance | 0 | |
| Assets transferred to parent and affiliates | 0 | |
| Balance, end of period | 0 | 0 |
| Foreign government securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 5 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | (1) |
| Addition (reductions) on securities with previous allowance | 0 | (4) |
| Write-downs charged against the allowance | 0 | |
| Assets transferred to parent and affiliates | 0 | |
| Balance, end of period | 0 | 0 |
| U.S. and Foreign Corporate Securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 2,000 | 4,755 |
| Additions to allowance for credit losses not previously recorded | 39,600 | 4,267 |
| Reductions for securities sold during the period | (2,002) | (5,118) |
| Addition (reductions) on securities with previous allowance | 337 | 436 |
| Write-downs charged against the allowance | (2,340) | |
| Assets transferred to parent and affiliates | 479 | |
| Balance, end of period | 40,414 | 2,000 |
| Asset-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 1 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 1 |
| Reductions for securities sold during the period | 0 | 0 |
| Addition (reductions) on securities with previous allowance | (1) | 0 |
| Write-downs charged against the allowance | 0 | |
| Assets transferred to parent and affiliates | 0 | |
| Balance, end of period | 0 | 1 |
| Commercial mortgage-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Addition (reductions) on securities with previous allowance | 0 | 0 |
| Write-downs charged against the allowance | 0 | |
| Assets transferred to parent and affiliates | 0 | |
| Balance, end of period | 0 | 0 |
| Residential mortgage-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 7 | 9 |
| Additions to allowance for credit losses not previously recorded | 5 | 0 |
| Reductions for securities sold during the period | 0 | (1) |
| Addition (reductions) on securities with previous allowance | (12) | (1) |
| Write-downs charged against the allowance | 0 | |
| Assets transferred to parent and affiliates | 0 | |
| Balance, end of period | $ 0 | $ 7 |
Investments (Commercial Mortgage and Other Loans) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 7,785,059 | $ 6,155,050 |
| Commercial mortgage loans, Percentage | 100.00% | 100.00% |
| Allowance for Credit Losses | $ (37,715) | $ (37,689) |
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 7,759,323 | 6,122,721 |
| Total net Commercial Mortgage and Other Loans | 7,759,323 | 6,122,721 |
| Other loans | 11,979 | 5,360 |
| Commercial Mortgage and Agricultural Loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 7,747,344 | 6,117,361 |
| Total net Commercial Mortgage and Other Loans | 7,747,344 | 6,117,361 |
| Other Collateralized Loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Other loans | 11,979 | 5,360 |
| Total Net Commercial Mortgage and Other Loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 7,759,323 | 6,122,721 |
| Total net Commercial Mortgage and Other Loans | 7,759,323 | 6,122,721 |
| Apartments and multi-family | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 1,949,926 | $ 1,578,785 |
| Commercial mortgage loans, Percentage | 25.00% | 25.70% |
| Hospitality | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 97,603 | $ 102,952 |
| Commercial mortgage loans, Percentage | 1.30% | 1.70% |
| Industrial | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 2,906,413 | $ 2,486,230 |
| Commercial mortgage loans, Percentage | 37.30% | 40.40% |
| Office | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 556,586 | $ 604,611 |
| Commercial mortgage loans, Percentage | 7.10% | 9.80% |
| Other | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 750,541 | $ 456,720 |
| Commercial mortgage loans, Percentage | 9.60% | 7.40% |
| Retail | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 693,949 | $ 363,706 |
| Commercial mortgage loans, Percentage | 9.00% | 5.90% |
| Commercial mortgage loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 6,955,018 | $ 5,593,004 |
| Commercial mortgage loans, Percentage | 89.30% | 90.90% |
| Agricultural property loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 830,041 | $ 562,046 |
| Commercial mortgage loans, Percentage | 10.70% | 9.10% |
Investments (Allowance for Credit Losses) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Balance, beginning of year | $ 37,689 | $ 20,263 | $ 5,951 |
| Addition to (release of) allowance for expected losses | 9,393 | 17,426 | 14,312 |
| Write-downs charged against allowance | (9,367) | ||
| Total ending balance | 37,715 | 37,689 | 20,263 |
| Commercial mortgage loans | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Balance, beginning of year | 36,758 | 19,665 | 5,847 |
| Addition to (release of) allowance for expected losses | 5,613 | 17,093 | 13,818 |
| Write-downs charged against allowance | (9,367) | ||
| Total ending balance | 33,004 | 36,758 | 19,665 |
| Agricultural Property Loans | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Balance, beginning of year | 931 | 598 | 104 |
| Addition to (release of) allowance for expected losses | 3,780 | 333 | 494 |
| Write-downs charged against allowance | 0 | ||
| Total ending balance | $ 4,711 | $ 931 | $ 598 |
Investments (Credit Quality Indicators) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Recording investment gross of allowance for credit losses | $ 7,797,038 | $ 6,160,410 |
| Commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 1,788,998 | 1,142,205 |
| One Year Prior | 1,139,236 | 782,796 |
| Two Year Prior | 770,354 | 1,261,597 |
| Three Year Prior | 1,258,169 | 363,599 |
| Four Year Prior | 255,562 | 528,288 |
| Prior | 1,736,220 | 1,514,519 |
| Revolving Loans | 6,479 | |
| Recording investment gross of allowance for credit losses | 6,955,018 | 5,593,004 |
| Commercial mortgage loans | ≥ 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 1,728,895 | 1,038,315 |
| One Year Prior | 962,290 | 779,282 |
| Two Year Prior | 755,350 | 1,261,597 |
| Three Year Prior | 1,256,699 | 292,561 |
| Four Year Prior | 255,562 | 497,407 |
| Prior | 1,616,904 | 1,402,831 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 6,575,700 | 5,271,993 |
| Commercial mortgage loans | 1.0X to 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 60,103 | 103,890 |
| One Year Prior | 176,946 | 3,514 |
| Two Year Prior | 15,004 | 0 |
| Three Year Prior | 0 | 0 |
| Four Year Prior | 0 | 15,632 |
| Prior | 59,871 | 40,521 |
| Revolving Loans | 6,479 | |
| Recording investment gross of allowance for credit losses | 318,403 | 163,557 |
| Commercial mortgage loans | Less than 1.0X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 0 | 0 |
| Three Year Prior | 1,470 | 71,038 |
| Four Year Prior | 0 | 15,249 |
| Prior | 59,445 | 71,167 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 60,915 | 157,454 |
| Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 271,275 | 126,949 |
| One Year Prior | 108,965 | 235,585 |
| Two Year Prior | 220,325 | 132,042 |
| Three Year Prior | 131,581 | 25,875 |
| Four Year Prior | 25,145 | 15,824 |
| Prior | 38,478 | 25,771 |
| Revolving Loans | 34,272 | |
| Recording investment gross of allowance for credit losses | 830,041 | 562,046 |
| Agricultural Property Loans | ≥ 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 259,647 | 126,949 |
| One Year Prior | 95,087 | 233,585 |
| Two Year Prior | 211,030 | 130,353 |
| Three Year Prior | 129,865 | 24,063 |
| Four Year Prior | 23,488 | 15,824 |
| Prior | 38,478 | 25,771 |
| Revolving Loans | 18,834 | |
| Recording investment gross of allowance for credit losses | 776,429 | 556,545 |
| Agricultural Property Loans | 1.0X to 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 11,628 | 0 |
| One Year Prior | 13,878 | 2,000 |
| Two Year Prior | 9,295 | 0 |
| Three Year Prior | 0 | 1,812 |
| Four Year Prior | 0 | 0 |
| Prior | 0 | 0 |
| Revolving Loans | 15,438 | |
| Recording investment gross of allowance for credit losses | 50,239 | 3,812 |
| Agricultural Property Loans | Less than 1.0X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 0 | 1,689 |
| Three Year Prior | 1,716 | 0 |
| Four Year Prior | 1,657 | 0 |
| Prior | 0 | 0 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 3,373 | 1,689 |
| 0%-59.99% | Commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 452,940 | 249,037 |
| One Year Prior | 232,276 | 245,914 |
| Two Year Prior | 306,684 | 482,718 |
| Three Year Prior | 482,596 | 109,249 |
| Four Year Prior | 134,403 | 265,053 |
| Prior | 1,138,394 | 1,068,763 |
| Revolving Loans | 6,479 | |
| Recording investment gross of allowance for credit losses | 2,753,772 | 2,420,734 |
| 0%-59.99% | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 241,715 | 73,774 |
| One Year Prior | 89,569 | 179,375 |
| Two Year Prior | 163,820 | 132,042 |
| Three Year Prior | 126,368 | 25,875 |
| Four Year Prior | 23,488 | 15,824 |
| Prior | 38,478 | 25,771 |
| Revolving Loans | 18,834 | |
| Recording investment gross of allowance for credit losses | 702,272 | 452,661 |
| 60%-69.99% | Commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 972,161 | 675,153 |
| One Year Prior | 541,849 | 355,984 |
| Two Year Prior | 273,258 | 449,878 |
| Three Year Prior | 360,457 | 172,721 |
| Four Year Prior | 110,515 | 225,803 |
| Prior | 303,107 | 206,237 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 2,561,347 | 2,085,776 |
| 60%-69.99% | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 29,560 | 47,489 |
| One Year Prior | 19,396 | 56,210 |
| Two Year Prior | 49,210 | 0 |
| Three Year Prior | 0 | 0 |
| Four Year Prior | 0 | 0 |
| Prior | 0 | 0 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 98,166 | 103,699 |
| 70%-79.99% | Commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 362,701 | 218,015 |
| One Year Prior | 365,111 | 133,343 |
| Two Year Prior | 134,208 | 255,299 |
| Three Year Prior | 330,355 | 77,812 |
| Four Year Prior | 6,774 | 20,924 |
| Prior | 77,399 | 86,806 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 1,276,548 | 792,199 |
| 70%-79.99% | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 5,686 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 0 | 0 |
| Three Year Prior | 5,213 | 0 |
| Four Year Prior | 0 | 0 |
| Prior | 0 | 0 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 5,213 | 5,686 |
| 80% or greater | Commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 1,196 | 0 |
| One Year Prior | 0 | 47,555 |
| Two Year Prior | 56,204 | 73,702 |
| Three Year Prior | 84,761 | 3,817 |
| Four Year Prior | 3,870 | 16,508 |
| Prior | 217,320 | 152,713 |
| Revolving Loans | 0 | |
| Recording investment gross of allowance for credit losses | 363,351 | 294,295 |
| 80% or greater | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 7,295 | 0 |
| Three Year Prior | 0 | 0 |
| Four Year Prior | 1,657 | 0 |
| Prior | 0 | 0 |
| Revolving Loans | 15,438 | |
| Recording investment gross of allowance for credit losses | $ 24,390 | $ 0 |
Investments (Amortized Cost Basis of Loan Modifications made to Borrowers Experiencing Financial Difficulties) (Details) - Commercial Portfolio Segment $ in Thousands |
12 Months Ended |
|---|---|
|
Dec. 31, 2024
USD ($)
| |
| Term Extension | |
| Financing Receivable, Modified [Line Items] | |
| Financing Receivable, Modified in Period, Amount | $ 14,546 |
| Financing Receivable, Modified in Period, to Total Financing Receivables, Percentage | 0.20% |
| Other Than Insignificant Delay in Payment | |
| Financing Receivable, Modified [Line Items] | |
| Financing Receivable, Modified in Period, Amount | $ 4,570 |
| Financing Receivable, Modified in Period, to Total Financing Receivables, Percentage | 0.10% |
Investments (Analysis of Past Due Commercial Mortgage, Agricultural and Other Loans) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | $ 7,797,038 | $ 6,160,410 |
| Non-Accrual Status | 29,885 | 1,301 |
| Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 7,767,876 | 6,160,410 |
| 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 2,505 | 0 |
| 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 26,657 | 0 |
| Commercial mortgage loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 6,955,018 | 5,593,004 |
| Non-Accrual Status | 5,120 | 0 |
| Commercial mortgage loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 6,951,093 | 5,593,004 |
| Commercial mortgage loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Commercial mortgage loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Commercial mortgage loans | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 3,925 | 0 |
| Agricultural Loan | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 830,041 | 562,046 |
| Non-Accrual Status | 24,765 | 1,301 |
| Agricultural Loan | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 804,804 | 562,046 |
| Agricultural Loan | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Agricultural Loan | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 2,505 | 0 |
| Agricultural Loan | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 22,732 | 0 |
| Other Collateralized Loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 11,979 | 5,360 |
| Non-Accrual Status | 0 | 0 |
| Other Collateralized Loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 11,979 | 5,360 |
| Other Collateralized Loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Other Collateralized Loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Other Collateralized Loans | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Loans | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Accruing Interest | $ 0 | $ 0 |
Investments (Other Invested Assets) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | $ 1,582,094 | $ 1,222,985 |
| Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 1,533,210 | 1,191,808 |
| Derivatives | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 24,499 | 17,718 |
| Other | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 24,385 | 13,459 |
| Equity Method | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 1,489,086 | 1,124,501 |
| Equity Method | Private equity | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 388,822 | 333,863 |
| Equity Method | Hedge funds | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 1,024,534 | 720,360 |
| Equity Method | Real estate-related | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 75,730 | 70,278 |
| Fair Value | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 44,124 | 67,307 |
| Fair Value | Private equity | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 28,094 | 48,483 |
| Fair Value | Hedge funds | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 14 | 137 |
| Fair Value | Real estate-related | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | $ 16,016 | $ 18,687 |
Investments (Equity Method Investments, Statement of Financial Position) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Schedule of Equity Method Investments [Line Items] | ||
| Total assets | $ 238,454,729 | $ 213,269,687 |
| Total liabilities | 233,752,749 | 208,766,823 |
| Partners’ capital | 4,596,441 | 4,472,670 |
| Total liabilities and partners’ capital | 238,454,729 | 213,269,687 |
| LP/LLC Interests | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Total liabilities and partners’ capital included above | 1,338,056 | 979,271 |
| Equity in LP/LLC interests not included above | 230,687 | 216,205 |
| Carrying value | 1,568,743 | 1,195,476 |
| Equity Method Investment | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Total assets | 66,477,439 | 44,591,082 |
| Total liabilities | 1,894,242 | 2,802,022 |
| Partners’ capital | 64,583,197 | 41,789,060 |
| Total liabilities and partners’ capital | $ 66,477,439 | $ 44,591,082 |
Investments (Equity Method Investments, Statement of Operations) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Investments [Abstract] | |||
| Total Revenue | $ 1,678,772 | $ 3,465,807 | $ 11,062,060 |
| Total Expenses | (473,445) | (979,287) | (1,655,673) |
| Net earnings (losses) | 1,205,327 | 2,486,520 | 9,406,387 |
| Earnings in net earnings (losses) included above | 57,119 | 17,795 | (36,513) |
| Equity in net earnings (losses) of LP/LLC interests not included above | 18,193 | 11,792 | 7,320 |
| Total equity in net earnings (losses) | $ 75,312 | $ 29,587 | $ (29,193) |
Investments (Accrued Investment Income) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Net Investment Income | ||
| Accrued investment income | $ 466,394 | $ 333,838 |
| Fixed maturities | ||
| Net Investment Income | ||
| Accrued investment income | 396,173 | 272,031 |
| Equity securities | ||
| Net Investment Income | ||
| Accrued investment income | 436 | 220 |
| Commercial mortgage and other loans | ||
| Net Investment Income | ||
| Accrued investment income | 29,437 | 21,070 |
| Policy loans | ||
| Net Investment Income | ||
| Accrued investment income | 30,820 | 35,210 |
| Other invested assets | ||
| Net Investment Income | ||
| Accrued investment income | 0 | 43 |
| Short-term investments and cash equivalents | ||
| Net Investment Income | ||
| Accrued investment income | $ 9,528 | $ 5,264 |
Investments (Net Investment Income) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | $ 2,527,151 | $ 1,752,819 | $ 939,282 |
| Less: investment expenses | (105,134) | (77,297) | (55,281) |
| Net investment income | 2,422,017 | 1,675,522 | 884,001 |
| Equity securities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 30,698 | 14,772 | 8,226 |
| Commercial mortgage and other loans | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 328,853 | 231,994 | 119,358 |
| Policy loans | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 65,825 | 48,118 | 21,189 |
| Other invested assets | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 140,376 | 98,369 | 101,289 |
| Short-term investments and cash equivalents | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 182,094 | 123,857 | 44,182 |
| Available-for-sale | Fixed maturities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 1,622,898 | 1,139,581 | 589,248 |
| Trading | Fixed maturities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | $ 156,407 | $ 96,128 | $ 55,790 |
Investments (Realized Investment Gains Losses, Net) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||
| Schedule of Gain (Loss) on Investments [Line Items] | |||||||
| Realized investment gains (losses), net | $ 451,417 | $ (1,147,099) | [1] | $ 289,929 | [1] | ||
| Fixed maturities | |||||||
| Schedule of Gain (Loss) on Investments [Line Items] | |||||||
| Realized investment gains (losses), net | (167,394) | (31,193) | (74,005) | ||||
| Commercial mortgage and other loans | |||||||
| Schedule of Gain (Loss) on Investments [Line Items] | |||||||
| Realized investment gains (losses), net | (11,113) | (17,854) | (18,201) | ||||
| LPs/LLCs | |||||||
| Schedule of Gain (Loss) on Investments [Line Items] | |||||||
| Realized investment gains (losses), net | 576 | (272) | (11,351) | ||||
| Derivatives | |||||||
| Schedule of Gain (Loss) on Investments [Line Items] | |||||||
| Realized investment gains (losses), net | 713,403 | (1,136,331) | 460,859 | ||||
| Short-term investments and cash equivalents | |||||||
| Schedule of Gain (Loss) on Investments [Line Items] | |||||||
| Realized investment gains (losses), net | 974 | 2,033 | (54) | ||||
| Other | |||||||
| Schedule of Gain (Loss) on Investments [Line Items] | |||||||
| Realized investment gains (losses), net | $ (85,029) | $ 36,518 | $ (67,319) | ||||
| |||||||
Investments (Net Unrealized Gains Losses on Investments by Asset Class) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|
| Gain (Loss) on Securities [Line Items] | |||
| Net Unrealized Gains (Losses) on Investments | $ (1,846,285) | $ (1,402,193) | $ (2,156,655) |
| Fixed maturities | Available-for-sale | With an allowance | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net Unrealized Gains (Losses) on Investments | 893 | 1,987 | 4,371 |
| Fixed maturities | Available-for-sale | Without an allowance | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net Unrealized Gains (Losses) on Investments | (1,955,252) | (1,406,265) | (2,285,288) |
| Derivatives designated as cash flow hedges | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net Unrealized Gains (Losses) on Investments | 110,565 | 11,934 | 138,627 |
| Affiliated notes | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net Unrealized Gains (Losses) on Investments | (3,276) | (8,760) | (13,189) |
| Other investments | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net Unrealized Gains (Losses) on Investments | $ 785 | $ (1,089) | $ (1,176) |
Investments (Repurchase Agreements and Securities Lending) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | $ 121,372 | $ 218,310 |
| Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 121,372 | 218,310 |
| Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| 30 days or greater | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Obligations of U.S. states and their political subdivisions | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 1,139 | 0 |
| Obligations of U.S. states and their political subdivisions | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 1,139 | 0 |
| Obligations of U.S. states and their political subdivisions | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Foreign government securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 486 |
| Foreign government securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 486 |
| Foreign government securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| U.S. public corporate securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 6,949 | 27,247 |
| U.S. public corporate securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 6,949 | 27,247 |
| U.S. public corporate securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| U.S. private corporate securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 18 | 0 |
| U.S. private corporate securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 18 | 0 |
| U.S. private corporate securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Foreign public corporate securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 10,100 | 13,101 |
| Foreign public corporate securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 10,100 | 13,101 |
| Foreign public corporate securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Equity securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 103,166 | 177,476 |
| Equity securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 103,166 | 177,476 |
| Equity securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | $ 0 | $ 0 |
Investments (Securities Pledged) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | $ 3,956,834 | $ 4,254,386 |
| Total liabilities supported by pledged collateral | 3,743,968 | 2,869,657 |
| Equity securities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | 100,601 | 172,995 |
| Cash collateral for loaned securities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total liabilities supported by pledged collateral | 121,372 | 218,310 |
| Available-for-sale | Fixed maturities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | 3,856,216 | 4,081,391 |
| Trading | Fixed maturities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | $ 17 | $ 0 |
Derivative Instruments (Gross Notional Amount and Fair Value of Derivatives Contracts) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Derivative [Line Items] | ||
| Gross Notional | $ 358,596,065 | $ 266,639,029 |
| Fair Value Assets | 15,332,694 | 9,045,737 |
| Fair Value Liabilities | (27,242,213) | (21,248,026) |
| Derivatives Designated as Hedge Accounting Instruments: | ||
| Derivative [Line Items] | ||
| Gross Notional | 3,311,693 | 2,277,700 |
| Fair Value Assets | 202,606 | 121,243 |
| Fair Value Liabilities | (27,732) | (54,282) |
| Derivatives Designated as Hedge Accounting Instruments: | Interest Rate Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 2,851 | 3,064 |
| Fair Value Assets | 0 | 0 |
| Fair Value Liabilities | (209) | (238) |
| Derivatives Designated as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 3,308,842 | 2,274,636 |
| Fair Value Assets | 202,606 | 121,243 |
| Fair Value Liabilities | (27,523) | (54,044) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | ||
| Derivative [Line Items] | ||
| Gross Notional | 355,284,372 | 264,361,329 |
| Fair Value Assets | 15,130,088 | 8,924,494 |
| Fair Value Liabilities | (27,214,481) | (21,193,744) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 174,170,160 | 163,179,764 |
| Fair Value Assets | 9,029,399 | 6,605,817 |
| Fair Value Liabilities | (20,888,553) | (17,820,436) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Future | ||
| Derivative [Line Items] | ||
| Gross Notional | 1,518,400 | 1,332,600 |
| Fair Value Assets | 1,967 | 3,055 |
| Fair Value Liabilities | (1,443) | (210) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Option | ||
| Derivative [Line Items] | ||
| Gross Notional | 29,135,000 | 29,738,000 |
| Fair Value Assets | 279,414 | 189,112 |
| Fair Value Liabilities | (1,406,265) | (969,718) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | interest rate forward | ||
| Derivative [Line Items] | ||
| Gross Notional | 0 | 1,458,000 |
| Fair Value Assets | 0 | 741 |
| Fair Value Liabilities | 0 | (3,196) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Total Return Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 223,721 | 0 |
| Fair Value Assets | 1,472 | 0 |
| Fair Value Liabilities | (2,121) | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Forwards | ||
| Derivative [Line Items] | ||
| Gross Notional | 1,146,861 | 744,576 |
| Fair Value Assets | 30,078 | 1,772 |
| Fair Value Liabilities | (181) | (12,232) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit Default Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 911,850 | 643,280 |
| Fair Value Assets | 9,606 | 7,727 |
| Fair Value Liabilities | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 2,285,052 | 2,237,331 |
| Fair Value Assets | 164,152 | 96,618 |
| Fair Value Liabilities | (9,277) | (31,294) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Total Return Swap | ||
| Derivative [Line Items] | ||
| Gross Notional | 23,025,217 | 15,049,993 |
| Fair Value Assets | 1,160,080 | 418,084 |
| Fair Value Liabilities | (1,182,913) | (803,452) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Options | ||
| Derivative [Line Items] | ||
| Gross Notional | 117,107,059 | 49,247,510 |
| Fair Value Assets | 4,453,762 | 1,600,335 |
| Fair Value Liabilities | (3,717,637) | (1,552,706) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Futures | ||
| Derivative [Line Items] | ||
| Gross Notional | 1,802,205 | 418,973 |
| Fair Value Assets | 15 | 1,232 |
| Fair Value Liabilities | (6,060) | (500) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Synthetic Gics | ||
| Derivative [Line Items] | ||
| Gross Notional | 3,958,847 | 311,302 |
| Fair Value Assets | 143 | 1 |
| Fair Value Liabilities | $ (31) | $ 0 |
Derivative Instruments (Offsetting Balance Sheet) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Offsetting of Financial Assets, Derivatives | ||
| Derivatives, Gross Amounts of Recognized Financial Instruments | $ 15,332,538 | $ 9,045,718 |
| Derivatives, Gross Amounts Offset in the Consolidated Statement of Financial Position | (15,308,195) | (9,028,019) |
| Derivatives, Net Amounts Presented in the Consolidated Statements of Financial Position | 24,343 | 17,699 |
| Derivatives, Financial Instruments/Collateral | 0 | 0 |
| Derivatives, Net Amount | 24,343 | 17,699 |
| Offsetting of Financial Assets, Securities Purchased Under Agreements to Resell | ||
| Securities Purchased Under Agreements to Resell, Gross Amounts of Recognized Financial Instruments | 0 | 25,000 |
| Securities Purchased Under Agreements to Resell, Gross Amounts Offset in the Consolidated Statement of Financial Position | 0 | 0 |
| Securities Purchased Under Agreements to Resell, Net Amounts Presented in the Consolidated Statements of Financial Position | 0 | 25,000 |
| Securities Purchased Under Agreements to Resell, Financial Instruments/Collateral | 0 | 0 |
| Security Purchased under Agreement to Resell, Net Amount | 0 | 25,000 |
| Offsetting of Financial Assets, Total Assets | ||
| Total Assets, Gross Amounts of Recognized Financial Instruments | 15,332,538 | 9,070,718 |
| Total Assets, Gross Amounts Offset in the Consolidated Statement of Financial Position | (15,308,195) | (9,028,019) |
| Total Assets, Net Amounts Presented in the Consolidated Statements of Financial Position | 24,343 | 42,699 |
| Total Assets, Financial Instruments/Collateral | 0 | 0 |
| Total Assets, Net Amount | 24,343 | 42,699 |
| Offsetting of Financial Liabilities, Derivatives | ||
| Derivatives, Gross Amounts of Recognized Financial Instruments | 27,242,182 | 21,248,026 |
| Derivatives, Gross Amounts Offset in the Consolidated Statement of Financial Position | (23,619,586) | (18,596,679) |
| Derivatives, Net Amounts Presented in the Consolidated Statements of Financial Position | 3,622,596 | 2,651,347 |
| Derivatives, Financial Instruments/Collateral | (3,622,596) | (2,651,347) |
| Derivatives, Net Amount | 0 | 0 |
| Offsetting of Financial Liabilities, Total Liabilities | ||
| Total Liabilities, Gross Amounts of Recognized Financial Instruments | 27,242,182 | 21,248,026 |
| Total Liabilities, Gross Amounts Offset in the Consolidated Statement of Financial Position | (23,619,586) | (18,596,679) |
| Total Liabilities, Net Amounts Presented in the Consolidated Statements of Financial Position | 3,622,596 | 2,651,347 |
| Total Liabilities, Financial Instruments/Collateral | (3,622,596) | (2,651,347) |
| Total Liabilities, Net Amount | $ 0 | $ 0 |
Derivative Instruments (Financial Statement Classification and Impact of Derivatives Used in Qualifying and Non-qualifying Hedge Relationships) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | $ 713,403 | $ (1,133,219) | $ 460,859 |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Realized Investment Gains (Losses) | Realized Investment Gains (Losses) | Realized Investment Gains (Losses) |
| Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | $ (2,856,118) | $ (2,377,803) | $ (4,179,946) |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Change in value of market risk benefits, net of related hedging gain (losses) | Change in value of market risk benefits, net of related hedging gain (losses) | Change in value of market risk benefits, net of related hedging gain (losses) |
| Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | $ 48,405 | $ 43,816 | $ 36,726 |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Net investment income | Net investment income | Net investment income |
| Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | $ 35,350 | $ (26,463) | $ 34,627 |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Other Income (loss) | Other Income (loss) | Other Income (loss) |
| AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | $ 98,631 | $ (126,693) | $ 98,731 |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Other Comprehensive Income (Loss), Net of Tax | Other Comprehensive Income (Loss), Net of Tax | Other Comprehensive Income (Loss), Net of Tax |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | $ 2,259 | $ (634) | $ 7,637 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 48,405 | 43,816 | 36,726 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 34,827 | (26,206) | 34,070 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 98,631 | (126,693) | 98,731 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate Contract | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 3 | 2 | 1 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate Contract | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate Contract | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | (118) | (118) | (8) |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate Contract | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate Contract | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 46 | 72 | (312) |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 2,256 | (636) | 7,636 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 48,523 | 43,934 | 36,734 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 34,827 | (26,206) | 34,070 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 98,585 | (126,765) | 99,043 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 711,144 | (1,132,585) | 453,222 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | (2,856,118) | (2,377,803) | (4,179,946) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 523 | (257) | 557 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Contract | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 35,600 | 25,329 | 661,978 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Contract | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | (2,094,268) | (1,555,807) | (5,230,085) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Contract | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Contract | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Contract | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 54,543 | (16,012) | 18,952 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 77,166 | (102,238) | 107,388 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 523 | (257) | 557 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 16,856 | 14,350 | (15,904) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 3,207,538 | 1,744,218 | 40,076 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | (761,850) | (821,996) | 1,050,139 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivative Financial Instruments | Realized investment gains (losses), net | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | (2,680,559) | (2,798,232) | (359,268) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivative Financial Instruments | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivative Financial Instruments | Investment Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivative Financial Instruments | Other Income | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | 0 | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivative Financial Instruments | AOCI | |||
| Derivative Instruments, Gain (Loss) [Line Items] | |||
| Derivative, gain (loss) on derivative, net | $ 0 | $ 0 | $ 0 |
Derivative Instruments (Current Period Cash Flow Hedges in AOCI (loss) before Taxes) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
| Beginning Balance | $ 4,502,864 | ||
| Ending Balance | 4,701,980 | $ 4,502,864 | |
| Accumulated Gain (Loss), Net, Cash Flow Hedge | |||
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
| Beginning Balance | 11,934 | 138,627 | $ 39,896 |
| Total amount recorded in AOCI | 184,122 | (109,717) | 177,164 |
| Total amount reclassified from AOCI to income | (85,491) | (16,976) | (78,433) |
| Ending Balance | 110,565 | 11,934 | 138,627 |
| Interest Rate Contract | Accumulated Gain (Loss), Net, Cash Flow Hedge | |||
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
| Total amount recorded in AOCI | (69) | (44) | (319) |
| Total amount reclassified from AOCI to income | 115 | 116 | 7 |
| Currency/Interest Rate | Accumulated Gain (Loss), Net, Cash Flow Hedge | |||
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
| Total amount recorded in AOCI | 184,191 | (109,673) | 177,483 |
| Total amount reclassified from AOCI to income | $ (85,606) | $ (17,092) | $ (78,440) |
Derivative Instruments (Narrative) (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Derivative [Line Items] | ||
| Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | $ 41,000,000 | |
| Embedded Derivative, Fair Value of Embedded Derivative, Net Liability | (11,968,000,000) | $ (7,505,000,000) |
| Credit derivatives exposure on purchased credit protection | 0 | 0 |
| Credit Default Swap, Selling Protection | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 912,000,000 | 643,000,000 |
| Credit Risk Derivatives, at Fair Value, Net Asset (Liability) (less than) | 10,000,000 | $ 8,000,000 |
| Credit Default Swap, Selling Protection | NAIC 3 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 877,000,000 | |
| Credit Default Swap, Selling Protection | NAIC 6 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | $ 35,000,000 |
Fair Value of Assets and Liabilities (Balances of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
|---|---|---|---|---|---|
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | $ 34,986,160 | $ 26,131,780 | |||
| Market risk benefit assets | 2,637,363 | 2,367,243 | |||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,845,045 | 2,796,446 | |||
| Equity securities | 2,623,820 | 844,950 | |||
| Short-term investments | 517,386 | ||||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 1,582,094 | 1,222,985 | |||
| Receivables from parent and affiliates | 678,028 | 332,583 | |||
| Separate account assets | 118,143,256 | 119,188,485 | |||
| TOTAL ASSETS | 238,454,729 | 213,269,687 | |||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | [1] | ||
| Payables to parent and affiliates | 3,653,848 | 2,667,696 | |||
| Total liabilities | 233,752,749 | 208,766,823 | |||
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 1,099,241 | 975,287 | |||
| Obligations of U.S. states and their political subdivisions | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 541,066 | 776,627 | |||
| Foreign government securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 310,334 | 281,986 | |||
| U.S. corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 13,238,428 | 9,495,912 | |||
| U.S. corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 5,754,097 | 4,989,494 | |||
| Foreign corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 3,698,851 | 1,706,094 | |||
| Foreign corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 5,341,633 | 4,630,982 | |||
| Asset-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 3,750,663 | 2,027,550 | |||
| Commercial mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 895,775 | 851,778 | |||
| Residential mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 356,072 | 396,070 | |||
| Equity securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fair value investment measured at NAV per share | 14,600 | ||||
| Fair Value, Measurements, Recurring | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 34,986,160 | 26,131,780 | |||
| Market risk benefit assets | 2,637,363 | 2,367,243 | |||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,845,045 | 2,796,446 | |||
| Equity securities | 2,623,820 | 830,340 | |||
| Short-term investments | 496,285 | 313,866 | |||
| Cash equivalents | 2,851,283 | 1,644,125 | |||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 24,499 | 17,718 | |||
| Reinsurance recoverables and deposit receivables | 645,193 | 192,642 | |||
| Receivables from parent and affiliates | 520,462 | 147,984 | |||
| Subtotal excluding separate account assets | 48,630,110 | 34,442,144 | |||
| Separate account assets | 111,699,552 | 113,929,793 | |||
| TOTAL ASSETS | 160,329,662 | 148,371,937 | |||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | |||
| Policyholders’ account balances | 12,624,585 | 7,697,627 | |||
| Payables to parent and affiliates | 3,615,277 | 2,651,123 | |||
| Other liabilities | 7,350 | 225 | |||
| Total liabilities | 20,528,456 | 15,505,833 | |||
| Assets netting | (15,308,195) | (9,028,019) | |||
| Liabilities netting | (23,619,586) | (18,596,679) | |||
| Derivative liability, cash collateral | (8,311,000) | (9,569,000) | |||
| Fair Value, Measurements, Recurring | Payables to parent and affiliates | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Liabilities netting | (23,617,643) | (18,588,647) | |||
| Fair Value, Measurements, Recurring | Other liabilities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Liabilities netting | (1,943) | (8,032) | |||
| Fair Value, Measurements, Recurring | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 1,099,241 | 975,287 | |||
| Fair Value, Measurements, Recurring | Obligations of U.S. states and their political subdivisions | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 541,066 | 776,627 | |||
| Fair Value, Measurements, Recurring | Foreign government securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 310,334 | 281,986 | |||
| Fair Value, Measurements, Recurring | U.S. corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 13,238,428 | 9,495,912 | |||
| Fair Value, Measurements, Recurring | U.S. corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 5,754,097 | 4,989,494 | |||
| Fair Value, Measurements, Recurring | Foreign corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 3,698,851 | 1,706,094 | |||
| Fair Value, Measurements, Recurring | Foreign corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 5,341,633 | 4,630,982 | |||
| Fair Value, Measurements, Recurring | Asset-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 3,750,663 | 2,027,550 | |||
| Fair Value, Measurements, Recurring | Commercial mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 895,775 | 851,778 | |||
| Fair Value, Measurements, Recurring | Residential mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 356,072 | 396,070 | |||
| Fair Value, Measurements, Recurring | Level 1 | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Market risk benefit assets | 0 | 0 | |||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 0 | 0 | |||
| Equity securities | 2,587,791 | 790,346 | |||
| Short-term investments | 0 | 31,879 | |||
| Cash equivalents | 0 | 447,396 | |||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 2,302 | 23,432 | |||
| Reinsurance recoverables and deposit receivables | 0 | 0 | |||
| Receivables from parent and affiliates | 0 | 0 | |||
| Subtotal excluding separate account assets | 2,590,093 | 1,293,053 | |||
| Separate account assets | 273,288 | 176,239 | |||
| TOTAL ASSETS | 2,863,381 | 1,469,292 | |||
| Market risk benefit liabilities | 0 | 0 | |||
| Policyholders’ account balances | 0 | 0 | |||
| Payables to parent and affiliates | 0 | 0 | |||
| Other liabilities | 7,988 | 8,032 | |||
| Total liabilities | 7,988 | 8,032 | |||
| Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | Obligations of U.S. states and their political subdivisions | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | Foreign government securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | U.S. corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | U.S. corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | Foreign corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | Foreign corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | Asset-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | Commercial mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 1 | Residential mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 2 | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 33,086,013 | 24,939,518 | |||
| Market risk benefit assets | 0 | 0 | |||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,778,760 | 2,762,398 | |||
| Equity securities | 15,514 | 11,285 | |||
| Short-term investments | 390,745 | 280,228 | |||
| Cash equivalents | 2,851,250 | 1,196,729 | |||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 15,330,249 | 9,022,304 | |||
| Reinsurance recoverables and deposit receivables | 0 | 0 | |||
| Receivables from parent and affiliates | 169,072 | 147,984 | |||
| Subtotal excluding separate account assets | 55,621,603 | 38,360,446 | |||
| Separate account assets | 111,415,717 | 113,747,569 | |||
| TOTAL ASSETS | 167,037,320 | 152,108,015 | |||
| Market risk benefit liabilities | 0 | 0 | |||
| Policyholders’ account balances | 0 | 0 | |||
| Payables to parent and affiliates | 27,232,920 | 21,239,770 | |||
| Other liabilities | 1,274 | 225 | |||
| Total liabilities | 27,234,194 | 21,239,995 | |||
| Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 1,099,241 | 975,287 | |||
| Fair Value, Measurements, Recurring | Level 2 | Obligations of U.S. states and their political subdivisions | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 541,066 | 776,627 | |||
| Fair Value, Measurements, Recurring | Level 2 | Foreign government securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 309,686 | 281,304 | |||
| Fair Value, Measurements, Recurring | Level 2 | U.S. corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 13,238,428 | 9,495,912 | |||
| Fair Value, Measurements, Recurring | Level 2 | U.S. corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 4,996,400 | 4,476,258 | |||
| Fair Value, Measurements, Recurring | Level 2 | Foreign corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 3,692,124 | 1,698,965 | |||
| Fair Value, Measurements, Recurring | Level 2 | Foreign corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 4,906,450 | 4,137,004 | |||
| Fair Value, Measurements, Recurring | Level 2 | Asset-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 3,126,089 | 1,928,428 | |||
| Fair Value, Measurements, Recurring | Level 2 | Commercial mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 820,457 | 773,663 | |||
| Fair Value, Measurements, Recurring | Level 2 | Residential mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 356,072 | 396,070 | |||
| Fair Value, Measurements, Recurring | Level 3 | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 1,900,147 | 1,192,262 | |||
| Market risk benefit assets | 2,637,363 | 2,367,243 | |||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 66,285 | 34,048 | |||
| Equity securities | 20,515 | 28,709 | |||
| Short-term investments | 105,540 | 1,759 | |||
| Cash equivalents | 33 | 0 | |||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 143 | 1 | |||
| Reinsurance recoverables and deposit receivables | 645,193 | 192,642 | |||
| Receivables from parent and affiliates | 351,390 | 0 | |||
| Subtotal excluding separate account assets | 5,726,609 | 3,816,664 | |||
| Separate account assets | 10,547 | 5,985 | |||
| TOTAL ASSETS | 5,737,156 | 3,822,649 | |||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | |||
| Policyholders’ account balances | 12,624,585 | 7,697,627 | |||
| Payables to parent and affiliates | 0 | 0 | |||
| Other liabilities | 31 | 0 | |||
| Total liabilities | 16,905,860 | 12,854,485 | |||
| Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 3 | Obligations of U.S. states and their political subdivisions | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 3 | Foreign government securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 648 | 682 | |||
| Fair Value, Measurements, Recurring | Level 3 | U.S. corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Fair Value, Measurements, Recurring | Level 3 | U.S. corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 757,697 | 513,236 | |||
| Fair Value, Measurements, Recurring | Level 3 | Foreign corporate public securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 6,727 | 7,129 | |||
| Fair Value, Measurements, Recurring | Level 3 | Foreign corporate private securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 435,183 | 493,978 | |||
| Fair Value, Measurements, Recurring | Level 3 | Asset-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 624,574 | 99,122 | |||
| Fair Value, Measurements, Recurring | Level 3 | Commercial mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 75,318 | 78,115 | |||
| Fair Value, Measurements, Recurring | Level 3 | Residential mortgage-backed securities | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 0 | 0 | |||
| Other invested assets | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fair value investment measured at NAV per share | 44,000 | 67,000 | |||
| Separate account assets | |||||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Fair value investment measured at NAV per share | $ 6,444,000 | $ 5,259,000 | |||
| |||||
Fair Value of Assets and Liabilities (Quantitative Info for Level 3 Inputs) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Corporate securities | $ 2,650,542 | $ 824,270 | |||
| Market risk benefit assets | 2,637,363 | 2,367,243 | |||
| Receivables from parent and affiliates | 678,028 | 332,583 | |||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | [1] | ||
| Fair Value, Measurements, Recurring | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Market risk benefit assets | 2,637,363 | 2,367,243 | |||
| Reinsurance recoverables and deposit receivables | 645,193 | 192,642 | |||
| Receivables from parent and affiliates | 520,462 | 147,984 | |||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | |||
| Policyholders’ account balances | 12,624,585 | 7,697,627 | |||
| Level 3 | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Funds held under reinsurance agreements | $ 10,000,000 | ||||
| Level 3 | Minimum | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Fair Value Inputs, Policyholder Age | 50 years | ||||
| Level 3 | Minimum | Market risk benefit liabilities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Mortality rate | 0.00% | ||||
| Level 3 | Maximum | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Fair Value Inputs, Policyholder Age | 90 years | ||||
| Level 3 | Fair Value, Measurements, Recurring | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Market risk benefit assets | $ 2,637,363 | 2,367,243 | |||
| Reinsurance recoverables and deposit receivables | 645,193 | 192,642 | |||
| Receivables from parent and affiliates | 351,390 | 0 | |||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | |||
| Policyholders’ account balances | $ 12,624,585 | $ 7,697,627 | |||
| Level 3 | Internal | Minimum | Discounted cash flow | Market risk benefit liabilities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 1.00% | 1.00% | |||
| Spread over SOFR | 0.29% | 0.41% | |||
| Utilization rate | 37.00% | 38.00% | |||
| Withdrawal rate (greater than maximum range) | 78.00% | 81.00% | |||
| Mortality rate | 0.00% | 0.00% | |||
| Equity volatility curve | 16.00% | 15.00% | |||
| Level 3 | Internal | Minimum | Discounted cash flow | Policyholders' account balances | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 0.00% | 1.00% | |||
| Spread over SOFR | 0.29% | 0.41% | |||
| Mortality rate | 0.00% | 0.00% | |||
| Option budget | (1.00%) | (1.00%) | |||
| Level 3 | Internal | Minimum | Discounted cash flow | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Discount rate | 2.15% | 6.98% | |||
| Level 3 | Internal | Minimum | Discounted cash flow | Asset-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Discount rate | 2.30% | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Commercial mortgage-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidity premium | 1.00% | 0.60% | |||
| Level 3 | Internal | Minimum | Discounted cash flow | Market risk benefit assets | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 1.00% | 1.00% | |||
| Spread over SOFR | 0.29% | 0.41% | |||
| Utilization rate | 37.00% | 38.00% | |||
| Withdrawal rate (greater than maximum range) | 78.00% | 81.00% | |||
| Mortality rate | 0.00% | 0.00% | |||
| Equity volatility curve | 16.00% | 15.00% | |||
| Level 3 | Internal | Minimum | Discounted cash flow | Reinsurance recoverables and deposit receivables | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 0.00% | 1.00% | |||
| Spread over SOFR | 0.29% | 0.41% | |||
| Option budget | (1.00%) | (1.00%) | |||
| Level 3 | Internal | Minimum | Market comparables | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| EBITDA multiples | 5.0 | ||||
| Level 3 | Internal | Minimum | Liquidation | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidation value | 75.00% | 63.62% | |||
| Level 3 | Internal | Minimum | Liquidation | Receivables from parent and affiliates | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidation value | 100.00% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Market risk benefit liabilities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 20.00% | 20.00% | |||
| Spread over SOFR | 1.79% | 1.91% | |||
| Utilization rate | 94.00% | 95.00% | |||
| Withdrawal rate (greater than maximum range) | 100.00% | 100.00% | |||
| Mortality rate | 16.00% | 15.00% | |||
| Equity volatility curve | 25.00% | 25.00% | |||
| Level 3 | Internal | Maximum | Discounted cash flow | Policyholders' account balances | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 80.00% | 80.00% | |||
| Spread over SOFR | 1.73% | 1.85% | |||
| Mortality rate | 23.00% | 23.00% | |||
| Option budget | 7.00% | 7.00% | |||
| Level 3 | Internal | Maximum | Discounted cash flow | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Discount rate | 20.00% | 20.00% | |||
| Level 3 | Internal | Maximum | Discounted cash flow | Asset-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Discount rate | 10.70% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Commercial mortgage-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidity premium | 1.00% | 0.75% | |||
| Level 3 | Internal | Maximum | Discounted cash flow | Market risk benefit assets | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 20.00% | 20.00% | |||
| Spread over SOFR | 1.79% | 1.91% | |||
| Utilization rate | 94.00% | 95.00% | |||
| Withdrawal rate (greater than maximum range) | 100.00% | 100.00% | |||
| Mortality rate | 16.00% | 15.00% | |||
| Equity volatility curve | 25.00% | 25.00% | |||
| Level 3 | Internal | Maximum | Discounted cash flow | Reinsurance recoverables and deposit receivables | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Lapse rate | 80.00% | 80.00% | |||
| Spread over SOFR | 1.71% | 1.82% | |||
| Option budget | 7.00% | 7.00% | |||
| Level 3 | Internal | Maximum | Market comparables | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| EBITDA multiples | 5.0 | ||||
| Level 3 | Internal | Maximum | Liquidation | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidation value | 75.00% | 63.62% | |||
| Level 3 | Internal | Maximum | Liquidation | Receivables from parent and affiliates | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidation value | 100.00% | ||||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Discount rate | 11.15% | 9.73% | |||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Asset-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Discount rate | 6.18% | ||||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Commercial mortgage-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidity premium | 1.00% | 0.71% | |||
| Level 3 | Internal | Weighted Average | Market comparables | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| EBITDA multiples | 5.0 | ||||
| Level 3 | Internal | Weighted Average | Liquidation | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidation value | 75.00% | 63.62% | |||
| Level 3 | Internal | Weighted Average | Liquidation | Receivables from parent and affiliates | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Liquidation value | 100.00% | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Market risk benefit liabilities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Market risk benefit liabilities | $ 4,281,244 | $ 5,156,858 | |||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Policyholders' account balances | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Policyholders’ account balances | 12,624,585 | 7,697,627 | |||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Corporate securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Corporate securities | 1,130,627 | 81,635 | |||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Asset-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Asset backed securities | 90,370 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Commercial mortgage-backed securities | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Commercial mortgage-backed securities | 75,318 | 78,115 | |||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Market risk benefit assets | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Market risk benefit assets | 2,637,363 | 2,367,243 | |||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Reinsurance recoverables and deposit receivables | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Reinsurance recoverables and deposit receivables | 645,193 | $ 192,642 | |||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Receivables from parent and affiliates | |||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||||
| Receivables from parent and affiliates | $ 328,001 | ||||
| |||||
Fair Value of Assets and Liabilities (Changes in Level 3 Assets and Liabilities) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Market risk benefit assets | $ 2,637,363 | $ 2,367,243 | ||||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | [1] | |||
| Equity securities | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 28,709 | 28,593 | ||||
| Purchases | 273 | 2,531 | ||||
| Sales | (6,120) | 0 | ||||
| Issuances | 0 | 0 | ||||
| Settlements | (6,332) | 0 | ||||
| Other | 6,120 | (1,487) | ||||
| Transfers into Level 3 | 0 | 0 | ||||
| Transfers out of Level 3 | 0 | 0 | ||||
| Fair Value, end of period | 20,515 | 28,709 | $ 28,593 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (2,135) | (928) | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (230) | (928) | ||||
| Equity securities | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Equity securities | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (2,135) | (928) | (3,310) | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (230) | (928) | (3,872) | |||
| Equity securities | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Equity securities | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Equity securities | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Other invested assets | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 1 | 0 | ||||
| Purchases | 0 | 0 | ||||
| Sales | 0 | 0 | ||||
| Issuances | 0 | 0 | ||||
| Settlements | 0 | 0 | ||||
| Other | 0 | 0 | ||||
| Transfers into Level 3 | 0 | 0 | ||||
| Transfers out of Level 3 | 0 | 0 | ||||
| Fair Value, end of period | 143 | 1 | 0 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 142 | 1 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 142 | 1 | ||||
| Other invested assets | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 142 | 1 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 142 | 1 | ||||
| Other invested assets | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | ||||
| Other invested assets | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | ||||
| Other invested assets | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | ||||
| Other invested assets | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | ||||
| Short-term investments | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 1,759 | 16,945 | ||||
| Purchases | 117,046 | 4,922 | ||||
| Sales | (13,113) | 0 | ||||
| Issuances | 0 | 0 | ||||
| Settlements | (1,488) | (21,322) | ||||
| Other | (203) | (1,359) | ||||
| Transfers into Level 3 | 0 | 0 | ||||
| Transfers out of Level 3 | 0 | 0 | ||||
| Fair Value, end of period | 105,540 | 1,759 | 16,945 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 1,539 | 2,573 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 321 | 0 | ||||
| Short-term investments | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 1,142 | 1,857 | 77 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (64) | 0 | 0 | |||
| Short-term investments | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Short-term investments | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Short-term investments | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 385 | (73) | 73 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 385 | 0 | 73 | |||
| Short-term investments | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 12 | 789 | (36) | |||
| Cash equivalents | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 0 | |||||
| Purchases | 744 | |||||
| Sales | 0 | |||||
| Issuances | 0 | |||||
| Settlements | (65) | |||||
| Other | (605) | |||||
| Transfers into Level 3 | 0 | |||||
| Transfers out of Level 3 | 0 | |||||
| Fair Value, end of period | 33 | 0 | ||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (41) | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (41) | |||||
| Cash equivalents | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (41) | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (41) | |||||
| Cash equivalents | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Cash equivalents | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Cash equivalents | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Cash equivalents | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Reinsurance recoverables and deposit receivables | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 192,642 | 115,886 | ||||
| Purchases | 333,291 | 183,716 | ||||
| Sales | 0 | 0 | ||||
| Issuances | 0 | 0 | ||||
| Settlements | 0 | 0 | ||||
| Other | 93,231 | (2,364) | ||||
| Transfers into Level 3 | 0 | 0 | ||||
| Transfers out of Level 3 | 0 | 0 | ||||
| Fair Value, end of period | 645,193 | 192,642 | 115,886 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 26,029 | (104,596) | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (122,807) | (119,067) | ||||
| Reinsurance recoverables and deposit receivables | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 26,029 | (104,596) | 111,382 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (122,807) | (119,067) | 115,303 | |||
| Reinsurance recoverables and deposit receivables | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Reinsurance recoverables and deposit receivables | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Reinsurance recoverables and deposit receivables | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Reinsurance recoverables and deposit receivables | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Separate account assets | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 5,985 | 4,645 | ||||
| Purchases | 5,823 | 2,216 | ||||
| Sales | (2,050) | (1,124) | ||||
| Issuances | 0 | 0 | ||||
| Settlements | (126) | (160) | ||||
| Other | 0 | 0 | ||||
| Transfers into Level 3 | 458 | 0 | ||||
| Transfers out of Level 3 | 0 | 0 | ||||
| Fair Value, end of period | 10,547 | 5,985 | 4,645 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 457 | 408 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 457 | 406 | ||||
| Separate account assets | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Separate account assets | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Separate account assets | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 457 | 408 | (70) | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 457 | 406 | (70) | |||
| Separate account assets | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Separate account assets | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Receivables from parent and affiliates | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 0 | |||||
| Purchases | 418,916 | |||||
| Sales | (51,199) | |||||
| Issuances | 0 | |||||
| Settlements | 0 | |||||
| Other | 0 | |||||
| Transfers into Level 3 | 0 | |||||
| Transfers out of Level 3 | (16,417) | |||||
| Fair Value, end of period | 351,390 | 0 | ||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 90 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 90 | |||||
| Receivables from parent and affiliates | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Receivables from parent and affiliates | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Receivables from parent and affiliates | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Receivables from parent and affiliates | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 90 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 90 | |||||
| Receivables from parent and affiliates | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Policyholders' account balances | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | (7,697,627) | (3,502,096) | ||||
| Purchases | 0 | 0 | ||||
| Sales | 0 | 0 | ||||
| Issuances | (2,286,786) | (1,653,026) | ||||
| Settlements | 0 | 0 | ||||
| Other | 46,929 | 106,631 | ||||
| Transfers into Level 3 | 0 | 0 | ||||
| Transfers out of Level 3 | 0 | 0 | ||||
| Fair Value, end of period | (12,624,585) | (7,697,627) | (3,502,096) | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (2,687,101) | (2,649,136) | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 1,254,144 | (368,507) | ||||
| Policyholders' account balances | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (2,687,101) | (2,649,136) | (409,912) | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 1,254,144 | (368,507) | (289,548) | |||
| Policyholders' account balances | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Policyholders' account balances | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Policyholders' account balances | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Policyholders' account balances | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Other liabilities | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 0 | |||||
| Purchases | 0 | |||||
| Sales | 0 | |||||
| Issuances | 0 | |||||
| Settlements | 0 | |||||
| Other | 0 | |||||
| Transfers into Level 3 | 0 | |||||
| Transfers out of Level 3 | 0 | |||||
| Fair Value, end of period | (31) | 0 | ||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (31) | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (31) | |||||
| Other liabilities | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (31) | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (31) | |||||
| Other liabilities | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Other liabilities | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Other liabilities | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | |||||
| Other liabilities | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | |||||
| Available-for-sale | Fixed maturities | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (54,924) | (2,081) | (16,829) | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (40,765) | (2,904) | (14,416) | |||
| Available-for-sale | Fixed maturities | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Available-for-sale | Fixed maturities | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | 0 | |||
| Available-for-sale | Fixed maturities | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (19,313) | (2,808) | (56,470) | |||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (23,684) | (2,420) | (59,239) | |||
| Available-for-sale | Fixed maturities | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (841) | 490 | (242) | |||
| Available-for-sale | Fixed maturities | Foreign government | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 682 | 724 | ||||
| Purchases | 0 | 0 | ||||
| Sales | 0 | 0 | ||||
| Issuances | 0 | 0 | ||||
| Settlements | 0 | 0 | ||||
| Other | 0 | 0 | ||||
| Transfers into Level 3 | 0 | 0 | ||||
| Transfers out of Level 3 | 0 | 0 | ||||
| Fair Value, end of period | 648 | 682 | 724 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (34) | (42) | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (44) | (53) | ||||
| Available-for-sale | Fixed maturities | Corporate securities | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 1,014,343 | 507,496 | ||||
| Purchases | 1,172,201 | 567,936 | ||||
| Sales | (702,073) | (39,722) | ||||
| Issuances | 0 | 0 | ||||
| Settlements | (183,577) | (130,688) | ||||
| Other | (64,672) | 3,129 | ||||
| Transfers into Level 3 | 33,043 | 117,671 | ||||
| Transfers out of Level 3 | 0 | (11,564) | ||||
| Fair Value, end of period | 1,199,607 | 1,014,343 | 507,496 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (69,658) | 85 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (61,011) | (973) | ||||
| Available-for-sale | Fixed maturities | Structured securities | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 177,237 | 104,724 | ||||
| Purchases | 771,208 | 241,159 | ||||
| Sales | (40,508) | (37) | ||||
| Issuances | 0 | 0 | ||||
| Settlements | (96,067) | (2,147) | ||||
| Other | 65,480 | (2,222) | ||||
| Transfers into Level 3 | 34,578 | 4,537 | ||||
| Transfers out of Level 3 | (206,650) | (164,335) | ||||
| Fair Value, end of period | 699,892 | 177,237 | 104,724 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (5,386) | (4,442) | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (3,394) | (4,298) | ||||
| Trading | Fixed maturities | ||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||
| Fair Value, beginning of period | 34,048 | 0 | ||||
| Purchases | 261,968 | 36,284 | ||||
| Sales | (52) | 0 | ||||
| Issuances | 0 | 0 | ||||
| Settlements | (2,261) | 0 | ||||
| Other | 0 | 2,931 | ||||
| Transfers into Level 3 | 18,842 | 0 | ||||
| Transfers out of Level 3 | (236,606) | (6,250) | ||||
| Fair Value, end of period | 66,285 | 34,048 | $ 0 | |||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (9,654) | 1,083 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (9,705) | 1,225 | ||||
| Trading | Fixed maturities | Realized investment gains (losses), net | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | ||||
| Trading | Fixed maturities | Other income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | (9,661) | 1,080 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | (9,705) | 1,225 | ||||
| Trading | Fixed maturities | Interest credited to policyholders' account balances | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | ||||
| Trading | Fixed maturities | Included in other comprehensive income (loss) | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | 0 | 0 | ||||
| Unrealized gains (losses) for assets/liabilities still held: | ||||||
| Included in earnings | 0 | 0 | ||||
| Trading | Fixed maturities | Net investment income | ||||||
| Total gains (losses) (realized/unrealized): | ||||||
| Included in earnings | $ 7 | $ 3 | ||||
| ||||||
Fair Value of Assets and Liabilities (Nonrecurring Fair Value Measurements) (Details) - Level 3 - Fair Value, Nonrecurring - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Investment in joint venture | |||
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
| Equity in earnings of operating joint venture, net of taxes | $ 0 | $ 0 | $ (75,000) |
| Other invested assets | |||
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
| Gains (losses) | $ 0 | $ 0 | $ (11,125) |
Fair Value of Assets and Liabilities (Financial Instruments where Carrying Amounts and Fair Values May Differ) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Policy loans | $ 1,541,480 | $ 1,472,677 | |||||
| Short-term investments | 517,386 | ||||||
| Cash and cash equivalents | 3,325,698 | 2,139,792 | |||||
| Accrued investment income | 466,394 | 333,838 | |||||
| Receivables from parent and affiliates | 678,028 | 332,583 | |||||
| Liabilities: | |||||||
| Cash collateral for loaned securities | 121,372 | 218,310 | |||||
| Reinsurance Payable And Funds Withheld Payable | 8,611,141 | 2,738,979 | [1],[2] | ||||
| Fair Value | |||||||
| Assets: | |||||||
| Commercial mortgage and other loans | 7,534,909 | 5,918,386 | |||||
| Policy loans | 1,541,480 | 1,472,677 | |||||
| Short-term investments | 21,101 | 66,500 | |||||
| Cash and cash equivalents | 474,415 | 495,667 | |||||
| Accrued investment income | 466,394 | 333,838 | |||||
| Reinsurance recoverables and deposit receivables | 2,355,489 | 1,512,138 | |||||
| Receivables from parent and affiliates | 157,566 | 184,599 | |||||
| Other assets | 203,493 | 80,646 | |||||
| Total assets | 12,754,847 | 10,064,451 | |||||
| Liabilities: | |||||||
| Policyholders’ account balances - investment contracts | 10,811,361 | 6,352,532 | |||||
| Cash collateral for loaned securities | 121,372 | 218,310 | |||||
| Reinsurance Payable And Funds Withheld Payable | 2,602,140 | 1,517,131 | |||||
| Short-term debt to affiliates | 176,110 | ||||||
| Payables to parent and affiliates | 38,571 | 16,573 | |||||
| Other liabilities | 880,884 | 637,153 | |||||
| Total liabilities | 14,454,328 | 8,917,809 | |||||
| Carrying Amount | |||||||
| Assets: | |||||||
| Commercial mortgage and other loans | 7,759,323 | 6,122,721 | |||||
| Policy loans | 1,541,480 | 1,472,677 | |||||
| Short-term investments | 21,101 | 66,500 | |||||
| Cash and cash equivalents | 474,415 | 495,667 | |||||
| Accrued investment income | 466,394 | 333,838 | |||||
| Reinsurance recoverables and deposit receivables | 2,357,292 | 1,513,520 | |||||
| Receivables from parent and affiliates | 157,566 | 184,599 | |||||
| Other assets | 203,493 | 80,646 | |||||
| Total assets | 12,981,064 | 10,270,168 | |||||
| Liabilities: | |||||||
| Policyholders’ account balances - investment contracts | 10,826,931 | 6,368,061 | |||||
| Cash collateral for loaned securities | 121,372 | 218,310 | |||||
| Reinsurance Payable And Funds Withheld Payable | 2,602,140 | 1,517,131 | |||||
| Short-term debt to affiliates | 180,411 | ||||||
| Payables to parent and affiliates | 38,571 | 16,573 | |||||
| Other liabilities | 880,884 | 637,153 | |||||
| Total liabilities | 14,469,898 | 8,937,639 | |||||
| Level 1 | Fair Value | |||||||
| Assets: | |||||||
| Commercial mortgage and other loans | 0 | 0 | |||||
| Policy loans | 0 | 0 | |||||
| Short-term investments | 21,101 | 66,500 | |||||
| Cash and cash equivalents | 474,415 | 470,668 | |||||
| Accrued investment income | 0 | 0 | |||||
| Reinsurance recoverables and deposit receivables | 0 | 0 | |||||
| Receivables from parent and affiliates | 0 | 0 | |||||
| Other assets | 0 | 0 | |||||
| Total assets | 495,516 | 537,168 | |||||
| Liabilities: | |||||||
| Policyholders’ account balances - investment contracts | 0 | 0 | |||||
| Cash collateral for loaned securities | 0 | 0 | |||||
| Reinsurance Payable And Funds Withheld Payable | 0 | 0 | |||||
| Short-term debt to affiliates | 0 | ||||||
| Payables to parent and affiliates | 0 | 0 | |||||
| Other liabilities | 0 | 0 | |||||
| Total liabilities | 0 | 0 | |||||
| Level 2 | Fair Value | |||||||
| Assets: | |||||||
| Commercial mortgage and other loans | 0 | 0 | |||||
| Policy loans | 0 | 0 | |||||
| Short-term investments | 0 | 0 | |||||
| Cash and cash equivalents | 0 | 24,999 | |||||
| Accrued investment income | 466,394 | 333,838 | |||||
| Reinsurance recoverables and deposit receivables | 0 | 0 | |||||
| Receivables from parent and affiliates | 157,566 | 184,599 | |||||
| Other assets | 203,493 | 80,646 | |||||
| Total assets | 827,453 | 624,082 | |||||
| Liabilities: | |||||||
| Policyholders’ account balances - investment contracts | 815,520 | 955,647 | |||||
| Cash collateral for loaned securities | 121,372 | 218,310 | |||||
| Reinsurance Payable And Funds Withheld Payable | 2,602,140 | 1,517,131 | |||||
| Short-term debt to affiliates | 176,110 | ||||||
| Payables to parent and affiliates | 38,571 | 16,573 | |||||
| Other liabilities | 849,278 | 604,730 | |||||
| Total liabilities | 4,426,881 | 3,488,501 | |||||
| Level 3 | Fair Value | |||||||
| Assets: | |||||||
| Commercial mortgage and other loans | 7,534,909 | 5,918,386 | |||||
| Policy loans | 1,541,480 | 1,472,677 | |||||
| Short-term investments | 0 | 0 | |||||
| Cash and cash equivalents | 0 | 0 | |||||
| Accrued investment income | 0 | 0 | |||||
| Reinsurance recoverables and deposit receivables | 2,355,489 | 1,512,138 | |||||
| Receivables from parent and affiliates | 0 | 0 | |||||
| Other assets | 0 | 0 | |||||
| Total assets | 11,431,878 | 8,903,201 | |||||
| Liabilities: | |||||||
| Policyholders’ account balances - investment contracts | 9,995,841 | 5,396,885 | |||||
| Cash collateral for loaned securities | 0 | 0 | |||||
| Reinsurance Payable And Funds Withheld Payable | 0 | 0 | |||||
| Short-term debt to affiliates | 0 | ||||||
| Payables to parent and affiliates | 0 | 0 | |||||
| Other liabilities | 31,606 | 32,423 | |||||
| Total liabilities | $ 10,027,447 | $ 5,429,308 | |||||
| |||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements (Balance of and Changes in DAC) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||||
| Deferred Policy Acquisition Cost, Beginning Balance | $ 7,144,736 | [1] | $ 6,956,197 | $ 7,029,308 | |||
| Capitalization | 1,533,858 | 1,121,435 | 989,342 | ||||
| Amortization Expense | (603,357) | (539,510) | (521,269) | ||||
| Other | (268,177) | (393,386) | (541,184) | ||||
| Balance, end of period | 7,807,060 | 7,144,736 | [1] | 6,956,197 | |||
| Fixed Annuities | |||||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||||
| Deferred Policy Acquisition Cost, Beginning Balance | 197,937 | 102,251 | 84,481 | ||||
| Capitalization | 216,410 | 117,851 | 31,494 | ||||
| Amortization Expense | (42,705) | (22,165) | (13,724) | ||||
| Other | 0 | 0 | 0 | ||||
| Balance, end of period | 371,642 | 197,937 | 102,251 | ||||
| Variable Annuties | |||||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||||
| Deferred Policy Acquisition Cost, Beginning Balance | 3,298,935 | 3,759,819 | 3,806,732 | ||||
| Capitalization | 430,520 | 263,869 | 296,597 | ||||
| Amortization Expense | (356,254) | (331,368) | (343,510) | ||||
| Other | 0 | (393,385) | 0 | ||||
| Balance, end of period | 3,373,201 | 3,298,935 | 3,759,819 | ||||
| Term Life | |||||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||||
| Deferred Policy Acquisition Cost, Beginning Balance | 743,888 | 648,837 | 577,084 | ||||
| Capitalization | 183,463 | 159,000 | 127,541 | ||||
| Amortization Expense | (63,447) | (63,949) | (55,423) | ||||
| Other | (249,836) | 0 | (365) | ||||
| Balance, end of period | 614,068 | 743,888 | 648,837 | ||||
| Variable / Universal Life | |||||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||||
| Deferred Policy Acquisition Cost, Beginning Balance | 2,903,976 | 2,445,290 | 2,561,011 | ||||
| Capitalization | 703,465 | 580,715 | 533,710 | ||||
| Amortization Expense | (140,951) | (122,028) | (108,612) | ||||
| Other | (18,341) | (1) | (540,819) | ||||
| Balance, end of period | $ 3,448,149 | $ 2,903,976 | $ 2,445,290 | ||||
| |||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements (Balance of and Changes in Deferred Reinsurance Losses) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of period | $ 255,115 | $ 292,893 | $ 333,003 |
| Amortization expense | (54,749) | (37,777) | (40,105) |
| Other | 1,330,028 | (1) | (5) |
| Balance, end of period | 1,530,394 | 255,115 | 292,893 |
| PARCC | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, end of period | 351,000 | ||
| Variable Annuties | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of period | 194,111 | 223,515 | 254,577 |
| Amortization expense | (29,876) | (29,403) | (31,057) |
| Other | 3 | (1) | (5) |
| Balance, end of period | 164,238 | 194,111 | 223,515 |
| Term Life | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of period | 61,004 | 69,378 | 78,426 |
| Amortization expense | (15,345) | (8,374) | (9,048) |
| Other | 351,025 | 0 | 0 |
| Balance, end of period | 396,684 | 61,004 | 69,378 |
| Variable / Universal Life | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of period | 0 | 0 | 0 |
| Amortization expense | (9,528) | 0 | 0 |
| Other | 979,000 | 0 | 0 |
| Balance, end of period | $ 969,472 | $ 0 | $ 0 |
Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements (Balance of and Changes in Deferred Reinsurance Gain) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, beginning of period | $ 1,673,291 | $ 1,492,856 | $ 252,736 |
| Amortization | (151,767) | (96,864) | (86,389) |
| Other | 1,797,261 | 277,299 | 1,326,509 |
| Balance, end of period | 3,318,785 | 1,673,291 | 1,492,856 |
| Lotus Re | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Other | 1,352,000 | ||
| Fixed Annuities | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, beginning of period | 48,074 | 57,898 | 78,138 |
| Amortization | (10,516) | (9,790) | (6,437) |
| Other | (10) | (34) | (13,803) |
| Balance, end of period | 37,548 | 48,074 | 57,898 |
| Variable Annuties | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, beginning of period | 261,721 | 0 | 0 |
| Amortization | (20,061) | (15,612) | 0 |
| Other | (32) | 277,333 | 0 |
| Balance, end of period | 241,628 | 261,721 | 0 |
| Variable / Universal Life | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, beginning of period | 1,363,496 | 1,434,958 | 174,598 |
| Amortization | (121,190) | (71,462) | (79,952) |
| Other | 1,797,303 | 0 | 1,340,312 |
| Balance, end of period | 3,039,609 | $ 1,363,496 | $ 1,434,958 |
| Variable / Universal Life | Somerset Re | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Other | 1,207,000 | ||
| Variable / Universal Life | PURC | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Other | 116,000 | ||
| Variable / Universal Life | Wilton Re | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Other | $ 798,000 | ||
Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements (Balance of and Changes in DSI) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Movement in Deferred Sales Inducements [Roll Forward] | |||
| Beginning Balance | $ 351,424 | ||
| Ending Balance | 322,351 | $ 351,424 | |
| Variable Annuties | |||
| Movement in Deferred Sales Inducements [Roll Forward] | |||
| Beginning Balance | 351,424 | 381,504 | $ 414,619 |
| Capitalization | 1,243 | 1,514 | 676 |
| Amortization expense | (30,316) | (31,625) | (33,791) |
| Other adjustments | 31 | ||
| Ending Balance | $ 322,351 | $ 351,424 | $ 381,504 |
Separate Accounts (Separate Account Assets) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | $ 118,143,256 | $ 119,188,485 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 15,548 | 2,954 |
| Obligations of U.S. states and their political subdivisions authorities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 115 | 0 |
| U.S. corporate securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 24,458 | 9,504 |
| Foreign corporate securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 3,158 | 1,763 |
| Asset-Backed Securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 1,099 | 0 |
| Mortgage-backed securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 82 | 186 |
| Equity | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 73,226,610 | 72,614,821 |
| Fixed Income | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 33,828,097 | 37,065,162 |
| Other | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 4,431,975 | 4,101,661 |
| Equity securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 126,792 | 104,159 |
| Other invested assets | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 6,444,077 | 5,258,900 |
| Short-term investments | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 2,559 | 2,126 |
| Cash and cash equivalents | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | $ 38,686 | $ 27,249 |
Separate Accounts (Separate Account Liabilities) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Separate Account, Liability [Roll Forward] | |||
| Balance, beginning of period | $ 119,188,485 | $ 114,051,246 | $ 149,797,828 |
| Deposits | 4,114,974 | 3,186,458 | 2,933,695 |
| Investment performance | 13,052,608 | 16,530,506 | (25,870,874) |
| Policy charges | (3,133,536) | (3,126,398) | (3,280,999) |
| Surrenders and withdrawals | (14,278,004) | (10,035,327) | (8,821,162) |
| Benefit payments | (351,709) | (300,033) | (340,726) |
| Net transfers (to) from general account | (481,062) | (1,190,696) | (420,021) |
| Other | 31,500 | 72,729 | 53,505 |
| Balance, end of period | 118,143,256 | 119,188,485 | 114,051,246 |
| Cash surrender value | 113,918,263 | 114,901,916 | 109,783,645 |
| Variable Annuties | |||
| Separate Account, Liability [Roll Forward] | |||
| Balance, beginning of period | 92,383,121 | 91,785,447 | 123,977,624 |
| Deposits | 601,236 | 440,707 | 658,695 |
| Investment performance | 8,395,586 | 12,219,777 | (21,600,783) |
| Policy charges | (2,210,261) | (2,296,859) | (2,513,831) |
| Surrenders and withdrawals | (13,827,431) | (9,687,372) | (8,481,231) |
| Benefit payments | (66,029) | (73,791) | (62,586) |
| Net transfers (to) from general account | (100,193) | (15,121) | (206,269) |
| Other | 7,026 | 10,333 | 13,828 |
| Balance, end of period | 85,183,055 | 92,383,121 | 91,785,447 |
| Cash surrender value | 84,325,382 | 91,201,190 | 90,208,083 |
| Variable Life | |||
| Separate Account, Liability [Roll Forward] | |||
| Balance, beginning of period | 26,805,364 | 22,265,799 | 25,820,204 |
| Deposits | 3,513,738 | 2,745,751 | 2,275,000 |
| Investment performance | 4,657,022 | 4,310,729 | (4,270,091) |
| Policy charges | (923,275) | (829,539) | (767,168) |
| Surrenders and withdrawals | (450,573) | (347,955) | (339,931) |
| Benefit payments | (285,680) | (226,242) | (278,140) |
| Net transfers (to) from general account | (380,869) | (1,175,575) | (213,752) |
| Other | 24,474 | 62,396 | 39,677 |
| Balance, end of period | 32,960,201 | 26,805,364 | 22,265,799 |
| Cash surrender value | $ 29,592,881 | 23,700,726 | $ 19,575,562 |
| Policy loan funding to an affiliated irrevocable trust | Variable Life | |||
| Separate Account, Liability [Roll Forward] | |||
| Net transfers (to) from general account | $ (900,000) | ||
Liability for Future Policy Benefits (Benefit Reserves) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Other adjustments | $ 20,643 | $ (3,952) | $ (55,099) | |
| Other Businesses | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 1,765 | 2,127 | ||
| Balance after transition, at current discount rate | 1,474 | 1,765 | 2,127 | |
| Total | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 18,656,760 | 18,042,105 | ||
| Balance after transition, at current discount rate | 17,928,959 | 18,656,760 | 18,042,105 | |
| Term Life | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Balance, beginning of period | 10,927,833 | 10,911,794 | 12,485,056 | |
| Effect of cumulative changes in discount rate assumptions, beginning of period | 225,711 | 554,896 | (1,826,120) | |
| Balance at original discount rate, beginning of period | 11,153,544 | 11,466,690 | 10,658,936 | |
| Effect of assumption update | 21,466 | (790) | $ 1,295,294 | |
| Effect of actual variances from expected experiences and other activity | (219,878) | (200,513) | (112,661) | |
| Adjusted balance, beginning of period | 10,955,132 | 11,265,387 | 11,841,569 | |
| Issuances | 827,606 | 712,495 | 439,874 | |
| Net Premium / Consideration Collected | (1,319,501) | (1,345,514) | (1,339,902) | |
| Interest accural | 511,817 | 521,176 | 525,149 | |
| Other adjustments | 7,092 | |||
| Balance at original discount rate, end of period | 10,982,146 | 11,153,544 | 11,466,690 | |
| Effect of cumulative changes in discount rate assumptions, end of period | (567,443) | (225,711) | (554,896) | |
| Balance, end of period | 10,414,703 | 10,927,833 | 10,911,794 | |
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 18,426,207 | 17,835,251 | 20,937,097 | |
| Effect of cumulative changes in discount rate assumptions, beginning of period | 331,571 | 962,035 | (3,607,275) | |
| Balance at original discount rate, beginning of period | 18,757,778 | 18,797,286 | 17,329,822 | |
| Effect of assumption update | 21,480 | (1,044) | 1,756,995 | |
| Effect of actual variance from expected experience and other activity | (259,137) | (263,243) | (206,175) | |
| Adjusted balance, beginning of period | 18,520,121 | 18,532,999 | 18,880,642 | |
| Issuances | 827,606 | 712,495 | 439,874 | |
| Interest accrual | 893,983 | 895,023 | 888,525 | |
| Benefit Payments | (1,471,863) | (1,386,583) | (1,416,823) | |
| Other adjustments | 11,225 | 3,844 | 5,068 | |
| Balance at original discount rate, end of period | 18,781,072 | 18,757,778 | 18,797,286 | |
| Effect of cumulative changes in discount rate assumptions, end of period | (1,091,673) | (331,571) | (962,035) | |
| Balance after transition, at current discount rate | 17,689,399 | 18,426,207 | 17,835,251 | |
| Balance, end of period, pre-flooring | 7,274,696 | 7,498,374 | 6,923,457 | |
| Flooring impact, end of period | 44 | 44 | 0 | |
| Balance, end of period, post-flooring | 7,274,740 | 7,498,418 | 6,923,457 | |
| Less: Reinsurance Recoverable | 6,753,842 | 6,817,488 | 6,497,257 | |
| Balance after transition, net of reinsurance recoverable | 520,898 | 680,930 | 426,200 | |
| Term Life | Gross Basis | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Undiscounted expected future gross premiums | 21,815,010 | 21,871,767 | 22,223,836 | |
| Discounted expected future gross premiums (at original discount rate) | 14,889,078 | 15,027,611 | 15,322,180 | |
| Discounted expected future gross premiums (at current discount rate) | 14,154,658 | 14,748,999 | 14,587,657 | |
| Undiscounted expected future benefits and expenses | $ 29,163,241 | $ 29,118,532 | $ 29,330,574 | |
| Weighted-average duration of the liability in years (at original discount rate) | 10 years | 10 years | 11 years | |
| Weighted-average duration of the liability in years (at current discount rate) | 9 years | 10 years | 10 years | |
| Weighted-Average Interest Rate (At Original Discount Rate) | 5.13% | 5.17% | 5.23% | |
| Weighted-average interest rate (at current discount rate) | 5.59% | 4.99% | 5.39% | |
| Fixed Annuities | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Balance, beginning of period | $ 0 | $ 0 | $ 0 | |
| Effect of cumulative changes in discount rate assumptions, beginning of period | 0 | 0 | 0 | |
| Balance at original discount rate, beginning of period | 0 | 0 | 0 | |
| Effect of assumption update | 0 | 0 | 0 | |
| Effect of actual variances from expected experiences and other activity | 58 | (989) | (1,143) | |
| Adjusted balance, beginning of period | 58 | |||
| Issuances | 35,717 | 36,646 | 30,469 | |
| Net Premium / Consideration Collected | (35,775) | (35,657) | (29,326) | |
| Interest accural | 0 | 0 | 0 | |
| Other adjustments | 0 | |||
| Balance at original discount rate, end of period | 0 | 0 | 0 | |
| Effect of cumulative changes in discount rate assumptions, end of period | 0 | 0 | 0 | |
| Balance, end of period | 0 | 0 | 0 | |
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 228,788 | 204,727 | 237,065 | |
| Effect of cumulative changes in discount rate assumptions, beginning of period | 19,521 | 24,876 | (16,704) | |
| Balance at original discount rate, beginning of period | 248,309 | 229,603 | 220,361 | |
| Effect of assumption update | (3,643) | 0 | 0 | |
| Effect of actual variance from expected experience and other activity | 502 | 6,991 | (1,639) | |
| Adjusted balance, beginning of period | 245,168 | 236,594 | 218,722 | |
| Issuances | 35,717 | 36,646 | 30,469 | |
| Interest accrual | 9,119 | 8,440 | 7,836 | |
| Benefit Payments | (32,225) | (33,287) | (27,138) | |
| Other adjustments | (251) | (84) | (286) | |
| Balance at original discount rate, end of period | 257,528 | 248,309 | 229,603 | |
| Effect of cumulative changes in discount rate assumptions, end of period | (19,442) | (19,521) | (24,876) | |
| Balance after transition, at current discount rate | 238,086 | 228,788 | 204,727 | |
| Balance, end of period, pre-flooring | 238,086 | 228,788 | 204,727 | |
| Flooring impact, end of period | 0 | 0 | 0 | |
| Balance, end of period, post-flooring | 238,086 | 228,788 | 204,727 | |
| Less: Reinsurance Recoverable | 20,516 | 18,489 | 16,460 | |
| Balance after transition, net of reinsurance recoverable | 217,570 | 210,299 | 188,267 | |
| Fixed Annuities | Gross Basis | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Undiscounted expected future gross premiums | 0 | 0 | 0 | |
| Discounted expected future gross premiums (at original discount rate) | 0 | 0 | 0 | |
| Discounted expected future gross premiums (at current discount rate) | 0 | 0 | 0 | |
| Undiscounted expected future benefits and expenses | $ 346,892 | $ 332,902 | $ 306,286 | |
| Weighted-average duration of the liability in years (at original discount rate) | 7 years | 7 years | 7 years | |
| Weighted-average duration of the liability in years (at current discount rate) | 6 years | 6 years | 6 years | |
| Weighted-Average Interest Rate (At Original Discount Rate) | 3.94% | 3.70% | 3.60% | |
| Weighted-average interest rate (at current discount rate) | 5.49% | 4.95% | 5.33% | |
| Fixed Annuity | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Adjusted balance, beginning of period | $ (989) | (1,143) | ||
| Term Life and Fixed Annuities | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Balance, beginning of period | $ 10,927,833 | $ 10,911,794 | 12,485,056 | |
| Effect of cumulative changes in discount rate assumptions, beginning of period | 225,711 | 554,896 | (1,826,120) | |
| Balance at original discount rate, beginning of period | 11,153,544 | 11,466,690 | 10,658,936 | |
| Effect of assumption update | 21,466 | (790) | 1,295,294 | |
| Effect of actual variances from expected experiences and other activity | (219,820) | (201,502) | (113,804) | |
| Adjusted balance, beginning of period | 10,955,190 | 11,264,398 | 11,840,426 | |
| Issuances | 863,323 | 749,141 | 470,343 | |
| Net Premium / Consideration Collected | (1,355,276) | (1,381,171) | (1,369,228) | |
| Interest accural | 511,817 | 521,176 | 525,149 | |
| Other adjustments | 7,092 | |||
| Balance at original discount rate, end of period | 10,982,146 | 11,153,544 | 11,466,690 | |
| Effect of cumulative changes in discount rate assumptions, end of period | (567,443) | (225,711) | (554,896) | |
| Balance, end of period | 10,414,703 | 10,927,833 | 10,911,794 | |
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 18,654,995 | 18,039,978 | 21,174,162 | |
| Effect of cumulative changes in discount rate assumptions, beginning of period | 351,092 | 986,911 | (3,623,979) | |
| Balance at original discount rate, beginning of period | 19,006,087 | 19,026,889 | 17,550,183 | |
| Effect of assumption update | 17,837 | (1,044) | 1,756,995 | |
| Effect of actual variance from expected experience and other activity | (258,635) | (256,252) | (207,814) | |
| Adjusted balance, beginning of period | 18,765,289 | 18,769,593 | $ 19,099,364 | |
| Issuances | 863,323 | 749,141 | 470,343 | |
| Interest accrual | 903,102 | 903,463 | 896,361 | |
| Benefit Payments | (1,504,088) | (1,419,870) | (1,443,961) | |
| Other adjustments | 10,974 | 3,760 | 4,782 | |
| Balance at original discount rate, end of period | 19,038,600 | 19,006,087 | 19,026,889 | |
| Effect of cumulative changes in discount rate assumptions, end of period | (1,111,115) | (351,092) | (986,911) | |
| Balance after transition, at current discount rate | 17,927,485 | 18,654,995 | 18,039,978 | |
| Balance, end of period, pre-flooring | 7,512,782 | 7,727,162 | 7,128,184 | |
| Flooring impact, end of period | 44 | 44 | 0 | |
| Balance, end of period, post-flooring | 7,512,826 | 7,727,206 | 7,128,184 | |
| Less: Reinsurance Recoverable | 6,774,358 | 6,835,977 | 6,513,717 | |
| Balance after transition, net of reinsurance recoverable | 738,468 | 891,229 | 614,467 | |
| Nonparticipating Traditional and Limited-Pay Business | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Loss in net income | 28,000 | 30,000 | 83,000 | |
| Gain in net income | $ 29,000 | $ 31,000 | $ 82,000 | |
Liability for Future Policy Benefits (Deferred Profit Liability) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Other adjustments | $ 20,643 | $ (3,952) | $ (55,099) | |
| Fixed Annuities | Deferred Profit Liability | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 14,818 | 18,193 | 15,765 | |
| Effect of assumption update | 2,110 | 0 | $ 0 | |
| Effect of actual variance from expected experience and other activity | 580 | (6,978) | 1,250 | |
| Adjusted balance, beginning of period | 17,508 | 11,215 | $ 17,015 | |
| Profits deferred | 7,070 | 5,191 | 2,511 | |
| Interest accrual | 729 | 552 | 616 | |
| Amortization | (2,345) | (2,129) | (1,909) | |
| Other adjustments | (23) | (11) | (40) | |
| Balance, end of period | 22,939 | 14,818 | 18,193 | |
| Less: Reinsurance Recoverable | 1,513 | 1,365 | 1,684 | |
| Balance after reinsurance recoverable | $ 21,426 | $ 13,453 | $ 16,509 | |
Liability for Future Policy Benefits (Additional Insurance Reserves) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Insurance [Abstract] | ||||
| Balance including amounts in AOCI, beginning of period, post-flooring | $ 14,280,792 | $ 12,664,445 | $ 11,660,527 | |
| Flooring Impact and amounts in AOCI | 831,583 | 1,269,236 | (896,931) | |
| Balance, excluding amounts in AOCI, beginning of period, pre-flooring | 15,112,375 | 13,933,681 | $ 10,763,596 | |
| Effect of assumption updates | 154,058 | 22,910 | 2,197,592 | |
| Effect of actual variance from expected experience and other activity | 265,684 | 34,021 | (223,185) | |
| Adjusted balance, beginning of period | 15,532,117 | 13,990,612 | $ 12,738,003 | |
| Assessments collected | 1,242,684 | 929,709 | 961,924 | |
| Interest accrual | 536,678 | 486,253 | 433,631 | |
| Benefits paid | (343,241) | (294,199) | (199,877) | |
| Balance, excluding amounts in AOCI, end of period, pre-flooring | 16,968,238 | 15,112,375 | 13,933,681 | |
| Flooring Impact and amounts in AOCI | (617,186) | (831,583) | (1,269,236) | |
| Balance, including amounts in AOCI, end of period, post-flooring | 16,351,052 | 14,280,792 | 12,664,445 | |
| Less: Reinsurance recoverable | 16,129,846 | 14,054,600 | 12,458,184 | |
| Balance after reinsurance recoverable, including amounts in AOCI, end of period | $ 221,206 | $ 226,192 | $ 206,261 | |
| Weighted-average duration of the liability in years (at original discount rate) | 22 years | 22 years | 23 years | |
| Weighted-average interest rate (at original discount rate) | 3.33% | 3.39% | 3.37% | |
Liability for Future Policy Benefits (Future Policy Benefits Reconciliation) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|
| Insurance [Abstract] | |||
| Benefit reserves, end of period, post-flooring | $ 7,512,826 | $ 7,727,206 | $ 7,128,184 |
| Deferred profit liability, end of period, post-flooring | 22,939 | 14,818 | 18,193 |
| Additional insurance reserves, including amounts in AOCI, end of period, post-flooring | 16,351,052 | 14,280,792 | 12,664,445 |
| Subtotal of amounts disclosed above | 23,886,817 | 22,022,816 | 19,810,822 |
| Other future policy benefit reserves | 1,226,950 | 1,182,389 | 1,018,211 |
| Future policy benefits | $ 25,113,767 | $ 23,205,205 | $ 20,829,033 |
Liability for Future Policy Benefits (Revenue and Interest Expense) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Benefit Reserves | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | $ 1,833,017 | $ 1,804,955 | $ 1,831,360 |
| Interest expense | 382,165 | 373,845 | 363,375 |
| Benefit Reserves | Variable / Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 |
| Benefit Reserves | Fixed Annuities | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 43,092 | 41,111 | 32,105 |
| Interest expense | 9,119 | 8,440 | 7,836 |
| Benefit Reserves | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 1,876,109 | 1,846,066 | 1,863,465 |
| Interest expense | 391,284 | 382,285 | 371,211 |
| Deferred Profit Liability | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 |
| Deferred Profit Liability | Variable / Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 |
| Deferred Profit Liability | Fixed Annuities | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 3,375 | ||
| Interest expense | 729 | 552 | 616 |
| Deferred Profit Liability | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 3,375 | ||
| Interest expense | 729 | 552 | 616 |
| Deferred Profit Liability | Fixed Annuities | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | (8,121) | (2,428) | |
| Deferred Profit Liability | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | (8,121) | (2,428) | |
| Additional Insurance Reserves | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 |
| Additional Insurance Reserves | Variable / Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 2,050,441 | 1,405,696 | 1,367,796 |
| Interest expense | 536,678 | 486,253 | 433,631 |
| Additional Insurance Reserves | Fixed Annuities | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 |
| Additional Insurance Reserves | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 2,050,441 | 1,405,696 | 1,367,796 |
| Interest expense | 536,678 | 486,253 | 433,631 |
| Revenues | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 1,833,017 | 1,804,955 | 1,831,360 |
| Revenues | Variable / Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 2,050,441 | 1,405,696 | 1,367,796 |
| Revenues | Fixed Annuities | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 34,971 | 44,486 | 29,677 |
| Revenues | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 3,918,429 | 3,255,137 | 3,228,833 |
| Interest Expense | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest expense | 382,165 | 373,845 | 363,375 |
| Interest Expense | Variable / Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest expense | 536,678 | 486,253 | 433,631 |
| Interest Expense | Fixed Annuities | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest expense | 9,848 | 8,992 | 8,452 |
| Interest Expense | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest expense | $ 928,691 | $ 869,090 | $ 805,458 |
Policyholders' Liabilities (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Balance, beginning of period | $ 52,986,700 | [1] | $ 41,912,536 | ||||
| Transfer (to) from separate account | 481,062 | 1,190,696 | $ 420,021 | ||||
| Unearned revenue reserve | 4,415,187 | 3,741,426 | 3,067,336 | ||||
| Other | 107,324 | 102,583 | 100,980 | ||||
| Total Policyholders' account balance | $ 69,628,318 | $ 52,986,700 | [1] | $ 41,912,536 | |||
| Weighted-average crediting rate | 2.23% | 2.12% | 2.26% | ||||
| Net amount at risk | $ 345,969,582 | $ 323,508,447 | $ 304,864,585 | ||||
| Cash surrender value | 60,772,383 | 44,474,822 | 33,949,928 | ||||
| As Previously Reported | |||||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Balance, beginning of period | 53,012,800 | ||||||
| Total Policyholders' account balance | 53,012,800 | ||||||
| Total | |||||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Balance, beginning of period | 49,142,691 | 38,744,220 | 33,492,392 | ||||
| Deposits | 15,688,604 | 9,363,655 | 7,478,092 | ||||
| Interest credited | 1,309,522 | 901,157 | 813,272 | ||||
| Policy charges | (1,869,445) | (1,842,450) | (1,806,479) | ||||
| Surrenders and withdrawals | (2,115,797) | (1,591,318) | (1,223,874) | ||||
| Benefit payments | (156,746) | (164,392) | (229,040) | ||||
| Transfer (to) from separate account | 481,062 | 1,190,696 | 420,021 | ||||
| Change in market value and other adjustments | 2,625,916 | 2,541,123 | (200,164) | ||||
| Balance, end of period | 65,105,807 | 49,142,691 | 38,744,220 | ||||
| Total Policyholders' account balance | 49,142,691 | 38,744,220 | |||||
| Fixed Annuities | |||||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Balance, beginning of period | 6,164,313 | 3,575,823 | 3,005,867 | ||||
| Deposits | 5,215,817 | 2,612,775 | 754,397 | ||||
| Interest credited | 222,516 | 101,192 | 53,884 | ||||
| Policy charges | (5,290) | (8,438) | (5,118) | ||||
| Surrenders and withdrawals | (554,653) | (229,843) | (68,343) | ||||
| Benefit payments | (55,956) | (50,522) | (90,640) | ||||
| Transfer (to) from separate account | 0 | 0 | 0 | ||||
| Change in market value and other adjustments | 210,590 | 163,326 | (74,224) | ||||
| Balance, end of period | $ 11,197,337 | 6,164,313 | 3,575,823 | ||||
| Total Policyholders' account balance | $ 6,164,313 | $ 3,575,823 | |||||
| Weighted-average crediting rate | 2.56% | 2.08% | 1.64% | ||||
| Net amount at risk | $ 11 | $ 15 | $ 3 | ||||
| Cash surrender value | 9,863,990 | 5,307,537 | 2,968,033 | ||||
| Variable Annuties | |||||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Balance, beginning of period | 22,810,665 | 16,432,032 | 11,723,977 | ||||
| Deposits | 8,315,212 | 4,633,727 | 4,550,660 | ||||
| Interest credited | 516,018 | 243,908 | 175,574 | ||||
| Policy charges | (32,987) | (23,368) | (5,482) | ||||
| Surrenders and withdrawals | (782,216) | (516,039) | (282,497) | ||||
| Benefit payments | (30,427) | (30,461) | (35,042) | ||||
| Transfer (to) from separate account | 100,193 | 15,121 | 206,269 | ||||
| Change in market value and other adjustments | 2,320,873 | 2,055,745 | 98,573 | ||||
| Balance, end of period | $ 33,217,331 | 22,810,665 | 16,432,032 | ||||
| Total Policyholders' account balance | $ 22,810,665 | $ 16,432,032 | |||||
| Weighted-average crediting rate | 1.72% | 1.40% | 1.26% | ||||
| Net amount at risk | $ 0 | $ 0 | $ 0 | ||||
| Cash surrender value | 31,516,776 | 20,490,433 | 13,844,151 | ||||
| Variable / Universal Life | |||||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Balance, beginning of period | 20,167,713 | 18,736,365 | 18,762,548 | ||||
| Deposits | 2,157,575 | 2,117,153 | 2,173,035 | ||||
| Interest credited | 570,988 | 556,057 | 583,814 | ||||
| Policy charges | (1,831,168) | (1,810,644) | (1,795,879) | ||||
| Surrenders and withdrawals | (778,928) | (845,436) | (873,034) | ||||
| Benefit payments | (70,363) | (83,409) | (103,358) | ||||
| Transfer (to) from separate account | 380,869 | 1,175,575 | 213,752 | ||||
| Change in market value and other adjustments | 94,453 | 322,052 | (224,513) | ||||
| Balance, end of period | $ 20,691,139 | 20,167,713 | 18,736,365 | ||||
| Total Policyholders' account balance | $ 20,167,713 | $ 18,736,365 | |||||
| Weighted-average crediting rate | 2.79% | 2.86% | 3.11% | ||||
| Net amount at risk | $ 345,969,571 | $ 323,508,432 | $ 304,864,582 | ||||
| Cash surrender value | 19,391,617 | 18,676,852 | 17,137,744 | ||||
| Variable Life | |||||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Transfer (to) from separate account | $ 380,869 | 1,175,575 | $ 213,752 | ||||
| Policy loans | Variable Life | |||||||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||||||
| Transfer (to) from separate account | $ 900,000 | ||||||
| |||||||
Policyholders' Liabilities (Guaranteed Minimum Crediting Rate) (Details) $ in Thousands |
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
|||
|---|---|---|---|---|---|---|---|
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 69,628,318 | $ 52,986,700 | [1] | $ 41,912,536 | |||
| 1 - 50 bps above guaranteed minimum | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholder account balance, above guaranteed minimum crediting rate | 50 | 50 | 50 | ||||
| 1 - 50 bps above guaranteed minimum | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholder account balance, above guaranteed minimum crediting rate | 1 | 1 | 1 | ||||
| 51 - 150 bps above guaranteed minimum | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholder account balance, above guaranteed minimum crediting rate | 150 | 150 | 150 | ||||
| 51 - 150 bps above guaranteed minimum | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholder account balance, above guaranteed minimum crediting rate | 51 | 51 | 51 | ||||
| Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholder account balance, above guaranteed minimum crediting rate | 150 | 150 | 150 | ||||
| Fixed Annuities | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 6,164,313 | $ 3,575,823 | $ 3,005,867 | ||||
| Variable Annuties | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 22,810,665 | 16,432,032 | 11,723,977 | ||||
| Variable / Universal Life | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 20,167,713 | 18,736,365 | $ 18,762,548 | ||||
| Less than 1.00% | Fixed Annuities | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 1,037,125 | $ 118,813 | $ 0 | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | 1.00% | ||||
| Less than 1.00% | Fixed Annuities | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 249 | $ 105 | $ 0 | ||||
| Less than 1.00% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 3,103 | 337 | 0 | ||||
| Less than 1.00% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 11,939 | 994 | 0 | ||||
| Less than 1.00% | Fixed Annuities | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,021,834 | 117,377 | 0 | ||||
| Less than 1.00% | Variable Annuties | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 1,279,398 | $ 1,733,642 | $ 1,888,628 | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | 1.00% | ||||
| Less than 1.00% | Variable Annuties | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 128,748 | $ 908,097 | $ 1,008,763 | ||||
| Less than 1.00% | Variable Annuties | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 502,988 | 807,460 | 861,119 | ||||
| Less than 1.00% | Variable Annuties | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 647,480 | 18,083 | 18,744 | ||||
| Less than 1.00% | Variable Annuties | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 182 | 2 | 2 | ||||
| Less than 1.00% | Variable / Universal Life | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 180,380 | $ 196,692 | $ 11,902 | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | 1.00% | ||||
| Less than 1.00% | Variable / Universal Life | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 3,167 | $ 0 | $ 11,902 | ||||
| Less than 1.00% | Variable / Universal Life | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Less than 1.00% | Variable / Universal Life | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Less than 1.00% | Variable / Universal Life | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 177,213 | 196,692 | 0 | ||||
| 1.00% - 1.99% | Fixed Annuities | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 734,846 | $ 874,784 | $ 927,039 | ||||
| 1.00% - 1.99% | Fixed Annuities | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 1.99% | 1.99% | 1.99% | ||||
| 1.00% - 1.99% | Fixed Annuities | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | 1.00% | ||||
| 1.00% - 1.99% | Fixed Annuities | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 430,477 | $ 487,191 | $ 521,189 | ||||
| 1.00% - 1.99% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 62,519 | 73,393 | 73,554 | ||||
| 1.00% - 1.99% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 172,877 | 234,487 | 248,881 | ||||
| 1.00% - 1.99% | Fixed Annuities | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 68,973 | 79,713 | 83,415 | ||||
| 1.00% - 1.99% | Variable Annuties | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 418,465 | $ 217,498 | $ 246,774 | ||||
| 1.00% - 1.99% | Variable Annuties | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 1.99% | 1.99% | 1.99% | ||||
| 1.00% - 1.99% | Variable Annuties | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | 1.00% | ||||
| 1.00% - 1.99% | Variable Annuties | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 121,336 | $ 214,377 | $ 243,223 | ||||
| 1.00% - 1.99% | Variable Annuties | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 294,635 | 2,061 | 2,257 | ||||
| 1.00% - 1.99% | Variable Annuties | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 2,494 | 1,060 | 1,294 | ||||
| 1.00% - 1.99% | Variable Annuties | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| 1.00% - 1.99% | Variable / Universal Life | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 3,652,804 | $ 3,317,734 | $ 3,120,332 | ||||
| 1.00% - 1.99% | Variable / Universal Life | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 1.99% | 1.99% | 1.99% | ||||
| 1.00% - 1.99% | Variable / Universal Life | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | 1.00% | ||||
| 1.00% - 1.99% | Variable / Universal Life | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 289,677 | $ 201,121 | $ 418,399 | ||||
| 1.00% - 1.99% | Variable / Universal Life | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| 1.00% - 1.99% | Variable / Universal Life | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,849,854 | 2,588,458 | 773,591 | ||||
| 1.00% - 1.99% | Variable / Universal Life | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,513,273 | 528,155 | 1,928,342 | ||||
| 2.00% - 2.99% | Fixed Annuities | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 1,335,411 | $ 1,349,636 | $ 208,420 | ||||
| 2.00% - 2.99% | Fixed Annuities | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 2.99% | 2.99% | 2.99% | ||||
| 2.00% - 2.99% | Fixed Annuities | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 2.00% | 2.00% | 2.00% | ||||
| 2.00% - 2.99% | Fixed Annuities | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 302,520 | $ 301,132 | $ 208,420 | ||||
| 2.00% - 2.99% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 459,748 | 469,276 | 0 | ||||
| 2.00% - 2.99% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 557,349 | 562,347 | 0 | ||||
| 2.00% - 2.99% | Fixed Annuities | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 15,794 | 16,881 | 0 | ||||
| 2.00% - 2.99% | Variable Annuties | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 25,030 | $ 31,529 | $ 27,751 | ||||
| 2.00% - 2.99% | Variable Annuties | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 2.99% | 2.99% | 2.99% | ||||
| 2.00% - 2.99% | Variable Annuties | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 2.00% | 2.00% | 2.00% | ||||
| 2.00% - 2.99% | Variable Annuties | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 17,039 | $ 23,323 | $ 26,778 | ||||
| 2.00% - 2.99% | Variable Annuties | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 3,829 | 4,071 | 973 | ||||
| 2.00% - 2.99% | Variable Annuties | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 4,162 | 4,135 | 0 | ||||
| 2.00% - 2.99% | Variable Annuties | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| 2.00% - 2.99% | Variable / Universal Life | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 4,652,202 | $ 4,523,671 | $ 4,391,725 | ||||
| 2.00% - 2.99% | Variable / Universal Life | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 2.99% | 2.99% | 2.99% | ||||
| 2.00% - 2.99% | Variable / Universal Life | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 2.00% | 2.00% | 2.00% | ||||
| 2.00% - 2.99% | Variable / Universal Life | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 30,500 | $ 28,061 | $ 32,651 | ||||
| 2.00% - 2.99% | Variable / Universal Life | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,535,762 | 1,445,439 | 121,200 | ||||
| 2.00% - 2.99% | Variable / Universal Life | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 2,695,823 | 2,789,520 | 2,413,571 | ||||
| 2.00% - 2.99% | Variable / Universal Life | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 390,117 | 260,651 | 1,824,303 | ||||
| 3.00% - 4.00% | Fixed Annuities | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 1,914,875 | $ 29,131 | $ 38,195 | ||||
| 3.00% - 4.00% | Fixed Annuities | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | 4.00% | ||||
| 3.00% - 4.00% | Fixed Annuities | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 3.00% | 3.00% | 3.00% | ||||
| 3.00% - 4.00% | Fixed Annuities | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 1,894,646 | $ 29,131 | $ 38,195 | ||||
| 3.00% - 4.00% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 6,114 | 0 | 0 | ||||
| 3.00% - 4.00% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 10,896 | 0 | 0 | ||||
| 3.00% - 4.00% | Fixed Annuities | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 3,219 | 0 | 0 | ||||
| 3.00% - 4.00% | Variable Annuties | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 821,176 | $ 913,231 | $ 1,073,205 | ||||
| 3.00% - 4.00% | Variable Annuties | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | 4.00% | ||||
| 3.00% - 4.00% | Variable Annuties | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 3.00% | 3.00% | 3.00% | ||||
| 3.00% - 4.00% | Variable Annuties | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 819,316 | $ 903,953 | $ 1,070,958 | ||||
| 3.00% - 4.00% | Variable Annuties | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,860 | 9,245 | 2,247 | ||||
| 3.00% - 4.00% | Variable Annuties | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 33 | 0 | ||||
| 3.00% - 4.00% | Variable Annuties | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| 3.00% - 4.00% | Variable / Universal Life | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 6,948,038 | $ 7,281,490 | $ 6,964,283 | ||||
| 3.00% - 4.00% | Variable / Universal Life | Maximum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | 4.00% | ||||
| 3.00% - 4.00% | Variable / Universal Life | Minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Range of Guaranteed Minimum Crediting Rates | 3.00% | 3.00% | 3.00% | ||||
| 3.00% - 4.00% | Variable / Universal Life | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 4,149,638 | $ 3,956,631 | $ 4,737,864 | ||||
| 3.00% - 4.00% | Variable / Universal Life | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,716,374 | 2,217,133 | 3,510 | ||||
| 3.00% - 4.00% | Variable / Universal Life | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,082,026 | 1,107,726 | 2,093,511 | ||||
| 3.00% - 4.00% | Variable / Universal Life | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 129,398 | ||||
| Greater than 4.00% | Fixed Annuities | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 0 | $ 0 | $ 0 | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | 4.00% | ||||
| Greater than 4.00% | Fixed Annuities | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 0 | $ 0 | $ 0 | ||||
| Greater than 4.00% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Fixed Annuities | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Variable Annuties | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 1,978 | $ 2,046 | $ 2,172 | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | 4.00% | ||||
| Greater than 4.00% | Variable Annuties | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 1,978 | $ 2,046 | $ 2,172 | ||||
| Greater than 4.00% | Variable Annuties | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Variable Annuties | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Variable Annuties | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Variable / Universal Life | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 2,095,235 | $ 2,136,137 | $ 2,145,123 | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | 4.00% | ||||
| Greater than 4.00% | Variable / Universal Life | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 2,095,235 | $ 2,136,137 | $ 2,145,123 | ||||
| Greater than 4.00% | Variable / Universal Life | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Variable / Universal Life | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Greater than 4.00% | Variable / Universal Life | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 0 | 0 | 0 | ||||
| Total | Fixed Annuities | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 5,022,257 | 2,372,364 | 1,173,654 | ||||
| Total | Fixed Annuities | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 2,627,892 | 817,559 | 767,804 | ||||
| Total | Fixed Annuities | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 531,484 | 543,006 | 73,554 | ||||
| Total | Fixed Annuities | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 753,061 | 797,828 | 248,881 | ||||
| Total | Fixed Annuities | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,109,820 | 213,971 | 83,415 | ||||
| Total | Variable Annuties | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 2,546,047 | 2,897,946 | 3,238,530 | ||||
| Total | Variable Annuties | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 1,088,417 | 2,051,796 | 2,351,894 | ||||
| Total | Variable Annuties | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 803,312 | 822,837 | 866,596 | ||||
| Total | Variable Annuties | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 654,136 | 23,311 | 20,038 | ||||
| Total | Variable Annuties | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 182 | 2 | 2 | ||||
| Total | Variable / Universal Life | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 17,528,659 | 17,455,724 | 16,633,365 | ||||
| Total | Variable / Universal Life | At guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 6,568,217 | 6,321,950 | 7,345,939 | ||||
| Total | Variable / Universal Life | 1 - 50 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 3,252,136 | 3,662,572 | 124,710 | ||||
| Total | Variable / Universal Life | 51 - 150 bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | 5,627,703 | 6,485,704 | 5,280,673 | ||||
| Total | Variable / Universal Life | Greater than 150bps above guaranteed minimum | |||||||
| Policyholder Account Balance [Line Items] | |||||||
| Policyholders’ account balances | $ 2,080,603 | $ 985,498 | $ 3,882,043 | ||||
| |||||||
Policyholders' Liabilities (Additional Insurance Reserves) (Details) - Variable / Universal Life - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | |||
| Balance, beginning of period | $ 3,741,426 | $ 3,067,336 | $ 2,398,788 |
| Unearned revenue | 859,231 | 827,960 | 799,185 |
| Amortization expense | (185,468) | (153,779) | (129,525) |
| Other adjustments | (2) | (91) | (1,112) |
| Balance, end of period | $ 4,415,187 | $ 3,741,426 | $ 3,067,336 |
Market Risk Benefits - Rollforward of Balances for Variable Annuity Products (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Variable Annuties | |||
| Market Risk Benefit [Roll Forward] | |||
| Balance, beginning of period | $ 3,707,407 | $ 4,550,625 | $ 8,884,362 |
| Effect of cumulative changes in non-performance risk | 1,067,983 | 1,727,910 | 287,605 |
| Balance, beginning of period, before effect of changes in non-performance risk | 4,775,390 | 6,278,535 | 9,171,967 |
| Attributed fees collected | 1,095,139 | 1,158,879 | 1,249,956 |
| Claims Paid | (57,083) | (85,898) | (64,406) |
| Interest accrual | 226,734 | 293,205 | 143,483 |
| Actual in force different from expected | 49,864 | 79,030 | 105,996 |
| Effect of changes in interest rates | (1,436,230) | (1,438,873) | (7,271,427) |
| Effect of changes in equity markets | (1,660,907) | (1,845,207) | 3,103,563 |
| Effect of assumption update | 85,619 | 330,769 | (160,597) |
| Issuances | 70,965 | 29,433 | |
| Other adjustments | (34,183) | (24,483) | |
| Effect of changes in current period counterparty non-performance risk | 0 | 0 | 0 |
| Balance, end of period, before effect of changes in non-performance risk | 3,115,308 | 4,775,390 | 6,278,535 |
| Effect of cumulative changes in non-performance risk | (626,845) | (1,067,983) | (1,727,910) |
| Balance, end of period | 2,488,463 | 3,707,407 | 4,550,625 |
| Less: Reinsured Market Risk Benefits | |||
| Market Risk Benefit [Roll Forward] | |||
| Balance, beginning of period | (917,792) | (422,261) | (906,484) |
| Effect of cumulative changes in non-performance risk | 0 | 0 | 0 |
| Balance, beginning of period, before effect of changes in non-performance risk | (917,792) | (422,261) | (906,484) |
| Interest accrual | (56,043) | (53,016) | (13,438) |
| Actual in force different from expected | (21,062) | (13,338) | (9,968) |
| Effect of changes in interest rates | 277,354 | 455,062 | 767,394 |
| Effect of changes in equity markets | 177,329 | 180,953 | (326,575) |
| Effect of assumption update | 3,984 | (54,067) | 23,171 |
| Issuances | 7,680 | ||
| Other adjustments | 11,566 | (635,011) | |
| Effect of changes in current period counterparty non-performance risk | (61,469) | (146,999) | 187,910 |
| Balance, end of period, before effect of changes in non-performance risk | (844,582) | (917,792) | (422,261) |
| Effect of cumulative changes in non-performance risk | 0 | 0 | 0 |
| Balance, end of period | (844,582) | (917,792) | (422,261) |
| Less: Reinsured Market Risk Benefits | Augustar | |||
| Market Risk Benefit [Roll Forward] | |||
| Other adjustments | 638,000 | ||
| Less: Reinsured Market Risk Benefits | |||
| Market Risk Benefit [Roll Forward] | |||
| Attributed fees collected | (259,099) | (246,747) | (147,727) |
| Claims Paid | 5,669 | 9,952 | 3,456 |
| Issuances | (5,019) | ||
| Total, Net of Reinsurance | |||
| Market Risk Benefit [Roll Forward] | |||
| Balance, beginning of period | 2,789,615 | 4,128,364 | 7,977,878 |
| Effect of cumulative changes in non-performance risk | 1,067,983 | 1,727,910 | 287,605 |
| Balance, beginning of period, before effect of changes in non-performance risk | 3,857,598 | 5,856,274 | 8,265,483 |
| Attributed fees collected | 836,040 | 912,132 | 1,102,229 |
| Claims Paid | (51,414) | (75,946) | (60,950) |
| Interest accrual | 170,691 | 240,189 | 130,045 |
| Actual in force different from expected | 28,802 | 65,692 | 96,028 |
| Effect of changes in interest rates | (1,158,876) | (983,811) | (6,504,033) |
| Effect of changes in equity markets | (1,483,578) | (1,664,254) | 2,776,988 |
| Effect of assumption update | 89,603 | 276,702 | (137,426) |
| Issuances | 65,946 | 37,113 | |
| Other adjustments | (22,617) | (659,494) | |
| Effect of changes in current period counterparty non-performance risk | (61,469) | (146,999) | 187,910 |
| Balance, end of period, before effect of changes in non-performance risk | 2,270,726 | 3,857,598 | 5,856,274 |
| Effect of cumulative changes in non-performance risk | (626,845) | (1,067,983) | (1,727,910) |
| Balance, end of period | $ 1,643,881 | $ 2,789,615 | $ 4,128,364 |
Market Risk Benefits - Market Risk Benefits In Asset and Liability Positions (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
||||
| Liability for Future Policy Benefit, Activity [Line Items] | |||||||
| Total market risk benefit assets | $ 2,637,363 | $ 2,367,243 | |||||
| Total market risk benefit liabilities | 4,281,244 | 5,156,858 | [1] | ||||
| Variable Annuties | |||||||
| Liability for Future Policy Benefit, Activity [Line Items] | |||||||
| Net amount at risk | $ 8,722,499 | $ 9,041,651 | $ 12,141,947 | ||||
| Weighted-average attained age of contractholders | 71 years | 70 years | 68 years | ||||
| Direct and assumed | $ 1,492,186 | $ 1,201,945 | $ 850,060 | ||||
| Ceded | 1,145,177 | 1,165,298 | 543,177 | ||||
| Total market risk benefit assets | 2,637,363 | 2,367,243 | 1,393,237 | ||||
| Direct and assumed(1) | 3,980,650 | 4,909,352 | 5,400,685 | ||||
| Ceded | 300,594 | 247,506 | 120,916 | ||||
| Total market risk benefit liabilities | 4,281,244 | 5,156,858 | 5,521,601 | ||||
| Net liability | 3,707,407 | 4,550,625 | $ 8,884,362 | ||||
| Total, Net of Reinsurance | |||||||
| Liability for Future Policy Benefit, Activity [Line Items] | |||||||
| Net liability | $ 1,643,881 | $ 2,789,615 | $ 4,128,364 | $ 7,977,878 | |||
| |||||||
Reinsurance (Balance Sheet Reinsurance Results) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Oct. 01, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| Effects of Reinsurance [Line Items] | ||||||||||
| Reinsurance recoverables and deposit receivables | $ 48,247,817 | $ 40,256,800 | ||||||||
| Policy loans | (1,541,480) | (1,472,677) | ||||||||
| Deferred policy acquisition costs | 7,807,060 | 7,144,736 | [1] | $ 6,956,197 | $ 7,029,308 | |||||
| Deferred sales inducements | (322,351) | (351,424) | ||||||||
| Total market risk benefit assets | 2,637,363 | 2,367,243 | ||||||||
| Other assets | 1,850,800 | 440,276 | [2] | |||||||
| Future policy benefits | 25,113,767 | 23,205,205 | 20,829,033 | |||||||
| Total market risk benefit liabilities | 4,281,244 | 5,156,858 | [1] | |||||||
| Reinsurance Payable And Funds Withheld Payable | 8,611,141 | 2,738,979 | [1],[2] | |||||||
| Other Liabilities | 4,199,803 | 2,424,179 | [2] | |||||||
| Deferred reinsurance loss | 1,530,394 | 255,115 | $ 292,893 | $ 333,003 | ||||||
| Wilton Re | ||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||
| Reinsurance recoverables and deposit receivables | $ 7,478,000 | |||||||||
| Deferred reinsurance loss | $ 979,000 | |||||||||
| Impacts of Reinsurance | ||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||
| Reinsurance recoverables and deposit receivables | 48,247,817 | 40,256,800 | ||||||||
| Policy loans | (1,143,726) | (1,082,584) | ||||||||
| Deferred policy acquisition costs | (3,319,067) | (3,189,110) | ||||||||
| Deferred sales inducements | (32,573) | (35,313) | ||||||||
| Total market risk benefit assets | 1,145,580 | 1,165,378 | ||||||||
| Other assets | 1,538,231 | 258,748 | ||||||||
| Policyholders’ account balances | 5,567,661 | 5,977,108 | ||||||||
| Future policy benefits | 7,443,997 | 7,026,209 | ||||||||
| Total market risk benefit liabilities | 302,310 | 251,318 | ||||||||
| Reinsurance Payable And Funds Withheld Payable | 8,611,141 | 2,738,979 | ||||||||
| Other Liabilities | 3,282,713 | 1,651,733 | ||||||||
| Unaffiliated activity | ||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||
| Total market risk benefit assets | 804,015 | 745,662 | ||||||||
| Other assets | 1,118,974 | 176,436 | ||||||||
| Policyholders’ account balances | 1,665,998 | 1,830,579 | ||||||||
| Future policy benefits | 160 | 453 | ||||||||
| Total market risk benefit liabilities | 151,432 | 133,374 | ||||||||
| Reinsurance Payable And Funds Withheld Payable | 3,360,901 | 1,620,504 | ||||||||
| Other Liabilities | 257,929 | 287,551 | ||||||||
| Unaffiliated activity | ||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||
| Policy loans | (48,644) | 0 | ||||||||
| Deferred policy acquisition costs | (637,555) | $ 71,315 | ||||||||
| Unaffiliated activity | Wilton Re | ||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||
| Deferred policy acquisition costs | 699,000 | |||||||||
| Deferred reinsurance loss | $ 979,000 | |||||||||
| ||||||||||
Reinsurance (Reinsurance Recoverable and Deposit Receivables by Counterparty) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | $ 48,247,817 | $ 40,256,800 |
| PAR U | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 11,426,975 | 15,722,061 |
| PURC | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 0 | 7,565,968 |
| PARCC | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 7,049,164 | 2,304,270 |
| GUL Re | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 0 | 3,211,899 |
| PAR Term | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 0 | 2,101,004 |
| Prudential Insurance | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 7,507,414 | 1,331,202 |
| Term Re | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 0 | 2,080,564 |
| Lotus Re | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 2,130,095 | 2,051,831 |
| DART | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 0 | 744,043 |
| PURE | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | 7,951,965 | 0 |
| Unaffiliated activity | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverables and deposit receivables | $ 12,182,204 | $ 3,143,958 |
Reinsurance (Income Statement Reinsurance Results) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||||
| Premiums: | |||||||||
| Direct | $ 1,846,109 | $ 1,853,184 | $ 1,868,709 | ||||||
| Assumed | 92 | (61) | 776 | ||||||
| Ceded | (1,453,074) | (1,524,226) | (1,604,277) | ||||||
| Net premiums | 393,127 | 328,897 | 265,208 | ||||||
| Policy charges and fee income: | |||||||||
| Direct | 3,190,753 | 2,995,595 | 3,034,193 | ||||||
| Assumed | 899,767 | 604,311 | 594,622 | ||||||
| Ceded | 3,292,277 | (2,063,300) | (2,398,214) | ||||||
| Net policy charges and fee income | 7,382,797 | 1,536,606 | 1,230,601 | ||||||
| Net investment income: | |||||||||
| Direct | 2,474,541 | 1,700,684 | 920,674 | ||||||
| Assumed | 1,325 | 1,364 | 1,513 | ||||||
| Ceded | (53,849) | (26,526) | (38,186) | ||||||
| Net investment income | 2,422,017 | 1,675,522 | 884,001 | ||||||
| Asset administration fees: | |||||||||
| Direct | 329,181 | 323,444 | 351,600 | ||||||
| Assumed | 0 | 0 | 0 | ||||||
| Ceded | (105,618) | (90,494) | (67,418) | ||||||
| Net asset administration fees | 223,563 | 232,950 | 284,182 | ||||||
| Other income (loss): | |||||||||
| Direct | 297,868 | 636,930 | (731,796) | ||||||
| Assumed | 2,983 | (475) | 271 | ||||||
| Ceded | 458,905 | 114,908 | 95,252 | ||||||
| Net other income | 759,756 | 751,363 | [1] | (636,273) | [1] | ||||
| Realized investment gains (losses), net: | |||||||||
| Direct | 500,023 | (1,203,453) | 497,016 | ||||||
| Assumed | 85,248 | 162,291 | (291,679) | ||||||
| Ceded | (133,854) | (105,937) | 84,592 | ||||||
| Realized investment gains (losses), net | 451,417 | (1,147,099) | [1] | 289,929 | [1] | ||||
| Change in value of market risk benefits, net of related hedging gains (losses): | |||||||||
| Direct | (98,562) | 287,936 | (181,260) | ||||||
| Assumed | 2,626 | (4,115) | 0 | ||||||
| Ceded | (338,019) | (390,594) | (519,321) | ||||||
| Net change in value of market risk benefits, net of related hedging gains (losses) | (433,955) | (106,773) | [2] | (700,581) | |||||
| Policyholders’ benefits (including change in reserves): | |||||||||
| Direct | 3,825,305 | 3,354,306 | 3,362,353 | ||||||
| Assumed | 1,058,315 | 1,258,651 | 1,107,436 | ||||||
| Ceded | 3,468,713 | (4,109,168) | (4,011,416) | ||||||
| Net policyholders’ benefits (including change in reserves) | 8,352,333 | 503,789 | 458,373 | ||||||
| Change in estimates of liability for future policy benefits: | |||||||||
| Direct | 303,141 | (18,361) | 1,716,983 | ||||||
| Assumed | 92,766 | 8,644 | 679,863 | ||||||
| Ceded | (416,550) | 13,669 | (2,341,747) | ||||||
| Change in estimates of liability for future policy benefits | (20,643) | 3,952 | 55,099 | ||||||
| Interest credited to policyholders’ account balances: | |||||||||
| Direct | 1,310,867 | 884,527 | 805,411 | ||||||
| Assumed | 153,052 | 136,725 | 74,402 | ||||||
| Ceded | (426,188) | (399,607) | (434,598) | ||||||
| Net interest credited to policyholders’ account balances | 1,037,731 | 621,645 | [1] | 445,215 | |||||
| Reinsurance expense allowances and general and administrative expenses, net of capitalization and amortization | (1,398,843) | (403,517) | (152,779) | ||||||
| Unaffiliated activity | |||||||||
| Premiums: | |||||||||
| Assumed | 89 | (69) | 149 | ||||||
| Ceded | (107,449) | (70,169) | (42,721) | ||||||
| Policy charges and fee income: | |||||||||
| Assumed | 1,381 | 1,563 | 2,113 | ||||||
| Ceded | (191,368) | (143,764) | (81,781) | ||||||
| Net investment income: | |||||||||
| Ceded | (1,659) | 23,023 | 10,802 | ||||||
| Asset administration fees: | |||||||||
| Ceded | (28,354) | (22,415) | 0 | ||||||
| Other income (loss): | |||||||||
| Assumed | 2,983 | (475) | 270 | ||||||
| Ceded | 142,267 | 44,260 | 18,440 | ||||||
| Realized investment gains (losses), net: | |||||||||
| Assumed | 85,248 | 162,291 | 778,620 | ||||||
| Ceded | (91,712) | (101,449) | 83,612 | ||||||
| Change in value of market risk benefits, net of related hedging gains (losses): | |||||||||
| Assumed | 2,626 | (4,115) | 0 | ||||||
| Ceded | 124,816 | 186,996 | 120,663 | ||||||
| Policyholders’ benefits (including change in reserves): | |||||||||
| Assumed | 348 | 804 | 2,566 | ||||||
| Ceded | (366,669) | (157,344) | (94,402) | ||||||
| Change in estimates of liability for future policy benefits: | |||||||||
| Ceded | 96,014 | (1,367) | (6,824) | ||||||
| Interest credited to policyholders’ account balances: | |||||||||
| Assumed | 39,263 | 16,243 | (95,285) | ||||||
| Ceded | $ (24,550) | $ 0 | $ 0 | ||||||
| |||||||||
Reinsurance (Life Insurance In Force) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|
| Reinsurance Disclosures [Abstract] | |||
| Direct gross life insurance face amount in force | $ 1,181,531,932 | $ 1,127,561,798 | $ 1,093,610,227 |
| Assumed gross life insurance face amount in force | 34,530,341 | 35,558,423 | 36,668,045 |
| Reinsurance ceded | (1,080,451,145) | (1,027,473,705) | (1,009,571,304) |
| Net life insurance face amount in force | $ 135,611,128 | $ 135,646,516 | $ 120,706,968 |
Reinsurance (Narrative) (Details) $ in Thousands |
3 Months Ended | 12 Months Ended | 21 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 15, 2024 |
Oct. 01, 2024
USD ($)
|
Apr. 01, 2023
USD ($)
|
Jan. 01, 2022
USD ($)
|
Jul. 01, 2019 |
Jul. 01, 2017 |
Jan. 01, 2015 |
Dec. 31, 2014 |
Jul. 01, 2012 |
Dec. 31, 2010 |
Dec. 31, 2009 |
Jan. 31, 2001 |
Dec. 31, 2021
USD ($)
|
Dec. 31, 2024
USD ($)
counterparty
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2016 |
Dec. 31, 2019 |
Dec. 31, 2019 |
Dec. 31, 2016 |
Dec. 31, 2013 |
Dec. 31, 2017 |
Dec. 31, 2013 |
Dec. 31, 2019 |
Jan. 01, 2024
USD ($)
|
Oct. 01, 2021
USD ($)
|
|
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred reinsurance gain | $ 252,736 | $ 3,318,785 | $ 1,673,291 | $ 1,492,856 | ||||||||||||||||||||||
| Deferred Reinsurance Loss | 333,003 | 1,530,394 | 255,115 | 292,893 | ||||||||||||||||||||||
| Policy charges and fee income | 7,382,797 | 1,536,606 | 1,230,601 | |||||||||||||||||||||||
| Policy loans | 1,541,480 | 1,472,677 | ||||||||||||||||||||||||
| Reinsurance recoverables | 48,247,817 | 40,256,800 | ||||||||||||||||||||||||
| Variable Annuties | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred reinsurance gain | 0 | 241,628 | 261,721 | 0 | ||||||||||||||||||||||
| Deferred Reinsurance Loss | 254,577 | 164,238 | 194,111 | 223,515 | ||||||||||||||||||||||
| Fixed Annuities | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred reinsurance gain | $ 78,138 | 37,548 | 48,074 | 57,898 | ||||||||||||||||||||||
| Impacts of Reinsurance | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Policy loans | 1,143,726 | 1,082,584 | ||||||||||||||||||||||||
| Reinsurance recoverables | 48,247,817 | 40,256,800 | ||||||||||||||||||||||||
| PAR U | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 11,426,975 | 15,722,061 | ||||||||||||||||||||||||
| PURE | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 7,951,965 | 0 | ||||||||||||||||||||||||
| PURC | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 0 | 7,565,968 | ||||||||||||||||||||||||
| PARCC | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred Reinsurance Loss | 351,000 | |||||||||||||||||||||||||
| Reinsurance recoverables | 7,049,164 | 2,304,270 | ||||||||||||||||||||||||
| GUL Re | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 0 | 3,211,899 | ||||||||||||||||||||||||
| PAR Term | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 0 | 2,101,004 | ||||||||||||||||||||||||
| Term Re | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 0 | 2,080,564 | ||||||||||||||||||||||||
| Prudential Insurance | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 7,507,414 | 1,331,202 | ||||||||||||||||||||||||
| Lotus Re | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 2,130,095 | 2,051,831 | ||||||||||||||||||||||||
| DART | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 0 | 744,043 | ||||||||||||||||||||||||
| AuguStar | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred reinsurance gain | $ 277,000 | |||||||||||||||||||||||||
| Reinsured Amount | $ 10,000,000 | |||||||||||||||||||||||||
| Percent of total reinsured block | 0.10 | |||||||||||||||||||||||||
| AuguStar | Separate account liabilities under MODCO | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | |||||||||||||||||||||||||
| AuguStar | General account liabilities under MODCO | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | |||||||||||||||||||||||||
| FLIAC | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | 1,395,000 | 1,429,000 | ||||||||||||||||||||||||
| FLIAC | Variable Annuties | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Funds held under reinsurance agreements | 5,300,000 | |||||||||||||||||||||||||
| FLIAC | Fixed Annuities | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Funds held under reinsurance agreements | $ 2,000,000 | |||||||||||||||||||||||||
| Percent of total reinsured block | 0.80 | |||||||||||||||||||||||||
| Somerset Re | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Recapture loss | $ 990,000 | |||||||||||||||||||||||||
| Deferred reinsurance gain | 1,207,000 | |||||||||||||||||||||||||
| Deposit assets on reinsurance | $ 2,582,000 | 1,526,000 | ||||||||||||||||||||||||
| Funds withheld liabilities | 2,434,000 | $ 1,412,000 | ||||||||||||||||||||||||
| Union Hamilton | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance recoverables | $ 1,900,000 | |||||||||||||||||||||||||
| Union Hamilton | Quote Share Reinsurance | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 50.00% | |||||||||||||||||||||||||
| Wilton Re | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Recapture gain | $ 270,000 | |||||||||||||||||||||||||
| Deferred reinsurance gain | 798,000 | |||||||||||||||||||||||||
| Deferred Reinsurance Loss | 979,000 | |||||||||||||||||||||||||
| Reinsurance recoverables | 7,478,000 | |||||||||||||||||||||||||
| Affiliated Entity | PAR U | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred reinsurance gain | 94,000 | |||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | 25.00% | 70.00% | |||||||||||||||||||||||
| Affiliated Entity | PURE | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 75.00% | |||||||||||||||||||||||||
| Affiliated Entity | PURC | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred reinsurance gain | $ 116,000 | |||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | 70.00% | ||||||||||||||||||||||||
| Affiliated Entity | PARCC | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Deferred Reinsurance Loss | $ 351,000 | |||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | 100.00% | 90.00% | |||||||||||||||||||||||
| Affiliated Entity | GUL Re | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 30.00% | 95.00% | ||||||||||||||||||||||||
| Affiliated Entity | PAR Term | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | 95.00% | ||||||||||||||||||||||||
| Affiliated Entity | Prudential of Taiwan | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Related Party Transaction, Term | 2 years | |||||||||||||||||||||||||
| Affiliated Entity | Term Re | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | |||||||||||||||||||||||||
| Affiliated Entity | Prudential Insurance | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | |||||||||||||||||||||||||
| Affiliated Entity | Prudential Insurance | Impacts of Reinsurance | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Recapture loss | $ (3,000) | |||||||||||||||||||||||||
| Policy charges and fee income | $ (305,000) | |||||||||||||||||||||||||
| Number Of Counterparties | counterparty | 2 | |||||||||||||||||||||||||
| Affiliated Entity | Lotus Re | Impacts of Reinsurance | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance liabilities associated with the risks of the coinsurance agreement | $ 32,000 | |||||||||||||||||||||||||
| Reinsurance agreement ceded risk | 100.00% | 100.00% | ||||||||||||||||||||||||
| Net liabilities associated with the transaction for coinsurance | 1,387,000 | |||||||||||||||||||||||||
| Net liabilities associated with the transaction for modified coinsurance | 14,037,000 | |||||||||||||||||||||||||
| Policy loans | 855,000 | |||||||||||||||||||||||||
| Cash received | $ 820,000 | |||||||||||||||||||||||||
| Recognized gains | $ 1,352,000 | |||||||||||||||||||||||||
| Deposit receivables | $ 52,000 | |||||||||||||||||||||||||
| Affiliated Entity | DART | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | |||||||||||||||||||||||||
| PLNJ | PAR U | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Recapture loss | 29,000 | |||||||||||||||||||||||||
| Deferred reinsurance gain | $ 8,000 | |||||||||||||||||||||||||
| PLNJ | Affiliated Entity | PAR U | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | 100.00% | ||||||||||||||||||||||||
| PLNJ | Affiliated Entity | PURE | ||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | ||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | |||||||||||||||||||||||||
Income Taxes (Components of Income Tax Expense (Benefit)) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||
| Current tax expense (benefit): | |||||||
| U.S. federal | $ 151,544 | $ 698,170 | $ (345,263) | ||||
| State and local | 5,763 | 14,550 | 4,479 | ||||
| Total | 157,307 | 712,720 | (340,784) | ||||
| Deferred tax expense (benefit): | |||||||
| U.S. federal | (22,612) | (686,252) | 44,097 | ||||
| State and local | 454 | 0 | 0 | ||||
| Total | (22,158) | (686,252) | 44,097 | ||||
| Income tax expense (benefit) | 135,149 | 26,468 | [1] | (296,687) | [1] | ||
| Income tax expense (benefit) on equity in earnings of operating joint ventures | 24 | (109) | (193) | ||||
| Income tax expense (benefit) reported in equity related to: | |||||||
| Other comprehensive income (loss) | (151,234) | (5,638) | (106,197) | ||||
| Total income tax expense (benefit) | $ (16,061) | $ 20,721 | $ (403,077) | ||||
| |||||||
Income Taxes (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Income Tax Disclosure [Abstract] | |||
| Statutory federal income tax rate | 21.00% | 21.00% | 21.00% |
| Effective tax rate | 13.90% | 5.50% | 29.90% |
| Percent of income tax expense (benefit) | 5.00% | ||
| Deferred Tax Assets, Valuation Allowance | $ 0 | $ 0 | |
| Income (loss) from domestic operations | 973 | 478 | $ (993) |
| Unrecognized Tax Benefits | 0 | 0 | 0 |
| DRD constituting non-taxable investment income | 41 | 40 | 44 |
| Non-taxable investment income | $ 43 | $ 43 | $ 46 |
Income Taxes (Reconciliation To Effective Rate) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||
| Income Tax Disclosure [Abstract] | |||||||
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 21.00% | 21.00% | 21.00% | ||||
| Effective Income Tax Rate Reconciliation, Amount [Abstract] | |||||||
| Expected federal income tax expense (benefit) | $ 204,342 | $ 100,305 | $ (208,444) | ||||
| Non-taxable investment income | (42,621) | (42,730) | (46,426) | ||||
| Tax credits | (29,001) | (42,578) | (47,544) | ||||
| State and Local Income Tax Expense (Benefit) | 4,911 | 11,495 | 3,538 | ||||
| Other | (2,482) | (24) | 2,189 | ||||
| Total income tax expense (benefit) on income (loss) before equity in earnings of operating joint ventures | $ 135,149 | $ 26,468 | [1] | $ (296,687) | [1] | ||
| Effective tax rate | 13.90% | 5.50% | 29.90% | ||||
| |||||||
Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Deferred tax assets: | ||
| Insurance reserves | $ 1,749,792 | $ 1,663,037 |
| Deferred Tax Assets, Investments | 1,033,856 | 788,425 |
| Net unrealized loss on securities | 410,718 | 296,749 |
| Other | 5,647 | 4,723 |
| Deferred tax assets | 3,200,013 | 2,752,934 |
| Deferred tax liabilities: | ||
| Deferred policy acquisition cost | 1,227,858 | 946,846 |
| Deferred sales inducements | 66,686 | 72,791 |
| Deferred tax liabilities | 1,294,544 | 1,019,637 |
| Net deferred tax asset | $ 1,905,469 | $ 1,733,297 |
Equity (Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | [1] | $ (30,961) | ||||
| Income tax benefit (expense) | 151,234 | $ 5,638 | $ 106,197 | |||
| Ending balance | (601,877) | (30,961) | [1] | |||
| Foreign Currency Translation Adjustment | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | (18,085) | (20,007) | (11,274) | |||
| Change in OCI before reclassifications | (4,595) | 2,419 | (9,337) | |||
| Amounts reclassified from AOCI | 0 | 0 | 0 | |||
| Income tax benefit (expense) | 739 | (497) | 604 | |||
| Ending balance | (21,941) | (18,085) | (20,007) | |||
| Net Unrealized Investment Gains (Losses) | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | (927,778) | (1,474,475) | 306,331 | |||
| Change in OCI before reclassifications | (416,996) | 677,735 | (2,249,609) | |||
| Amounts reclassified from AOCI | 81,903 | 14,217 | (4,428) | |||
| Income tax benefit (expense) | 70,169 | (145,255) | 473,231 | |||
| Ending balance | (1,192,702) | (927,778) | (1,474,475) | |||
| AOCI, Liability for Future Policy Benefit, Parent | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | 71,195 | 119,368 | (125,809) | |||
| Change in OCI before reclassifications | 58,676 | (60,978) | 310,351 | |||
| Amounts reclassified from AOCI | 0 | 0 | 0 | |||
| Income tax benefit (expense) | (12,313) | 12,805 | (65,174) | |||
| Ending balance | 117,558 | 71,195 | 119,368 | |||
| AOCI, Market Risk Benefit, Instrument-Specific Credit Risk | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | 843,707 | 1,365,049 | 227,206 | |||
| Change in OCI before reclassifications | (441,138) | (659,927) | 1,440,307 | |||
| Amounts reclassified from AOCI | 0 | 0 | 0 | |||
| Income tax benefit (expense) | 92,639 | 138,585 | (302,464) | |||
| Ending balance | 495,208 | 843,707 | 1,365,049 | |||
| Total Accumulated Other Comprehensive Income (Loss) | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | (30,961) | (10,065) | 396,454 | |||
| Change in OCI before reclassifications | (804,053) | (40,751) | (508,288) | |||
| Amounts reclassified from AOCI | 81,903 | 14,217 | (4,428) | |||
| Income tax benefit (expense) | 151,234 | 5,638 | 106,197 | |||
| Ending balance | (601,877) | (30,961) | (10,065) | |||
| Cash flow hedges | Net Unrealized Investment Gains (Losses) | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | 12,000 | 139,000 | ||||
| Ending balance | $ 111,000 | $ 12,000 | $ 139,000 | |||
| ||||||
Equity (Reclassification out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Total net unrealized investment gains (losses) | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
| Amounts reclassified from AOCI | $ 81,903 | $ 14,217 | $ (4,428) |
| Accumulated Other Comprehensive Income (Loss) | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
| Amounts reclassified from AOCI | 81,903 | 14,217 | (4,428) |
| Amounts reclassified from AOCI | Total net unrealized investment gains (losses) | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
| Amounts reclassified from AOCI | (81,903) | (14,217) | 4,428 |
| Amounts reclassified from AOCI | Accumulated Other Comprehensive Income (Loss) | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
| Amounts reclassified from AOCI | (81,903) | (14,217) | 4,428 |
| Amounts reclassified from AOCI | Net unrealized investment gains (losses) on available-for-sale securities | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
| Unrealized Gain (Loss) on Investments | (167,394) | (31,193) | (74,005) |
| Amounts reclassified from AOCI | Currency/Interest Rate | Cash flow hedges | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
| Unrealized Gain (Loss) on Investments | $ 85,491 | $ 16,976 | $ 78,433 |
Equity (Net Unrealized Investment Gains (Losses) in AOCI on AFS Fixed Maturity Securities with OTTI, Allowance for Credit Losses and All Other Investments (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | [1] | $ (30,961) | ||||
| Ending balance | (601,877) | $ (30,961) | [1] | |||
| Accumulated Other Comprehensive Income (Loss) Related to Net Unrealized Investment Gains (Losses) | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | (927,778) | (1,474,475) | $ 306,331 | |||
| Ending balance | (1,192,702) | (927,778) | (1,474,475) | |||
| Net Unrealized Investment Gains (losses) | Accumulated Net Unrealized Investment Gains (Losses) Pre-Tax with Allowance | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | 1,987 | 4,371 | 3,685 | |||
| Net unrealized investment gains (losses) on investments arising during period | (773) | (4,482) | (149) | |||
| Reclassification adjustment for (gains) losses included in net income | (175) | (265) | 831 | |||
| Reclassification due to allowance for credit losses recorded during the period | (146) | 2,363 | 4 | |||
| Impact of net unrealized investment (gains) losses | 0 | 0 | 0 | |||
| Ending balance | 893 | 1,987 | 4,371 | |||
| Net Unrealized Investment Gains (losses) | Accumulated Net Unrealized Investment Gains (Losses) Pre Tax All Other | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | (1,404,180) | (2,161,026) | 581,718 | |||
| Net unrealized investment gains (losses) on investments arising during period | (525,222) | 744,727 | (2,737,481) | |||
| Reclassification adjustment for (gains) losses included in net income | 82,078 | 14,482 | (5,259) | |||
| Reclassification due to allowance for credit losses recorded during the period | 146 | (2,363) | (4) | |||
| Impact of net unrealized investment (gains) losses | 0 | 0 | 0 | |||
| Ending balance | (1,847,178) | (1,404,180) | (2,161,026) | |||
| Net Unrealized Investment Gains (losses) | Deferred Policy Acquisition Costs and Other Costs | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | (801,351) | (1,198,422) | 835,430 | |||
| Net unrealized investment gains (losses) on investments arising during period | 0 | 0 | 0 | |||
| Reclassification adjustment for (gains) losses included in net income | 0 | 0 | 0 | |||
| Reclassification due to allowance for credit losses recorded during the period | 0 | 0 | 0 | |||
| Impact of net unrealized investment (gains) losses | 217,642 | 397,071 | (2,033,852) | |||
| Ending balance | (583,709) | (801,351) | (1,198,422) | |||
| Net Unrealized Investment Gains (losses) | Future Policy Benefits and Policyholders' Account Balances and Other Liabilities | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | 1,029,098 | 1,488,679 | (1,033,194) | |||
| Net unrealized investment gains (losses) on investments arising during period | 0 | 0 | 0 | |||
| Reclassification adjustment for (gains) losses included in net income | 0 | 0 | 0 | |||
| Reclassification due to allowance for credit losses recorded during the period | 0 | 0 | 0 | |||
| Impact of net unrealized investment (gains) losses | (108,643) | (459,581) | 2,521,873 | |||
| Ending balance | 920,455 | 1,029,098 | 1,488,679 | |||
| Net Unrealized Investment Gains (losses) | Income Tax Benefit (Expense) | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | 246,668 | 391,923 | (81,308) | |||
| Net unrealized investment gains (losses) on investments arising during period | 110,227 | (155,393) | 574,760 | |||
| Reclassification adjustment for (gains) losses included in net income | (17,164) | (2,984) | 930 | |||
| Reclassification due to allowance for credit losses recorded during the period | 0 | 0 | 0 | |||
| Impact of net unrealized investment (gains) losses | (22,894) | 13,122 | (102,459) | |||
| Ending balance | 316,837 | 246,668 | 391,923 | |||
| Net Unrealized Investment Gains (losses) | Accumulated Other Comprehensive Income (Loss) Related to Net Unrealized Investment Gains (Losses) | ||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||
| Beginning balance | (927,778) | (1,474,475) | 306,331 | |||
| Net unrealized investment gains (losses) on investments arising during period | (415,768) | 584,852 | (2,162,870) | |||
| Reclassification adjustment for (gains) losses included in net income | 64,739 | 11,233 | (3,498) | |||
| Reclassification due to allowance for credit losses recorded during the period | 0 | 0 | 0 | |||
| Impact of net unrealized investment (gains) losses | 86,105 | (49,388) | 385,562 | |||
| Ending balance | $ (1,192,702) | $ (927,778) | $ (1,474,475) | |||
| ||||||
Equity - Narrative (Details) |
Dec. 31, 2024 |
|---|---|
| Certain Subsidiaries | |
| Subsidiary or Equity Method Investee [Line Items] | |
| Subsidiary, ownership percentage | 100.00% |
Statutory Net Income and Surplus and Dividend Restrictions (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Statutory Accounting Practices [Line Items] | |||
| Statutory net income (loss) | $ (5,195) | $ 4,923 | $ 3,317 |
| Statutory capital and surplus | 5,730 | 5,161 | 5,205 |
| Statutory surplus capacity to pay divided without prior approval in 2024 | 0 | ||
| Return of Capital | 550 | ||
| Statutory dividend paid to Prudential Insurance | $ 0 | $ 0 | $ 0 |
| Pruco Life Insurance | |||
| Statutory Accounting Practices [Line Items] | |||
| Statutory Accounting Practices Dividends And Distributions Surplus Restriction | 10.00% | ||
Related Party Transactions (Narrative) (Details) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2023
USD ($)
|
May 31, 2023
USD ($)
|
Feb. 28, 2023
USD ($)
|
Dec. 31, 2024
USD ($)
|
Jun. 30, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Sep. 30, 2023
USD ($)
|
Jun. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Jun. 30, 2022
USD ($)
|
Mar. 31, 2022
USD ($)
|
Dec. 31, 2024
USD ($)
entity
policy
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
|
| Related Party Transaction [Line Items] | ||||||||||||||
| Commissions and fees | $ 7,382,797,000 | $ 1,536,606,000 | $ 1,230,601,000 | |||||||||||
| Company's share of corporate expenses | 473,445,000 | 979,287,000 | 1,655,673,000 | |||||||||||
| Payments to Fund Policy Loans | 255,811,000 | 1,162,959,000 | 144,764,000 | |||||||||||
| Policy loans | $ 1,472,677,000 | $ 1,541,480,000 | $ 1,472,677,000 | 1,541,480,000 | 1,472,677,000 | |||||||||
| Net investment income | 2,422,017,000 | 1,675,522,000 | 884,001,000 | |||||||||||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 6,122,721,000 | 7,759,323,000 | 6,122,721,000 | 7,759,323,000 | 6,122,721,000 | |||||||||
| Accrued investment income | 333,838,000 | 466,394,000 | 333,838,000 | 466,394,000 | 333,838,000 | |||||||||
| Return of Capital | 550,000,000 | |||||||||||||
| Prudential Insurance | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Contributed capital | 7,000,000 | $ 405,000,000 | 416,000,000 | $ 7,000,000 | $ 3,000,000 | $ 8,000,000 | ||||||||
| Return of Capital | $ 550,000,000 | 450,000,000 | $ 650,000,000 | $ 300,000,000 | (550,000,000) | (1,400,000,000) | 0 | |||||||
| Dividend | 0 | 0 | 0 | |||||||||||
| Prudential Insurance and Prudential FInancial | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Life Insurance, Corporate or Bank Owned, amount | 4,156,000,000 | 4,657,000,000 | 4,156,000,000 | 4,657,000,000 | 4,156,000,000 | |||||||||
| Fees related to Life Insurance, Corporate or Bank Owned, amount | 55,000,000 | 50,000,000 | 52,000,000 | |||||||||||
| Prudential Insurance | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Stock option program plan expense | 1,000,000 | 1,000,000 | 1,000,000 | |||||||||||
| Deferred compensation program expense | 6,000,000 | 5,000,000 | 5,000,000 | |||||||||||
| Pension plan expense | 11,000,000 | 13,000,000 | 19,000,000 | |||||||||||
| Welfare plan expense | $ 18,000,000 | 14,000,000 | 15,000,000 | |||||||||||
| Defined contribution plan, employer matching contribution, percent (up to) | 4.00% | |||||||||||||
| Defined contribution plan, cost recognized | $ 8,000,000 | 7,000,000 | 9,000,000 | |||||||||||
| Number of Corporate Owned Life Insurance policies sold | policy | 5 | |||||||||||||
| PRUCO Life Insurance Company | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Company's share of corporate expenses | $ 131,000,000 | 144,000,000 | 105,000,000 | |||||||||||
| Number of Corporate Owned Life Insurance policies sold | policy | 1 | |||||||||||||
| Payments to Fund Policy Loans | $ 900,000,000 | |||||||||||||
| Policy loans | 898,000,000 | 897,000,000 | 898,000,000 | $ 897,000,000 | 898,000,000 | |||||||||
| Interest and Fee Income, Other Loans | $ 42,000,000 | 26,000,000 | ||||||||||||
| Affiliated Entity | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Number of other affiliated entities | entity | 3 | |||||||||||||
| Net investment income | $ 5,500,000 | 6,900,000 | 4,600,000 | |||||||||||
| Accrued interest receivable related to long-term notes | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | |||||||||
| Revenue related to long-term notes receivable | 3,000,000 | 3,000,000 | 3,000,000 | |||||||||||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 0 | 0 | ||||||||||||
| Accrued investment income | 500,000 | 0 | 500,000 | 0 | 500,000 | |||||||||
| Line of credit facility, maximum borrowing capacity | 7,000,000,000 | 7,000,000,000 | ||||||||||||
| Long-Term and Short-Term debt to affiliates | 180,411,000 | 0 | 180,411,000 | 0 | 180,411,000 | |||||||||
| Interest expense related to loans payable, Related Party | 39,000,000 | 17,000,000 | 3,000,000 | |||||||||||
| Affiliated Entity | PAD | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Commissions and fees | 820,000,000 | 587,000,000 | 611,000,000 | |||||||||||
| Affiliated Entity | ASTISI and Prudential Investments | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Fee income from revenue sharing agreement | 271,000,000 | 274,000,000 | 306,000,000 | |||||||||||
| Affiliated Entity | PGIM Investments | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Fee income from revenue sharing agreement | 47,000,000 | 38,000,000 | 36,000,000 | |||||||||||
| Affiliated Entity | PGIM | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Net investment income | $ 69,000,000 | 53,000,000 | 41,000,000 | |||||||||||
| Affiliated Entity | Prudential Advisors | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Selling expenses - Percentage return to Related Party | 98.00% | |||||||||||||
| Distribution Expenses | $ 56,000,000 | |||||||||||||
| Prudential Financial Joint Venture | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Net investment income | 68,000,000 | 5,000,000 | 21,000,000 | |||||||||||
| Other invested assets | $ 754,000,000 | $ 1,100,000,000 | $ 754,000,000 | 1,100,000,000 | 754,000,000 | |||||||||
| PGF | ||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||
| Investment Income, Interest | $ 490,000,000 | $ 499,000,000 | $ 137,000,000 | |||||||||||
Related Party Transactions (Affiliated Notes Receivable) (Details) - Affiliated Entity - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Related Party Transaction [Line Items] | ||
| Total long-term notes receivable - affiliated | $ 520,462 | $ 147,984 |
| U.S. Dollar fixed rate notes | ||
| Related Party Transaction [Line Items] | ||
| Total long-term notes receivable - affiliated | $ 520,462 | $ 147,984 |
| U.S. Dollar fixed rate notes | Minimum | ||
| Related Party Transaction [Line Items] | ||
| Interest Rates | 0.00% | |
| U.S. Dollar fixed rate notes | Maximum | ||
| Related Party Transaction [Line Items] | ||
| Interest Rates | 12.81% |
Related Party Transactions (Affiliate Commercial Mortgage Loan) (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Related Party Transaction [Line Items] | ||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | $ 7,759,323 | $ 6,122,721 |
| Affiliated Entity | ||
| Related Party Transaction [Line Items] | ||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | $ 0 | |
| Affiliated Entity | Commercial mortgage Loans | ||
| Related Party Transaction [Line Items] | ||
| Interest Rates | 9.67% | |
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | $ 0 | $ 71,038 |
Related Party Transactions (Affiliated Asset Transfers) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
[1] | Dec. 31, 2022 |
[1] | |||
| Related Party Transaction [Line Items] | |||||||
| Realized investment gains (losses), net | $ 451,417 | $ (1,147,099) | $ 289,929 | ||||
| Affiliated Entity | Prudential Insurance, January 2023, Purchase, Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 48,329 | ||||||
| Book Value | 50,372 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 1,614 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance, March 2023, Purchase, Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 7,175 | ||||||
| Book Value | 7,500 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 256 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURC, April 2023, Purchase, Fixed maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 102,804 | ||||||
| Book Value | 102,804 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Term Re, June 2023, Purchase, Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 115,573 | ||||||
| Book Value | 115,573 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance, June 2023, Purchase, Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 4,298 | ||||||
| Book Value | 4,443 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 114 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance, June 2023, Purchase, Fixed Maturities 1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 4,394 | ||||||
| Book Value | 4,494 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 80 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance, June 2023, Purchase, Fixed Maturities 2 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 19,453 | ||||||
| Book Value | 19,203 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | (198) | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance, June 2023, Purchase, Fixed Maturities 3 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 14,452 | ||||||
| Book Value | 15,086 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 502 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance, September 2023, Purchase, Fixed Maturities 4 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 15,880 | ||||||
| Book Value | 15,801 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | (62) | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURC - December 2023, Sale, Commercial Mortgage and Other Loans | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 762 | ||||||
| Book Value | 754 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 8 | ||||||
| Affiliated Entity | PAR U - January 2024, Transfer in, Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 1,598,161 | ||||||
| Book Value | 1,598,161 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PAR U, January 2024, Transfer in, Fixed Maturities 1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 778,745 | ||||||
| Book Value | 778,745 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURC - January 2024 - Transfer in - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 2,155,560 | ||||||
| Book Value | 2,155,560 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | GUL Re - January 2024 - Transfer in - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 1,685,582 | ||||||
| Book Value | 1,685,582 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | GUL Re - January 2024 - Transfer in - Equities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 4,976 | ||||||
| Book Value | 4,976 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 1,598,161 | ||||||
| Book Value | 1,598,161 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURE, January 2024, Transfer out, Fixed Maturities 1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 778,745 | ||||||
| Book Value | 778,745 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities 2 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 2,155,560 | ||||||
| Book Value | 2,155,560 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities 3 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 1,685,582 | ||||||
| Book Value | 1,685,582 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Equities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 4,976 | ||||||
| Book Value | 4,976 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Ironbound - January 2024 - Purchase - Other Invested Assets | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 60,414 | ||||||
| Book Value | 60,414 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 1, Ltd. - February 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 18,428 | ||||||
| Book Value | 18,858 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (430) | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - February 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 19,652 | ||||||
| Book Value | 20,057 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (405) | ||||||
| Affiliated Entity | PAR Term - February 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 43,084 | ||||||
| Book Value | 43,084 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 1, Ltd. - March 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 10,148 | ||||||
| Book Value | 10,387 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (239) | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - March 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 14,763 | ||||||
| Book Value | 15,091 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (328) | ||||||
| Affiliated Entity | Prudential Insurance - March 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 198,804 | ||||||
| Book Value | 206,285 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 5,910 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PAR U - March 2024 - Transfer in - Other Invested Assets | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 188,500 | ||||||
| Book Value | 188,500 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURE - March 2024 - Transfer out - Other Invested Assets | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 188,500 | ||||||
| Book Value | 188,500 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 1, Ltd. - April 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 2,261 | ||||||
| Book Value | 2,300 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (39) | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - May 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 14,034 | ||||||
| Book Value | 14,415 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (381) | ||||||
| Affiliated Entity | Windhill CLO 1, Ltd. - June 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 2,045 | ||||||
| Book Value | 2,100 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (55) | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - June 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 23,342 | ||||||
| Book Value | 23,743 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (401) | ||||||
| Affiliated Entity | PAR U - June 2024 - Transfer in - Other Invested Assets | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 326 | ||||||
| Book Value | 326 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PURE - June 2024 - Transfer out - Other Invested Assets | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 326 | ||||||
| Book Value | 326 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PAR U - June 2024 - Purchase - Commercial Mortgage and Othe Loans | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 12,555 | ||||||
| Book Value | 12,555 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - July 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 53,462 | ||||||
| Book Value | 54,628 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (1,166) | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - July 2024 - Sale - Fixed Maturities1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 6,579 | ||||||
| Book Value | 6,695 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (116) | ||||||
| Affiliated Entity | Windhill CLO 1, Ltd. - July 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 2,136 | ||||||
| Book Value | 2,200 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (64) | ||||||
| Affiliated Entity | PAR U - July 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 17,402 | ||||||
| Book Value | 17,402 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance - July 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 22,655 | ||||||
| Book Value | 23,433 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 614 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PAR U - July 2024 - Purchase - Fixed Maturities1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 1,239 | ||||||
| Book Value | 1,239 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PAR U - July 2024 - Purchase - Derivatives | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 2,975 | ||||||
| Book Value | 2,975 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - August 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 21,929 | ||||||
| Book Value | 22,500 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (571) | ||||||
| Affiliated Entity | Windhill CLO 1, Ltd. - August 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 13,650 | ||||||
| Book Value | 14,100 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (450) | ||||||
| Affiliated Entity | PAR U - August 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 46,742 | ||||||
| Book Value | 46,742 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PAR U - August 2024 - Purchase - Fixed Maturities1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 4,793 | ||||||
| Book Value | 4,793 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Prudential Insurance - August 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 35,872 | ||||||
| Book Value | 35,085 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | (621) | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - September 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 57,613 | ||||||
| Book Value | 57,613 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - September 2024 - Sale - Fixed Maturities1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 24,575 | ||||||
| Book Value | 24,911 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (336) | ||||||
| Affiliated Entity | Prudential Insurance - September 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 44,773 | ||||||
| Book Value | 43,632 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | (901) | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Hirakata - October 2024 - Purchase - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 21,229 | ||||||
| Book Value | 21,229 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Hirakata - October 2024 - Purchase - Fixed Maturities1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 3,901 | ||||||
| Book Value | 3,901 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | PAR U - October 2024 - Transfer in - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 6,615,438 | ||||||
| Book Value | 6,615,438 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 3, Ltd. - October 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 232,036 | ||||||
| Book Value | 235,610 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (3,574) | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - October 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 5,824 | ||||||
| Book Value | 5,899 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (75) | ||||||
| Affiliated Entity | Windhill CLO 2, Ltd. - October 2024 - Sale - Fixed Maturities1 | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 14,690 | ||||||
| Book Value | 14,959 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (269) | ||||||
| Affiliated Entity | Windhill CLO 1, Ltd. - October 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 3,038 | ||||||
| Book Value | 3,100 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (62) | ||||||
| Affiliated Entity | PAR U - October 2024 - Transfer in - Equities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 6,120 | ||||||
| Book Value | 6,120 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | 0 | ||||||
| Affiliated Entity | Windhill CLO 3, Ltd. - November 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 17,409 | ||||||
| Book Value | 17,518 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (109) | ||||||
| Affiliated Entity | Windhill CLO 3, Ltd. - December 2024 - Sale - Fixed Maturities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 38,020 | ||||||
| Book Value | 38,537 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (517) | ||||||
| Affiliated Entity | Windhill CLO 3, Ltd. - December 2024 - Sale - Short-term Investments | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 2,882 | ||||||
| Book Value | 2,905 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | (23) | ||||||
| Affiliated Entity | Prudential Insurance - December 2024 - Contributed Capital - Equities | |||||||
| Related Party Transaction [Line Items] | |||||||
| Fair Value | 415,696 | ||||||
| Book Value | 416,265 | ||||||
| APIC, Net of Tax Increase/ (Decrease) | 0 | ||||||
| Realized investment gains (losses), net | $ 0 | ||||||
| |||||||
Related Party Transactions (Debt Agreements) (Details) - Affiliated Entity - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Related Party Transaction [Line Items] | ||
| Short-term and Long-term debt | $ 0 | $ 180,411 |
| Short-term debt to affiliates | 180,000 | |
| Prudential Insurance Loan Issued 8/13/2021 | ||
| Related Party Transaction [Line Items] | ||
| Short-term and Long-term debt | $ 0 | 94,953 |
| Interest Rates | 3.95% | |
| Prudential Insurance Loan Issued 8/13/2021 | ||
| Related Party Transaction [Line Items] | ||
| Short-term and Long-term debt | $ 0 | 37,981 |
| Interest Rates | 3.95% | |
| Prudential Insurance Loan Issued 8/13/2021 | ||
| Related Party Transaction [Line Items] | ||
| Short-term and Long-term debt | $ 0 | $ 47,477 |
| Interest Rates | 3.95% |
Commitments and Contingent Liabilities (Details) - Fair Value Guarantee [Member] - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Commitments and Contingent Liabilities [Line Items] | ||
| Guaranteed value of third-party assets | $ 3,958,847 | $ 311,302 |
| Fair value of collateral supporting these assets | 3,543,500 | 287,621 |
| Asset (liability) associated with guarantee, carried at fair value | $ 111 | $ 1 |
Commitments and Contingent Liabilities (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Jul. 31, 2017 |
|
| Commitments and Contingent Liabilities [Line Items] | |||
| Litigation and regulatory matters loss contingency, range of possible loss, maximum (less than) | $ 100.0 | ||
| Indonesia | Joint Venture With CT Corp | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Joint Venture with CT Corp, Ownership Percentage | 49.00% | ||
| Commitments | Commercial mortgage loans | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Total outstanding commercial mortgage loan commitments | 230.0 | $ 270.0 | |
| Allowance for credit losses | 0.3 | 0.3 | |
| Change in allowance for credit loss expense (reversal) | 0.0 | 0.3 | |
| Commitments | Investments | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Commitments to purchase investment (excluding commercial mortgage loans) | 1,359.0 | 1,182.0 | |
| Purchase Commitment | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Change in allowance for credit loss expense (reversal) | 0.0 | 0.0 | |
| Other Guarantees | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Accrued Liabilities | $ 32.0 | $ 32.0 | |
Revision to Prior Year Information (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
||||||||||||||||
| Assets: | |||||||||||||||||||
| Deferred policy acquisition costs | $ 7,807,060 | $ 7,144,736 | [1] | $ 6,956,197 | $ 7,029,308 | ||||||||||||||
| Reinsurance recoverables and deposit receivables | 48,247,817 | 40,256,800 | |||||||||||||||||
| Income taxes assets | 2,120,654 | 1,742,585 | [1] | ||||||||||||||||
| Total assets | 238,454,729 | 213,269,687 | |||||||||||||||||
| Liabilities: | |||||||||||||||||||
| Policyholder Account Balance | 69,628,318 | 52,986,700 | [1] | 41,912,536 | |||||||||||||||
| Total market risk benefit liabilities | 4,281,244 | 5,156,858 | [1] | ||||||||||||||||
| Reinsurance Payable And Funds Withheld Payable | 8,611,141 | 2,738,979 | [1],[2] | ||||||||||||||||
| Total liabilities | 233,752,749 | 208,766,823 | |||||||||||||||||
| EQUITY | |||||||||||||||||||
| Retained Earnings (accumulated deficit) | 272,519 | (551,471) | [1] | ||||||||||||||||
| Accumulated other comprehensive income (loss) | (601,877) | (30,961) | [1] | ||||||||||||||||
| Total equity | 4,701,980 | 4,502,864 | |||||||||||||||||
| Total liabilities and partners’ capital | 238,454,729 | 213,269,687 | |||||||||||||||||
| REVENUES | |||||||||||||||||||
| Other Income (loss) | 759,756 | 751,363 | [3] | (636,273) | [3] | ||||||||||||||
| Realized investment gains (losses), net | 451,417 | (1,147,099) | [3] | 289,929 | [3] | ||||||||||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | (433,955) | (106,773) | [4] | (700,581) | |||||||||||||||
| TOTAL REVENUES | 11,198,722 | 3,271,466 | 1,617,067 | ||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Interest credited to policyholders’ account balances | 1,037,731 | 621,645 | [3] | 445,215 | |||||||||||||||
| Amortization of deferred policy acquisition costs | (372,201) | 539,510 | [3] | 521,269 | [3] | ||||||||||||||
| General, administrative and other expense | 1,228,443 | 1,124,923 | [3] | 1,129,700 | [3] | ||||||||||||||
| TOTAL BENEFITS AND EXPENSES | 10,225,663 | 2,793,819 | 2,609,656 | ||||||||||||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | 477,647 | (992,589) | |||||||||||||||||
| Income tax expense (benefit) | 135,149 | 26,468 | [3] | (296,687) | [3] | ||||||||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | 823,990 | 450,258 | (771,039) | ||||||||||||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (441,138) | (659,927) | [3] | 1,440,305 | |||||||||||||||
| Total | (722,150) | (26,534) | (512,716) | ||||||||||||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (151,234) | (5,638) | [3] | (106,197) | |||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (20,896) | (406,519) | ||||||||||||||||
| Comprehensive income (loss) | 266,569 | 429,850 | (1,177,558) | ||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | 4,502,864 | ||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | 837,485 | 450,746 | [4] | (771,039) | [4] | ||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (20,896) | (406,519) | ||||||||||||||||
| Total comprehensive income (loss) | 266,569 | 429,850 | (1,177,558) | ||||||||||||||||
| Ending Balance | 4,701,980 | 4,502,864 | |||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | 837,485 | 450,746 | [4] | (771,039) | [4] | ||||||||||||||
| Realized investment gains (losses), net | (451,417) | 1,147,099 | [3] | (289,929) | [3] | ||||||||||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | 433,955 | 106,773 | [4] | 700,581 | |||||||||||||||
| Change in: | |||||||||||||||||||
| Reinsurance related-balances | [5] | (1,124,001) | (678,725) | [4] | (1,786,851) | [4] | |||||||||||||
| Deferred policy acquisition costs | (950,022) | (581,925) | [4] | (468,074) | [4] | ||||||||||||||
| Income taxes | (228,166) | (40,796) | [4] | (335,921) | [4] | ||||||||||||||
| Cash flows from (used in) operating activities | 3,480,451 | 2,459,895 | 1,824,964 | ||||||||||||||||
| Scenario, Adjustment | |||||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Interest credited to policyholders’ account balances | 621,645 | ||||||||||||||||||
| Retained Earnings | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | 272,519 | (551,471) | [6] | (1,001,729) | [6] | (230,690) | [6] | ||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Comprehensive income (loss) | 823,990 | 450,258 | (771,039) | [6] | |||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | [6] | (551,471) | (1,001,729) | (230,690) | |||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | 823,990 | 450,258 | [6] | (771,039) | [6] | ||||||||||||||
| Total comprehensive income (loss) | 823,990 | 450,258 | (771,039) | [6] | |||||||||||||||
| Ending Balance | 272,519 | (551,471) | [6] | (1,001,729) | [6] | ||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | 823,990 | 450,258 | [6] | (771,039) | [6] | ||||||||||||||
| AOCI | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Accumulated other comprehensive income (loss) | (601,877) | (30,961) | (10,065) | 396,454 | |||||||||||||||
| Total equity | (601,877) | (30,961) | [6] | (10,065) | [6] | 396,454 | [6] | ||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (20,896) | [6] | (406,519) | |||||||||||||||
| Comprehensive income (loss) | (570,916) | (20,896) | (406,519) | [6] | |||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | [6] | (30,961) | (10,065) | 396,454 | |||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (20,896) | [6] | (406,519) | |||||||||||||||
| Total comprehensive income (loss) | (570,916) | (20,896) | (406,519) | [6] | |||||||||||||||
| Ending Balance | (601,877) | (30,961) | [6] | (10,065) | [6] | ||||||||||||||
| Total Equity | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | 4,701,980 | 4,502,864 | [6] | 5,028,620 | [6] | 6,210,755 | [6] | ||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (20,896) | [6] | (406,519) | |||||||||||||||
| Comprehensive income (loss) | 266,569 | 429,850 | (1,177,558) | [6] | |||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | [6] | 4,502,864 | 5,028,620 | 6,210,755 | |||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | 837,485 | 450,746 | [6] | (771,039) | [6] | ||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (20,896) | [6] | (406,519) | |||||||||||||||
| Total comprehensive income (loss) | 266,569 | 429,850 | (1,177,558) | [6] | |||||||||||||||
| Ending Balance | 4,701,980 | 4,502,864 | [6] | 5,028,620 | [6] | ||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | 837,485 | 450,746 | [6] | (771,039) | [6] | ||||||||||||||
| As Previously Reported | |||||||||||||||||||
| Assets: | |||||||||||||||||||
| Deferred policy acquisition costs | 7,097,511 | ||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 40,348,313 | ||||||||||||||||||
| Income taxes assets | 1,737,651 | ||||||||||||||||||
| Total assets | 213,309,041 | ||||||||||||||||||
| Liabilities: | |||||||||||||||||||
| Policyholder Account Balance | 53,012,800 | ||||||||||||||||||
| Total market risk benefit liabilities | 5,144,401 | ||||||||||||||||||
| Reinsurance Payable And Funds Withheld Payable | 2,746,129 | ||||||||||||||||||
| Total liabilities | 208,787,616 | ||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Retained Earnings (accumulated deficit) | (532,951) | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | (30,920) | ||||||||||||||||||
| Total equity | 4,521,425 | ||||||||||||||||||
| Total liabilities and partners’ capital | 213,309,041 | ||||||||||||||||||
| REVENUES | |||||||||||||||||||
| Other Income (loss) | 744,628 | (651,469) | |||||||||||||||||
| Realized investment gains (losses), net | (1,083,660) | 336,382 | |||||||||||||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | (94,368) | ||||||||||||||||||
| TOTAL REVENUES | 3,340,575 | 1,648,324 | |||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Interest credited to policyholders’ account balances | 655,445 | ||||||||||||||||||
| Amortization of deferred policy acquisition costs | 534,435 | 520,276 | |||||||||||||||||
| General, administrative and other expense | 1,151,452 | 1,156,464 | |||||||||||||||||
| TOTAL BENEFITS AND EXPENSES | 2,849,073 | 2,635,427 | |||||||||||||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | 491,502 | (987,103) | |||||||||||||||||
| Income tax expense (benefit) | 29,378 | (295,535) | |||||||||||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | 461,203 | (766,705) | |||||||||||||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (659,875) | ||||||||||||||||||
| Total | (26,482) | ||||||||||||||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (5,627) | ||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (20,855) | ||||||||||||||||||
| Comprehensive income (loss) | 440,836 | ||||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | 4,521,425 | ||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | 461,691 | (766,705) | |||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (20,855) | ||||||||||||||||||
| Total comprehensive income (loss) | 440,836 | ||||||||||||||||||
| Ending Balance | 4,521,425 | ||||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | 461,691 | (766,705) | |||||||||||||||||
| Interest credited to policyholders’ account balances | 655,445 | ||||||||||||||||||
| Realized investment gains (losses), net | 1,083,660 | (336,382) | |||||||||||||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | 94,368 | ||||||||||||||||||
| Change in: | |||||||||||||||||||
| Reinsurance related-balances | (671,990) | (1,771,655) | |||||||||||||||||
| Deferred policy acquisition costs | (560,471) | (442,303) | |||||||||||||||||
| Income taxes | (37,886) | (334,769) | |||||||||||||||||
| Cash flows from (used in) operating activities | 2,459,895 | 1,824,964 | |||||||||||||||||
| As Previously Reported | Retained Earnings | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | (532,951) | (994,154) | (227,449) | ||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Comprehensive income (loss) | 461,203 | (766,705) | |||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | (532,951) | (994,154) | (227,449) | ||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | 461,203 | (766,705) | |||||||||||||||||
| Total comprehensive income (loss) | 461,203 | (766,705) | |||||||||||||||||
| Ending Balance | (532,951) | (994,154) | |||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | 461,203 | (766,705) | |||||||||||||||||
| As Previously Reported | AOCI | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | (30,920) | (10,065) | 396,454 | ||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (20,855) | ||||||||||||||||||
| Comprehensive income (loss) | (20,855) | (406,519) | |||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | (30,920) | (10,065) | 396,454 | ||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (20,855) | ||||||||||||||||||
| Total comprehensive income (loss) | (20,855) | (406,519) | |||||||||||||||||
| Ending Balance | (30,920) | (10,065) | |||||||||||||||||
| As Previously Reported | Total Equity | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | 4,521,425 | 5,036,195 | 6,213,996 | ||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (20,855) | ||||||||||||||||||
| Comprehensive income (loss) | 440,836 | (1,173,224) | |||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | 4,521,425 | 5,036,195 | 6,213,996 | ||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | 461,691 | (766,705) | |||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (20,855) | ||||||||||||||||||
| Total comprehensive income (loss) | 440,836 | (1,173,224) | |||||||||||||||||
| Ending Balance | 4,521,425 | 5,036,195 | |||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | 461,691 | (766,705) | |||||||||||||||||
| Revision | |||||||||||||||||||
| Assets: | |||||||||||||||||||
| Deferred policy acquisition costs | 47,225 | ||||||||||||||||||
| Reinsurance recoverables and deposit receivables | (91,513) | ||||||||||||||||||
| Income taxes assets | 4,934 | ||||||||||||||||||
| Total assets | (39,354) | ||||||||||||||||||
| Liabilities: | |||||||||||||||||||
| Policyholder Account Balance | (26,100) | ||||||||||||||||||
| Total market risk benefit liabilities | 12,457 | ||||||||||||||||||
| Reinsurance Payable And Funds Withheld Payable | (7,150) | ||||||||||||||||||
| Total liabilities | (20,793) | ||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Retained Earnings (accumulated deficit) | (18,520) | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | (41) | ||||||||||||||||||
| Total equity | (18,561) | ||||||||||||||||||
| Total liabilities and partners’ capital | (39,354) | ||||||||||||||||||
| REVENUES | |||||||||||||||||||
| Other Income (loss) | 6,735 | 15,196 | |||||||||||||||||
| Realized investment gains (losses), net | (63,439) | (46,453) | |||||||||||||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | (12,405) | ||||||||||||||||||
| TOTAL REVENUES | (69,109) | (31,257) | |||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Interest credited to policyholders’ account balances | (33,800) | ||||||||||||||||||
| Amortization of deferred policy acquisition costs | 5,075 | 993 | |||||||||||||||||
| General, administrative and other expense | (26,529) | (26,764) | |||||||||||||||||
| TOTAL BENEFITS AND EXPENSES | (55,254) | (25,771) | |||||||||||||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | (13,855) | (5,486) | |||||||||||||||||
| Income tax expense (benefit) | (2,910) | (1,152) | |||||||||||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | (10,945) | (4,334) | |||||||||||||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (52) | ||||||||||||||||||
| Total | (52) | ||||||||||||||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (11) | ||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (41) | ||||||||||||||||||
| Comprehensive income (loss) | (10,986) | ||||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | (18,561) | ||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | (10,945) | (4,334) | |||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (41) | ||||||||||||||||||
| Total comprehensive income (loss) | (10,986) | ||||||||||||||||||
| Ending Balance | (18,561) | ||||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | (10,945) | (4,334) | |||||||||||||||||
| Interest credited to policyholders’ account balances | (33,800) | ||||||||||||||||||
| Realized investment gains (losses), net | 63,439 | 46,453 | |||||||||||||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | 12,405 | ||||||||||||||||||
| Change in: | |||||||||||||||||||
| Reinsurance related-balances | (6,735) | (15,196) | |||||||||||||||||
| Deferred policy acquisition costs | (21,454) | (25,771) | |||||||||||||||||
| Income taxes | (2,910) | (1,152) | |||||||||||||||||
| Cash flows from (used in) operating activities | 0 | 0 | |||||||||||||||||
| Revision | Retained Earnings | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | (18,520) | (7,575) | (3,241) | ||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Comprehensive income (loss) | (10,945) | (4,334) | |||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | (18,520) | (7,575) | (3,241) | ||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | (10,945) | (4,334) | |||||||||||||||||
| Total comprehensive income (loss) | (10,945) | (4,334) | |||||||||||||||||
| Ending Balance | (18,520) | (7,575) | |||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | (10,945) | (4,334) | |||||||||||||||||
| Revision | AOCI | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | (41) | 0 | 0 | ||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (41) | ||||||||||||||||||
| Comprehensive income (loss) | (41) | 0 | |||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | (41) | 0 | 0 | ||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (41) | ||||||||||||||||||
| Total comprehensive income (loss) | (41) | 0 | |||||||||||||||||
| Ending Balance | (41) | 0 | |||||||||||||||||
| Revision | Total Equity | |||||||||||||||||||
| EQUITY | |||||||||||||||||||
| Total equity | (18,561) | (7,575) | $ (3,241) | ||||||||||||||||
| BENEFITS AND EXPENSES | |||||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (41) | ||||||||||||||||||
| Comprehensive income (loss) | (10,986) | (4,334) | |||||||||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
| Beginning Balance | $ (18,561) | (7,575) | (3,241) | ||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||
| Net Income (Loss) | (10,945) | (4,334) | |||||||||||||||||
| Other Comprehensive Income (Loss), Net of Tax | (41) | ||||||||||||||||||
| Total comprehensive income (loss) | (10,986) | (4,334) | |||||||||||||||||
| Ending Balance | (18,561) | (7,575) | |||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
| Net Income (Loss) | $ (10,945) | $ (4,334) | |||||||||||||||||
| |||||||||||||||||||
Subsequent Events (Narrative) (Details) - Prudential Insurance - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Feb. 28, 2025 |
Dec. 31, 2023 |
Feb. 28, 2023 |
Dec. 31, 2024 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
|
| Subsequent Event [Line Items] | |||||||
| Contributed capital | $ 7 | $ 405 | $ 416 | $ 7 | $ 3 | $ 8 | |
| Subsequent Event | |||||||
| Subsequent Event [Line Items] | |||||||
| Contributed capital | $ 220 | ||||||
Schedule I - Summary of Investments Other Than investments in Related Parties (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | $ 36,980,933 | $ 27,538,066 |
| Fair Value | 34,986,160 | 26,131,780 |
| Equity securities, at cost | 2,650,542 | 824,270 |
| Equity securities, at fair value (cost: 2024 – $2,650,189; 2023 – $819,617) | 2,623,820 | 844,950 |
| Fixed maturities, trading, amortized cost | 4,415,277 | 3,476,746 |
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,845,045 | 2,796,446 |
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 7,759,323 | 6,122,721 |
| Policy loans | 1,541,480 | 1,472,677 |
| Short-term Investments | 517,386 | |
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 1,582,094 | 1,222,985 |
| Total Investment at Cost | 55,447,035 | |
| Total investment per Balance Sheet | 52,855,308 | 38,971,925 |
| Equity securities | ||
| Schedule of Investments [Line Items] | ||
| Equity securities, at cost | 2,650,542 | |
| Equity securities, at fair value (cost: 2024 – $2,650,189; 2023 – $819,617) | 2,623,820 | |
| Available-for-sale | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 36,980,933 | |
| Fair Value | 34,986,160 | |
| Trading | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, trading, amortized cost | 4,415,277 | |
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,845,045 | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 1,199,628 | 1,009,937 |
| Fair Value | 1,099,241 | 975,287 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fair Value | 1,099,241 | |
| Obligations of U.S. states and their political subdivisions | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 570,253 | 789,856 |
| Fair Value | 541,066 | 776,627 |
| Obligations of U.S. states and their political subdivisions | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fair Value | 541,066 | |
| Foreign government securities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 362,154 | 330,830 |
| Fair Value | 310,334 | 281,986 |
| Foreign government securities | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fair Value | 310,334 | |
| Asset-backed securities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 3,728,073 | 2,016,028 |
| Fair Value | 3,750,663 | 2,027,550 |
| Asset-backed securities | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fair Value | 3,750,663 | |
| Commercial mortgage-backed securities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 944,652 | 913,347 |
| Fair Value | 895,775 | 851,778 |
| Commercial mortgage-backed securities | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fair Value | 895,775 | |
| Residential mortgage-backed securities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 367,005 | 399,542 |
| Fair Value | 356,072 | 396,070 |
| Residential mortgage-backed securities | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fair Value | 356,072 | |
| Public utilities | Available-for-sale | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 2,869,299 | |
| Fair Value | 2,613,495 | |
| All other corporate bonds | Available-for-sale | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 26,934,775 | |
| Fair Value | 25,414,259 | |
| Redeemable preferred stock | Available-for-sale | Fixed maturities | ||
| Schedule of Investments [Line Items] | ||
| Fixed maturities, available-for-sale, amortized cost | 5,094 | |
| Fair Value | 5,255 | |
| Other common stocks | Equity securities | ||
| Schedule of Investments [Line Items] | ||
| Equity securities, at cost | 2,452,942 | |
| Equity securities, at fair value (cost: 2024 – $2,650,189; 2023 – $819,617) | 2,427,792 | |
| Mutual funds | Equity securities | ||
| Schedule of Investments [Line Items] | ||
| Equity securities, at cost | 177,939 | |
| Equity securities, at fair value (cost: 2024 – $2,650,189; 2023 – $819,617) | 175,882 | |
| Perpetual preferred stocks | Equity securities | ||
| Schedule of Investments [Line Items] | ||
| Equity securities, at cost | 19,661 | |
| Equity securities, at fair value (cost: 2024 – $2,650,189; 2023 – $819,617) | 20,146 | |
| Total Net Commercial Mortgage and Other Loans | ||
| Schedule of Investments [Line Items] | ||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | $ 7,759,323 | $ 6,122,721 |
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Financial Position) (Details) - USD ($) $ / shares in Units, $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | $ 34,986,160 | $ 26,131,780 | |||||||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,845,045 | 2,796,446 | |||||||
| Equity securities, at fair value (cost: 2024 – $2,650,189; 2023 – $819,617) | 2,623,820 | 844,950 | |||||||
| Policy loans | 1,541,480 | 1,472,677 | |||||||
| Short-term investments (net of allowance for credit losses: 2024 – $49; 2023 – $0) | 517,386 | 380,366 | |||||||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 7,759,323 | 6,122,721 | |||||||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 1,582,094 | 1,222,985 | |||||||
| Total investments | 52,855,308 | 38,971,925 | |||||||
| Cash and cash equivalents | 3,325,698 | 2,139,792 | |||||||
| Deferred policy acquisition costs | 7,807,060 | 7,144,736 | [1] | $ 6,956,197 | $ 7,029,308 | ||||
| Accrued investment income | 466,394 | 333,838 | |||||||
| Reinsurance recoverables and deposit receivables (includes $211,058 and $224,019 of embedded derivatives at fair value at December 31, 2024 and 2023, respectively) | 48,247,817 | 40,256,800 | [1],[2] | ||||||
| Receivables from parent and affiliates | 678,028 | 332,583 | |||||||
| Deferred sales inducements | 322,351 | 351,424 | |||||||
| Income taxes assets | 2,120,654 | 1,742,585 | [1] | ||||||
| Market risk benefit assets | 2,637,363 | 2,367,243 | |||||||
| Other assets | 1,850,800 | 440,276 | [2] | ||||||
| Separate account assets | 118,143,256 | 119,188,485 | |||||||
| TOTAL ASSETS | 238,454,729 | 213,269,687 | |||||||
| Liabilities: | |||||||||
| Policyholders’ account balances | 69,628,318 | 52,986,700 | [1] | 41,912,536 | |||||
| Future policy benefits | 25,113,767 | 23,205,205 | 20,829,033 | ||||||
| Market risk benefit liabilities | 4,281,244 | 5,156,858 | [1] | ||||||
| Cash collateral for loaned securities | 121,372 | 218,310 | |||||||
| Reinsurance and funds withheld payables (includes $0 and $6,115 of embedded derivatives at fair value at December 31, 2024 and 2023, respectively) | 8,611,141 | 2,738,979 | [1],[2] | ||||||
| Short-term debt to affiliates | 0 | 180,411 | |||||||
| Payables to parent and affiliates | 3,653,848 | 2,667,696 | |||||||
| Other liabilities | 4,199,803 | 2,424,179 | [2] | ||||||
| Separate account liabilities | 118,143,256 | 119,188,485 | 114,051,246 | 149,797,828 | |||||
| Total liabilities | 233,752,749 | 208,766,823 | |||||||
| Equity | |||||||||
| Common stock ($10 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding) | 2,500 | 2,500 | |||||||
| Additional paid-in capital | 4,923,299 | 5,052,602 | |||||||
| Retained Earnings (accumulated deficit) | 272,519 | (551,471) | [1] | ||||||
| Accumulated other comprehensive income (loss) | (601,877) | (30,961) | [1] | ||||||
| Total equity | 4,701,980 | 4,502,864 | |||||||
| TOTAL LIABILITIES AND EQUITY | 238,454,729 | 213,269,687 | |||||||
| Fixed Maturities, Available-for-sale, allowance for credit losses | 40,414 | 2,008 | 4,769 | ||||||
| Fixed maturities, available-for-sale, amortized cost | 36,980,933 | 27,538,066 | |||||||
| Fixed maturities, trading, amortized cost | 4,415,277 | 3,476,746 | |||||||
| Equity securities, at cost | 2,650,542 | 824,270 | |||||||
| Commercial mortgage and other loans, allowance for credit losses | 37,715 | 37,689 | $ 20,263 | $ 5,951 | |||||
| Other invested assets, at fair value | 68,623 | 85,025 | |||||||
| Reinsurance recoverable and deposit receivables, embedded derivatives at fair value | $ 645,193 | $ 192,642 | |||||||
| Common stock, par value (in dollars per share) | $ 10 | $ 10 | |||||||
| Common stock, shares authorized | 1,000,000 | 1,000,000 | |||||||
| Common stock, shares issued | 250,000 | 250,000 | |||||||
| Common stock, shares outstanding | 250,000 | 250,000 | |||||||
| ASU 2016-13 | |||||||||
| Equity | |||||||||
| Short-term investments, allowance for credit losses | $ 49 | $ 0 | |||||||
| PRUCO Life Insurance Company | |||||||||
| Assets: | |||||||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2024 – $40,414; 2023 – $2,004) (amortized cost: 2024 – $33,648,311; 2023 – $24,872,031) | 31,964,802 | 23,662,832 | |||||||
| Fixed maturities, trading, at fair value (amortized cost: 2024 – $4,391,322; 2023 – $3,451,001) | 3,823,792 | 2,773,006 | |||||||
| Equity securities, at fair value (cost: 2024 – $2,650,189; 2023 – $819,617) | 2,623,758 | 840,335 | |||||||
| Policy loans | 422,891 | 357,581 | |||||||
| Short-term investments (net of allowance for credit losses: 2024 – $49; 2023 – $0) | 505,991 | 374,407 | |||||||
| Commercial mortgage and other loans (net of $36,002 and $36,527 allowance for credit losses at December 31, 2024 and 2023, respectively) | 7,281,995 | 5,883,092 | |||||||
| Other invested assets (includes $12,999 and $80,638 of assets measured at fair value at December 31, 2024 and 2023, respectively) | 1,363,038 | 1,073,038 | |||||||
| Total investments | 47,986,267 | 34,964,291 | |||||||
| Cash and cash equivalents | 3,144,542 | 1,953,388 | |||||||
| Deferred policy acquisition costs | 7,389,743 | 6,751,597 | |||||||
| Accrued investment income | 405,115 | 279,567 | |||||||
| Reinsurance recoverables and deposit receivables (includes $211,058 and $224,019 of embedded derivatives at fair value at December 31, 2024 and 2023, respectively) | 44,233,228 | 36,691,407 | |||||||
| Investment in subsidiaries | 1,472,500 | 1,434,641 | |||||||
| Receivables from parent and affiliates | 567,631 | 308,635 | |||||||
| Deferred sales inducements | 322,351 | 351,424 | |||||||
| Income taxes assets | 2,013,349 | 1,675,310 | |||||||
| Market risk benefit assets | 2,144,919 | 1,829,584 | |||||||
| Other assets | 1,833,801 | 432,913 | |||||||
| Separate account assets | 103,635,702 | 105,111,382 | |||||||
| TOTAL ASSETS | 215,149,148 | 191,784,139 | |||||||
| Liabilities: | |||||||||
| Policyholders’ account balances | 65,114,184 | 48,950,516 | |||||||
| Future policy benefits | 23,096,707 | 20,864,146 | |||||||
| Market risk benefit liabilities | 3,788,800 | 4,619,199 | |||||||
| Cash collateral for loaned securities | 121,372 | 218,310 | |||||||
| Reinsurance and funds withheld payables (includes $0 and $6,115 of embedded derivatives at fair value at December 31, 2024 and 2023, respectively) | 7,192,595 | 2,348,162 | |||||||
| Short-term debt to affiliates | 0 | 180,411 | |||||||
| Payables to parent and affiliates | 3,653,229 | 2,658,870 | |||||||
| Other liabilities | 3,950,118 | 2,360,473 | |||||||
| Separate account liabilities | 103,635,702 | 105,111,382 | |||||||
| Total liabilities | 210,552,707 | 187,311,469 | |||||||
| Equity | |||||||||
| Common stock ($10 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding) | 2,500 | 2,500 | |||||||
| Additional paid-in capital | 4,923,299 | 5,052,602 | |||||||
| Retained Earnings (accumulated deficit) | 272,519 | (551,471) | |||||||
| Accumulated other comprehensive income (loss) | (601,877) | (30,961) | |||||||
| Total equity | 4,596,441 | 4,472,670 | |||||||
| TOTAL LIABILITIES AND EQUITY | 215,149,148 | 191,784,139 | |||||||
| Fixed Maturities, Available-for-sale, allowance for credit losses | 40,414 | 2,004 | |||||||
| Fixed maturities, available-for-sale, amortized cost | 33,648,311 | 24,872,031 | |||||||
| Fixed maturities, trading, amortized cost | 4,391,322 | 3,451,001 | |||||||
| Equity securities, at cost | 2,650,189 | 819,617 | |||||||
| Commercial mortgage and other loans, allowance for credit losses | 36,002 | 36,527 | |||||||
| Other invested assets, at fair value | 12,999 | 80,638 | |||||||
| Reinsurance recoverable and deposit receivables, embedded derivatives at fair value | $ 379,582 | $ 122,897 | |||||||
| Common stock, par value (in dollars per share) | $ 10 | $ 10 | |||||||
| Common stock, shares authorized | 1,000,000 | 1,000,000 | |||||||
| Common stock, shares issued | 250,000 | 250,000 | |||||||
| Common stock, shares outstanding | 250,000 | 250,000 | |||||||
| |||||||||
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Operations) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||||
| REVENUES | |||||||||
| Premiums (includes $(2,740), $6,296 and $(1,419) of gains (losses) from change in estimates on deferred profit liability amortization for the year ended December 31, 2024, 2023 and 2022, respectively) | $ 393,127 | $ 328,897 | $ 265,208 | ||||||
| Policy charges and fee income | 7,382,797 | 1,536,606 | 1,230,601 | ||||||
| Net investment income | 2,422,017 | 1,675,522 | 884,001 | ||||||
| Asset administration fees | 223,563 | 232,950 | 284,182 | ||||||
| Other Income (loss) | 759,756 | 751,363 | [1] | (636,273) | [1] | ||||
| Realized Investment Gains (Losses) | 451,417 | (1,147,099) | [1] | 289,929 | [1] | ||||
| Change in value of market risk benefits, net of related hedging gain (losses) | (433,955) | (106,773) | [2] | (700,581) | |||||
| TOTAL REVENUES | 11,198,722 | 3,271,466 | 1,617,067 | ||||||
| BENEFITS AND EXPENSES | |||||||||
| Policyholders’ benefits | 8,352,333 | 503,789 | 458,373 | ||||||
| Change in estimates of liability for future policy benefits | (20,643) | 3,952 | 55,099 | ||||||
| Interest credited to policyholders’ account balances | 1,037,731 | 621,645 | [1] | 445,215 | |||||
| Amortization of deferred policy acquisition costs | (372,201) | 539,510 | [1] | 521,269 | [1] | ||||
| General, administrative and other expense | 1,228,443 | 1,124,923 | [1] | 1,129,700 | [1] | ||||
| TOTAL BENEFITS AND EXPENSES | 10,225,663 | 2,793,819 | 2,609,656 | ||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF SUBSIDIARIES AND OPERATING JOINT VENTURE | 973,059 | 477,647 | (992,589) | ||||||
| Income tax expense (benefit) | 135,149 | 26,468 | [1] | (296,687) | [1] | ||||
| INCOME (LOSS) FROM OPERATIONS BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | 837,910 | 451,179 | (695,902) | ||||||
| Equity in earnings of operating joint venture, net of taxes | (425) | (433) | (75,137) | ||||||
| Net income (loss) | 837,485 | 450,746 | [2] | (771,039) | [2] | ||||
| Net unrealized investment gains (losses) | (335,093) | 691,952 | (2,254,037) | ||||||
| Interest rate remeasurement of future policy benefits | 58,676 | (60,978) | 310,353 | ||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (441,138) | (659,927) | [1] | 1,440,305 | |||||
| Total | (722,150) | (26,534) | (512,716) | ||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (151,234) | (5,638) | [1] | (106,197) | |||||
| Total Comprehensive Income (Loss) | 253,074 | 429,362 | (1,177,558) | ||||||
| Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Amortization Expense, Realized Gain (Loss) | (2,690) | 6,978 | (1,250) | ||||||
| PRUCO Life Insurance Company | |||||||||
| REVENUES | |||||||||
| Premiums (includes $(2,740), $6,296 and $(1,419) of gains (losses) from change in estimates on deferred profit liability amortization for the year ended December 31, 2024, 2023 and 2022, respectively) | 344,383 | 289,344 | 231,500 | ||||||
| Policy charges and fee income | 6,677,744 | 1,476,927 | 1,172,867 | ||||||
| Net investment income | 2,154,525 | 1,507,280 | 785,609 | ||||||
| Asset administration fees | 212,328 | 223,803 | 275,702 | ||||||
| Other Income (loss) | 743,843 | 747,789 | (634,120) | ||||||
| Realized Investment Gains (Losses) | 498,953 | (1,102,789) | 276,094 | ||||||
| Change in value of market risk benefits, net of related hedging gain (losses) | (473,209) | (169,565) | (558,535) | ||||||
| TOTAL REVENUES | 10,158,567 | 2,972,789 | 1,549,117 | ||||||
| BENEFITS AND EXPENSES | |||||||||
| Policyholders’ benefits | 7,338,059 | 448,286 | 430,184 | ||||||
| Change in estimates of liability for future policy benefits | (14,594) | 6,067 | 38,468 | ||||||
| Interest credited to policyholders’ account balances | 956,863 | 557,510 | 397,637 | ||||||
| Amortization of deferred policy acquisition costs | (285,676) | 518,939 | 501,979 | ||||||
| General, administrative and other expense | 1,180,030 | 1,074,134 | 1,072,835 | ||||||
| TOTAL BENEFITS AND EXPENSES | 9,174,682 | 2,604,936 | 2,441,103 | ||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF SUBSIDIARIES AND OPERATING JOINT VENTURE | 983,885 | 367,853 | (891,986) | ||||||
| Income tax expense (benefit) | 147,233 | 14,006 | (265,913) | ||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | 836,652 | 353,847 | (626,073) | ||||||
| Equity In Earnings Of Subsidiaries | (12,237) | 96,844 | (69,829) | ||||||
| Equity in earnings of operating joint venture, net of taxes | (425) | (433) | (75,137) | ||||||
| Net income (loss) | 823,990 | 450,258 | (771,039) | ||||||
| Net unrealized investment gains (losses) | (246,952) | 632,819 | (1,877,552) | ||||||
| Interest rate remeasurement of future policy benefits | 45,461 | (50,679) | 250,486 | ||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (401,884) | (597,135) | 1,298,259 | ||||||
| Other | (118,775) | (11,539) | (183,909) | ||||||
| Total | (722,150) | (26,534) | (512,716) | ||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (151,234) | (5,638) | (106,197) | ||||||
| Other Comprehensive Income (Loss), Net of Tax | (570,916) | (20,896) | (406,519) | ||||||
| Total Comprehensive Income (Loss) | 253,074 | 429,362 | (1,177,558) | ||||||
| Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Amortization Expense, Realized Gain (Loss) | $ (2,740) | $ 6,296 | $ (1,419) | ||||||
| |||||||||
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Cash Flow) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
| Cash flows from (used in) operating activities | $ 3,480,451 | $ 2,459,895 | $ 1,824,964 | |||
| Proceeds from the sale/maturity/prepayment of: | ||||||
| Fixed maturities, available-for-sale | 4,240,000 | 1,736,809 | 1,688,079 | |||
| Fixed maturities, trading | 802,378 | 97,693 | 907,941 | |||
| Equity securities | 961,421 | 189,237 | 242,292 | |||
| Policy loans | 188,153 | 182,973 | 169,723 | |||
| Ceded Policy Loans Proceeds | (113,148) | (119,787) | (112,164) | |||
| Short-term investments | 1,303,977 | 456,983 | 632,069 | |||
| Commercial mortgage and other loans | 731,440 | 167,888 | 196,672 | |||
| Other invested assets | 99,852 | 19,693 | 60,349 | |||
| Notes receivable from parent and affiliates | [1] | 722 | 4,500 | 833 | ||
| Payments for the purchase/origination of: | ||||||
| Fixed maturities, available-for-sale | (13,766,055) | (7,544,596) | (7,009,578) | |||
| Fixed maturities, trading | (1,819,224) | (857,717) | (425,267) | |||
| Equity securities | (2,373,486) | (678,847) | (281,684) | |||
| Policy loans | (255,811) | (1,162,959) | (144,764) | |||
| Ceded policy loans | 125,795 | 151,019 | 71,402 | |||
| Short-term investments | (1,441,031) | (690,173) | (558,161) | |||
| Commercial mortgage and other loans | (2,392,198) | (1,341,450) | (1,076,351) | |||
| Other invested assets | (460,721) | (190,826) | (166,345) | |||
| Notes receivable from parent and affiliates | [1] | (367,700) | (44) | (62) | ||
| Other, net | (3,264) | (4,808) | 57,687 | |||
| Cash flows from (used in) investing activities | (14,367,670) | (9,639,503) | (6,114,134) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
| Policyholders’ account deposits | 17,265,165 | 12,101,043 | 9,996,128 | |||
| Ceded policyholders’ account deposits | (1,169,002) | (1,189,331) | (1,216,195) | |||
| Policyholders’ account withdrawals | (3,980,496) | (3,695,248) | (3,727,579) | |||
| Ceded policyholders’ account withdrawals | 764,421 | 625,238 | 638,392 | |||
| Contributed capital | 0 | 405,000 | 0 | |||
| Return of capital | 550,000 | 1,400,000 | 0 | |||
| Other, net | [1] | 36,725 | 34,110 | (59,327) | ||
| Cash flows from (used in) financing activities | 12,073,125 | 6,921,773 | 5,767,866 | |||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 1,185,906 | (257,835) | 1,478,696 | |||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 3,325,698 | 2,139,792 | 2,397,627 | $ 918,931 | ||
| CASH AND CASH EQUIVALENTS, END OF YEAR | 3,325,698 | 2,139,792 | 2,397,627 | 918,931 | ||
| SUPPLEMENTAL CASH FLOW INFORMATION | ||||||
| Income taxes paid (refunded), net | 363,208 | 67,203 | 39,201 | |||
| Interest paid | 2,644 | 4,533 | 7,863 | |||
| PRUCO Life Insurance Company | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
| Cash flows from (used in) operating activities | 3,363,590 | 2,365,722 | 1,813,780 | |||
| Proceeds from the sale/maturity/prepayment of: | ||||||
| Fixed maturities, available-for-sale | 3,425,809 | 1,622,501 | 1,586,432 | |||
| Fixed maturities, trading | 800,588 | 95,872 | 901,690 | |||
| Equity securities | 957,650 | 189,210 | 242,247 | |||
| Policy loans | 157,478 | 152,275 | 140,937 | |||
| Ceded Policy Loans Proceeds | (87,521) | (117,589) | (110,477) | |||
| Short-term investments | 1,280,677 | 444,983 | 622,072 | |||
| Commercial mortgage and other loans | 724,559 | 157,116 | 178,564 | |||
| Other invested assets | 73,632 | 17,405 | 57,335 | |||
| Notes receivable from parent and affiliates | 722 | 3,858 | 832 | |||
| Payments for the purchase/origination of: | ||||||
| Fixed maturities, available-for-sale | (12,273,347) | (6,762,400) | (6,674,455) | |||
| Fixed maturities, trading | (1,819,224) | (857,717) | (425,267) | |||
| Equity securities | (2,373,213) | (678,790) | (281,502) | |||
| Policy loans | (222,724) | (236,886) | (122,982) | |||
| Ceded policy loans | 117,552 | 147,961 | 69,369 | |||
| Short-term investments | (1,412,350) | (679,224) | (551,161) | |||
| Commercial mortgage and other loans | (2,145,910) | (1,239,173) | (1,024,697) | |||
| Other invested assets | (406,031) | (174,680) | (149,837) | |||
| Notes receivable from parent and affiliates | (297,850) | (31) | (25) | |||
| Capital contributions to subsidiaries | (549,964) | (323,909) | (325,000) | |||
| Return of capital from subsidiaries | 414,859 | 0 | 0 | |||
| Other, net | 164,779 | (60,358) | (316,977) | |||
| Cash flows from (used in) investing activities | (13,469,829) | (8,299,576) | (6,182,902) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
| Policyholders’ account deposits | 16,148,664 | 10,508,549 | 9,500,054 | |||
| Ceded policyholders’ account deposits | (826,393) | (870,031) | (902,233) | |||
| Policyholders’ account withdrawals | (3,600,010) | (3,287,164) | (3,343,369) | |||
| Ceded policyholders’ account withdrawals | 454,788 | 360,211 | 398,101 | |||
| Contributed capital | 0 | 405,000 | 0 | |||
| Return of capital | 550,000 | 1,400,000 | 0 | |||
| Other, net | (329,656) | 28,817 | 75,814 | |||
| Cash flows from (used in) financing activities | 11,297,393 | 5,745,382 | 5,728,367 | |||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 1,191,154 | (188,472) | 1,359,245 | |||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 3,144,542 | 1,953,388 | 2,141,860 | 782,615 | ||
| CASH AND CASH EQUIVALENTS, END OF YEAR | 3,144,542 | 1,953,388 | 2,141,860 | $ 782,615 | ||
| SUPPLEMENTAL CASH FLOW INFORMATION | ||||||
| Income taxes paid (refunded), net | 360,742 | 57,749 | 61,613 | |||
| Interest paid | $ 2,644 | $ 4,377 | $ 7,863 | |||
| ||||||
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Cash Flow) (Narratives) (Details)) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Assets | Prudential Insurance | |||
| Non-cash activity | $ 18 | ||
| Capital contributions | Prudential Insurance | |||
| Non-cash activity | $ 416 | ||
| FLIAC | Reinsurance agreement | |||
| Non-cash activity | $ 475 | 4,656 | |
| Lotus Re | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | $ 531 | ||
| PARCC | Affiliated Entity | |||
| Non-cash activity | (78) | ||
| PARCC | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | (102) | ||
| PURE and Prudential Insurance | Affiliated Entity | |||
| Non-cash activity | 936 | ||
| PURE and Prudential Insurance | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | 1,129 | ||
| Wilton Re | Reinsurance agreement | |||
| Non-cash activity | 6,722 | ||
| Non-cash activity | (7,469) | ||
| PAR U | Affiliated Entity | |||
| Non-cash activity | 7,190 | ||
| Non-cash activity | (6,722) | ||
| PAR U | Reinsurance agreement | Affiliated Entity | |||
| Non-cash activity | 7,218 | ||
| Non-cash activity | $ (6,722) | ||